<SEC-DOCUMENT>0001628280-23-016255.txt : 20230508
<SEC-HEADER>0001628280-23-016255.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230508070504
ACCESSION NUMBER:		0001628280-23-016255
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		56
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Foghorn Therapeutics Inc.
		CENTRAL INDEX KEY:			0001822462
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39634
		FILM NUMBER:		23895817

	BUSINESS ADDRESS:	
		STREET 1:		500 TECHNOLOGY SQUARE
		STREET 2:		SUITE 700
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-586-3100

	MAIL ADDRESS:	
		STREET 1:		500 TECHNOLOGY SQUARE
		STREET 2:		SUITE 700
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>fhtx-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:15bd0678-6723-4159-8d23-9a6c2981f314,g:5f09f729-e9b1-474a-a25d-c866e4e94b81,d:d19142a81b5f479380a5a5b4606181d7--><html xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:fhtx="http://www.foghorntx.com/20230331" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>fhtx-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180L2ZyYWc6YzYxNjUyOTBmN2EwNDc5MmE4YmFiNjY1MmQzMGRjMDgvdGFibGU6NzM5YjRiMTJiYTFmNDFmZmI4ZWQ1MTRhODA5YWZkMzAvdGFibGVyYW5nZTo3MzliNGIxMmJhMWY0MWZmYjhlZDUxNGE4MDlhZmQzMF8zLTEtMS0xLTU0NDgz_b2ae829e-c78f-4fab-9bed-03ecff0d9bb4">false</ix:nonNumeric><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180L2ZyYWc6YzYxNjUyOTBmN2EwNDc5MmE4YmFiNjY1MmQzMGRjMDgvdGFibGU6NzM5YjRiMTJiYTFmNDFmZmI4ZWQ1MTRhODA5YWZkMzAvdGFibGVyYW5nZTo3MzliNGIxMmJhMWY0MWZmYjhlZDUxNGE4MDlhZmQzMF81LTEtMS0xLTU0NDgz_b9031f36-59b6-47c4-81a5-5a26e412e374">2023</ix:nonNumeric><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180L2ZyYWc6YzYxNjUyOTBmN2EwNDc5MmE4YmFiNjY1MmQzMGRjMDgvdGFibGU6NzM5YjRiMTJiYTFmNDFmZmI4ZWQ1MTRhODA5YWZkMzAvdGFibGVyYW5nZTo3MzliNGIxMmJhMWY0MWZmYjhlZDUxNGE4MDlhZmQzMF82LTEtMS0xLTU0NDgz_c5bec5f3-53d8-47eb-baa0-02436b3367fc">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180L2ZyYWc6YzYxNjUyOTBmN2EwNDc5MmE4YmFiNjY1MmQzMGRjMDgvdGFibGU6NzM5YjRiMTJiYTFmNDFmZmI4ZWQ1MTRhODA5YWZkMzAvdGFibGVyYW5nZTo3MzliNGIxMmJhMWY0MWZmYjhlZDUxNGE4MDlhZmQzMF84LTEtMS0xLTU0NDgz_c2145b4d-3b17-4cdb-bc23-fb9e085b62e6">0001822462</ix:nonNumeric><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180L2ZyYWc6YzYxNjUyOTBmN2EwNDc5MmE4YmFiNjY1MmQzMGRjMDgvdGFibGU6NzM5YjRiMTJiYTFmNDFmZmI4ZWQ1MTRhODA5YWZkMzAvdGFibGVyYW5nZTo3MzliNGIxMmJhMWY0MWZmYjhlZDUxNGE4MDlhZmQzMF85LTEtMS0xLTU0NDgz_5e9d13ee-df5c-43ad-8e7b-85ce4822a8b9">--12-31</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="ibd8b8e5dc009459889ce53123905d4df_D20220101-20220331" decimals="-5" name="fhtx:CashPaymentsRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN183MC9mcmFnOjEyMGEwMWQyN2FhOTQyNDFiZTBmNDFkOTJkYjRkM2RiL3RleHRyZWdpb246MTIwYTAxZDI3YWE5NDI0MWJlMGY0MWQ5MmRiNGQzZGJfMTY0OTI2NzQ0MTY3MQ_ef5a2369-ab26-40e6-a272-9eef7626d373">0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i6b1fc9ad680a4413a21c30cd0cfce61f_D20230101-20230331" decimals="-5" name="fhtx:CashPaymentsRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN183MC9mcmFnOjEyMGEwMWQyN2FhOTQyNDFiZTBmNDFkOTJkYjRkM2RiL3RleHRyZWdpb246MTIwYTAxZDI3YWE5NDI0MWJlMGY0MWQ5MmRiNGQzZGJfMTY0OTI2NzQ0MTY3MQ_f74b5a4f-e17b-46e8-a070-dec805e4ad45">0</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="fhtx-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84f4b765c1c48fdba1e4fd385e7f0b1_I20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ifc737888b72c4abab3c2751c5194dcad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b067aab926342a7b5676d4d0a0c6d41_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ef9ae80fb5b4395b13666e9e9eec82c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bae992474dd40a79505422be056e6f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fdced88f45c4e409092a68fcf300833_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf21555867444ead906d71488062bf8e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19705a121aa44c47a0ae367e9f64af9d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23676a510c4248498851adfc7c094aaf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63934d7043544300b103bf3da31fea12_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eccb4d2959a4de3bd53fc39077255b5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11b5f1d57baf4341bcf36040f1462577_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbd53253722c4ae18279a572bbe8e780_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff92410149e84214befd6916fd3f5b77_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i624ef726f33c46a5a6ec3afd0efedb0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7d893999d4a40eaa90ed425123e9436_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if526a94d14254a2cb8672d7917c4be62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i349820509fee4399845fd358bd72501a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06768c28c0ca47a8bc549474a90e8b80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbe741aac4fe4bb0a0aac627966aa459_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4436ac0de3fc454787e9c9e801be2074_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dd7d3cc806949ecb93485d8665161b4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie34084e716da4a5392ab043797b8f9eb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f0c2d1581754c7d9a66865d89a11383_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icac4105ae32e47b4aab639de679600d4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c0a4519d9204d06bd778e69b95b2266_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23366ef09153432283da882a9c6f62f8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4605cd6df8cb432e8da81b434c0b12ff_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f17ba797a20458c8d273718a2faf5b2_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:MerckCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5ff53cf442042cdb4b36d6e72142a1b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:USTreasuryNotesSecuritiesDueWithinOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a624a02dc70405cb5fbe4a2e977a9f9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:USGovernmentAgenciesDueWithinOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87b3ffa3baf7435c93a45a49e8b25af7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74970c52e4004e8b8552988d5f7c2170_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:CorporateDebtSecuritiesDueWithinOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idda5759b36f940b19380a66d34dae73c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb5c24a093394ecba28d4a9c5bcdbb9d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a16fe60e7940d0acb3671bc0544537_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:USTreasuryNotesSecuritiesDueWithinOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2f9150da3aa40d8b086ad8ea1702556_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icccd4d043a644533bb05611e707ac152_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:CorporateDebtSecuritiesDueWithinOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a297b2b298d4b4d8e5832e54f043948_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e7d370e72b448e2a20136c9d41a611a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i686a387809184aaa8b50bc8cc6187e9a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86ecb94b9d984d25b19dab4395167083_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24b9d85917e44b37a2c2ee5fba4bb13d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id28c0fdc526e4f449092eb7231d7981a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78bf0b3f545e49799c0cf64e8fcc4d0d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic48f4328d06740f69e82bae9d7f08326_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i226002d2e8c3483999dbe6e1536bc05d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e4e5e96f3f249ad8b7059648464f925_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02cfa68b2fd349328e287ea50a6ac000_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc1aa441de3a4917a6058ce4f3a680f5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec137b73eb794feb8171dd03dd591a9e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7a6e0cb2e5a44cbb8cc75a960fa04b7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib00daf24652143c5a0de12e6924f3607_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d88f74ab4b24a56895f526a176976f8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60b16e50543348558175caaea85b3122_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id59576d83db143329d18b549ecb1cac8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7519c80b092a4ac7a57f59e62e77991e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1225ef2f386f4a42975c134708350d10_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i685de5a7038c45189760b9c211f5be9d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i469fee02bf054803a29064895742bcca_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b3eb52799bb4915b8ccdde486715eba_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i644cf406771343be85fb0303035cc30a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20240e23302249feb5d81f005bfe4920_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ab63392b2c74b5ab99240d3a67ddf2e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf60218770ed4221baf7f3056c9eb494_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id35b96fd44f74edfa4730b85402d177b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9d68f7e99d1431eb12bc2400a498113_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaae8d45dbde14f8d8de46117ec781d4d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57c7ac8901bd4d7daac300b48c7919ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id695c0b8a3e24d06a747342d16c3d091_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f4e06b5736f4b7f90965814e6fb2834_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3816c705b119429ea8c4ca667dd7af1a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3e370a92af44ccbaa5d713dfe2a8fb1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5aa2802907e4a0e80ba161a3b27fac2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f3c7b44e12a4950b574e402e90a4e96_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11f9d139c334e3e877bbc1b71a3bcb0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b0898b80bf94bd3a1898a19e50c68e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91c08e1329914a148a2969a210c89c47_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71476e1da87a4e8f9ea82e1558b4b1a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icec32c8d710e4052a2ea76320025a801_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73e10639ef0246c198a7a50e793bbcbd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i314ef289b4614198b2006dc7331ea1c7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4950fd3c93f40b8917a76b077c0c64b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2b1e949f6974b58964fd91bd5f979d7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa55d59c40f34aaba7d356a0fbff653f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i817ec589b1634a54955b21c64565e8ea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9df0cfa07c49422683e3147992721a62_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf0f225480c34371bc29f61873b9ae64_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icee323c63b8a4f55a03f6972bf66bacb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1ce20a435b94f1782ba0f50fd86a8b8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8a50f4fbb394949aeccc379c70c428a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a9f200afdd4b0499bec1ec0815830a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8af856e6f8244114882cf272fe719890_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f76a5224ab9460ab1687a0e61c62469_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i313c23ac84db459aa067b05c470e8c41_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e381c984bf544cfb0a2749f7b7bde14_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia478d511da57498795c16881932b6687_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8db8c7bc36df4ad98557037afc88e098_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4069cd6268314c4eb4dc21bd8aa31034_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15776fdc2f634cd2b8afecdccc812ee3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c2ae1d1ba35403ba1cfeec4178824b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff620723fc0c49618aaa87a660c11285_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a85b1b3aa94e2a88d7205cbf50b9a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic713b3b8646d4e9c952914b317f34c25_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:AssetsNotYetPlacedInServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f03ccf48fbd464fbb077f9ae05ad5f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:AssetsNotYetPlacedInServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>fhtx:vote</xbrli:measure></xbrli:unit><xbrli:context id="i4cc0d48a32c3455495ce27d4f7ddeea1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdd9cd9080824f859292dd01a8c3382f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6f5962b24a487098593ec15299f24a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i253b75ffb52440b49b4e9bbe4fb210dd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ff3d19669cd4af68367e024a5550402_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id06ab9cb3fff4cedb3c46e4ccf43eb35_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:A2016StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d79c74373c442b499c7ddd85c70b8dd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2c27d19751c94d7eb6c46feae55f646f_D20220101-20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69fa4e2b8bc24bf388f1f890c4ecf2e2_I20201021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8a38bc229cb4e8bb77f5c2c4c4b0cd0_D20201021-20201021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-21</xbrli:startDate><xbrli:endDate>2020-10-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i891fd370eb434c04aa39afcf2287fbff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09392e1f7a274b01845cedcdc8ed5acd_D20230101-20230101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6182cbed24bc4b8ab1aa853c3f9e2cb3_I20230101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6ce4bd203a74a629ec0457813c1657f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95f74147740a473d8c886cfbe8d8cf9f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e516a981dbe4601a952b105e005f398_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6112131b7aec49b494f0b988b8f51e90_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ac8dbde3e704d4ea43e4284fbd658c5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id704eaec79f3499d8b4e968f504e58eb_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="target"><xbrli:measure>fhtx:target</xbrli:measure></xbrli:unit><xbrli:context id="id3e63d9fb12c49febbf0ab26cfed6a9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="program"><xbrli:measure>fhtx:program</xbrli:measure></xbrli:unit><xbrli:context id="ie2d1ee7b60654dcdbf509fe84739b901_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:ResearchDevelopmentAndRegulatoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2c5f857c11b4186bd0df9d1860dcca9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:SalesBasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8e4b7ca8d86457dbee60cfa6bc83796_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:ResearchDevelopmentAndRegulatoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i932a791f229b4a74be687fda2016ec96_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:SalesBasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a2f456ce08c4f34b028f7e715d90a75_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee2a6d2ade0542e99376dda986298f86_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib745f408204748faa6b611ba2acc4301_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09acd48542c84107bda3a6fcc7e01a93_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd64aeec1acc4410ab6e14c3aec0a76f_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f0b1f2ac17b45e3b3937dfb1cd9b00a_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:ResearchDevelopmentAndRegulatoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c03ef7903fc425585c24387daf3a22a_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12af85d4d118413c83b0955c275f72f5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:ResearchDevelopmentAndRegulatoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4780b20d5ac143ea81ecc13b5a9624b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if77adc7cf7cb4adc886eb30f55a05415_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23ab0c9afb5749d5ab747dfcc565c03a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:MerckCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ac24b7249a14fd6a8da298f2934b7dd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:MerckCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i207a64c5b4d845b1a5061cf046b448ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i863abf2c04774158b2e8e819d2eb86f1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:StanfordLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddc9c1a9a4bd41f8b1fbb60001dd16b4_D20151001-20151031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-10-01</xbrli:startDate><xbrli:endDate>2015-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a4bd34abd04cd7a7c910806002b5ce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbf92bd0426f4ca5a06dce27507acf0c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd8b8e5dc009459889ce53123905d4df_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b1fc9ad680a4413a21c30cd0cfce61f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822462</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id19142a81b5f479380a5a5b4606181d7_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDg5_78714738-2e1d-4ee4-8734-60663754aa8d">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">_____________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6MmUxMDA3YTc1NGMwNDQ0MTk3M2Q2ODA1YmQwNDQwYzgvdGFibGVyYW5nZToyZTEwMDdhNzU0YzA0NDQxOTczZDY4MDViZDA0NDBjOF8wLTAtMS0xLTU0NDgz_341a4547-cb10-484e-a266-537968aba7c2">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8xNzY_f191b156-a4d6-418e-81cc-bcb0abed7684">March&#160;31, 2023</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6MDAwNzdkYjA3MjRlNGVjNGI0NTY1YjMxOTJkMjBhZTEvdGFibGVyYW5nZTowMDA3N2RiMDcyNGU0ZWM0YjQ1NjViMzE5MmQyMGFlMV8wLTAtMS0xLTU0NDgz_45e2b859-97f1-441b-bccd-c50706b3f3c8">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from __________________ to __________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDg0_65ddc675-2d9e-42d8-9b75-437cdee5a08f">001-39634</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDkx_04f0b981-69f2-49b0-8c33-e419f64d1187">Foghorn Therapeutics Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8wLTAtMS0xLTU0NDgzL3RleHRyZWdpb246ZWJhOTNhOTM5NGQzNDAzMGFhOTk0MDY3YzI1MzFiZDRfNQ_32f23715-b329-4c1d-b8cf-17de0d69dd84">Delaware</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8wLTEtMS0xLTU0NDgzL3RleHRyZWdpb246M2VhYzczZjk0YmZiNDcyZmIyYzAzM2MwZGYzNjE5NDlfNQ_0be7ae35-adce-458a-83c9-8551c48e1877">47-5271393</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8yLTAtMS0xLTU0NDgzL3RleHRyZWdpb246MWFjZWM2ODZiNDIwNDhiNTg5ODkyYTM1OGU4MzBmZmJfNQ_052bced7-9e23-45eb-9d16-c2a288cc0c70">500 Technology Square, Ste 700</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8yLTAtMS0xLTU0NDgzL3RleHRyZWdpb246MWFjZWM2ODZiNDIwNDhiNTg5ODkyYTM1OGU4MzBmZmJfOA_63169b38-1fef-418d-a61e-d882a5a04c41">Cambridge</ix:nonNumeric> <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8yLTAtMS0xLTU0NDgzL3RleHRyZWdpb246MWFjZWM2ODZiNDIwNDhiNTg5ODkyYTM1OGU4MzBmZmJfMTE_c0871467-b65b-4dc8-9a10-857c0043309d">MA</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8yLTEtMS0xLTU0NDgzL3RleHRyZWdpb246YmQ2NTZmNjc2ZmU5NDlhNDhjM2Y2ZmZiZTFlNDk0NzdfNA_9561c621-bad0-4122-9389-f4454add5a3d">02139</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Zip Code)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl80NzI_b758dc50-6f05-4ac1-b1d6-727658a5b52c">617</ix:nonNumeric>-<ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDg2_e5b3cbf5-3779-4063-97ae-95ee107218b7">586-3100</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:40.042%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6YTY1ZTY2ODMzY2QzNDk0NjgyZGZjZDhjYjRiYzU1ZWIvdGFibGVyYW5nZTphNjVlNjY4MzNjZDM0OTQ2ODJkZmNkOGNiNGJjNTVlYl8xLTAtMS0xLTU0NDgz_1eb581ee-db3f-487a-9790-b19834f26e98">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6YTY1ZTY2ODMzY2QzNDk0NjgyZGZjZDhjYjRiYzU1ZWIvdGFibGVyYW5nZTphNjVlNjY4MzNjZDM0OTQ2ODJkZmNkOGNiNGJjNTVlYl8xLTItMS0xLTU0NDgz_01541d82-d8d4-4e28-b0fd-627543fb811c">FHTX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6YTY1ZTY2ODMzY2QzNDk0NjgyZGZjZDhjYjRiYzU1ZWIvdGFibGVyYW5nZTphNjVlNjY4MzNjZDM0OTQ2ODJkZmNkOGNiNGJjNTVlYl8xLTQtMS0xLTU0NDgz_14349fd7-5a07-423c-b515-b4115ad9193e">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDg3_c443274a-35c9-425e-b09d-8ae3579f16d6">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDky_6f51ada0-2b90-48f2-921a-8e0379517d09">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#168;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6NjYxZDBiZTQ0NTE3NGQ0OWJlYjQzZGYxZDBmOTYyMWQvdGFibGVyYW5nZTo2NjFkMGJlNDQ1MTc0ZDQ5YmViNDNkZjFkMGY5NjIxZF8yLTAtMS0xLTU0NDgz_d7c25dfc-c6f8-4e42-b033-1b57df324833">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6NjYxZDBiZTQ0NTE3NGQ0OWJlYjQzZGYxZDBmOTYyMWQvdGFibGVyYW5nZTo2NjFkMGJlNDQ1MTc0ZDQ5YmViNDNkZjFkMGY5NjIxZF8yLTMtMS0xLTU0NDgz_8e1589fd-4c3d-4453-9ab5-f5c659174679">x</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6NjYxZDBiZTQ0NTE3NGQ0OWJlYjQzZGYxZDBmOTYyMWQvdGFibGVyYW5nZTo2NjFkMGJlNDQ1MTc0ZDQ5YmViNDNkZjFkMGY5NjIxZF80LTMtMS0xLTU0NDgz_30d28db3-8a60-4840-8369-a613f1b5e07f">x</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDkz_cf22cc16-f46a-4bf8-910d-965ecb726e2e">&#168;</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDg4_82febb18-238a-40e3-8bbc-0ea2e9d6ca6f">x</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">As of April&#160;28, 2023, the registrant had <ix:nonFraction unitRef="shares" contextRef="ia84f4b765c1c48fdba1e4fd385e7f0b1_I20230428" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDIw_af77dd0c-492e-411b-a773-e683d0185726">41,824,758</ix:nonFraction> shares of common stock, $0.0001 par value per share, outstanding.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.258%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.026%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_16">PART I.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_16">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_19">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_19">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_19">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_22">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_22">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_25">Condensed Consolidated Statements of Operations and Comprehensive Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_25">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_28">Condensed Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_28">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_31">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_31">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_34">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_34">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_73">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_73">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_73">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_97">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_97">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_97">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_100">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_100">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_100">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_103">PART II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_103">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_103">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_106">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_106">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_106">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_109">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_109">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_109">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_112">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_112">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_112">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_115">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#id19142a81b5f479380a5a5b4606181d7_115">24</a></span></div></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains forward-looking statements that are based on management&#8217;s beliefs and assumptions and on information currently available to management. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, but are not limited to, statements concerning:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the initiation, timing, progress and results of our research and development programs, preclinical and clinical studies, including the potential resolution of the full clinical hold and anticipated timing of release of clinical data;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to advance any product candidates that we may develop and to successfully complete preclinical and clinical studies;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to leverage our initial programs to develop additional product candidates using our Gene Traffic Control</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">developments related to our competitors and our industry;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to expand the target populations of our programs and the availability of patients for clinical testing;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to obtain regulatory approval for FHD-286 and any future product candidates from the U.S. Food and Drug Administration (the &#8220;FDA&#8221;) and other regulatory authorities;</span></div><div id="id19142a81b5f479380a5a5b4606181d7_13"></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to identify and enter into future license agreements and collaborations;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to continue to rely on our contract development and manufacturing organizations (&#8220;CDMOs&#8221;) or contract research organizations (&#8220;CROs&#8221;) for our manufacturing and research needs;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory developments in the United States and foreign countries;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">general economic conditions, including recessionary conditions, interest rates, monetary fluctuations and supply chain constraints;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to attract and retain key scientific and management personnel;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the scope of protection we are able to establish, maintain and enforce for intellectual property rights covering FHD-286, our future products and our Gene Traffic Control platform; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possibility of a prolonged government shutdown and the subsequent impact on the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions; and </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the impact of the COVID-19 pandemic on our and our collaborators&#8217; business operations, including our research and development programs and preclinical and clinical studies, as well as recent geopolitical instability and other developments that may negatively impact the ability to utilize CDMOs, and CROs, that are located outside of the United States.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this Quarterly Report on Form 10-Q are only predictions and are based largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q and are subject to a number of known and unknown risks, uncertainties and assumptions, including those described under the section entitled &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. Moreover, we operate in an evolving environment. New risks and uncertainties may emerge from time to time, and it is not possible for management to predict all risks and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div id="id19142a81b5f479380a5a5b4606181d7_19"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Financial Statements (unaudited)</span></div><div id="id19142a81b5f479380a5a5b4606181d7_22"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foghorn Therapeutics Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMy0xLTEtMS01NDQ4Mw_6af70139-a9d1-4e3b-8fca-d4822f1e3d36">50,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMy0zLTEtMS01NDQ4Mw_ceb90a20-e45f-49ab-8e56-ea2f4b35b8d6">52,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfNC0xLTEtMS01NDQ4Mw_66c83866-d3dd-48c7-abb1-dd8a90d35eeb">265,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfNC0zLTEtMS01NDQ4Mw_35772d55-71c6-424e-9e5a-302ea1e9d7d1">293,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfNy0xLTEtMS01NDQ4Mw_145ec95d-2e3c-4722-bdc8-0cc21291c0c3">4,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfNy0zLTEtMS01NDQ4Mw_5d5ca720-2cc5-40fc-8b56-e4014188176b">5,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfOC0xLTEtMS01NDQ4Mw_f4ba0233-12d2-4c14-b752-dd246848d05e">320,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfOC0zLTEtMS01NDQ4Mw_ca8a5993-d5ba-4112-8979-93833e1abbcb">351,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfOS0xLTEtMS01NDQ4Mw_bf6e5a30-1325-4a91-b34d-618aebd2774b">15,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfOS0zLTEtMS01NDQ4Mw_80fabe03-097b-4fc2-89d4-259ca32e62c4">15,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTAtMS0xLTEtNTQ0ODM_8d00c16b-7aa2-4c9e-b930-de51aaf3b911">1,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTAtMy0xLTEtNTQ0ODM_89abbbd4-ac4d-400a-8443-8cc7760ecfdc">1,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTEtMS0xLTEtNTQ0ODM_7b5c52f8-a4aa-454c-b0db-b155064c51d7">2,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTEtMy0xLTEtNTQ0ODM_03e7812f-b72e-4030-9e1d-5602fcf4c790">2,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTItMS0xLTEtNTQ0ODM_ab94d871-b502-44f5-94d4-7ba4606989e6">32,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTItMy0xLTEtNTQ0ODM_f001a22b-4dd4-47fe-ae1b-d460e93ed4ac">34,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTMtMS0xLTEtNTQ0ODM_b26e4a56-7980-408c-bffa-bf2c5d9a9c35">372,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTMtMy0xLTEtNTQ0ODM_c11a304d-20c5-4ba5-b2f0-b5a619c03370">404,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTYtMS0xLTEtNTQ0ODM_79340950-f710-494d-a608-3a5f7face453">7,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTYtMy0xLTEtNTQ0ODM_b0c5ea6a-7e88-4cf6-9876-9c1c1840abcf">5,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTctMS0xLTEtNTQ0ODM_531c8419-cc7f-44f1-8499-0a73efddd1d6">8,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTctMy0xLTEtNTQ0ODM_7d2d9b6d-95e3-4bab-a168-b44be6283e71">11,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTgtMS0xLTEtNTQ0ODM_36efa1b4-3394-4ba5-a730-33abbac798b7">6,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTgtMy0xLTEtNTQ0ODM_aa87c241-10cb-4085-84e3-033e2c1e1bc7">5,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTktMS0xLTEtNTQ0ODM_e3a5361c-3a09-449a-bbae-648d3b331bdf">33,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTktMy0xLTEtNTQ0ODM_2c1c57bf-2eae-48c9-bd7c-a165139006cb">32,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjAtMS0xLTEtNTQ0ODM_a9f2685a-74e8-47b2-a9a5-3b95c3da5301">55,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjAtMy0xLTEtNTQ0ODM_382ef9bd-65b2-4802-ad19-f7ddaebd0dc7">55,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjEtMS0xLTEtNTQ0ODM_ca57bdd4-9589-44cc-ae30-7dc1d32687d0">43,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjEtMy0xLTEtNTQ0ODM_5d132f17-827e-4095-b64a-a7e13cda3e5b">45,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjItMS0xLTEtNTQ0ODM_8e811bf6-d41f-460d-9de9-3eee87a4a557">298,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjItMy0xLTEtNTQ0ODM_22c8f02f-cc40-4bac-b656-5ecad81ce0e5">304,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjMtMS0xLTEtNTQ0ODM_7690230a-66ad-4013-84c8-78eb036ad559">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjMtMy0xLTEtNTQ0ODM_290b4c11-ab1f-473e-a18f-e930a19769c8">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjQtMS0xLTEtNTQ0ODM_bbc28d7e-b4c5-4096-ac2e-eef7d8cefd5b">397,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjQtMy0xLTEtNTQ0ODM_4b86c82a-beff-48a7-9ebb-6a0b292a726f">404,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 10)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjUtMS0xLTEtNTQ0ODM_05a3ed3f-c1e6-4f88-98a1-7b7a2f88fd0b"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjUtMy0xLTEtNTQ0ODM_09e0f124-3f0d-4775-a022-b3208352be01"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity (deficit):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl8yMQ_70e2d580-4d2a-4911-94a5-57b6f4505ede"><ix:nonFraction unitRef="usdPerShare" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl8yMQ_c90bad1d-4833-4520-b9be-80a2ee8a9608">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl8zNQ_31c4ae08-ac2b-40d6-8a0c-bf4baab37b4c"><ix:nonFraction unitRef="shares" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl8zNQ_80f4c759-cdad-4d25-b8d1-c604c56c0128">25,000,000</ix:nonFraction></ix:nonFraction> shares authorized at March&#160;31, 2023</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;and December&#160;31, 2022; <ix:nonFraction unitRef="shares" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl83Mw_62ab0460-e9b6-4df7-8f9b-f247ed9cd793"><ix:nonFraction unitRef="shares" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl83Mw_699ab8c2-1299-4feb-bc40-396dd0b58011"><ix:nonFraction unitRef="shares" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl83Mw_8090a041-87aa-4f95-8a61-984504f42d0b"><ix:nonFraction unitRef="shares" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl83Mw_c618dba6-ad11-441d-bd0b-90ee5fafa992">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at March&#160;31, 2023 and</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMS0xLTEtNTQ0ODM_eb8c356f-6927-47f9-a91d-3de05feecbfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMy0xLTEtNTQ0ODM_c53cc8af-c6f4-4614-93a8-833bcc029866">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8xOA_485be21a-0ab8-43dd-9358-cded15236928"><ix:nonFraction unitRef="usdPerShare" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8xOA_d35d0612-704a-4ff7-b2fc-3f021e2218dc">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8zMg_3b9c9955-71a8-4c3b-abb9-93b9a696acd4"><ix:nonFraction unitRef="shares" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8zMg_e2d22eb0-2cd3-4d3c-953d-2056a8f21491">175,000,000</ix:nonFraction></ix:nonFraction> shares authorized at March&#160;31, 2023 and December&#160;31, 2022; <ix:nonFraction unitRef="shares" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF82Nw_4489adc4-f061-420c-a196-2e0d7fc1e95d"><ix:nonFraction unitRef="shares" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF82Nw_c044553c-31a8-4377-9612-1193efc1bdc9">41,824,758</ix:nonFraction></ix:nonFraction> shares issued and outstanding at March&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8xMTA_4691e49e-3bc8-4fb5-b5a9-341180a47452"><ix:nonFraction unitRef="shares" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8xMTA_b1147e5b-b3a4-495c-bec6-ca6240f3e97e">41,803,436</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMS0xLTEtNTQ0ODM_8fd3e9bd-3ad2-4a8e-9c9c-f739ce53bdcc">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMy0xLTEtNTQ0ODM_8727dc79-1eb1-4d4b-8079-54d536a0e542">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjktMS0xLTEtNTQ0ODM_2c44f8c1-00d9-462f-90ad-8137451236ae">381,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjktMy0xLTEtNTQ0ODM_6d314ccf-26d7-49d4-9199-7c473d09ef7d">377,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzAtMS0xLTEtNTQ0ODM_6116a8bb-53d0-4dde-a3ed-8704a3a84dbf">2,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzAtMy0xLTEtNTQ0ODM_c00a61f2-b1c3-497b-99da-e0b4b67bbdef">3,986</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzEtMS0xLTEtNTQ0ODM_79a59d4f-1f45-4635-afc9-20a0e2d6407c">403,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzEtMy0xLTEtNTQ0ODM_049793b0-e666-4814-befb-d3e25314e46b">373,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity (deficit)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzItMS0xLTEtNTQ0ODM_df101cee-c77b-4438-b735-606a181a81c3">24,586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzItMy0xLTEtNTQ0ODM_f37de219-06f9-47fd-96d2-fce0de577556">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity (deficit)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzMtMS0xLTEtNTQ0ODM_55744605-51cd-4912-909d-17cdf8f177fa">372,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzMtMy0xLTEtNTQ0ODM_869497ad-7cc6-4474-b20a-4e2a9c2a8048">404,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foghorn Therapeutics Inc.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:72.124%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.509%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMi01LTEtMS01NDQ4Mw_32fb303b-0c6a-4c93-aa69-984f5c665507">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMi03LTEtMS01NDQ4Mw_3686c246-7995-4996-a550-a8cb77480331">3,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNC01LTEtMS01NDQ4Mw_91be1fc9-c90c-415a-8f21-26593e53c960">29,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNC03LTEtMS01NDQ4Mw_485d96b8-96a5-4a44-ae38-9bb6addaab1a">24,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNS01LTEtMS01NDQ4Mw_5a5d6135-b609-4f01-bf27-2828b303df14">8,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNS03LTEtMS01NDQ4Mw_13cccbe3-eaa5-44a0-baa8-d19de97f26b3">7,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNi01LTEtMS01NDQ4Mw_27774282-b201-4ff9-85cd-83a80a56a340">38,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNi03LTEtMS01NDQ4Mw_9e05dd97-a921-4537-9cef-8a07138d8348">31,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNy01LTEtMS01NDQ4Mw_e771c7db-0e55-4e91-a6a0-d314d299cfd6">33,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNy03LTEtMS01NDQ4Mw_92755bf0-1088-41e5-bbaa-7664c1262c11">27,804</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:InterestIncomeOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfOS01LTEtMS01NDQ4Mw_82f44ae2-05e0-4580-b0e5-ff5f5ee7c179">2,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:InterestIncomeOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfOS03LTEtMS01NDQ4Mw_2bb2cec1-2bd2-4e99-bb0f-cd9c9b99d133">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="fhtx:InterestIncomeAndOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTAtNS0xLTEtNTQ0ODM_d2ec6e37-e7ca-4da3-b2fc-3336d2c47b9d">720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="fhtx:InterestIncomeAndOtherIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTAtNy0xLTEtNTQ0ODM_aff1fe59-6b76-42e5-9378-a0f6023814a5">655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTEtNS0xLTEtNTQ0ODM_a602f0a3-b090-4057-acd2-6c0e78a75481">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTEtNy0xLTEtNTQ0ODM_ad6b90c2-f927-47ce-beaa-04c906136ecc">890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTItNS0xLTEtNzIzMTM_1ee14342-ff87-432c-8923-6624df0cc528">29,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTItNy0xLTEtNzIzMjE_c92275db-110f-4750-a195-bb92d6f42de5">26,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNS0xLTEtNzIzMTM_97d2a64c-6e9a-4751-bff2-5f2e22f3443b">560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNy0xLTEtNzIzMjE_1f3f859f-fed7-453f-a32b-e76273c0b814">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTItNS0xLTEtNTQ0ODM_7c510c1c-9452-408f-abde-5769f5b318c9">30,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTItNy0xLTEtNTQ0ODM_2dad6f1d-a00f-4454-8be2-87454564cadc">26,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders&#8212;basic and diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNS0xLTEtNTQ0ODM_b6cd1595-c49e-4573-852c-0d09b9f83de0"><ix:nonFraction unitRef="usdPerShare" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNS0xLTEtNTQ0ODM_f7d4cd43-d987-4eae-ade8-2b2b7e2dcb9e">0.73</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNy0xLTEtNTQ0ODM_11455191-f170-4303-aed1-e017ff4ee198"><ix:nonFraction unitRef="usdPerShare" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNy0xLTEtNTQ0ODM_e309a4f3-4e31-4557-9b99-e360145236d5">0.65</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding&#8212;basic and diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTQtNS0xLTEtNTQ0ODM_483478b4-6c92-46a6-aad1-ad854506f28c"><ix:nonFraction unitRef="shares" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTQtNS0xLTEtNTQ0ODM_5327cca9-3144-4497-a382-882efb7ca4a2">41,811,087</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTQtNy0xLTEtNTQ0ODM_369add31-726a-44a4-a306-6feb15e71c14"><ix:nonFraction unitRef="shares" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTQtNy0xLTEtNTQ0ODM_90ca0f06-8e3f-4557-a515-9b3d7e8e67a4">41,370,186</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTYtNS0xLTEtNTQ0ODM_c01d24e9-f57d-418e-a0b4-c57b244a6db0">30,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTYtNy0xLTEtNTQ0ODM_f201a4d5-f658-4cac-82b1-c05568286891">26,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) on marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTgtNS0xLTEtNTQ0ODM_adc3ed4d-ac30-4157-8bf8-4f4e3f58c7f8">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTgtNy0xLTEtNTQ0ODM_971d2086-30b4-43bc-84ec-7cee9474d59b">1,184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive gain (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTktNS0xLTEtNTQ0ODM_21a17253-568e-49d9-a35c-ec56c314a1bc">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTktNy0xLTEtNTQ0ODM_6117c351-e81e-407d-8953-a5fdc04b6cfa">1,184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMjAtNS0xLTEtNTQ0ODM_5bb24026-106b-4acb-90b0-5d2a9a8a587c">29,372</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMjAtNy0xLTEtNTQ0ODM_003d2e06-6b29-4ff1-87b4-ae628d9112cd">28,098</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foghorn Therapeutics Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.435%"><tr><td style="width:1.0%"></td><td style="width:38.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.564%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.559%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.273%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity (Deficit)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b067aab926342a7b5676d4d0a0c6d41_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi0xLTEtMS01NDQ4Mw_2a2cc546-1757-426a-905d-84dae9f92d1c">41,803,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b067aab926342a7b5676d4d0a0c6d41_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi0zLTEtMS01NDQ4Mw_666a3c61-62a9-4be4-ba79-a726fb7347fa">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef9ae80fb5b4395b13666e9e9eec82c_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi01LTEtMS01NDQ4Mw_671edee3-46f0-41d3-8aea-f713345958a4">377,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bae992474dd40a79505422be056e6f5_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi03LTEtMS01NDQ4Mw_54e182d1-43a6-45ca-b8d4-b6b187f039f1">3,986</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fdced88f45c4e409092a68fcf300833_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi05LTEtMS01NDQ4Mw_53c2d8dd-3fd5-4399-a0d3-00f2d5beb0d1">373,138</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi0xMS0xLTEtNTQ0ODM_d10ab4ad-3e81-465e-a939-13eabc31276d">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock<br/>&#160;&#160;&#160;options and employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf21555867444ead906d71488062bf8e_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMy0xLTEtMS01NDQ4Mw_45479f61-7ff1-4d7f-9212-81ed4c8ddafd">21,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19705a121aa44c47a0ae367e9f64af9d_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMy01LTEtMS01NDQ4Mw_d20ed687-a5e7-41bf-8ce9-b50a647686f1">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMy0xMS0xLTEtNTQ0ODM_4de49a6f-8b39-4d6d-9262-3b8c419d14a1">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19705a121aa44c47a0ae367e9f64af9d_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNC01LTEtMS01NDQ4Mw_3532b390-d40e-4f47-a318-ebbc18e03f16">4,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNC0xMS0xLTEtNTQ0ODM_02435cca-d37a-466e-9542-5c6ae1b53284">4,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized Gains on marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23676a510c4248498851adfc7c094aaf_D20230101-20230331" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNS03LTEtMS01NDQ4Mw_dac6d1b8-b9e6-4bc1-b6b7-e0ff91893066">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNS0xMS0xLTEtNTQ0ODM_21ad53d4-89c3-4deb-833e-13d80aee09ac">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63934d7043544300b103bf3da31fea12_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNi05LTEtMS01NDQ4Mw_54937ab6-534e-46da-ba31-00a4860841e5">30,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNi0xMS0xLTEtNTQ0ODM_adcfdae8-fa4b-4b34-be6a-e61ef2647c94">30,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3eccb4d2959a4de3bd53fc39077255b5_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctMS0xLTEtNTQ0ODM_339f71c3-1edd-4eb8-a5fa-3ad46d3c3e53">41,824,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eccb4d2959a4de3bd53fc39077255b5_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctMy0xLTEtNTQ0ODM_28b0260a-c443-45cf-b8e6-ef2b4162403d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b5f1d57baf4341bcf36040f1462577_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctNS0xLTEtNTQ0ODM_9a056183-a630-46f6-95cc-009421d4bf0a">381,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbd53253722c4ae18279a572bbe8e780_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctNy0xLTEtNTQ0ODM_753b8a6a-2969-4369-a2af-063f1c6a4335">2,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff92410149e84214befd6916fd3f5b77_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctOS0xLTEtNTQ0ODM_bcb9b26e-fe5d-4d66-a859-a17fefb9c9f9">403,626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctMTEtMS0xLTU0NDgz_913c62a6-8bb2-4567-8db5-3a71564ec68b">24,586</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.435%"><tr><td style="width:1.0%"></td><td style="width:37.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.985%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.989%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Gain (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i624ef726f33c46a5a6ec3afd0efedb0a_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi0xLTEtMS01NDQ4Mw_0950599a-3e67-447a-90df-8853f5fcb2e4">41,299,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i624ef726f33c46a5a6ec3afd0efedb0a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi0zLTEtMS01NDQ4Mw_13692a24-8855-4628-b314-3bd8c8f8ddea">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7d893999d4a40eaa90ed425123e9436_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi01LTEtMS01NDQ4Mw_7e9fee3e-d926-4a4e-9ab2-908f841a5fc9">361,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if526a94d14254a2cb8672d7917c4be62_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi03LTEtMS01NDQ4Mw_0258d749-1250-4c48-871e-27b3c0b75e8e">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i349820509fee4399845fd358bd72501a_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi05LTEtMS01NDQ4Mw_17c4232f-d2e3-47c0-a407-dd6f80342875">264,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06768c28c0ca47a8bc549474a90e8b80_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi0xMS0xLTEtNTQ0ODM_33a09f80-b5ea-41e7-abeb-5dcf2b87b9e3">96,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock<br/>&#160;&#160;&#160;options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe741aac4fe4bb0a0aac627966aa459_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMy0xLTEtMS01NDQ4Mw_90bc5ca9-4ea7-4910-82cb-d36243475a30">129,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4436ac0de3fc454787e9c9e801be2074_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMy01LTEtMS01NDQ4Mw_dcccbdf0-52cd-40d0-8199-f5e4df2f8641">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMy0xMS0xLTEtNTQ0ODM_22356679-1816-42cf-a801-7195602d662d">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4436ac0de3fc454787e9c9e801be2074_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNC01LTEtMS01NDQ4Mw_408eb2b2-5b86-4eb5-a854-2407d233783d">3,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNC0xMS0xLTEtNTQ0ODM_3bfacaa6-89b9-4bb7-a47e-3c4febe5876e">3,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7dd7d3cc806949ecb93485d8665161b4_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNS03LTEtMS01NDQ4Mw_7e6dafb0-80e8-4e92-9676-c7e8fdbf3f9a">1,184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNS0xMS0xLTEtNTQ0ODM_612db69d-f213-4919-a2ce-3e0d67620450">1,184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie34084e716da4a5392ab043797b8f9eb_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNi05LTEtMS01NDQ4Mw_341d0f3c-eaec-40df-b6af-57040dc9c447">26,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNi0xMS0xLTEtNTQ0ODM_427ab4f1-b8bc-451e-b29d-16986f02dcdb">26,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f0c2d1581754c7d9a66865d89a11383_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctMS0xLTEtNTQ0ODM_c3227894-1a1f-4323-886e-1807a920d7a4">41,429,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f0c2d1581754c7d9a66865d89a11383_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctMy0xLTEtNTQ0ODM_6e5eda4b-8eda-4b76-98ef-e4029e3c90d8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icac4105ae32e47b4aab639de679600d4_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctNS0xLTEtNTQ0ODM_03b97bd2-41ab-42df-9c60-f72797e3ba04">364,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c0a4519d9204d06bd778e69b95b2266_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctNy0xLTEtNTQ0ODM_93fb0eeb-1ee5-43ec-9956-93a9abe54ae7">1,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23366ef09153432283da882a9c6f62f8_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctOS0xLTEtNTQ0ODM_f9931280-9b06-437e-b805-f2776bc9c28d">291,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctMTEtMS0xLTU0NDgz_3074faca-cf7c-4f45-a440-9406b491b93d">72,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foghorn Therapeutics Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMy0xLTEtMS01NDQ4Mw_83eeff9e-ee12-412e-89af-f0e3ab05a9b7">30,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMy0zLTEtMS01NDQ4Mw_0c2e45a6-a882-4d34-8e25-879d1265b34a">26,914</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfNS0xLTEtMS01NDQ4Mw_5f671949-d917-4a8e-aafb-da339ea3dc2f">4,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfNS0zLTEtMS01NDQ4Mw_d22c7e1b-15d3-4855-b1ef-a2fd31ca61fb">3,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfNi0xLTEtMS01NDQ4Mw_cfa26681-4f80-4e0c-b88e-cfcd231af7d6">859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfNi0zLTEtMS01NDQ4Mw_dafb12e3-1b98-49ce-94bb-8480111650d8">811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfOC0xLTEtMS01NDQ4Mw_11cf8150-e2ca-4c0d-b5f0-8f78e8d90c6c">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfOC0zLTEtMS01NDQ4Mw_ac6b78ac-30de-470d-a70a-96b698e98f58">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization (accretion) of discount on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTAtMS0xLTEtNTQ0ODM_cc2c7671-8f3f-4c96-a978-d567659dc394">770</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTAtMy0xLTEtNTQ0ODM_b470377c-6d62-4b4d-9816-5cebb3f0a61d">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTItMS0xLTEtNTQ0ODM_ff0fdb69-ede2-4721-bfcd-9137730ebf29">887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTItMy0xLTEtNTQ0ODM_0bc5bb29-2364-456e-8e19-a8f061b4fdf6">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTMtMS0xLTEtNTQ0ODM_dda42500-f1a9-4d2d-84cb-d20302740e7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTMtMy0xLTEtNTQ0ODM_5a202d3d-2627-495d-99fa-7a3dd30d3935">300,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTQtMS0xLTEtNTQ0ODM_bd36364e-256c-4978-90ed-a7e6aacb6ca5">1,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTQtMy0xLTEtNTQ0ODM_2182f493-45df-46f2-b1b0-359c32e30aa2">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTUtMS0xLTEtNTQ0ODM_0c9027b2-8f33-4b5c-bd87-f335275a2054">2,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTUtMy0xLTEtNTQ0ODM_b56b13ae-dbbb-432c-b80e-ac46c716d0bb">2,542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTYtMS0xLTEtNTQ0ODM_62497fb6-ccb9-48c9-8b49-408dd32871e5">1,668</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTYtMy0xLTEtNTQ0ODM_989f7a54-5565-4c47-8f79-19b0564c5a15">1,752</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTctMS0xLTEtNTQ0ODM_b81eabe6-26ce-403c-b1e5-c3874123aa97">5,309</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTctMy0xLTEtNTQ0ODM_fb2d0e9f-9cec-4ef1-a52c-4d716c7684bd">3,920</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTgtMS0xLTEtNTQ0ODM_ce44d3ac-25ee-4bd9-83f3-7333e16298a0">31,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTgtMy0xLTEtNTQ0ODM_2416e50e-dfc9-4a2a-977c-73d1952b1592">271,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjAtMS0xLTEtNTQ0ODM_4be9910a-0aa8-4c94-a1db-6654e541a1b3">636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjAtMy0xLTEtNTQ0ODM_46573b5f-b9a9-4399-abcd-0cc62c5aecec">247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjItMS0xLTEtNTQ0ODM_403dabed-4db6-4a11-9ebf-8a1124b4f227">26,232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjItMy0xLTEtNTQ0ODM_1e705d99-edfa-403c-b1da-11b4ebb7a20f">212,294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjMtMS0xLTEtNTQ0ODM_f24bc524-bdb8-42b5-842b-bdab9090a1fc">56,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjMtMy0xLTEtNTQ0ODM_6a3fa2cc-e913-4d2c-ba4b-525f0c030e60">53,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjQtMS0xLTEtNTQ0ODM_c390abef-1064-440d-ac5c-308f17d7d674">29,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjQtMy0xLTEtNTQ0ODM_cce7e235-d65d-4187-a7d9-a918c2de6e5b">159,409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock upon exercise of stock options and <br/>&#160;&#160;&#160;employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjYtMS0xLTEtNTQ0ODM_49a56c0b-317a-4894-b2bd-a504c3308ab7">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjYtMy0xLTEtNTQ0ODM_ea3ef048-3241-4a2a-8ba5-315f5696b152">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjgtMS0xLTEtNTQ0ODM_f42a9132-9b03-446e-8359-5c2904c1110a">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjgtMy0xLTEtNTQ0ODM_7d4f033c-34b0-4ee2-81cc-622d27b4c677">384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjktMS0xLTEtNTQ0ODM_b317da86-7a33-43c8-a0ff-604ca3ab700e">1,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjktMy0xLTEtNTQ0ODM_b89880f1-8535-44fc-bf84-9826b8d879d8">112,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzAtMS0xLTEtNTQ0ODM_ea8e1063-8ac3-45be-b89c-1bbbed7d8d81">53,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06768c28c0ca47a8bc549474a90e8b80_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzAtMy0xLTEtNTQ0ODM_79cc7892-df02-4095-9560-6b6ab64ae801">102,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzEtMS0xLTEtNTQ0ODM_c0210794-a079-4915-abc4-fe5a851963e2">52,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzEtMy0xLTEtNTQ0ODM_209d7dde-b638-4f90-8712-97ee9fe48209">215,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of noncash investing and financing information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment included in accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzUtMS0xLTEtNTQ0ODM_2d6bd656-14e5-4f96-beeb-a220c16ccee2">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzUtMy0xLTEtNTQ0ODM_a45a49c9-0328-465c-931b-d0c21774adb6">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of cash, cash equivalents and restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzctMS0xLTEtNTQ0ODM_0dd0b711-675b-40bb-99b8-dd8cb1999436">50,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzctMy0xLTEtNTQ0ODM_301af3a0-f612-4653-91e7-9750858494cc">213,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (current and non-current)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:RestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzgtMS0xLTEtNTQ0ODM_2238154b-f32c-4501-9467-2ca45db9a797">1,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331" decimals="-3" name="us-gaap:RestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzgtMy0xLTEtNTQ0ODM_2af005e4-1862-478e-8ac3-e17dd134dc5a">1,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash shown in the statement of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzktMS0xLTEtNTQ0ODM_ae43c108-a07a-4e7e-9cf7-8d8d39b85929">52,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzktMy0xLTEtNTQ0ODM_8defc577-cb72-45dc-b3ba-a9dc818c3056">215,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foghorn Therapeutics Inc.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="id19142a81b5f479380a5a5b4606181d7_37"></div><div style="margin-top:16pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:1.5pt"> <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfNTIwMA_be4fdd83-b136-42a1-bf86-bd16dde69ce0" continuedAt="icd476edab46147308aa8a56cb6f3d04a" escape="true">Nature of Business, Going Concern and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="icd476edab46147308aa8a56cb6f3d04a"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foghorn Therapeutics&#160;Inc. (the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company discovering and developing a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. The Company uses its proprietary Gene Traffic Control platform to identify, validate and potentially drug targets within the system. The Company was founded in October 2015 as a Delaware corporation. The Company is headquartered in Cambridge, Massachusetts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks similar to those of other early-stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, and the need to obtain adequate additional financing to fund the development of its products. There can be no assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going concern</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. Since inception, the Company has funded its operations primarily with proceeds from sales of preferred stock, debt financing, an upfront payment from a collaboration agreement, a public offering and a stock purchase agreement all prior to 2022. In January 2022, the Company received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i4605cd6df8cb432e8da81b434c0b12ff_D20220101-20220131" decimals="-5" name="fhtx:ProceedsFromUpfrontPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfMjQ1OA_41fd2593-a07c-4dc5-8cf7-be8d53f11440">300.0</ix:nonFraction> million pursuant to a collaboration agreement completed with Lilly (the &#8220;Lilly Collaboration Agreement&#8221;) (see Note 8). In the third quarter of 2022, the Company achieved a research milestone related to the Merck Collaboration Agreement and received a $<ix:nonFraction unitRef="usd" contextRef="i8f17ba797a20458c8d273718a2faf5b2_D20220701-20220930" decimals="-5" name="fhtx:PaymentReceivedForAchievementOfMilestones" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfNTQ5NzU1ODE0NTE3NA_155bfef4-8f34-4f68-9d04-0819116db676">5.0</ix:nonFraction> million milestone payment from Merck. The Company has incurred recurring losses, including net losses of $<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfMjU5Mw_737a6c1a-bcdb-4791-8e87-6a8278802f1d">30.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfMjYwMA_0bab6652-4fc7-48e6-b4a4-bb028be4310e">26.9</ix:nonFraction>&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively. As of March&#160;31, 2023, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfMjcwNA_9edb47fb-a459-41a6-924b-c97463539918">403.6</ix:nonFraction> million. The Company expects to continue to generate operating losses in the foreseeable future. As of the issuance date of these interim condensed consolidated financial statements the Company expects that its cash, cash equivalents and marketable securities will be sufficient to fund its operating expenses and capital expenditure requirements for at least 12 months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will need to obtain additional funding through public or private equity offerings, debt financings, collaborations, strategic alliances and/or licensing arrangements to continue to fund its operations. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborative or strategic alliances or licensing arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company&#8217;s stockholders. Arrangements with collaborators or others may require the Company to relinquish rights to certain of its technologies or programs. If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate some or all of its research and development programs, pipeline expansion or commercialization efforts, which could adversely affect its business prospects. Although management will continue to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding in the future on terms acceptable to the Company to fund continuing operations when needed or at all.</span></div><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfNTE5OQ_5aeff100-3a9f-4e68-947d-8d539f6be33e" escape="true"><div style="margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:16pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180MC9mcmFnOmVjNDIzZGFjNDE5MDRkNGZiZWZmMjIxZDBhM2RmZDdiL3RleHRyZWdpb246ZWM0MjNkYWM0MTkwNGQ0ZmJlZmYyMjFkMGEzZGZkN2JfMjU3MA_8c10fa83-80d6-458e-9c6b-bf1da4e42768" continuedAt="ic98ee973f37a408ea6b359ad3866b3e5" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ic98ee973f37a408ea6b359ad3866b3e5"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the Company are set forth in Note 2 to the consolidated financial statements contained in the Company&#8217;s 2022 Annual Report on Form 10-K. The Company includes herein certain updates to those policies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities are classified as&#160;available-for-sale&#160;and are carried at fair value with the unrealized gains and losses reported as a component of accumulated other comprehensive loss in stockholders&#8217; equity. The Company classifies its marketable securities with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities are available for current operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews marketable securities whenever the fair value of an investment is less than the amortized cost and evidence indicates that an investment&#8217;s carrying value is not recoverable. For available-for-sale debt securities, the credit allowance is limited to the amount that fair value is less than amortized cost. Unrealized losses are evaluated for impairment under ASC 326, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine if the impairment is credit-related or noncredit-related. Credit-related impairment is recognized as an allowance on the condensed consolidated balance sheets with a corresponding adjustment to earnings, and noncredit-related impairment is recognized in other comprehensive loss. Evidence considered in this assessment includes reasons for the impairment, compliance with our investment policy, the severity of the impairment, collectability of the security, and any adverse conditions specifically related to the security, an industry, or geographic area.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses are included as a component of accumulated other comprehensive loss in the consolidated balance sheets and condensed consolidated statements of stockholders&#8217; equity and a component of total comprehensive loss. Realized gains and losses are included as a component of other income (expense), net based on the specific identification method.</span></div><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180MC9mcmFnOmVjNDIzZGFjNDE5MDRkNGZiZWZmMjIxZDBhM2RmZDdiL3RleHRyZWdpb246ZWM0MjNkYWM0MTkwNGQ0ZmJlZmYyMjFkMGEzZGZkN2JfMjU3MQ_5d788564-075a-415c-b989-3d40f3959166" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently issued accounting pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to &#8220;opt out&#8221; of the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i)&#160;irrevocably elects to opt out of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No.&#160;2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The new standard adjusts the accounting for assets held at amortized costs basis by eliminating the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses as an allowance for credit losses. For nonpublic entities and emerging growth companies that choose to take advantage of the extended transition period, the guidance was initially effective for annual reporting periods beginning after December&#160;15, 2020. However, in November 2019, the FASB issued ASU No.&#160;2019-10, which deferred the effective date for nonpublic entities to annual reporting periods beginning after December&#160;15, 2022, including interim periods within those fiscal years. The Company adopted this s as of January 1, 2023 and the adoption had no material impact to the Company&#8217;s consolidated financial position, results of operation, or cash flows.</span></div></ix:nonNumeric></ix:continuation><div id="id19142a81b5f479380a5a5b4606181d7_43"></div><div style="margin-top:16pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="fhtx:MarketableSecuritiesAndFairValueMeasurementsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RleHRyZWdpb246Njc5Y2YwNGUwMTg5NGQxMmI3ZmFiYTIwZGVhNGY1NmNfNTIw_504a7d97-791b-436b-97a3-3a8fc9338bfe" continuedAt="i42b91662c7584dfd8b56f1ea67714dc0" escape="true">Marketable Securities and Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i42b91662c7584dfd8b56f1ea67714dc0" continuedAt="i105425e2ce1e45f4a0a7d36f2809f199"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RleHRyZWdpb246Njc5Y2YwNGUwMTg5NGQxMmI3ZmFiYTIwZGVhNGY1NmNfNTIx_aee71e01-912f-4a96-b637-9c6ed5f8d0a9" continuedAt="i760e5d2bee1648358e157a086c45bf2f" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, available for sale marketable securities by security type consisted of (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes (due within one year)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ff53cf442042cdb4b36d6e72142a1b_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMS0xLTEtMS01NDQ4Mw_c292daec-a8ad-4f0e-a998-2a8652e59381">2,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ff53cf442042cdb4b36d6e72142a1b_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMS0zLTEtMS01NDQ4Mw_42b98b59-5a53-422b-95c4-9d62554abc5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5ff53cf442042cdb4b36d6e72142a1b_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMS01LTEtMS01NDQ4Mw_85dac92a-3f76-428b-8d76-a7b37f71bf4e">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ff53cf442042cdb4b36d6e72142a1b_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMS03LTEtMS01NDQ4Mw_3aada0d2-9506-4571-996f-bbd4426a7c90">2,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies (due within one year)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a624a02dc70405cb5fbe4a2e977a9f9_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi0xLTEtMS03MTk5Ng_c51b5b0e-138b-46d5-bb62-e2bd0699ee01">7,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a624a02dc70405cb5fbe4a2e977a9f9_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi0zLTEtMS03MTk5Ng_40780b2c-3e3d-401d-be6a-021228d14cee">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a624a02dc70405cb5fbe4a2e977a9f9_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi01LTEtMS03MTk5Ng_9fd7c483-fbd7-42e3-97ae-1ec59a5e3b40">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a624a02dc70405cb5fbe4a2e977a9f9_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi03LTEtMS03MTk5Ng_54998c3b-510c-478a-bda9-77f7fc4318e3">7,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper (due within one year)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b3ffa3baf7435c93a45a49e8b25af7_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi0xLTEtMS01NDQ4Mw_2ce7e4fd-121d-4df6-8923-e862b6885fa1">38,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b3ffa3baf7435c93a45a49e8b25af7_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi0zLTEtMS01NDQ4Mw_68c82073-cc51-4560-b634-68e09c0daaf5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87b3ffa3baf7435c93a45a49e8b25af7_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi01LTEtMS01NDQ4Mw_519bcd80-234d-4e64-93c0-966429af7458">102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b3ffa3baf7435c93a45a49e8b25af7_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi03LTEtMS01NDQ4Mw_b8fa8e1f-b2f5-4f42-b71c-33f1dea4f515">38,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due within one year)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74970c52e4004e8b8552988d5f7c2170_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMy0xLTEtMS01NDQ4Mw_4776964a-9aa9-450f-86aa-f1fdf2d1deea">165,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74970c52e4004e8b8552988d5f7c2170_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMy0zLTEtMS01NDQ4Mw_198769b2-b147-41f1-b408-64c2ac45ab10">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74970c52e4004e8b8552988d5f7c2170_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMy01LTEtMS01NDQ4Mw_e32180e8-5aa1-4c1e-a942-156279041c1e">1,565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74970c52e4004e8b8552988d5f7c2170_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMy03LTEtMS01NDQ4Mw_d65d914c-1ff7-4cc8-91ad-6623401e4030">163,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies (due after one year through two years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda5759b36f940b19380a66d34dae73c_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi0xLTEtMS03MjAwNA_ec22d341-30b2-47ed-9432-15cd380e9329">2,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda5759b36f940b19380a66d34dae73c_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi0zLTEtMS03MjAwNA_22bc8b0b-af2c-41c6-8691-12d970f00b1c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda5759b36f940b19380a66d34dae73c_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi01LTEtMS03MjAwNA_18cc3279-35b2-467d-82f1-f4b91faae346">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda5759b36f940b19380a66d34dae73c_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi03LTEtMS03MjAwNA_bef55b29-9e11-476b-b567-46dd1c16737f">2,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due after one year through three<br/>&#160;&#160;&#160;years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb5c24a093394ecba28d4a9c5bcdbb9d_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNS0xLTEtMS01NDQ4Mw_d7b43d7c-641e-4734-8ce6-b59d01690e45">50,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb5c24a093394ecba28d4a9c5bcdbb9d_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNS0zLTEtMS01NDQ4Mw_a85cc2a1-cd97-47ac-90b3-11d79c8ab105">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb5c24a093394ecba28d4a9c5bcdbb9d_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNS01LTEtMS01NDQ4Mw_db08430f-60a9-45a2-9091-ad315e644e8c">1,132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb5c24a093394ecba28d4a9c5bcdbb9d_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNS03LTEtMS01NDQ4Mw_72186336-3f90-477c-a2ad-25ddd1ecbf7a">49,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi0xLTEtMS01NDQ4Mw_f827bdd6-4d0b-439b-8ab5-7242fb7fd468">268,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi0zLTEtMS01NDQ4Mw_a0c66a6f-aaa6-4ffb-acb3-1e91f814b704">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi01LTEtMS01NDQ4Mw_d159ffc0-b77a-42a1-891d-86d4d19f84a7">2,883</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi03LTEtMS01NDQ4Mw_27e5dd4b-3351-4401-b5fa-cd6bd6436206">265,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><ix:continuation id="i105425e2ce1e45f4a0a7d36f2809f199"><ix:continuation id="i760e5d2bee1648358e157a086c45bf2f"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, available for sale marketable securities by security type consisted of (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes (due within one year)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2a16fe60e7940d0acb3671bc0544537_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS0xLTEtMS03MDY4MA_703d533a-17e1-4992-b436-969628529b3d">7,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2a16fe60e7940d0acb3671bc0544537_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS0zLTEtMS03MDY4Mg_cbceee27-c21b-46dd-8625-fa6c2599861d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2a16fe60e7940d0acb3671bc0544537_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS01LTEtMS03MDY4NA_c7746442-c0f6-4ef7-a1bb-82db0b29b6c6">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2a16fe60e7940d0acb3671bc0544537_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS03LTEtMS03MDY4Ng_29b14461-ac0b-4429-a109-3d2b61bbe680">7,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper (due within one year)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f9150da3aa40d8b086ad8ea1702556_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS0xLTEtMS01NDQ4Mw_0da3ef82-3a3e-4c32-88cb-31f3a0ba13c4">56,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f9150da3aa40d8b086ad8ea1702556_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS0zLTEtMS01NDQ4Mw_ea7560a1-480b-48c1-ab93-ff90e7dfc623">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2f9150da3aa40d8b086ad8ea1702556_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS01LTEtMS01NDQ4Mw_3abcf502-0055-4c42-9a62-586cafc44b4d">301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f9150da3aa40d8b086ad8ea1702556_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS03LTEtMS01NDQ4Mw_8d2c3f67-29fd-4ebd-82aa-e16cfdf20f40">56,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due within one year)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icccd4d043a644533bb05611e707ac152_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMi0xLTEtMS01NDQ4Mw_08405a94-e085-46a0-85e9-7786416b5036">139,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icccd4d043a644533bb05611e707ac152_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMi0zLTEtMS01NDQ4Mw_40fbb4d3-4b01-48ee-888b-1ebe1dcdbce7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icccd4d043a644533bb05611e707ac152_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMi01LTEtMS01NDQ4Mw_06da0a0c-4415-4372-b2ce-efb6704b53f2">1,342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icccd4d043a644533bb05611e707ac152_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMi03LTEtMS01NDQ4Mw_d34a5af0-16de-40f9-aa4d-6693d3ef12db">138,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due after one year through three<br/>&#160;&#160;&#160;years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a297b2b298d4b4d8e5832e54f043948_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfNC0xLTEtMS03MDY3Mg_e4ad1207-2925-4b6d-a2e6-f23716e2a037">93,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a297b2b298d4b4d8e5832e54f043948_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfNC0zLTEtMS03MDY3NA_a9a930b6-479e-4ccf-9cd6-71d7ed3e2bc4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a297b2b298d4b4d8e5832e54f043948_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfNC01LTEtMS03MDY3Ng_73ae31fb-fef6-46a2-a9f8-06f53a9f9ede">2,234</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a297b2b298d4b4d8e5832e54f043948_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfNC03LTEtMS03MDY3OA_80ea432c-8b87-468b-b74d-f24f8488b656">90,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMy0xLTEtMS01NDQ4Mw_9be58dfa-46bb-44ca-bf6c-162c6efb8afa">297,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMy0zLTEtMS01NDQ4Mw_42d19926-75d5-4312-b829-476983e170e6">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMy01LTEtMS01NDQ4Mw_a2582c63-54c3-40b5-a7d6-3eccd25fe51d">3,992</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMy03LTEtMS01NDQ4Mw_0c4844f7-aa6b-4054-a126-01454424eccc">293,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RleHRyZWdpb246Njc5Y2YwNGUwMTg5NGQxMmI3ZmFiYTIwZGVhNGY1NmNfNTIy_9710f799-a39f-492c-a7d6-cb7b9137ff33" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s fair value hierarchy for its assets and liabilities, which are measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at March 31, 2023 Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e7d370e72b448e2a20136c9d41a611a_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNC0xLTEtMS01NDQ4Mw_861a9582-ba00-42bc-922a-ec9fb1114aef">33,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i686a387809184aaa8b50bc8cc6187e9a_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNC0zLTEtMS01NDQ4Mw_3e7483cb-9a2f-4f2d-9624-bddc56b7363f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86ecb94b9d984d25b19dab4395167083_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNC01LTEtMS01NDQ4Mw_69d954d0-9ca3-42e5-87c7-bb89a01524e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b9d85917e44b37a2c2ee5fba4bb13d_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNC03LTEtMS01NDQ4Mw_b1a187a8-0638-49ec-8ca3-3381b74b25c7">33,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28c0fdc526e4f449092eb7231d7981a_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNi0xLTEtMS03MjA3Nw_51c4cc66-2a2a-45dc-bce3-de3de5c45f7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78bf0b3f545e49799c0cf64e8fcc4d0d_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNi0zLTEtMS03MjA3Nw_921be66d-4958-4b7f-8c5a-a31d711be43f">16,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic48f4328d06740f69e82bae9d7f08326_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNi01LTEtMS03MjA3Nw_6e732331-d7ef-46a4-933a-2d2122fb6b88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226002d2e8c3483999dbe6e1536bc05d_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNi03LTEtMS03MjA3Nw_7307d213-6738-438c-a168-27e56ead9287">16,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e4e5e96f3f249ad8b7059648464f925_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOC0xLTEtMS01NDQ4Mw_655aff9b-083e-4f11-bcd7-ddd1ec015361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02cfa68b2fd349328e287ea50a6ac000_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOC0zLTEtMS01NDQ4Mw_4139c6bd-d47d-4c2c-acdb-a5fbd4363110">2,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1aa441de3a4917a6058ce4f3a680f5_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOC01LTEtMS01NDQ4Mw_e3466847-ba16-41f4-adee-9737e356c35b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec137b73eb794feb8171dd03dd591a9e_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOC03LTEtMS01NDQ4Mw_4fd31c70-d8ed-4cc5-a0be-c0ff471f0d1a">2,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7a6e0cb2e5a44cbb8cc75a960fa04b7_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtMS0xLTEtNzIwODM_b085a524-9b61-4b47-a305-469de16ab173">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib00daf24652143c5a0de12e6924f3607_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtMy0xLTEtNzIwODM_35a4d73d-0ceb-4578-8272-c60e1bbf1bba">10,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d88f74ab4b24a56895f526a176976f8_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtNS0xLTEtNzIwODM_f2da6e97-164f-41a0-bcc4-6685d05fdbd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b16e50543348558175caaea85b3122_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtNy0xLTEtNzIwODM_cda436c0-8dc8-4130-852f-20ed00f54159">10,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id59576d83db143329d18b549ecb1cac8_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOS0xLTEtMS01NDQ4Mw_de998947-e3d3-4afd-90e2-b8f471aa2bfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7519c80b092a4ac7a57f59e62e77991e_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOS0zLTEtMS01NDQ4Mw_b4f719e6-e183-40d4-aa72-3c05420e4dd0">38,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1225ef2f386f4a42975c134708350d10_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOS01LTEtMS01NDQ4Mw_c6601e81-94aa-4af4-9b88-bb87f37ec2f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i685de5a7038c45189760b9c211f5be9d_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOS03LTEtMS01NDQ4Mw_fc35c30d-f90b-4e7e-a950-270f945b9609">38,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i469fee02bf054803a29064895742bcca_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtMS0xLTEtNTQ0ODM_729ccc66-c1a5-4dcc-9b8f-f6477f1d0ffa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3eb52799bb4915b8ccdde486715eba_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtMy0xLTEtNTQ0ODM_4da33bf6-3b5c-4aab-bb84-bcfe9c8b9077">213,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644cf406771343be85fb0303035cc30a_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtNS0xLTEtNTQ0ODM_9dcca048-4d52-44bd-90c0-d583395212dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20240e23302249feb5d81f005bfe4920_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtNy0xLTEtNTQ0ODM_1d5b0057-1323-416d-8bba-28cbd43fb83c">213,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ab63392b2c74b5ab99240d3a67ddf2e_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTEtMS0xLTEtNTQ0ODM_71502a63-93c1-4e94-886c-f90e867b1e49">33,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf60218770ed4221baf7f3056c9eb494_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTEtMy0xLTEtNTQ0ODM_1a8ce7ee-df02-45fe-8834-27481c2cdd56">282,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id35b96fd44f74edfa4730b85402d177b_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTEtNS0xLTEtNTQ0ODM_040d87ce-635f-4c4b-84a3-16ab08797dbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9d68f7e99d1431eb12bc2400a498113_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTEtNy0xLTEtNTQ0ODM_1f259b01-fe2d-42e7-a2a8-887366be1de5">315,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at December 31, 2022 Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae8d45dbde14f8d8de46117ec781d4d_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTYtMS0xLTEtNTQ0ODM_3a9bc025-353f-4fa2-b246-167869aeeb28">28,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c7ac8901bd4d7daac300b48c7919ec_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTYtMy0xLTEtNTQ0ODM_7a37740e-ebe1-4aa3-ac77-9b3fb7a8c611">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id695c0b8a3e24d06a747342d16c3d091_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTYtNS0xLTEtNTQ0ODM_b9c66a53-e2dd-491b-b453-551663d810ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f4e06b5736f4b7f90965814e6fb2834_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTYtNy0xLTEtNTQ0ODM_1599477f-adf5-45a1-a2f2-e5325f92e3d6">28,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3816c705b119429ea8c4ca667dd7af1a_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctMS0xLTEtNzA2OTA_e4b224a7-0969-43b8-8533-eede28957902">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e370a92af44ccbaa5d713dfe2a8fb1_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctMy0xLTEtNzA2OTA_56e3216f-b52c-4d8c-8209-bbcd1b2cb5ef">1,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5aa2802907e4a0e80ba161a3b27fac2_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctNS0xLTEtNzA2OTA_e8fb3a1f-e4a9-47ae-b953-5a1e59888cec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f3c7b44e12a4950b574e402e90a4e96_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctNy0xLTEtNzA2OTA_60eece9d-4eb2-4e26-be36-d80441b23679">1,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id11f9d139c334e3e877bbc1b71a3bcb0_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctMS0xLTEtNTQ0ODM_add91716-4835-45a7-be90-9e98f3a57a53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b0898b80bf94bd3a1898a19e50c68e4_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctMy0xLTEtNTQ0ODM_afc8ec87-cdd8-49e4-93a0-ccef4529a084">22,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c08e1329914a148a2969a210c89c47_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctNS0xLTEtNTQ0ODM_e831cb7a-c561-4df1-b4d5-54b82f66591c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71476e1da87a4e8f9ea82e1558b4b1a0_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctNy0xLTEtNTQ0ODM_7c0d6727-7a50-4ede-8343-f37b89dfab6d">22,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icec32c8d710e4052a2ea76320025a801_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtMS0xLTEtNzA2OTI_b0c42bd4-47a7-4b55-b15c-dfa82a776894">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73e10639ef0246c198a7a50e793bbcbd_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtMy0xLTEtNzA2OTI_ec911bef-50a7-4997-90f1-489ba4c43bdd">7,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i314ef289b4614198b2006dc7331ea1c7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtNS0xLTEtNzA2OTI_a4abcf34-5a03-4bd2-b681-3e1451d6b8d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4950fd3c93f40b8917a76b077c0c64b_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtNy0xLTEtNzA2OTI_03b6a9a1-853b-4649-b3d6-b759e000205f">7,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b1e949f6974b58964fd91bd5f979d7_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTktMS0xLTEtNTQ0ODM_e8aec726-00e5-4059-8095-ca11eab0b683">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa55d59c40f34aaba7d356a0fbff653f_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTktMy0xLTEtNTQ0ODM_ca51fde4-51b1-4e8d-a193-6a7e4e7eea85">56,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i817ec589b1634a54955b21c64565e8ea_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTktNS0xLTEtNTQ0ODM_5836d21b-4fab-4199-a6e5-f050d60b4b92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9df0cfa07c49422683e3147992721a62_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTktNy0xLTEtNTQ0ODM_5ab67153-d2b7-4b1d-a816-9646e43968fe">56,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf0f225480c34371bc29f61873b9ae64_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtMS0xLTEtNTQ0ODM_f7755e71-d8bd-4716-97c3-32a1cdb8adb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icee323c63b8a4f55a03f6972bf66bacb_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtMy0xLTEtNTQ0ODM_68ca4775-d393-4f7f-a814-ba5133bdb716">229,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ce20a435b94f1782ba0f50fd86a8b8_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtNS0xLTEtNTQ0ODM_0897cf91-8b1c-4291-a491-1df78be014d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8a50f4fbb394949aeccc379c70c428a_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtNy0xLTEtNTQ0ODM_710de2b5-5693-42dd-b2cb-bf981d6d991a">229,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a9f200afdd4b0499bec1ec0815830a_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjEtMS0xLTEtNTQ0ODM_5599deb0-acc5-4127-a641-764a0201a184">28,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af856e6f8244114882cf272fe719890_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjEtMy0xLTEtNTQ0ODM_45bb9ae1-8caa-4904-a417-099fe4c8a666">317,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f76a5224ab9460ab1687a0e61c62469_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjEtNS0xLTEtNTQ0ODM_459e03d2-a9b0-4ba9-b202-26199f8df3bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313c23ac84db459aa067b05c470e8c41_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjEtNy0xLTEtNTQ0ODM_433b22ff-9a4c-4886-b7f8-89a2c0a5bff1">345,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022, there were no transfers between Level&#160;1, Level&#160;2 and Level&#160;3.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RleHRyZWdpb246NTM5ZTZjYzRmZDhkNGM5NGJhODZhZTczMTE1MDNkYjFfMjcy_c65e8433-a9a7-48cf-a59e-3ac9cee9fde4" continuedAt="i45cf7a86de4c4bdd8258275b37b7208e" escape="true">Property and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="i45cf7a86de4c4bdd8258275b37b7208e" continuedAt="i14ac08883cb240a99ea1166e150c0ea5"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RleHRyZWdpb246NTM5ZTZjYzRmZDhkNGM5NGJhODZhZTczMTE1MDNkYjFfMjcz_246b1089-9389-434f-a814-cda794533784" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:70.138%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e381c984bf544cfb0a2749f7b7bde14_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMS0xLTEtMS01NDQ4Mw_8fad5d10-7352-4422-8669-000608f1d3fb">6,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia478d511da57498795c16881932b6687_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMS0zLTEtMS01NDQ4Mw_8ebd4119-54e9-425f-ba91-95648e7c75a0">5,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8db8c7bc36df4ad98557037afc88e098_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMi0xLTEtMS01NDQ4Mw_4b20be78-6cb5-4960-929f-192ddfd17af4">815</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4069cd6268314c4eb4dc21bd8aa31034_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMi0zLTEtMS01NDQ4Mw_732de853-5d4a-4590-998a-d8dcf6f51c1c">815</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15776fdc2f634cd2b8afecdccc812ee3_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMy0xLTEtMS01NDQ4Mw_3a4d921e-159d-4011-910b-e0966c5e55cb">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c2ae1d1ba35403ba1cfeec4178824b6_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMy0zLTEtMS01NDQ4Mw_8db3beb1-dabc-4363-a998-8ec9a8ff14b9">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff620723fc0c49618aaa87a660c11285_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNC0xLTEtMS01NDQ4Mw_0e2065e8-be72-486e-964e-d0f869aa39da">17,235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a85b1b3aa94e2a88d7205cbf50b9a0_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNC0zLTEtMS01NDQ4Mw_1c900e34-75b5-4b0d-9855-aa4be2447ecb">17,123</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets not yet placed in service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic713b3b8646d4e9c952914b317f34c25_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNS0xLTEtMS01NDQ4Mw_13848450-edf7-478c-8df5-5b493fee69bc">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f03ccf48fbd464fbb077f9ae05ad5f5_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNS0zLTEtMS01NDQ4Mw_10dd9c4d-e68c-47e4-a3d4-4673c7b290d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNi0xLTEtMS01NDQ4Mw_1edad350-c288-445c-84ec-4a16a0fb9936">24,695</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNi0zLTEtMS01NDQ4Mw_0fd2678c-ca77-4467-b871-fba054a230e8">23,922</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNy0xLTEtMS01NDQ4Mw_5d90d259-b0f9-429a-ae37-9ccb01751ec6">9,470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNy0zLTEtMS01NDQ4Mw_2314d414-4893-4d51-95b0-4e52304b92e5">8,611</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfOC0xLTEtMS01NDQ4Mw_98b2d215-bc95-4b02-bd70-43a1c85a1547">15,225</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfOC0zLTEtMS01NDQ4Mw_2d1df288-fd8e-4fec-85a6-c28ed9c10e0c">15,311</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i14ac08883cb240a99ea1166e150c0ea5">Depreciation and amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RleHRyZWdpb246NTM5ZTZjYzRmZDhkNGM5NGJhODZhZTczMTE1MDNkYjFfMTQ5_8df2eb02-71aa-4579-bb36-f02bf2b54523">0.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RleHRyZWdpb246NTM5ZTZjYzRmZDhkNGM5NGJhODZhZTczMTE1MDNkYjFfNTQ5NzU1ODEzOTI4OA_476dc952-842e-4770-99f5-715cba724b09">0.8</ix:nonFraction>&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively</ix:continuation>.</span></div><div id="id19142a81b5f479380a5a5b4606181d7_49"></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RleHRyZWdpb246OThlNDNkYTc5OTE1NDA1OTlhNmQwN2E1NDU3Yjk2MDRfMTE0_6456c431-b597-4bc5-b7f7-85e817a98a7e" continuedAt="i362ce7163e10471c896e0124174d0c40" escape="true">Accrued Expenses and Other Current Liabilities</ix:nonNumeric></span></div><ix:continuation id="i362ce7163e10471c896e0124174d0c40"><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RleHRyZWdpb246OThlNDNkYTc5OTE1NDA1OTlhNmQwN2E1NDU3Yjk2MDRfMTEz_ae8b28bf-569d-4e6b-9b32-2a006f5598e4" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:70.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.932%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued external research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="fhtx:AccruedResearchAndDevelopmentExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMS0xLTEtMS03Mzg2Nw_0b8f159f-56fc-4c23-88be-d28b234e3e87">5,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="fhtx:AccruedResearchAndDevelopmentExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMS0zLTEtMS03Mzg2Nw_75af4f39-13b7-4e86-9d0d-72e78e464422">5,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AccruedIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMi0xLTEtMS03Mzg4Ng_d5214ac0-cdc6-4190-99b5-499e0e78866c">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AccruedIncomeTaxes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMi0zLTEtMS03Mzg4Ng_9aeadf4d-92e6-4684-bc4e-5adfdb3b6979">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMS0xLTEtMS01NDQ4Mw_c393d574-0893-4848-aeb4-389397538fb9">1,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMS0zLTEtMS01NDQ4Mw_41847210-4e81-436a-9821-5a36c9edcf67">4,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMy0xLTEtMS01NDQ4Mw_d5273256-a591-4233-9873-291f5e9cfd7d">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMy0zLTEtMS01NDQ4Mw_a8cd3dff-eb9c-4622-a10e-8f79d6ed2667">678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfNS0xLTEtMS01NDQ4Mw_5b14e13e-160e-473d-9e27-9e9a1d0b7bc7">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfNS0zLTEtMS01NDQ4Mw_8be12e06-8161-4c57-85e4-1059dca141d8">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfNi0xLTEtMS01NDQ4Mw_2f1b4252-ec75-4e31-908c-b602dde59320">8,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfNi0zLTEtMS01NDQ4Mw_a6c61d1e-23b3-4d5c-92da-23cc7798bc0f">11,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="id19142a81b5f479380a5a5b4606181d7_52"></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RleHRyZWdpb246YTE2NDI4ZjYxN2RhNDY0N2FlNWYyZGI4MGY1YmU0MWZfNTMw_784529fb-7a08-4d46-b5de-560be1b6c6d0" continuedAt="i8b93482dbdb04080b738b61ff4bd7645" escape="true">Common Stock and Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="i8b93482dbdb04080b738b61ff4bd7645"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock entitles the holder to <ix:nonFraction unitRef="vote" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="INF" name="fhtx:CommonStockVotingRightsVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RleHRyZWdpb246YTE2NDI4ZjYxN2RhNDY0N2FlNWYyZGI4MGY1YmU0MWZfMTA1_6a8dc13a-4bb7-4707-b73a-51f3187e970e">one</ix:nonFraction> vote on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RleHRyZWdpb246YTE2NDI4ZjYxN2RhNDY0N2FlNWYyZGI4MGY1YmU0MWZfNTMy_67688bb0-3b0e-48c2-8e56-8400bfdd5cf4" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents presented based on amounts outstanding at each period end have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4cc0d48a32c3455495ce27d4f7ddeea1_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfMi0xLTEtMS01NDQ4Mw_d4089eb5-e6b9-4014-a478-3da78a998af2">9,666,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdd9cd9080824f859292dd01a8c3382f_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfMi0zLTEtMS01NDQ4Mw_011d4d88-ea92-4245-a5e4-aae1aac46f4e">7,772,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d6f5962b24a487098593ec15299f24a_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfMy0xLTEtMS01NDQ4Mw_fdd983d8-56f2-4916-9cb6-6a41258e0c8d">18,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i253b75ffb52440b49b4e9bbe4fb210dd_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfMy0zLTEtMS01NDQ4Mw_bc5f1f56-a2a0-466b-a7e7-d6d8aa02cd76">18,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfNC0xLTEtMS01NDQ4Mw_b47464b5-f4d8-4ae5-a7d9-6ff4fccef3dd">9,684,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfNC0zLTEtMS01NDQ4Mw_e444dd47-b44b-4ed2-bbc4-4beaa39812d4">7,790,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="id19142a81b5f479380a5a5b4606181d7_55"></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNDEzNQ_637b94e0-e18c-4811-97cc-a26f2a0bb2f9" continuedAt="i96d5516136944a7eaa533420c83f9a5e" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i96d5516136944a7eaa533420c83f9a5e" continuedAt="i1a5c5f02f75d4734903e5ba862306c02"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Equity Incentive Plan</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2020 Equity Incentive Plan ( the &#8220;2020 Plan&#8221;) provides for the grant of incentive stock options, non-qualified options, stock appreciation rights, restricted stock awards, restricted stock units and other stock-based awards. The number of shares initially reserved for issuance under the 2020 Plan was (i) <ix:nonFraction unitRef="shares" contextRef="i3ff3d19669cd4af68367e024a5550402_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNzQz_421ebac8-ee46-4bd2-945d-b70e0b5e7d05">2,200,000</ix:nonFraction> shares (the &#8220;share pool&#8221;), plus (ii) the number of shares of common stock available for issuance under the Company&#8217;s 2016 Stock Incentive Plan (the &#8220;2016 Plan&#8221;) as of the effective date of the 2020 Plan, plus the number of shares of common stock underlying awards under the 2016 Plan that on or </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><ix:continuation id="i1a5c5f02f75d4734903e5ba862306c02"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">after the date of adoption expire or become unexercisable without delivery of shares, are forfeited to, or repurchased for cash, are settled in cash, or otherwise become available again for grant under the 2016 Plan, in each case, in accordance with its terms (up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="id06ab9cb3fff4cedb3c46e4ccf43eb35_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMTI4MA_4d2ccb6e-1ce2-491b-8841-eafcf15d5417">5,078,295</ix:nonFraction> shares). As of March&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="i3ff3d19669cd4af68367e024a5550402_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMTMwMg_1a9ca0d4-cbc1-420b-b4fe-5a235e63b459">1,359,407</ix:nonFraction> shares remained available for future grant under the 2020 Plan.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The share pool will automatically increase on January 1 of each year from 2021 to 2030 by the lesser of (i) <ix:nonFraction unitRef="number" contextRef="i1d79c74373c442b499c7ddd85c70b8dd_D20230101-20230331" decimals="2" name="fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMTQ3Nw_651d5f68-a920-4329-9d53-2aa02b5f4b0f">four</ix:nonFraction> percent of the number of shares of our common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares determined by the board of directors on or prior to such date for such year. The number of shares reserved for issuance under the 2020 Plan was increased by <ix:nonFraction unitRef="shares" contextRef="i2c27d19751c94d7eb6c46feae55f646f_D20220101-20220101" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMTgwMA_03c51650-3c02-4ae4-8651-cc0b635af110">1,672,137</ix:nonFraction> shares effective January 1, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Plan is administered by the board of directors or, at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or its committee if so delegated. Stock options granted with service-based vesting conditions generally vest over <ix:nonNumeric contextRef="i1d79c74373c442b499c7ddd85c70b8dd_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMjIxMA_4ed4e167-3b3e-44d2-98a1-b992cba43cde">four years</ix:nonNumeric> and expire after <ix:nonNumeric contextRef="i1d79c74373c442b499c7ddd85c70b8dd_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMjIzMA_7f80503a-cf57-4633-8c62-4ff42c91863a">ten years</ix:nonNumeric>. The exercise price for stock options granted is not less than the fair value of common stock on the date of grant. The Company bases fair value of common stock on the quoted market price. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Employee Stock Purchase Plan</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 21, 2020, the Company&#8217;s board of directors adopted and its stockholders approved the 2020 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), which became effective on October 21, 2020. The aggregate number of shares of common stock available for purchase pursuant to the exercise of options under the ESPP is <ix:nonFraction unitRef="shares" contextRef="i69fa4e2b8bc24bf388f1f890c4ecf2e2_I20201021" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMzExNA_24770ea8-9e02-40b7-a19c-f82656279f04">360,000</ix:nonFraction> shares, plus an automatic annual increase, as of January 1 of each year from 2021 to 2030, equal to the lesser of <ix:nonFraction unitRef="number" contextRef="ib8a38bc229cb4e8bb77f5c2c4c4b0cd0_D20201021-20201021" decimals="2" name="fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMzIzMQ_1518ffb6-20c7-4b03-adfe-64cda1d5b0cb">one</ix:nonFraction> percent of the number of shares of common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares determined by the board of directors on or prior to such date for such year (up to a maximum of <ix:nonFraction unitRef="shares" contextRef="i891fd370eb434c04aa39afcf2287fbff_I20230331" decimals="INF" name="fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMzQ4OQ_3a4ddcec-ceec-4a1f-9927-67182b81f84b">3,220,520</ix:nonFraction> shares). The number of shares reserved for issuance under the ESPP was increased by <ix:nonFraction unitRef="shares" contextRef="i09392e1f7a274b01845cedcdc8ed5acd_D20230101-20230101" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMzU3Ng_bdf238a6-65b0-4e77-81d9-a1443069ac07">418,034</ix:nonFraction> shares to <ix:nonFraction unitRef="shares" contextRef="i6182cbed24bc4b8ab1aa853c3f9e2cb3_I20230101" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMzU4OQ_ebe4fb74-4f34-44b7-a317-d147d4eefe35">1,184,497</ix:nonFraction> shares effective January 1, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eligible employees may authorize payroll deductions of up to <ix:nonFraction unitRef="number" contextRef="i891fd370eb434c04aa39afcf2287fbff_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNjU5NzA2OTc3NTMyNA_c4b159b9-7192-4a93-8eec-ab5dd1df81fd">15</ix:nonFraction>% of their eligible compensation during an offering period. The purchase of shares is done at a <ix:nonFraction unitRef="number" contextRef="id6ce4bd203a74a629ec0457813c1657f_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNjU5NzA2OTc3NTMxOA_1c425423-e397-46b5-88f5-9cd37a15d908">15</ix:nonFraction>% discount on the lesser of (i) the Fair Market Value of a share of Stock on the first day of the offering period and (ii) the Fair Market Value of a share of Stock on the last day of the offering period. The Company currently holds two offering periods, September 1 and March 1, respectively.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first offering period commenced under the ESPP on September 1, 2021. The Company recognized a de minimis amount of expense related to the ESPP for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNDEzNw_64eddafa-515b-46a5-a2d5-d41d675f7bbb" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:72.490%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.809%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95f74147740a473d8c886cfbe8d8cf9f_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfMi01LTEtMS01NDQ4Mw_003d88e6-e4aa-4c91-9e96-e30799d50b0d">2,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e516a981dbe4601a952b105e005f398_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfMi03LTEtMS01NDQ4Mw_3ccb7a70-ffe8-46a2-bbb9-824b5f7a70b0">1,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6112131b7aec49b494f0b988b8f51e90_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfMy01LTEtMS01NDQ4Mw_96b32c0d-ac2a-4fab-ad0e-6cbe13267a8d">2,533</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ac8dbde3e704d4ea43e4284fbd658c5_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfMy03LTEtMS01NDQ4Mw_de8891f9-9d57-4ea9-9025-f0f36f20ac4b">1,735</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfNC01LTEtMS01NDQ4Mw_5c445cca-c032-490e-8a3b-b2138e1d385a">4,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfNC03LTEtMS01NDQ4Mw_8e2184fd-e51d-48ce-9cea-7454de94fde8">3,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, total unrecognized compensation cost related to unvested options was $<ix:nonFraction unitRef="usd" contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNDA2MA_3d8fe3d2-9b16-496a-8b32-fb810d6079ff">40.6</ix:nonFraction> million, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNDEzMw_702d1bc8-47c0-4082-9014-5d5640972391">2.7</ix:nonNumeric> years.</span></div></ix:continuation><div id="id19142a81b5f479380a5a5b4606181d7_58"></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTg1MzM_95c0e76d-537a-43ef-97e7-3a32cf9695ce" continuedAt="ib9819bce0a974d739163cff692f70218" escape="true">Collaboration Agreements</ix:nonNumeric></span></div><ix:continuation id="ib9819bce0a974d739163cff692f70218" continuedAt="i29917a934f374ff2b947859e0c1e5d04"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lilly Collaboration Agreement and Stock Purchase Agreement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into the Lilly Collaboration Agreement with Lilly to create novel oncology medicines by applying Foghorn&#8217;s proprietary Gene Traffic Control platform. The collaboration includes a co-development and co-commercialization agreement for the Company&#8217;s selective BRM oncology target, consisting of two programs, and one additional undisclosed oncology target (collectively, the &#8220;Joint Programs&#8221;). The collaboration also includes <ix:nonFraction unitRef="target" contextRef="id704eaec79f3499d8b4e968f504e58eb_D20211201-20211231" decimals="INF" name="fhtx:NumberOfAdditionalTargets" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNTgx_113d35b8-30b6-4cfb-ad07-ac91c2452358">three</ix:nonFraction> additional discovery targets or programs (collectively, the &#8220;Discovery Programs&#8221;) for a total of <ix:nonFraction unitRef="program" contextRef="id3e63d9fb12c49febbf0ab26cfed6a9a_I20211231" decimals="INF" name="fhtx:NumberOfPrograms" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNjgx_b864110e-55d1-4d45-8892-0b2d71077412">six</ix:nonFraction> programs directed at <ix:nonFraction unitRef="target" contextRef="id3e63d9fb12c49febbf0ab26cfed6a9a_I20211231" decimals="INF" name="fhtx:NumberOfTargets" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNzA1_ca76e40c-59b9-46be-88f2-47a020ecb7b0">five</ix:nonFraction> targets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the Joint Programs, the Company will lead discovery and early research activities through the successful completion of dose finding toxicity studies for the identified compound, while Lilly will lead development and commercialization activities of the identified compound with participation from the Company in development activities and 50% cost sharing until registrational clinical trials. The Company and Lilly may jointly develop and commercialize the Joint Program compound though the Company may, in its sole discretion, opt-out on a program-by-program basis of further </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><ix:continuation id="i29917a934f374ff2b947859e0c1e5d04" continuedAt="iea6a0ca7964f4969a36353f6ff9f9ed7"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">participation in the development and commercialization efforts prior to the first registrational clinical trial. If the Company does not opt-out, Lilly and the Company will continue to share in the costs to further develop and commercialize the Joint Program compound on a worldwide basis, equally share in the U.S. profits on product sales, subject to certain adjustments and receive royalties on sales outside of the United States (&#8220;Ex-U.S.&#8221;) at royalty rates ranging from low double digits to high twenties. If the Company opts-out of further development and commercialization efforts, it will have no further obligations to share in the development and commercialization costs, will receive royalties rather than profit share on U.S. sales and will receive royalties at a lower rate on Ex-U.S. sales.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the Discovery Programs, the Company will lead discovery and early research activities through the successful completion of dose finding toxicity studies for the identified compounds. The Company may, in its sole discretion, opt-in on a program-by-program basis after the successful completion of dose finding toxicity to participate in the further development and commercialization efforts of the Discovery Program compounds. If the Company opts-in to the development and commercialization of the Discovery Program compounds, it will be eligible to receive milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="ie2d1ee7b60654dcdbf509fe84739b901_I20211231" decimals="-5" name="fhtx:MilestoneReceivableUponAchievement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMjcxNg_808c18f3-c87a-4a61-a298-1f11b49f2732">10.0</ix:nonFraction> million per program upon specified research and development milestones and up to $<ix:nonFraction unitRef="usd" contextRef="ia2c5f857c11b4186bd0df9d1860dcca9_I20211231" decimals="-5" name="fhtx:MilestoneReceivableUponAchievement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMjc5Mg_79998fee-f1cc-4b91-9837-df9884d50009">180.0</ix:nonFraction> million per program upon achievement of specified regulatory and commercial milestones and will also be eligible to share in the U.S. profits at pre-determined percentages on product sales. The Company would also be eligible to receive tiered Ex-U.S. royalty rates, calculated on a product-by-product and country-by-country basis, on net sales outside of the United States, if any, ranging from low single digits to low double digits, but less then teens. If the Company does not opt-in to further development and commercialization efforts for the Discovery Programs, it will be eligible to receive milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="ic8e4b7ca8d86457dbee60cfa6bc83796_D20211201-20211231" decimals="-5" name="fhtx:OptOutMilestoneReceivableUponAchievement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMzQxNA_17db4506-0579-4c95-98d8-7585700b4c45">70.0</ix:nonFraction> million per program upon specified research and development milestones and up to $<ix:nonFraction unitRef="usd" contextRef="i932a791f229b4a74be687fda2016ec96_D20211201-20211231" decimals="-5" name="fhtx:OptOutMilestoneReceivableUponAchievement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMzQ5MA_904e8027-c339-4194-becd-95c73bee85a4">360.0</ix:nonFraction> million per program upon achievement of specified regulatory and commercial milestones per approved product, if any. The Company would also be eligible to receive tiered royalties on net sales of products worldwide at royalty rates ranging from low single digits to low double digits, but less then teens.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lilly has the right to make substitutions for each of the five targets during the research term of each program, subject to certain limitations. Pursuant to the Lilly Collaboration Agreement, the Company will also participate in joint decision-making through the joint steering committee and subcommittees. Unless terminated earlier, the Lilly Collaboration Agreement will continue on a product-by-product basis until the expiration of all royalty obligations under the Lilly Collaboration Agreement and when neither the Company nor Lilly is developing, commercializing or manufacturing any product under the Lilly Collaboration Agreement. The Company or Lilly may terminate the Lilly Collaboration Agreement upon an uncured material breach by the other party. Lilly may also terminate the Lilly Collaboration Agreement in its entirety or on a target-by-target, program-by-program or product-by-product basis for any reason upon certain notice to the Company.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that (1) the research activities performed by the Company for both the Joint Programs and the Discovery Programs (2) the development activities and cost sharing for the Joint Program development efforts after dose finding toxicity until registrational clinical trials (3) the research, development, manufacture and commercialization licenses and (4) service on the joint steering committee and subcommittees represent a single performance obligation under the Lilly Collaboration Agreement. The Company determined that Lilly cannot benefit from the licenses separately from the research activities, the development activities until registrational clinical trials and participation on the joint steering committee and subcommittees because these services are specialized and rely on the Company&#8217;s expertise such that these activities are highly interrelated and therefore not distinct. Accordingly, the promised goods and services represent one combined performance obligation, and the entire transaction price was allocated to that single combined performance obligation. The performance obligation will be satisfied over time as the Company performs the research activities, participates and shares in the cost of the development activities for the Joint Programs and participates in a joint steering committee and subcommittees to oversee these activities. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s options to share in further development and commercialization efforts via its opt-in/opt-out rights will be assessed and accounted for as separate units of accounting under the relevant guidance if, and when, such options are exercised by the Company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation was $<ix:nonFraction unitRef="usd" contextRef="i0a2f456ce08c4f34b028f7e715d90a75_I20230331" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfOTMyNA_24a5d6bc-423e-40bf-8ebc-a89ee127c392">315.1</ix:nonFraction>&#160;million, which is expected to be recognized as revenue through 2029 or beyond depending on the timing of certain clinical development activities. As of December 31, 2022, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation was $<ix:nonFraction unitRef="usd" contextRef="iee2a6d2ade0542e99376dda986298f86_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNTQ5NzU1ODE4MzMxNg_77a4ef9a-93bc-48c0-bb43-273d2a8616a9">319.8</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022, the Company had recorded $<ix:nonFraction unitRef="usd" contextRef="ib745f408204748faa6b611ba2acc4301_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTA4NjU_c40b238e-8008-4bb5-a33d-c060472931ae">4.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i09acd48542c84107bda3a6fcc7e01a93_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNzY5NjU4MTQyNzIwMg_ccbafb2e-719e-404d-98e2-6ed79afbdddb">3.8</ix:nonFraction> million, respectively, of revenue under the Lilly Collaboration Agreement, which was included in deferred revenue at the beginning of the respective periods.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><ix:continuation id="iea6a0ca7964f4969a36353f6ff9f9ed7" continuedAt="i2b8b5b1b785946cba772a4519d285954"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merck Collaboration Agreement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company entered into a collaboration agreement (the &#8220;Merck Collaboration Agreement&#8221;) with Merck Sharp &amp; Dohme Corp. (or &#8220;Merck&#8221;). The Company and Merck will apply Foghorn&#8217;s proprietary Gene Traffic Control platform to discover and develop novel therapeutics. Under the Merck Collaboration Agreement, the Company granted Merck exclusive global rights to develop, manufacture and commercialize drugs that target dysregulation of a single transcription factor. Under the terms of the Merck Collaboration Agreement, the Company and Merck are each responsible to perform certain research activities in accordance with a mutually-agreed upon research plan. Merck may substitute the selected transcription factor during certain stages of the research program, subject to certain limitations. Following completion of the research program, Merck is responsible for the development and commercialization of the compounds developed pursuant to the research program and any product containing such compounds. Pursuant to the Merck Collaboration Agreement, the Company will also participate on a joint steering committee.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, Foghorn received a nonrefundable upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ibd64aeec1acc4410ab6e14c3aec0a76f_D20200701-20200731" decimals="-5" name="fhtx:ProceedsFromUpfrontPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTIzODc_e70b149d-c755-4592-bec7-eb962e3232e8">15.0</ix:nonFraction> million from Merck, and is eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="i0f0b1f2ac17b45e3b3937dfb1cd9b00a_I20200731" decimals="-5" name="fhtx:MilestoneReceivableUponAchievement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTI0MzU_32ba094d-4ea6-4eac-8873-3403fa059d2b">245.0</ix:nonFraction> million upon achievement of specified research, development and regulatory milestones by any product candidate generated by the collaboration, and up to $<ix:nonFraction unitRef="usd" contextRef="i6c03ef7903fc425585c24387daf3a22a_I20200731" decimals="-5" name="fhtx:MilestoneReceivableUponAchievement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTI1ODM_a91aef3a-ea02-4b94-be3b-296181569f51">165.0</ix:nonFraction> million upon achievement of specified sales-based milestones per approved product from the collaboration, if any. The Company will be eligible to receive tiered royalties, calculated on a product-by-product and country-by-country basis, on net sales of approved products from the collaboration, if any, at royalty rates ranging from the mid-single digits to low tens, depending on whether the products are covered by patent rights it licenses to Merck.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless terminated earlier, the Merck Collaboration Agreement will continue in full force and effect until one or more products has received marketing authorization and, thereafter, until expiration of all royalty obligations under the Merck Collaboration Agreement. The Company or Merck may terminate the Merck Collaboration Agreement upon an uncured material breach by the other party or insolvency of the other party. Merck may also terminate the Merck Collaboration Agreement for any reason upon certain notice to the Company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the (1)&#160;research, development, manufacture and commercialization licenses, (2) the research activities performed by the Company and (3)&#160;service on the joint committees represent a single performance obligation under the Merck Collaboration Agreement. The Company determined that Merck cannot benefit from the licenses separately from the research activities and participation on the joint steering committee because these services are specialized and rely on the Company&#8217;s expertise such that these activities are highly interrelated and therefore not distinct. Accordingly, the promised goods and services represent one combined performance obligation and the entire transaction price was allocated to that single combined performance obligation. The performance obligation will be satisfied over the research term as the Company performs the research activities and participates in a joint steering committee to oversee research activities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the $<ix:nonFraction unitRef="usd" contextRef="i12af85d4d118413c83b0955c275f72f5_I20230331" decimals="-5" name="fhtx:MilestoneReceivableUponAchievement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNTQ5NzU1ODE3MjExMw_4f5c83eb-ea54-4cbd-80da-ef4996ffa058">240.0</ix:nonFraction> million of potential research, development and regulatory milestone payments that the Company is eligible to receive and have not already been achieved were excluded from the transaction price as they were fully constrained by uncertain events. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, the Company achieved a research milestone related to the Merck Collaboration Agreement and received a $<ix:nonFraction unitRef="usd" contextRef="i8f17ba797a20458c8d273718a2faf5b2_D20220701-20220930" decimals="-5" name="fhtx:PaymentReceivedForAchievementOfMilestones" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNTQ5NzU1ODE4NDIzOA_155bfef4-8f34-4f68-9d04-0819116db676">5.0</ix:nonFraction> million milestone payment from Merck.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation is $<ix:nonFraction unitRef="usd" contextRef="i4780b20d5ac143ea81ecc13b5a9624b9_I20230331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTY2ODQ_9e3e91e4-c293-459c-bc4c-a81ee37c29cd">16.4</ix:nonFraction> million, which is expected to be recognized as revenue through approximately 2028. As of December&#160;31, 2022, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation is $<ix:nonFraction unitRef="usd" contextRef="if77adc7cf7cb4adc886eb30f55a05415_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNTQ5NzU1ODE4NDA1NA_fbecd130-87f1-492f-808d-e3a6990ddfc4">17.0</ix:nonFraction> million.</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2b8b5b1b785946cba772a4519d285954">For the three months ended March&#160;31, 2023 and 2022, the Company had recorded $<ix:nonFraction unitRef="usd" contextRef="i23ab0c9afb5749d5ab747dfcc565c03a_D20230101-20230331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTgzMjQ_2885ec68-521a-4a08-b109-d28f63882d4a">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1ac24b7249a14fd6a8da298f2934b7dd_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTgzMzE_3384fed8-6279-4a6d-b1ea-155e56fc92b3">0.1</ix:nonFraction> million, respectively, of the revenue under the Merck Collaboration Agreement, which was included in deferred revenue at the beginning of the respective periods and the classification of deferred revenue between short term and long term.</ix:continuation> </span></div><div id="id19142a81b5f479380a5a5b4606181d7_950"></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN185NTAvZnJhZzowNWEzNDAwZDM0YzM0ZjRlODRlNjJjNzkzMTFkYzQ2Mi90ZXh0cmVnaW9uOjA1YTM0MDBkMzRjMzRmNGU4NGU2MmM3OTMxMWRjNDYyXzE2NDkyNjc0NDE4NTY_e4f6a0de-7262-4571-b193-7516924b3625" continuedAt="i39412eb4c1c9406a965abc95ebb3e0cb" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i39412eb4c1c9406a965abc95ebb3e0cb" continuedAt="i23ac7344a32d443c8ac0c536561d9dc5">For the three months ended March&#160;31, 2023, the Company recorded a provision for income taxes of $<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN185NTAvZnJhZzowNWEzNDAwZDM0YzM0ZjRlODRlNjJjNzkzMTFkYzQ2Mi90ZXh0cmVnaW9uOjA1YTM0MDBkMzRjMzRmNGU4NGU2MmM3OTMxMWRjNDYyXzE4MTQxOTQxODYyNDg4_232999a1-cce5-4a3b-9dfc-31cfe7c2421e">0.6</ix:nonFraction>&#160;million representing an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN185NTAvZnJhZzowNWEzNDAwZDM0YzM0ZjRlODRlNjJjNzkzMTFkYzQ2Mi90ZXh0cmVnaW9uOjA1YTM0MDBkMzRjMzRmNGU4NGU2MmM3OTMxMWRjNDYyXzY1OTcwNjk3NzA4MzI_74d5c123-9f0d-4135-ae7b-96f27fa27814">1.86</ix:nonFraction>%. The income tax provision and the effective tax rate is primarily driven by the current federal and state taxes related to the $<ix:nonFraction unitRef="usd" contextRef="i207a64c5b4d845b1a5061cf046b448ba_D20220101-20221231" decimals="-5" name="fhtx:ProceedsFromUpfrontPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN185NTAvZnJhZzowNWEzNDAwZDM0YzM0ZjRlODRlNjJjNzkzMTFkYzQ2Mi90ZXh0cmVnaW9uOjA1YTM0MDBkMzRjMzRmNGU4NGU2MmM3OTMxMWRjNDYyXzU0OTc1NTgxNDIzNDg_7cc305a0-3105-4f41-bbf2-b7ae9a3d215f">300.0</ix:nonFraction> million upfront payment for Lilly Collaboration Agreement, which will be recognized as taxable income in the current year, and the required capitalization of research and development costs pursuant to Internal Revenue Code Section 174. As a result, the Company expects to have taxable income in the current year, which will be reduced by utilizing available net operating loss carryforwards and research and development tax credit carryforwards.The Company accrued the provision for income taxes in accrued expenses and other current liabilities on the condensed consolidated balance sheets.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i23ac7344a32d443c8ac0c536561d9dc5">The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. Management has considered the Company&#8217;s history of cumulative net losses incurred since inception and its lack of commercialization of any products that would generate revenue from product sales and has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets.</ix:continuation></span></div><div id="id19142a81b5f479380a5a5b4606181d7_61"></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182MS9mcmFnOjgyNWViZDE4NzdiNzQ4ZTk4M2UyMmJmYzU4ZGRlNjA5L3RleHRyZWdpb246ODI1ZWJkMTg3N2I3NDhlOTgzZTIyYmZjNThkZGU2MDlfMjI5OQ_0a4b4058-c1a8-4127-924e-adc33b4a5962" continuedAt="i47dceca9174442a792ac72f889dfcc67" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i47dceca9174442a792ac72f889dfcc67"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office space under a non-cancelable operating lease. There have been no material changes to the Company's lease during the three months ended March&#160;31, 2023. For additional information, see Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the consolidated financial statements in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License agreements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into various exclusive and non-exclusive license agreements for certain technologies. Under the terms of these license agreements, the Company could be required to reimburse the licensors for patent expenses and remit amounts in the low single-digit as sales-based royalties upon the occurrence of specific events as outlined in the corresponding license agreements. The Company is also required to make annual license maintenance fees of less than $<ix:nonFraction unitRef="usd" contextRef="i863abf2c04774158b2e8e819d2eb86f1_D20230101-20230331" decimals="-5" name="fhtx:AnnualLicenseMaintenanceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182MS9mcmFnOjgyNWViZDE4NzdiNzQ4ZTk4M2UyMmJmYzU4ZGRlNjA5L3RleHRyZWdpb246ODI1ZWJkMTg3N2I3NDhlOTgzZTIyYmZjNThkZGU2MDlfODU3_c39cac8f-f679-4278-92a4-722756ee6a68">0.3</ix:nonFraction>&#160;million and pay up to $<ix:nonFraction unitRef="usd" contextRef="i863abf2c04774158b2e8e819d2eb86f1_D20230101-20230331" decimals="-5" name="fhtx:MilestonesPayableUponEvent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182MS9mcmFnOjgyNWViZDE4NzdiNzQ4ZTk4M2UyMmJmYzU4ZGRlNjA5L3RleHRyZWdpb246ODI1ZWJkMTg3N2I3NDhlOTgzZTIyYmZjNThkZGU2MDlfODc0_14a24a73-54d3-4ef9-8c0c-3bb6d79e86f1">1.1</ix:nonFraction>&#160;million in regulatory milestones on each licensed product upon the occurrence of specific events as outlined in one of the license agreements. None of our product candidates utilize technologies covered by these licenses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification agreements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, contract research organizations, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and its executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. The Company has not incurred any material costs as a result of such indemnifications and is not currently aware of any indemnification claims.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in litigation or other legal proceedings. The Company is not currently a party to any material litigation or legal proceedings.</span></div></ix:continuation><div id="id19142a81b5f479380a5a5b4606181d7_64"></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182NC9mcmFnOjAwYzMzOGQ1ODlhNzQzOTg5YzU4YThiNTE2ZGYyZjA3L3RleHRyZWdpb246MDBjMzM4ZDU4OWE3NDM5ODljNThhOGI1MTZkZjJmMDdfMjkx_4012d7e7-42e9-4272-8912-265c82a97117" continuedAt="i5864d935c3ff43e280b0068c0afddaa1" escape="true">Defined Contribution Plan</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5864d935c3ff43e280b0068c0afddaa1">The Company has a 401(k) defined contribution plan (the &#8220;401(k) Plan&#8221;) for its employees. Eligible employees may make pretax contributions to the 401(k) Plan up to statutory limits. During the three months ended March&#160;31, 2023, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182NC9mcmFnOjAwYzMzOGQ1ODlhNzQzOTg5YzU4YThiNTE2ZGYyZjA3L3RleHRyZWdpb246MDBjMzM4ZDU4OWE3NDM5ODljNThhOGI1MTZkZjJmMDdfNTQ5NzU1ODEzOTQyNQ_c4af7988-a115-4db1-988e-3af7a23f06af">0.2</ix:nonFraction>&#160;million of expense related to 401(k) discretionary match. For the three months ended March&#160;31, 2022, there was no discretionary match made under the 401(k)</ix:continuation>.</span></div><div id="id19142a81b5f479380a5a5b4606181d7_67"></div><div style="margin-top:12pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182Ny9mcmFnOjk4NGVlNTlkY2JkODRkNzliMmMyMzg1NDAzMGMxMDBlL3RleHRyZWdpb246OTg0ZWU1OWRjYmQ4NGQ3OWIyYzIzODU0MDMwYzEwMGVfNTgz_0814dedd-e6ec-4fe7-91a4-918b1b0d0420" continuedAt="i206c23e85dcd45029193e2fb4ea5306c" escape="true">Related Parties</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i206c23e85dcd45029193e2fb4ea5306c">In October 2015, the Company entered into a <ix:nonNumeric contextRef="iddc9c1a9a4bd41f8b1fbb60001dd16b4_D20151001-20151031" name="fhtx:ServiceAgreementTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182Ny9mcmFnOjk4NGVlNTlkY2JkODRkNzliMmMyMzg1NDAzMGMxMDBlL3RleHRyZWdpb246OTg0ZWU1OWRjYmQ4NGQ3OWIyYzIzODU0MDMwYzEwMGVfNTg1_dbccaa3e-d8e8-4283-b697-f3d5b9e01b17">five-year</ix:nonNumeric> consulting agreement with a scientific founder of the Company who is also a shareholder. This agreement was amended and extended to January 1, 2024 and is subject to automatic one-year renewal terms until terminated.  During the three months ended March&#160;31, 2023 and 2022, the Company paid the scientific founder a de minimis amount. As of March&#160;31, 2023 and December&#160;31, 2022, the Company had less than $<ix:nonFraction unitRef="usd" contextRef="id0a4bd34abd04cd7a7c910806002b5ce_I20221231" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182Ny9mcmFnOjk4NGVlNTlkY2JkODRkNzliMmMyMzg1NDAzMGMxMDBlL3RleHRyZWdpb246OTg0ZWU1OWRjYmQ4NGQ3OWIyYzIzODU0MDMwYzEwMGVfMzI5ODUzNDg4NDA3NA_3e8fbd12-93b6-480a-936c-95326986098f"><ix:nonFraction unitRef="usd" contextRef="ibbf92bd0426f4ca5a06dce27507acf0c_I20230331" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182Ny9mcmFnOjk4NGVlNTlkY2JkODRkNzliMmMyMzg1NDAzMGMxMDBlL3RleHRyZWdpb246OTg0ZWU1OWRjYmQ4NGQ3OWIyYzIzODU0MDMwYzEwMGVfMzI5ODUzNDg4NDA3NA_a60eefa5-7d87-49f9-bb6d-ad7f31f0719c">0.1</ix:nonFraction></ix:nonFraction>&#160;million accounts payable to the scientific founder.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the related notes to those statements included elsewhere in this Quarterly Report on Form 10-Q. In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Some of the numbers included herein have been rounded for the convenience of presentation. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 and in this Quarterly Report on Form 10-Q.</span></div><div id="id19142a81b5f479380a5a5b4606181d7_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foghorn is a clinical stage, precision therapeutics biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system, an untapped opportunity for therapeutic intervention in oncology and in a wide spectrum of other diseases including virology, autoimmune diseases and neurology.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The chromatin regulatory system orchestrates gene expression&#8212;the turning on and off of genes&#8212;which is fundamental to how all our cells function. The chromatin regulatory system is implicated in approximately 50% of all cancers, and understanding how this system works could lead to an entirely new class of precision medicines. To our knowledge, we are the only company  with the ability to study and target the chromatin regulatory system at scale, in context, and in an integrated way.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our proprietary Gene Traffic Control&#174; platform provides an integrated and mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within this system. We have developed unique capabilities that have yielded new insights and scalability in drugging this new, previously untapped and promising area.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in 2015, our platform has generated a broad pipeline of more than a dozen programs with two clinical-stage drug candidates currently in phase 1 development across multiple indications. We have discovered highly selective chemical matter for some of the most challenging targets in oncology including BRM, CBP, EP300 and ARID1B as well as other undisclosed targets. We believe our current pipeline has the potential to help more than 500,000 cancer patients. We take a small molecule modality agnostic approach to drugging targets which includes protein degraders, allosteric enzymatic inhibitors, and transcription factor disruptors. We are a biology first company which means we focus first on the underlying genetics and biology of a disease relevant target and then leverage the most appropriate drugging approach to impact the disease biology.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lead clinical-stage candidate, FHD-286, a selective, allosteric ATPase inhibitor is being developed in separate Phase 1 studies in (i) metastatic uveal melanoma and (ii) relapsed and/or refractory acute myeloid leukemia (&#8220;AML&#8221;), and myelodysplastic syndrome (&#8220;MDS&#8221;). We expect initial clinical data for metastatic uveal melanoma in the second quarter of 2023. The relapsed and/or refractory AML and MDS study has been placed on full clinical hold by the FDA due to potential differentiation syndrome and we plan to provide a regulatory update in the second quarter of 2023.  </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On April 24th, 2023, we provided an update on the FHD-609 Phase 1 program in synovial sarcoma and SMARCB1-deleted tumors. We have paused enrollment in the FHD-609 study due to a grade 4 QTc prolongation event in a synovial sarcoma patient at the second highest dose being evaluated. Enrollment of the dose escalation portion of the study has been completed and a maximum tolerated dose has been identified. Consequently, the FDA placed the study on partial clinical hold, while allowing patients currently enrolled and benefiting from therapy to continue dosing and to remain on FHD-609. The Company is not, at this time, planning to pursue a dose expansion study independently. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe Foghorn has the potential to be a major biopharmaceutical company with our current pipeline addressing more than 20 tumor types impacting more than 500,000 new patients annually. We believe we have the potential to file at least six new INDs over the next four years.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have focused substantially all of our resources on building our Gene Traffic Control platform, organizing and staffing our company, business planning, raising capital, conducting discovery and research activities, protecting our trade secrets, filing patent applications, identifying potential product candidates, undertaking preclinical studies and clinical trial activities, establishing arrangements with third parties for the manufacture of initial quantities of our product candidates and component materials and initiating two strategic collaborations. We do not have any products approved for sale and have not generated any revenue from product sales.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 10, 2021, we entered into a collaboration agreement (the &#8220;Lilly Collaboration Agreement&#8221;) with Eli Lilly and Company (&#8220;Lilly&#8221;), for which we received an upfront payment of $300.0 million in January 2022 (see Note 8 to our notes to unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q). Concurrent with the Lilly Collaboration Agreement, we also entered into a stock purchase agreement (the &#8220;Lilly SPA&#8221;) and issued and sold </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lilly 4,000,000 shares of our common stock at a price of $20.00 per share, resulting in net proceeds of $80.0&#160;million, of which $42.2&#160;million was allocated to equity upon the issuance of the Company&#8217;s common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, the Company achieved a research milestone related to a Research Collaboration and Exclusive License Agreement (the &#8220;Merck Collaboration Agreement&#8221;) with Merck Sharp &amp; Dohme Corp. (&#8220;Merck&#8221;) and received a $5.0 million milestone payment from Merck.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses since our inception. For the three months ended March&#160;31, 2023 and the year ended December&#160;31, 2022, we reported net losses of $30.5 million and $108.9&#160;million, respectively. As of March&#160;31, 2023, we had an accumulated deficit of $403.6 million. We expect to continue to incur significant expenses and increasing operating losses for at least the next several years. Our ability to generate any product revenue or product revenue sufficient to achieve profitability will depend on the successful development and eventual commercialization of one or more product candidates we are developing and may develop.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our expenses and capital requirements will increase substantially in connection with our ongoing activities, particularly if and as we:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;advance our FHD-286 product candidate and continue our preclinical development of product candidates from our current research programs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;identify and advance additional research programs and additional product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;initiate preclinical testing for any new product candidates we identify and develop;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;obtain, maintain, expand, enforce, defend and protect our trade secrets and intellectual property portfolio and provide reimbursement of third-party expenses related to our patent portfolio;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;hire additional research and development personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;add operational, legal, compliance, financial and management information systems and personnel to support our research, product development and operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;expand the capabilities of our platform;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;acquire or in-license product candidates, intellectual property and technologies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;operate as a public company;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;seek marketing approvals for any product candidates that successfully complete clinical trials; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;ultimately establish a sales, marketing and distribution infrastructure to commercialize any products for which we may obtain marketing approval.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will not generate revenue from product sales unless and until we successfully commercialize one of our product candidates, after completing clinical development and obtaining regulatory approval. If we obtain regulatory approval for any of our product candidates, we expect to incur significant expenses related to developing our commercialization capability to support product sales, marketing, manufacturing and distribution. Further, we expect to incur additional costs associated with operating as a public company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of equity offerings, debt financings and collaborations or licensing arrangements and our collaboration agreements with Merck and Lilly. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as, and when, needed, we may have to significantly delay, scale back our development or commercialization plans for one or more of our product candidates.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the numerous risks and uncertainties associated with pharmaceutical product development, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to achieve or maintain profitability. Even if we are able to generate product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Our Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not generated any revenue from product sales and do not expect to do so in the near future. If our development efforts for our product candidates are successful and result in regulatory approval or licenses with third parties, we may generate revenue in the future from product sales, milestone payments under our existing collaboration agreements or payments from other license agreements that we may enter into with third parties.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December of 2021, we entered into a strategic collaboration with Lilly to create novel oncology medicines by applying Foghorn&#8217;s proprietary Gene Traffic Control platform. The collaboration includes a co-development and co-commercialization agreement for the aforementioned selective BRM oncology program and an additional undisclosed oncology target. In addition, the collaboration includes three additional discovery programs using Foghorn&#8217;s proprietary Gene Traffic Control platform. Under the terms of the collaboration, Foghorn received upfront consideration of $300.0&#160;million in cash pursuant to the Lilly Collaboration Agreement, together with an equity investment by Lilly of $80.0&#160;million in shares of Foghorn common stock pursuant to the Lilly SPA.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the BRM-selective program and the additional undisclosed target program, Foghorn will lead discovery and early research activities, while Lilly will lead development and commercialization activities with participation from Foghorn in operational activities and cost sharing. Foghorn and Lilly will share 50/50 in the U.S. economics, and Foghorn is eligible to receive royalties on ex-U.S. sales starting in the low double-digit range and escalating into the twenties based on revenue levels.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the additional discovery programs, Foghorn will lead discovery and early research activities. Foghorn may receive up to a total of $1.3 billion in potential development and commercialization milestones. Additionally, Foghorn will have an option to participate in a percentage of the U.S. economics and is eligible to receive tiered royalties from the mid-single digit to low-double digit range on sales outside the U.S. that may be exercised after the successful completion of the dose-finding toxicity studies.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot provide assurances as to the timing of future milestones, royalty payments and economics associated with the strategic collaboration with Lilly.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized total deferred revenue of $337.8 million related to the Lilly Collaboration Agreement and the Lilly SPA, which included the $300.0 million upfront payment under the Lilly Collaboration Agreement as well as $37.8 million allocated to deferred revenue from the gross proceeds of the Lilly SPA to be recognized over the performance period. During the three months ended March&#160;31, 2023, we recognized $4.7&#160;million and $3.8&#160;million, respectively, of revenue under the Lilly Collaboration Agreement and, as of March&#160;31, 2023, we had $315.1&#160;million of deferred revenue related to the above mentioned upfront payment and revenue allocation remaining on our condensed consolidated balance sheets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we entered into the Merck Collaboration Agreement, pursuant to which we will apply our proprietary Gene Traffic Control platform to discover and develop novel therapeutics. Under the Merck Collaboration Agreement, we granted Merck exclusive global rights to develop and commercialize drugs that target dysregulation of a single transcription factor. Under the terms of the Merck Collaboration Agreement, we received a nonrefundable upfront payment of $15.0 million from Merck, and are eligible to receive up to $245.0 million upon achievement of specified research, development and regulatory milestones by any product candidate generated by the collaboration, and up to $165.0 million upon achievement of specified sales-based milestones per approved product from the collaboration, if any, as well as royalties on sales of any approved product from the collaboration. We cannot provide assurance as to the timing of future milestone or royalty payments or that we will receive any of these payments at all.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022, we recognized $0.6 million and $0.1 million of revenue under the Merck Collaboration Agreement. In the third quarter of 2022, the Company achieved a research milestone related to the Merck Collaboration Agreement and received a $5.0 million milestone payment from Merck. As of March&#160;31, 2023, we had $16.4 million&#160;of deferred revenue related to the upfront payment and milestone achievement remaining on our condensed consolidated balance sheets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses are comprised of research and development expenses and general and administrative expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist primarily of costs incurred for our research activities, including our discovery efforts, and progressing our programs, which include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">personnel-related costs, including salaries, benefits and stock-based compensation expense, for employees engaged in research and development functions;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses incurred in connection with our research programs and preclinical and clinical development of our product candidates, including under agreements with third parties, such as consultants and contractors and contract research organizations (&#8220;CROs&#8217;);</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of manufacturing drug substance and drug product for use in our research and preclinical studies and clinical trials under agreements with third parties, such as consultants and contractors and contract development and manufacturing organizations (&#8220;CDMOs)&#8221;;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory supplies and research materials;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">facilities, depreciation and amortization and other expenses, which include direct and allocated expenses for rent and maintenance of facilities and insurance; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payments made under third-party licensing agreements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We track our direct external research and development expenses on a program-by-program basis. These consist of costs that include fees, reimbursed materials, and other costs paid to consultants, contractors, CDMOs, and CROs in connection with our preclinical, clinical and manufacturing activities. We do not allocate employee costs, costs associated with our discovery efforts, laboratory supplies, and facilities expenses, including depreciation or other indirect costs, to specific product development programs because these costs are deployed across multiple programs and our platform and, as such, are not separately classified.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our research and development expenses will increase substantially as we advance our programs into clinical development and expand our discovery, research and preclinical activities in the near term and in the future. At this time, we cannot accurately estimate or know the nature, timing and costs of the efforts that will be necessary to complete the preclinical and clinical development of any product candidates we may develop.&#160;A change in the outcome of any number of variables with respect to product candidates we may develop could significantly change the costs and timing associated with the development of that product candidate. We may never succeed in obtaining regulatory approval for any product candidates we may develop.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of personnel-related costs, including salaries, benefits and stock-based compensation, for employees engaged in executive, legal, finance and accounting and other administrative functions. General and administrative expenses also include professional fees for legal, patent, consulting, investor and public relations, human resources, and accounting and audit services as well as direct and allocated facility-related costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our general and administrative expenses will increase in the future as we increase our headcount to support our continued research activities and development of our programs and platform. We also anticipate that we will continue to incur increased accounting, audit, legal, regulatory, compliance, director and officer insurance costs and investor and public relations expenses associated with operating as a public company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists of interest earned on our invested cash balances.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense) ,net consists of sublease income and miscellaneous expense unrelated to our core operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we had federal and state net operating loss carryforwards of $221.7&#160;million and $203.3&#160;million, respectively, which may be available to offset future taxable income. The federal net operating loss carryforwards include $5.3&#160;million which expire in 2037 and $216.4&#160;million which carryforward indefinitely but in some circumstances may be limited to offset 80% of annual taxable income. The state net operating loss carryforwards expire at various dates beginning in 2036. As of December&#160;31, 2022, we also had federal and state research and development tax credit carryforwards of $9.6&#160;million and $5.7&#160;million, respectively, which may be available to reduce future tax liabilities and expire at various dates beginning in 2036 and 2031, respectively. Due to our history of cumulative net losses since inception and uncertainties surrounding our ability to generate future taxable income, we have recorded a full valuation allowance against our net deferred tax assets at each balance sheet date. We expect to have taxable income in the current year, which will be reduced by utilizing available net operating loss carryforwards and research and development tax credit carryforwards.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;). The preparation of our condensed consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses and the disclosure of contingent assets and liabilities in our condensed consolidated financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 as well as elsewhere in this Quarterly Report on Form 10-Q, we </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">believe that revenue recognition and accrued research and development expenses are those most critical to the judgments and estimates used in the preparation of our condensed consolidated financial statements. There have been no material changes to our critical accounting policies and estimates detailed in the C</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ritical Accounting Policies and Significant Judgements</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 7. Managements Discussion and Analysis of financial Condition and Results of Operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.</span></div><div id="id19142a81b5f479380a5a5b4606181d7_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended March&#160;31, 2023 and 2022</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,309&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,317)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,804)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,513)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,499&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,928)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,914)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,014)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,488)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,914)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,574)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaboration Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue was $5.3 million for the three months ended March&#160;31, 2023, compared to $3.9 million for the three months ended March&#160;31, 2022. The increase in collaboration revenue is attributed to the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in Lilly collaboration revenue recognition of $0.9 million primarily due to work performed on the BRM Selective program pursuant to the Lilly Collaboration Agreement; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in Merck collaboration revenue recognition of $0.5 million due to continued advancement of the single specified transcription factor target under the Merck collaboration agreement. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our research and development expenses for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development program expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FHD-286</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,031&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FHD-609</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Platform, research and discovery, and unallocated expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Platform and other early stage research external costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personnel related (including stock-based compensation)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,373&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,911&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility related and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,985&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,508&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,477&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses were $30.0 million for the three months ended March&#160;31, 2023, compared to $24.5 million for the three months ended March&#160;31, 2022. The increase is attributed to the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in personnel-related costs of $2.5 million, including a $0.5 million increase in stock-based compensation expense, due primarily to increased headcount in our research and development function; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in platform and other early stage research investments of $1.9 million;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in facility-related and other expenses of $1.2 million, due to increased investments to support the growing research and development organization and research efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in our FHD-609 program costs of $0.4 million associated with the Phase 1 clinical trial in Synovial Sarcoma and SMARCB1-loss tumors.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">This was slightly offset by a decrease in our FHD-286 program costs of $0.4 million primarily driven by a decline in clinical trail spend due to the FDA&#8217;s full clinical hold on the Phase 1 study in AML/MDS in August 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our general and administrative expenses for the three months ended March&#160;31, 2023 and 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personnel related (including stock-based compensation)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional and consulting</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility related and other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total general and administrative expenses</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,641&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,216&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses were $8.6 million for the three months ended March&#160;31, 2023, compared to $7.2 million for the three months ended March&#160;31, 2022. The increase is primarily attributed to the following: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in personnel-related costs of $1.7 million, including a $0.8 million increase in stock-based compensation expense, which was the result of increased headcount in our general and administrative function to support our growing business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income was $2.7 million for the three months ended March&#160;31, 2023, compared to $0.2 million for the three months ended March&#160;31, 2022. The increase in interest and other income (expense), net for the three months ended March&#160;31, 2023 was due to an increase in the average interest rate compared to three months ended March&#160;31, 2022. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net was $0.7 million for the three months ended March&#160;31, 2023 and 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provision for income taxes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded an income tax provision of $0.6 million for the three months ended March&#160;31, 2023. The income tax provision is primarily driven by the current federal and state taxes related to the $300.0 million upfront payment for Lilly Collaboration Agreement, which will be recognized as taxable income in the current year, and the required capitalization of research and development costs pursuant to Internal Revenue Code Section 174. The Company did not record a provision for income taxes for the three months ended March&#160;31, 2022.</span></div><div id="id19142a81b5f479380a5a5b4606181d7_88"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception in October 2015, we have incurred significant operating losses. We expect to incur significant expenses and operating losses for the foreseeable future as we support our continued research activities and development of our programs and platform. Through March&#160;31, 2023, we have funded our operations with proceeds from our IPO in October 2020, sales of preferred stock, term loans, an upfront payment of $15.0 million we received in July 2020 under the Merck Collaboration Agreement and proceeds we received in December 2021 under the Lilly SPA of $80.0 million; an upfront payment of $300.0 million received in January 2022 under the Lilly Collaboration Agreement and a payment of $5.0 million received from Merck under the Merck Collaboration Agreement for the achievement of a research milestone. As of March&#160;31, 2023, we had cash, cash equivalents and marketable securities of $316.0 million. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our sources and uses of cash for each of the periods presented:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,505&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159,409)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,573)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,509&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, operating activities used $31.2 million of cash, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulting from the net cash used to fund our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net loss of $30.5 million and changes in our operating assets and liabilities of $6.6 million partially offset by net non-cash charges of $5.9 million. Net cash provided by changes in our operating assets and liabilities for the three months ended March&#160;31, 2023 was primarily driven by a $5.3 million decrease in deferred revenue resulting from the recognition of revenue on the upfront payments received in connection with our collaboration agreements and a $1.7 million decrease in operating lease liabilities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, operating activities provided $271.5 million of cash, resulting from our changes in our operating assets and liabilities of $293.2 million and net non-cash charges of $5.2 million partially offset by a net loss of $26.9 million. Net cash provided by changes in our operating assets and liabilities for the three months ended March 31, 2022 consisted primarily of the $300.0 million of cash received related to our collaboration receivable, an increase of $1.3 million in accounts payable and a decrease of $0.2 million of prepaid expenses and other current assets partially offset by a $3.9 million decrease in deferred revenue resulting from the recognition of revenue on the upfront payments received in connection</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with our collaboration agreements, a $2.5 million decrease in accrued expenses and other liabilities and a $1.8 million decrease in operating lease liabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 net cash used in investing activities was $29.5 million due to $26.2 million of purchases of marketable securities and $0.6 million in purchases of property and equipment partially offset by $56.4 million of maturities of marketable securities. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 net cash provided by investing activities was $159.4 million due to $212.3 million of purchases of marketable securities and $0.2 million in purchases of property and equipment partially offset by $53.1 million of maturities of marketable securities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, net cash provided by financing activities was $0.1 million consisting of net proceeds from the exercise of common stock options and the employee stock purchase plan.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, net cash provided by financing activities was $0.4 million consisting of net proceeds from the exercise of common stock options.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding Requirements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we advance the preclinical activities, initiate clinical trials for our product candidates in development and continue to fund on-going clinical efforts. As of the issuance date of these interim condensed consolidated financial statements, we expect that our cash, cash equivalents and marketable securities will be sufficient to fund our operating expenses and capital expenditure requirements for at least twelve months. We have based these estimates as to how long we expect we will be able to fund our operations on assumptions that may prove to be inaccurate. We could use our available capital resources sooner than we currently expect, in which case we would be required to obtain additional financing sooner than planned, which may not be available to us on acceptable terms, or at all. Our failure to raise capital as and when needed would have a negative impact on our financial condition and our ability to pursue our business strategy. We will be required to obtain further funding through public or private equity offerings, debt financings, collaborations and licensing arrangements or other sources.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to raise sufficient capital as and when needed, we may be required to significantly curtail, delay or discontinue one or more of our research or development programs or the commercialization of any product candidate we may develop, or be unable to expand our operations or otherwise capitalize on our business opportunities. If we raise additional funds through collaborations or licensing arrangements with third parties, we may have to relinquish valuable rights to future revenue streams or product candidates or grant licenses on terms that may not be favorable to us.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 for additional risks associated with our substantial capital requirements.</span></div><div id="id19142a81b5f479380a5a5b4606181d7_91"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-balance&#160;Sheet Arrangements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have during the periods presented, and we do not currently have, any&#160;off-balance&#160;sheet arrangements, as defined in the rules and regulations of the Securities and Exchange Commission.</span></div><div id="id19142a81b5f479380a5a5b4606181d7_94"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note&#160;2 to our condensed consolidated financial statements appearing elsewhere in this Quarterly Report.</span></div><div id="id19142a81b5f479380a5a5b4606181d7_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a smaller reporting company, as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended, for this reporting period and are not required to provide the information required under this item.</span></div><div id="id19142a81b5f479380a5a5b4606181d7_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Controls and Procedures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, under the supervision and with the participation of our Principal Executive Officer (our Chief Executive Officer) and Principal Accounting and Financial Officer (our Chief Financial Officer), has evaluated the effectiveness of our disclosure controls and procedures as of period end. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules&#160;13a-15(e)&#160;and&#160;15d-15(e)&#160;under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of March&#160;31, 2023, our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal Executive Officer and Principal Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No change in our internal control over financial reporting (as defined in Rules&#160;13a-15(f)&#160;and&#160;15d-15(f)&#160;under the Exchange Act) occurred during the three months ended March&#160;31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:16pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="id19142a81b5f479380a5a5b4606181d7_106"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that, in the opinion of our management, are probable to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on our business, financial condition, results of operations and prospects because of defense and settlement costs, diversion of management resources and other factors.</span></div><div id="id19142a81b5f479380a5a5b4606181d7_109"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of potential risks or uncertainties, please see &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022.  There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Exhibits.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fhtx-20230331xex311.htm">31.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fhtx-20230331xex311.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fhtx-20230331xex312.htm">31.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fhtx-20230331xex312.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fhtx-20230331xex321.htm">32.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fhtx-20230331xex321.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fhtx-20230331xex322.htm">32.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="fhtx-20230331xex322.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22pt">Filed herewith.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="id19142a81b5f479380a5a5b4606181d7_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#id19142a81b5f479380a5a5b4606181d7_7">Table of Contents</a></span></div></div><div style="margin-top:16pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.850%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FOGHORN THERAPEUTICS, INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 8, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Allan Reine</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allan Reine, M.D.<br/>Chief Financial Officer<br/>(Principal Accounting and Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>fhtx-20230331xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if0df576dd6d84349ad08e60f7c0bfb8a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Adrian Gottschalk, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this Quarterly Report on Form 10-Q of Foghorn Therapeutics Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Adrian Gottschalk</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adrian Gottschalk<br>President, Chief Executive Officer and Director<br>(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>fhtx-20230331xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i682aadda31b543eeb977fe98d81a3a8e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Allan Reine, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this Quarterly Report on Form 10-Q of Foghorn Therapeutics Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Allan Reine</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allan Reine, M.D.<br>Chief Financial Officer<br>(Principal Accounting and Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>fhtx-20230331xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5756ac365a3a4aa8a67f59bec15ea602_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Foghorn Therapeutics Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Adrian Gottschalk</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adrian Gottschalk<br>President, Chief Executive Officer and Director<br>(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>fhtx-20230331xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i73ed3a7522fe416a92ba084f1ed3c118_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Foghorn Therapeutics Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 8, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Allan Reine</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allan Reine, M.D.<br>Chief Financial Officer<br>(Principal Accounting and Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>fhtx-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:15bd0678-6723-4159-8d23-9a6c2981f314,g:5f09f729-e9b1-474a-a25d-c866e4e94b81-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:fhtx="http://www.foghorntx.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.foghorntx.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fhtx-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fhtx-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fhtx-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fhtx-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.foghorntx.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>0000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessGoingConcernandBasisofPresentation" roleURI="http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentation">
        <link:definition>0000007 - Disclosure - Nature of Business, Going Concern and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.foghorntx.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesandFairValueMeasurements" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurements">
        <link:definition>0000009 - Disclosure - Marketable Securities and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNet" roleURI="http://www.foghorntx.com/role/PropertyandEquipmentNet">
        <link:definition>0000010 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilities" roleURI="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilities">
        <link:definition>0000011 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandNetLossPerShare" roleURI="http://www.foghorntx.com/role/CommonStockandNetLossPerShare">
        <link:definition>0000012 - Disclosure - Common Stock and Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.foghorntx.com/role/StockBasedCompensation">
        <link:definition>0000013 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreements" roleURI="http://www.foghorntx.com/role/CollaborationAgreements">
        <link:definition>0000014 - Disclosure - Collaboration Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.foghorntx.com/role/IncomeTaxes">
        <link:definition>0000015 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.foghorntx.com/role/CommitmentsandContingencies">
        <link:definition>0000016 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedContributionPlan" roleURI="http://www.foghorntx.com/role/DefinedContributionPlan">
        <link:definition>0000017 - Disclosure - Defined Contribution Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedParties" roleURI="http://www.foghorntx.com/role/RelatedParties">
        <link:definition>0000018 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.foghorntx.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000019 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesandFairValueMeasurementsTables" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsTables">
        <link:definition>0000020 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTables" roleURI="http://www.foghorntx.com/role/PropertyandEquipmentNetTables">
        <link:definition>0000021 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesTables" roleURI="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables">
        <link:definition>0000022 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandNetLossPerShareTables" roleURI="http://www.foghorntx.com/role/CommonStockandNetLossPerShareTables">
        <link:definition>0000023 - Disclosure - Common Stock and Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.foghorntx.com/role/StockBasedCompensationTables">
        <link:definition>0000024 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofBusinessGoingConcernandBasisofPresentationDetails" roleURI="http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails">
        <link:definition>0000025 - Disclosure - Nature of Business, Going Concern and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails">
        <link:definition>0000026 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Available for Sale Marketable Securities By Security Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>0000027 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails" roleURI="http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails">
        <link:definition>0000028 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetAdditionalInformationDetails" roleURI="http://www.foghorntx.com/role/PropertyandEquipmentNetAdditionalInformationDetails">
        <link:definition>0000029 - Disclosure - Property and Equipment, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesDetails" roleURI="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails">
        <link:definition>0000030 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandNetLossPerShareNarrativeDetails" roleURI="http://www.foghorntx.com/role/CommonStockandNetLossPerShareNarrativeDetails">
        <link:definition>0000031 - Disclosure - Common Stock and Net Loss Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails" roleURI="http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails">
        <link:definition>0000032 - Disclosure - Common Stock and Net Loss Per Share - Summary of Earnings Per Share Diluted Anti Dilutive Impact (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetails" roleURI="http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails">
        <link:definition>0000033 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" roleURI="http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails">
        <link:definition>0000034 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsDetails" roleURI="http://www.foghorntx.com/role/CollaborationAgreementsDetails">
        <link:definition>0000035 - Disclosure - Collaboration Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.foghorntx.com/role/IncomeTaxesDetails">
        <link:definition>0000036 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.foghorntx.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000037 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DefinedContributionPlanDetails" roleURI="http://www.foghorntx.com/role/DefinedContributionPlanDetails">
        <link:definition>0000038 - Disclosure - Defined Contribution Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartiesDetails" roleURI="http://www.foghorntx.com/role/RelatedPartiesDetails">
        <link:definition>0000039 - Disclosure - Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="fhtx_NumberOfPrograms" abstract="false" name="NumberOfPrograms" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember" abstract="true" name="USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="fhtx_AssetsNotYetPlacedInServiceMember" abstract="true" name="AssetsNotYetPlacedInServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_ScientificFounderMember" abstract="true" name="ScientificFounderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_StanfordLicenseAgreementMember" abstract="true" name="StanfordLicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="fhtx_MilestoneReceivableUponAchievement" abstract="false" name="MilestoneReceivableUponAchievement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember" abstract="true" name="USTreasuryNotesSecuritiesDueWithinOneYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_EliLillyMember" abstract="true" name="EliLillyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_ResearchDevelopmentAndRegulatoryMember" abstract="true" name="ResearchDevelopmentAndRegulatoryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_MerckMember" abstract="true" name="MerckMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_CorporateDebtSecuritiesDueWithinOneYearMember" abstract="true" name="CorporateDebtSecuritiesDueWithinOneYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" abstract="true" name="TwoThousandTwentyEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="fhtx_A2016StockIncentivePlanMember" abstract="true" name="A2016StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_PaymentReceivedForAchievementOfMilestones" abstract="false" name="PaymentReceivedForAchievementOfMilestones" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fhtx_AccruedResearchAndDevelopmentExpenses" abstract="false" name="AccruedResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fhtx_AnnualLicenseMaintenanceFees" abstract="false" name="AnnualLicenseMaintenanceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fhtx_InterestIncomeAndOtherIncomeExpense" abstract="false" name="InterestIncomeAndOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fhtx_ProceedsFromUpfrontPayment" abstract="false" name="ProceedsFromUpfrontPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fhtx_MilestonesPayableUponEvent" abstract="false" name="MilestonesPayableUponEvent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fhtx_NumberOfAdditionalTargets" abstract="false" name="NumberOfAdditionalTargets" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="fhtx_MerckCollaborationAgreementMember" abstract="true" name="MerckCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_USGovernmentAgenciesDueWithinOneYearMember" abstract="true" name="USGovernmentAgenciesDueWithinOneYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_CommonStockVotingRightsVotes" abstract="false" name="CommonStockVotingRightsVotes" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="fhtx_SalesBasedMilestoneMember" abstract="true" name="SalesBasedMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_ServiceAgreementTerm" abstract="false" name="ServiceAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fhtx_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" abstract="false" name="MarketableSecuritiesAndFairValueMeasurementsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="fhtx_TwoThousandTwentyEquityIncentivePlanMember" abstract="true" name="TwoThousandTwentyEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember" abstract="true" name="CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fhtx_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fhtx_OptOutMilestoneReceivableUponAchievement" abstract="false" name="OptOutMilestoneReceivableUponAchievement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fhtx_CollaborationAgreementAbstract" abstract="true" name="CollaborationAgreementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" abstract="true" name="OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="fhtx_CashPaymentsRelatedParty" abstract="false" name="CashPaymentsRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fhtx_NumberOfTargets" abstract="false" name="NumberOfTargets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>fhtx-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:15bd0678-6723-4159-8d23-9a6c2981f314,g:5f09f729-e9b1-474a-a25d-c866e4e94b81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_543abd28-6663-4a28-b9a2-f4d923b83f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f01f6643-0913-4bea-a0be-7d6ef8aea4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_543abd28-6663-4a28-b9a2-f4d923b83f12" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f01f6643-0913-4bea-a0be-7d6ef8aea4b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0ab96576-30ad-4f99-8c67-ed63a373a176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_543abd28-6663-4a28-b9a2-f4d923b83f12" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0ab96576-30ad-4f99-8c67-ed63a373a176" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_42d59f14-eaca-4178-9a99-70bcaea43b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_543abd28-6663-4a28-b9a2-f4d923b83f12" xlink:to="loc_us-gaap_PreferredStockValue_42d59f14-eaca-4178-9a99-70bcaea43b3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3482f72c-d067-4105-9aa9-9e0cb74deaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_543abd28-6663-4a28-b9a2-f4d923b83f12" xlink:to="loc_us-gaap_CommonStockValue_3482f72c-d067-4105-9aa9-9e0cb74deaf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8fed8cbf-b2b1-40fd-b2ee-4cc5f4320fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_543abd28-6663-4a28-b9a2-f4d923b83f12" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8fed8cbf-b2b1-40fd-b2ee-4cc5f4320fbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d47b413c-ff4c-44a1-926e-cea86fa8f30f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_90060dee-d88c-4015-a951-8aa9904c15f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d47b413c-ff4c-44a1-926e-cea86fa8f30f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_90060dee-d88c-4015-a951-8aa9904c15f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_58cf3082-426d-4635-9227-51723651630c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d47b413c-ff4c-44a1-926e-cea86fa8f30f" xlink:to="loc_us-gaap_AccountsPayableCurrent_58cf3082-426d-4635-9227-51723651630c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_280e047e-f0de-409b-a5d9-c1dab52f1f54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d47b413c-ff4c-44a1-926e-cea86fa8f30f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_280e047e-f0de-409b-a5d9-c1dab52f1f54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1004bf3a-90a4-493b-a33b-7dffc75f5195" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d47b413c-ff4c-44a1-926e-cea86fa8f30f" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1004bf3a-90a4-493b-a33b-7dffc75f5195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f9ad404c-149f-426e-91b7-680c8f777e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_acd972af-05c9-412a-94db-d7dd626fd371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9ad404c-149f-426e-91b7-680c8f777e8c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_acd972af-05c9-412a-94db-d7dd626fd371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4717cf45-da52-41b8-aed1-11e0b17bad42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9ad404c-149f-426e-91b7-680c8f777e8c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4717cf45-da52-41b8-aed1-11e0b17bad42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_664923dd-dff5-43c4-8c1d-c070583039b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f9ad404c-149f-426e-91b7-680c8f777e8c" xlink:to="loc_us-gaap_MarketableSecurities_664923dd-dff5-43c4-8c1d-c070583039b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a4bb9257-7a77-4aa7-ac13-d8087a52caac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_aed6f1ff-dfdc-4a2d-8f7c-6d2f7a5596c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a4bb9257-7a77-4aa7-ac13-d8087a52caac" xlink:to="loc_us-gaap_LiabilitiesCurrent_aed6f1ff-dfdc-4a2d-8f7c-6d2f7a5596c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d174cacd-bbe3-4b35-9723-38191cac6d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a4bb9257-7a77-4aa7-ac13-d8087a52caac" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d174cacd-bbe3-4b35-9723-38191cac6d3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f8bb19c7-fd14-4e7f-ab37-c39635763cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a4bb9257-7a77-4aa7-ac13-d8087a52caac" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f8bb19c7-fd14-4e7f-ab37-c39635763cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7a749f8b-60a0-4832-a2fa-11483e70fbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a4bb9257-7a77-4aa7-ac13-d8087a52caac" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7a749f8b-60a0-4832-a2fa-11483e70fbf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dbbcff8e-6ff0-4710-b9a0-f8071dd5063e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_99c84dd4-9d12-48d3-94b5-136df8a618b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dbbcff8e-6ff0-4710-b9a0-f8071dd5063e" xlink:to="loc_us-gaap_AssetsCurrent_99c84dd4-9d12-48d3-94b5-136df8a618b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_191861a6-db14-4027-8a9d-cde60f63a9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dbbcff8e-6ff0-4710-b9a0-f8071dd5063e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_191861a6-db14-4027-8a9d-cde60f63a9f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_15d92407-f072-4f92-b621-bfbab1f0e4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dbbcff8e-6ff0-4710-b9a0-f8071dd5063e" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_15d92407-f072-4f92-b621-bfbab1f0e4d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5f522b71-fe8d-4bf2-b2be-3565cb389144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dbbcff8e-6ff0-4710-b9a0-f8071dd5063e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5f522b71-fe8d-4bf2-b2be-3565cb389144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3657e52b-2e34-47eb-a176-f50dbce068eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dbbcff8e-6ff0-4710-b9a0-f8071dd5063e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3657e52b-2e34-47eb-a176-f50dbce068eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d442fdec-3716-4542-b380-e21c8c51e28f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b8cc6f05-a256-4f31-8d8d-e9ef4cc6f445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d442fdec-3716-4542-b380-e21c8c51e28f" xlink:to="loc_us-gaap_StockholdersEquity_b8cc6f05-a256-4f31-8d8d-e9ef4cc6f445" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_480629e6-4117-4b7b-9d89-e5ecf5a94f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d442fdec-3716-4542-b380-e21c8c51e28f" xlink:to="loc_us-gaap_Liabilities_480629e6-4117-4b7b-9d89-e5ecf5a94f46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d1081429-4fbd-4a49-897e-0c5934963961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d442fdec-3716-4542-b380-e21c8c51e28f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d1081429-4fbd-4a49-897e-0c5934963961" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f4e7477b-1fcf-44d3-953c-60fafc056be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d620fdf5-a633-4ece-9647-2629b7eb2bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f4e7477b-1fcf-44d3-953c-60fafc056be2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d620fdf5-a633-4ece-9647-2629b7eb2bc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2aaf9d05-9fbb-4db9-85ab-ab1f72690e15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f4e7477b-1fcf-44d3-953c-60fafc056be2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2aaf9d05-9fbb-4db9-85ab-ab1f72690e15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_54a537a7-eaf6-45ce-8210-8e2048fb81dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_3ed03b7a-e72c-4f32-b266-cdc966cc83a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_54a537a7-eaf6-45ce-8210-8e2048fb81dd" xlink:to="loc_us-gaap_InterestIncomeOther_3ed03b7a-e72c-4f32-b266-cdc966cc83a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_InterestIncomeAndOtherIncomeExpense_edc3a205-9ae3-4410-b4b4-e8897f98d48c" xlink:href="fhtx-20230331.xsd#fhtx_InterestIncomeAndOtherIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_54a537a7-eaf6-45ce-8210-8e2048fb81dd" xlink:to="loc_fhtx_InterestIncomeAndOtherIncomeExpense_edc3a205-9ae3-4410-b4b4-e8897f98d48c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2c47ee4b-3f04-4ca8-8f2b-4a7e51246c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_adc8514c-520b-4552-9f57-5e56c44a4461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2c47ee4b-3f04-4ca8-8f2b-4a7e51246c48" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_adc8514c-520b-4552-9f57-5e56c44a4461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7782c617-6a53-45a3-9c48-6ad0a13b2c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2c47ee4b-3f04-4ca8-8f2b-4a7e51246c48" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7782c617-6a53-45a3-9c48-6ad0a13b2c81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3dd01f94-7e88-4064-80bb-4771bbea6413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dc1e7297-16bd-4b5c-a309-fc8478a2ac15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3dd01f94-7e88-4064-80bb-4771bbea6413" xlink:to="loc_us-gaap_OperatingIncomeLoss_dc1e7297-16bd-4b5c-a309-fc8478a2ac15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_53e4c349-bd09-46b6-8e0a-8b3d1cfd5382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3dd01f94-7e88-4064-80bb-4771bbea6413" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_53e4c349-bd09-46b6-8e0a-8b3d1cfd5382" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d93c0d55-3a3f-4a99-aedc-3e43a600725b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_18197b83-34ad-4562-a983-ec17cfceaab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d93c0d55-3a3f-4a99-aedc-3e43a600725b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_18197b83-34ad-4562-a983-ec17cfceaab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4b39fd26-0658-4a29-9069-f3b8613a465f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_dd36701d-01b5-4cf2-9c02-e5601a65d8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4b39fd26-0658-4a29-9069-f3b8613a465f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_dd36701d-01b5-4cf2-9c02-e5601a65d8db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_82766742-dc67-4905-a432-7997e4b7d0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4b39fd26-0658-4a29-9069-f3b8613a465f" xlink:to="loc_us-gaap_NetIncomeLoss_82766742-dc67-4905-a432-7997e4b7d0a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4c98c27b-897c-4a94-966d-db5e150fdbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f335902c-3331-4ec6-a1de-0eb518e4b854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_4c98c27b-897c-4a94-966d-db5e150fdbaa" xlink:to="loc_us-gaap_OperatingExpenses_f335902c-3331-4ec6-a1de-0eb518e4b854" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1aaff430-89ab-40d4-9c7a-81a6a479e0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_4c98c27b-897c-4a94-966d-db5e150fdbaa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1aaff430-89ab-40d4-9c7a-81a6a479e0c5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b45132aa-dce9-4919-966a-225fb29aaacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7e367ba5-a07e-4fa8-973e-0c60c9654b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b45132aa-dce9-4919-966a-225fb29aaacd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7e367ba5-a07e-4fa8-973e-0c60c9654b45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_110b8135-e40d-42f7-aff2-8f8b66c2081a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b45132aa-dce9-4919-966a-225fb29aaacd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_110b8135-e40d-42f7-aff2-8f8b66c2081a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c1ad391f-2005-43a4-8e9d-1097414a73a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b45132aa-dce9-4919-966a-225fb29aaacd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c1ad391f-2005-43a4-8e9d-1097414a73a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5505c0c5-f894-4fe2-afc1-2c3599d2e17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalents_91fcf96f-5f37-4b22-ad7a-e2adb1b92ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5505c0c5-f894-4fe2-afc1-2c3599d2e17f" xlink:to="loc_us-gaap_RestrictedCashEquivalents_91fcf96f-5f37-4b22-ad7a-e2adb1b92ff3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2b3f90ba-bf5e-44f2-98a6-77962c16c80e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5505c0c5-f894-4fe2-afc1-2c3599d2e17f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2b3f90ba-bf5e-44f2-98a6-77962c16c80e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_00ddcf52-26ae-4d98-b2fb-1e191bc55e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_us-gaap_NetIncomeLoss_00ddcf52-26ae-4d98-b2fb-1e191bc55e64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2dd915be-7374-48eb-8c7e-e0aee54c4cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2dd915be-7374-48eb-8c7e-e0aee54c4cb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_12a48959-2efd-4c7d-9522-4340ceadd64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_12a48959-2efd-4c7d-9522-4340ceadd64b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_c8507f69-5b88-49a2-a463-a9790fb44e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_c8507f69-5b88-49a2-a463-a9790fb44e12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_e448e5aa-97cc-4bc7-b403-304c901b62a7" xlink:href="fhtx-20230331.xsd#fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_e448e5aa-97cc-4bc7-b403-304c901b62a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_6db49fe0-df75-4bf4-a7cc-ab0e7b270084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_6db49fe0-df75-4bf4-a7cc-ab0e7b270084" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0e0635a1-ae9b-4307-9c75-f0b65c19c4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0e0635a1-ae9b-4307-9c75-f0b65c19c4c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_347634ed-8de6-4c88-9c74-3e17cfb09479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_347634ed-8de6-4c88-9c74-3e17cfb09479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_62f296b0-d699-4603-87df-d95363a006f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_62f296b0-d699-4603-87df-d95363a006f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_7d615695-0616-4dd9-96f8-b6c808e98800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_7d615695-0616-4dd9-96f8-b6c808e98800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d6d516ce-b9f3-4ad3-8852-08d9cb4bf885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d15bffd8-8c6a-4a64-8507-5837e8564345" xlink:to="loc_us-gaap_ShareBasedCompensation_d6d516ce-b9f3-4ad3-8852-08d9cb4bf885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_760db937-5a92-4630-8fbe-0001cfd7e5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2b100e48-d06d-4511-92d8-0968553f7ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_760db937-5a92-4630-8fbe-0001cfd7e5ef" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2b100e48-d06d-4511-92d8-0968553f7ee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3d68105f-6e30-467e-9cfe-1ecfef252b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_760db937-5a92-4630-8fbe-0001cfd7e5ef" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3d68105f-6e30-467e-9cfe-1ecfef252b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_710e73c6-449a-41bd-877b-35c53337616e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_760db937-5a92-4630-8fbe-0001cfd7e5ef" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_710e73c6-449a-41bd-877b-35c53337616e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27992729-1c6a-4fd5-89c2-8e7e05d83d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c37d04cb-b36a-4e53-b82f-51fbc9463110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_27992729-1c6a-4fd5-89c2-8e7e05d83d6b" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c37d04cb-b36a-4e53-b82f-51fbc9463110" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"/>
  <link:calculationLink xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e18aba0d-4cdb-4149-9f09-8a80cbe93ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_21683c4f-362b-462a-8578-587262b71a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e18aba0d-4cdb-4149-9f09-8a80cbe93ec0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_21683c4f-362b-462a-8578-587262b71a05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_aa390d6c-7191-4baa-b495-3fbe48ccc6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e18aba0d-4cdb-4149-9f09-8a80cbe93ec0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_aa390d6c-7191-4baa-b495-3fbe48ccc6a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_65ec41ac-d488-4b21-9f4c-5fc9ac12c42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e18aba0d-4cdb-4149-9f09-8a80cbe93ec0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_65ec41ac-d488-4b21-9f4c-5fc9ac12c42b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_0ddea11f-06a2-4d41-9eb7-a94bb8aca0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d3092e62-42e6-4592-a2f2-419fcca4764a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_0ddea11f-06a2-4d41-9eb7-a94bb8aca0db" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d3092e62-42e6-4592-a2f2-419fcca4764a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8257063b-0e42-441d-9dde-a124d61c620f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_0ddea11f-06a2-4d41-9eb7-a94bb8aca0db" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8257063b-0e42-441d-9dde-a124d61c620f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7f61b8f7-2d82-4ee0-a159-0f25b6d59426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_e79bea24-3764-4973-9526-e4d3fca06c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7f61b8f7-2d82-4ee0-a159-0f25b6d59426" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_e79bea24-3764-4973-9526-e4d3fca06c28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_e4c9b503-9d17-44fa-be89-a23b4e1aa0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7f61b8f7-2d82-4ee0-a159-0f25b6d59426" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_e4c9b503-9d17-44fa-be89-a23b4e1aa0f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5eb2ca39-e7df-403b-ae25-be23266d187b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6713b597-3ece-4e10-810f-ae91e8aae5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5eb2ca39-e7df-403b-ae25-be23266d187b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6713b597-3ece-4e10-810f-ae91e8aae5a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_eebcddab-f928-4a51-ab62-a7e03cf6723c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5eb2ca39-e7df-403b-ae25-be23266d187b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_eebcddab-f928-4a51-ab62-a7e03cf6723c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_AccruedResearchAndDevelopmentExpenses_9dd38279-b1e5-4fc7-9cde-d48286be351a" xlink:href="fhtx-20230331.xsd#fhtx_AccruedResearchAndDevelopmentExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5eb2ca39-e7df-403b-ae25-be23266d187b" xlink:to="loc_fhtx_AccruedResearchAndDevelopmentExpenses_9dd38279-b1e5-4fc7-9cde-d48286be351a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_42000589-a633-46c5-a21d-cab24c6d85a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5eb2ca39-e7df-403b-ae25-be23266d187b" xlink:to="loc_us-gaap_AccruedIncomeTaxes_42000589-a633-46c5-a21d-cab24c6d85a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_5b8e91a8-aa40-4d1e-a68c-5a847b122100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_5eb2ca39-e7df-403b-ae25-be23266d187b" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_5b8e91a8-aa40-4d1e-a68c-5a847b122100" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>fhtx-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:15bd0678-6723-4159-8d23-9a6c2981f314,g:5f09f729-e9b1-474a-a25d-c866e4e94b81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended" id="iec6d09e63abd4cbb802bbf775f1669b9_CondensedConsolidatedStatementsofStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bb6eb60b-6620-4116-8d0f-9afafb523e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bb6eb60b-6620-4116-8d0f-9afafb523e81" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f3744c58-153a-4be8-8cb7-fd54f58131ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_StockholdersEquity_f3744c58-153a-4be8-8cb7-fd54f58131ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f7aea109-1bf0-4378-9b8f-89854b5d7a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f7aea109-1bf0-4378-9b8f-89854b5d7a14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d06a37f7-7aae-4af7-8c0a-015c6684e060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d06a37f7-7aae-4af7-8c0a-015c6684e060" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bd6c72b6-86b3-4388-96ff-80503ae60133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bd6c72b6-86b3-4388-96ff-80503ae60133" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e1a14ae6-1826-4384-9776-7563205c9eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e1a14ae6-1826-4384-9776-7563205c9eaf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_eb411075-fd75-4d17-a2f4-d016f3e62b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_eb411075-fd75-4d17-a2f4-d016f3e62b6d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_808ebe53-21cc-46ef-9d68-f7d48ddc57f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_NetIncomeLoss_808ebe53-21cc-46ef-9d68-f7d48ddc57f6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ebe6952f-68c1-4914-b7af-ae6394991695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_35e01770-760f-49a4-bc61-f7e93fe09690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_56f0154f-7821-4a41-bfec-8d6ad9ea9c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bb6eb60b-6620-4116-8d0f-9afafb523e81" xlink:to="loc_us-gaap_StatementTable_56f0154f-7821-4a41-bfec-8d6ad9ea9c83" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_91afd82c-e920-4228-8322-46ade0e6c05e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_56f0154f-7821-4a41-bfec-8d6ad9ea9c83" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_91afd82c-e920-4228-8322-46ade0e6c05e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_91afd82c-e920-4228-8322-46ade0e6c05e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_91afd82c-e920-4228-8322-46ade0e6c05e" xlink:to="loc_us-gaap_EquityComponentDomain_91afd82c-e920-4228-8322-46ade0e6c05e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_91afd82c-e920-4228-8322-46ade0e6c05e" xlink:to="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a9678b35-3496-41a5-ac15-ffa8b1d2add1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:to="loc_us-gaap_CommonStockMember_a9678b35-3496-41a5-ac15-ffa8b1d2add1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8e185a35-86aa-450a-94b6-106177f97b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8e185a35-86aa-450a-94b6-106177f97b57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e729e891-39b8-4389-bc36-a453329c0f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e729e891-39b8-4389-bc36-a453329c0f69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6a568073-6d3f-4265-a0b2-d35f5f6c10c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:to="loc_us-gaap_RetainedEarningsMember_6a568073-6d3f-4265-a0b2-d35f5f6c10c6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#NatureofBusinessGoingConcernandBasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails" xlink:type="extended" id="icca154c797c148018bc3210106137957_NatureofBusinessGoingConcernandBasisofPresentationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:href="fhtx-20230331.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment_0ae524a6-2388-4629-ad2c-7577d3a3d153" xlink:href="fhtx-20230331.xsd#fhtx_ProceedsFromUpfrontPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:to="loc_fhtx_ProceedsFromUpfrontPayment_0ae524a6-2388-4629-ad2c-7577d3a3d153" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_PaymentReceivedForAchievementOfMilestones_c921a4da-80b6-4a52-9de2-c0e73a353fdc" xlink:href="fhtx-20230331.xsd#fhtx_PaymentReceivedForAchievementOfMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:to="loc_fhtx_PaymentReceivedForAchievementOfMilestones_c921a4da-80b6-4a52-9de2-c0e73a353fdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ed735c80-c337-4f71-b798-e11727864e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:to="loc_us-gaap_NetIncomeLoss_ed735c80-c337-4f71-b798-e11727864e8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_394c174d-8af7-4632-bafb-a363f2385b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_394c174d-8af7-4632-bafb-a363f2385b0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_89c1b024-d596-4b14-961f-b54edd668f3a" xlink:href="fhtx-20230331.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:to="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_89c1b024-d596-4b14-961f-b54edd668f3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_15642b38-ded4-4063-b43d-69978383a652" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_89c1b024-d596-4b14-961f-b54edd668f3a" xlink:to="loc_srt_CounterpartyNameAxis_15642b38-ded4-4063-b43d-69978383a652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_15642b38-ded4-4063-b43d-69978383a652_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_15642b38-ded4-4063-b43d-69978383a652" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_15642b38-ded4-4063-b43d-69978383a652_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_208a9801-f311-468b-8030-959ce2c1b382" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_15642b38-ded4-4063-b43d-69978383a652" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_208a9801-f311-468b-8030-959ce2c1b382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_EliLillyMember_8c6c25b0-5082-48b6-a274-064591e8fe84" xlink:href="fhtx-20230331.xsd#fhtx_EliLillyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_208a9801-f311-468b-8030-959ce2c1b382" xlink:to="loc_fhtx_EliLillyMember_8c6c25b0-5082-48b6-a274-064591e8fe84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MerckMember_2c633346-cc1c-46b2-8d2a-6ae08f12a4ed" xlink:href="fhtx-20230331.xsd#fhtx_MerckMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_208a9801-f311-468b-8030-959ce2c1b382" xlink:to="loc_fhtx_MerckMember_2c633346-cc1c-46b2-8d2a-6ae08f12a4ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_42f389bc-4485-4f7d-9dee-1978b5ec4e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_89c1b024-d596-4b14-961f-b54edd668f3a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_42f389bc-4485-4f7d-9dee-1978b5ec4e02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_42f389bc-4485-4f7d-9dee-1978b5ec4e02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_42f389bc-4485-4f7d-9dee-1978b5ec4e02" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_42f389bc-4485-4f7d-9dee-1978b5ec4e02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_235f68db-3dcd-43cf-8401-4a97069b37b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_42f389bc-4485-4f7d-9dee-1978b5ec4e02" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_235f68db-3dcd-43cf-8401-4a97069b37b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MerckCollaborationAgreementMember_dd83a415-f6a2-4ce2-acdf-fd6df6686c73" xlink:href="fhtx-20230331.xsd#fhtx_MerckCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_235f68db-3dcd-43cf-8401-4a97069b37b5" xlink:to="loc_fhtx_MerckCollaborationAgreementMember_dd83a415-f6a2-4ce2-acdf-fd6df6686c73" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails" xlink:type="extended" id="ic1a9be6bf326473d9c23206d5d32670d_MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9cc628d4-7f3d-4d7c-8c26-30b7c28ed456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9cc628d4-7f3d-4d7c-8c26-30b7c28ed456" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da818efc-288d-4790-b0e4-86170c47c297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da818efc-288d-4790-b0e4-86170c47c297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bb19e392-7078-47a9-8043-4d39e6866fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bb19e392-7078-47a9-8043-4d39e6866fa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c4630c76-09a1-4c1f-9d61-b28f1c2a0239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c4630c76-09a1-4c1f-9d61-b28f1c2a0239" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_11abcca1-157a-46b8-a060-e3876778ee23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_11abcca1-157a-46b8-a060-e3876778ee23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_398295a7-8abc-4139-9518-c29ef4d22b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_11abcca1-157a-46b8-a060-e3876778ee23" xlink:to="loc_us-gaap_FinancialInstrumentAxis_398295a7-8abc-4139-9518-c29ef4d22b40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_398295a7-8abc-4139-9518-c29ef4d22b40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_398295a7-8abc-4139-9518-c29ef4d22b40" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_398295a7-8abc-4139-9518-c29ef4d22b40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_398295a7-8abc-4139-9518-c29ef4d22b40" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember_c36d9fb7-70d8-4afc-9129-2e79371cc336" xlink:href="fhtx-20230331.xsd#fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember_c36d9fb7-70d8-4afc-9129-2e79371cc336" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_USGovernmentAgenciesDueWithinOneYearMember_a45d27c2-7e7d-4180-8039-5d4299ec4d44" xlink:href="fhtx-20230331.xsd#fhtx_USGovernmentAgenciesDueWithinOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_fhtx_USGovernmentAgenciesDueWithinOneYearMember_a45d27c2-7e7d-4180-8039-5d4299ec4d44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_85bdd7e7-982d-4967-b402-393e23086659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_us-gaap_CommercialPaperMember_85bdd7e7-982d-4967-b402-393e23086659" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember_1efcc5a7-3900-4bce-89ea-989a25c365da" xlink:href="fhtx-20230331.xsd#fhtx_CorporateDebtSecuritiesDueWithinOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember_1efcc5a7-3900-4bce-89ea-989a25c365da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember_27a5980c-ab09-47c7-8da4-f4caf5914947" xlink:href="fhtx-20230331.xsd#fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember_27a5980c-ab09-47c7-8da4-f4caf5914947" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember_661d7430-8506-4b8a-a7e3-ffc0c369ab47" xlink:href="fhtx-20230331.xsd#fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember_661d7430-8506-4b8a-a7e3-ffc0c369ab47" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i6a47f93259d54e56a41d7fc9fa393fb8_MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b4359df-b4e3-4d84-b782-92860badd2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0055620c-cc34-4b93-9069-e54376aa6efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b4359df-b4e3-4d84-b782-92860badd2fa" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0055620c-cc34-4b93-9069-e54376aa6efb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8675c8d2-035b-41f2-a345-8ebb026beb39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b4359df-b4e3-4d84-b782-92860badd2fa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8675c8d2-035b-41f2-a345-8ebb026beb39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_28ab4601-e033-4006-bc71-2c1aabfeae18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b4359df-b4e3-4d84-b782-92860badd2fa" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_28ab4601-e033-4006-bc71-2c1aabfeae18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b4359df-b4e3-4d84-b782-92860badd2fa" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cc42dbf5-57c9-410e-8b96-da42cd8d52aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cc42dbf5-57c9-410e-8b96-da42cd8d52aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cc42dbf5-57c9-410e-8b96-da42cd8d52aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cc42dbf5-57c9-410e-8b96-da42cd8d52aa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cc42dbf5-57c9-410e-8b96-da42cd8d52aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_554549fe-7e9e-4485-bbc5-6463bfe1dd62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cc42dbf5-57c9-410e-8b96-da42cd8d52aa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_554549fe-7e9e-4485-bbc5-6463bfe1dd62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b48f68b4-a49b-44c0-bb99-f0f665b59e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_554549fe-7e9e-4485-bbc5-6463bfe1dd62" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b48f68b4-a49b-44c0-bb99-f0f665b59e74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a923d11a-62e5-457e-8926-b86dcfaa16db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a923d11a-62e5-457e-8926-b86dcfaa16db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a923d11a-62e5-457e-8926-b86dcfaa16db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a923d11a-62e5-457e-8926-b86dcfaa16db" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a923d11a-62e5-457e-8926-b86dcfaa16db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc267a16-c7ba-46fe-8e45-9786ffb959ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a923d11a-62e5-457e-8926-b86dcfaa16db" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc267a16-c7ba-46fe-8e45-9786ffb959ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ff914095-1024-456b-aee3-6da18f156913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc267a16-c7ba-46fe-8e45-9786ffb959ed" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ff914095-1024-456b-aee3-6da18f156913" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_12ae60b6-f601-439b-b6c9-2c618394d007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc267a16-c7ba-46fe-8e45-9786ffb959ed" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_12ae60b6-f601-439b-b6c9-2c618394d007" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_838ba453-29d0-4940-ae48-fc6980980a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc267a16-c7ba-46fe-8e45-9786ffb959ed" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_838ba453-29d0-4940-ae48-fc6980980a1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_2ec255a5-bb68-4836-8a16-9856534ecc02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_2ec255a5-bb68-4836-8a16-9856534ecc02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ec255a5-bb68-4836-8a16-9856534ecc02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2ec255a5-bb68-4836-8a16-9856534ecc02" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2ec255a5-bb68-4836-8a16-9856534ecc02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e96c7e9f-8d01-4959-8e9b-ea1c3bf2c0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2ec255a5-bb68-4836-8a16-9856534ecc02" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e96c7e9f-8d01-4959-8e9b-ea1c3bf2c0ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_b56362fc-bebf-491b-9294-875fcbf5582c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e96c7e9f-8d01-4959-8e9b-ea1c3bf2c0ee" xlink:to="loc_us-gaap_MoneyMarketFundsMember_b56362fc-bebf-491b-9294-875fcbf5582c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember_001182c9-66fe-4e82-a4eb-2de11ed903c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e96c7e9f-8d01-4959-8e9b-ea1c3bf2c0ee" xlink:to="loc_us-gaap_USTreasuryNotesSecuritiesMember_001182c9-66fe-4e82-a4eb-2de11ed903c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e1565367-e53e-467d-82fe-b11caa2e90a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e96c7e9f-8d01-4959-8e9b-ea1c3bf2c0ee" xlink:to="loc_us-gaap_CommercialPaperMember_e1565367-e53e-467d-82fe-b11caa2e90a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_68eb59f0-3d1c-485e-812c-cfd1caca91fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:to="loc_us-gaap_FinancialInstrumentAxis_68eb59f0-3d1c-485e-812c-cfd1caca91fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_68eb59f0-3d1c-485e-812c-cfd1caca91fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_68eb59f0-3d1c-485e-812c-cfd1caca91fc" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_68eb59f0-3d1c-485e-812c-cfd1caca91fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_68eb59f0-3d1c-485e-812c-cfd1caca91fc" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember_0fbc15a3-672e-497b-8873-de49f9b705a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:to="loc_us-gaap_USTreasuryNotesSecuritiesMember_0fbc15a3-672e-497b-8873-de49f9b705a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_077edb0f-4dc6-427d-b5b9-09a7a8db3502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_077edb0f-4dc6-427d-b5b9-09a7a8db3502" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_67edb1bb-55b2-4251-9579-7418743f6212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:to="loc_us-gaap_CommercialPaperMember_67edb1bb-55b2-4251-9579-7418743f6212" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_79231edd-676b-442e-97da-149ea0377968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_79231edd-676b-442e-97da-149ea0377968" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails" xlink:type="extended" id="ic24a5c67306c4f74a9beab27ef9899e3_PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21ab7efb-9526-48fc-8920-88481e43a01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_6277540f-0a21-4a4b-ad88-fe4079fdceb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21ab7efb-9526-48fc-8920-88481e43a01b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_6277540f-0a21-4a4b-ad88-fe4079fdceb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b1d579f0-049e-49eb-80bb-6f0c9a97f65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_6277540f-0a21-4a4b-ad88-fe4079fdceb3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b1d579f0-049e-49eb-80bb-6f0c9a97f65e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_4cdb1ea7-8627-4bcc-9f17-dce26bd18f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_6277540f-0a21-4a4b-ad88-fe4079fdceb3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_4cdb1ea7-8627-4bcc-9f17-dce26bd18f77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_65c96099-26b9-4fb9-887a-f0d76247e571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_6277540f-0a21-4a4b-ad88-fe4079fdceb3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_65c96099-26b9-4fb9-887a-f0d76247e571" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ce97c3c6-b4c2-4acf-a439-7316d324483a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21ab7efb-9526-48fc-8920-88481e43a01b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ce97c3c6-b4c2-4acf-a439-7316d324483a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32abd7aa-4510-4219-ad53-16a7f96dad28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ce97c3c6-b4c2-4acf-a439-7316d324483a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32abd7aa-4510-4219-ad53-16a7f96dad28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_32abd7aa-4510-4219-ad53-16a7f96dad28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32abd7aa-4510-4219-ad53-16a7f96dad28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_32abd7aa-4510-4219-ad53-16a7f96dad28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32abd7aa-4510-4219-ad53-16a7f96dad28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_eec6fdfc-caaa-47c7-8133-7bf4c0407f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:to="loc_us-gaap_EquipmentMember_eec6fdfc-caaa-47c7-8133-7bf4c0407f2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_09cef66d-3198-471e-9609-7a2f157d03ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_09cef66d-3198-471e-9609-7a2f157d03ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ComputerEquipmentAndSoftwareMember_a781ccad-07b4-4116-8497-b252188a8c61" xlink:href="fhtx-20230331.xsd#fhtx_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:to="loc_fhtx_ComputerEquipmentAndSoftwareMember_a781ccad-07b4-4116-8497-b252188a8c61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_f0369cbe-2859-469d-9c92-5248d4fae438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_f0369cbe-2859-469d-9c92-5248d4fae438" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_AssetsNotYetPlacedInServiceMember_0ad6d55d-07de-463d-baf0-2fde9ee27fc2" xlink:href="fhtx-20230331.xsd#fhtx_AssetsNotYetPlacedInServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:to="loc_fhtx_AssetsNotYetPlacedInServiceMember_0ad6d55d-07de-463d-baf0-2fde9ee27fc2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails" xlink:type="extended" id="i453022d86d534526a084533eeba14e5d_CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_139d0de7-1824-4c89-a77e-830d8c34e6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b84ebbf4-06fb-4221-b800-9b7f86dacf79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_139d0de7-1824-4c89-a77e-830d8c34e6a1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b84ebbf4-06fb-4221-b800-9b7f86dacf79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5bfcab8-2eaa-4cf3-bb4a-34fbd8216733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_139d0de7-1824-4c89-a77e-830d8c34e6a1" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5bfcab8-2eaa-4cf3-bb4a-34fbd8216733" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3465cf80-56d5-4d32-be9b-26854b828cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5bfcab8-2eaa-4cf3-bb4a-34fbd8216733" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3465cf80-56d5-4d32-be9b-26854b828cc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3465cf80-56d5-4d32-be9b-26854b828cc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3465cf80-56d5-4d32-be9b-26854b828cc0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3465cf80-56d5-4d32-be9b-26854b828cc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_76a85f9f-b7e1-49b5-ae79-554aae6d39e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3465cf80-56d5-4d32-be9b-26854b828cc0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_76a85f9f-b7e1-49b5-ae79-554aae6d39e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_20c31564-16fb-4452-a3da-c11a00032288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_76a85f9f-b7e1-49b5-ae79-554aae6d39e7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_20c31564-16fb-4452-a3da-c11a00032288" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_730b9943-03a9-4fdb-8721-a85023d73dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_76a85f9f-b7e1-49b5-ae79-554aae6d39e7" xlink:to="loc_us-gaap_WarrantMember_730b9943-03a9-4fdb-8721-a85023d73dc4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended" id="iafe9d61a301e4517b9a6fee9bc1131af_StockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6debdeab-d3f0-410a-9468-ce91a94801cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6debdeab-d3f0-410a-9468-ce91a94801cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4a63e0e7-9fcc-40c6-a024-a7c5b07b5ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4a63e0e7-9fcc-40c6-a024-a7c5b07b5ccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage_66db45b7-6def-4065-bcca-0e3327fd0f95" xlink:href="fhtx-20230331.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage_66db45b7-6def-4065-bcca-0e3327fd0f95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7428955d-94e4-450c-9906-bcbd30c89a93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7428955d-94e4-450c-9906-bcbd30c89a93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1025d3b1-e157-4336-9117-1caa6aa47b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1025d3b1-e157-4336-9117-1caa6aa47b30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_00000d90-f85a-42ed-aff9-e6764c485501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_00000d90-f85a-42ed-aff9-e6764c485501" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_775c0401-19ff-448b-af08-9edf00dc499e" xlink:href="fhtx-20230331.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_775c0401-19ff-448b-af08-9edf00dc499e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_6a442140-d60a-4d70-ac9f-9f2b5724a211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_6a442140-d60a-4d70-ac9f-9f2b5724a211" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_879abfc7-58e2-483d-8e67-df93dc8d7d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_879abfc7-58e2-483d-8e67-df93dc8d7d4e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b2f4da3-c2a8-4618-b4c7-cc2ea3eeca82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b2f4da3-c2a8-4618-b4c7-cc2ea3eeca82" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ca90bb6d-4a12-4e97-a09c-57d437825a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ca90bb6d-4a12-4e97-a09c-57d437825a48" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_de075fee-a9f0-481d-bb58-62e5a429ef79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_de075fee-a9f0-481d-bb58-62e5a429ef79" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_dcba3ff2-b4bf-472c-a9f4-62f4af001852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_de075fee-a9f0-481d-bb58-62e5a429ef79" xlink:to="loc_us-gaap_PlanNameAxis_dcba3ff2-b4bf-472c-a9f4-62f4af001852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_dcba3ff2-b4bf-472c-a9f4-62f4af001852_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_dcba3ff2-b4bf-472c-a9f4-62f4af001852" xlink:to="loc_us-gaap_PlanNameDomain_dcba3ff2-b4bf-472c-a9f4-62f4af001852_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_69b7cd98-8d83-40cf-929c-72e3a1d12650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_dcba3ff2-b4bf-472c-a9f4-62f4af001852" xlink:to="loc_us-gaap_PlanNameDomain_69b7cd98-8d83-40cf-929c-72e3a1d12650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember_a2efbc54-754c-42c3-98f3-b90fef393793" xlink:href="fhtx-20230331.xsd#fhtx_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_69b7cd98-8d83-40cf-929c-72e3a1d12650" xlink:to="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember_a2efbc54-754c-42c3-98f3-b90fef393793" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_A2016StockIncentivePlanMember_9fb83df4-5424-4f22-b7d5-83a3728563a0" xlink:href="fhtx-20230331.xsd#fhtx_A2016StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_69b7cd98-8d83-40cf-929c-72e3a1d12650" xlink:to="loc_fhtx_A2016StockIncentivePlanMember_9fb83df4-5424-4f22-b7d5-83a3728563a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember_9572e926-5e33-4202-8435-ddf9080cae3d" xlink:href="fhtx-20230331.xsd#fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_69b7cd98-8d83-40cf-929c-72e3a1d12650" xlink:to="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember_9572e926-5e33-4202-8435-ddf9080cae3d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" xlink:type="extended" id="ie35a1cce20e84410a8787e3ad584186e_StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_e2fdfe2e-8df6-4556-9eb2-e561add072bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5c89aa42-d9e8-464f-95f8-914e29cdb804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_e2fdfe2e-8df6-4556-9eb2-e561add072bd" xlink:to="loc_us-gaap_ShareBasedCompensation_5c89aa42-d9e8-464f-95f8-914e29cdb804" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e69a5c-a3fc-45d8-bb43-55d362335884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_e2fdfe2e-8df6-4556-9eb2-e561add072bd" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e69a5c-a3fc-45d8-bb43-55d362335884" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e3e30918-d089-404f-a6bb-5f310b302a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e69a5c-a3fc-45d8-bb43-55d362335884" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e3e30918-d089-404f-a6bb-5f310b302a26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e3e30918-d089-404f-a6bb-5f310b302a26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e3e30918-d089-404f-a6bb-5f310b302a26" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e3e30918-d089-404f-a6bb-5f310b302a26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_22a799a8-7706-4f5b-bde0-5ef357d9e237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e3e30918-d089-404f-a6bb-5f310b302a26" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_22a799a8-7706-4f5b-bde0-5ef357d9e237" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_664d0b2a-e7ae-4d11-94d6-a36689a3cae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_22a799a8-7706-4f5b-bde0-5ef357d9e237" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_664d0b2a-e7ae-4d11-94d6-a36689a3cae9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_59111e8f-04f1-424c-a5b8-911c05ae8c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_22a799a8-7706-4f5b-bde0-5ef357d9e237" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_59111e8f-04f1-424c-a5b8-911c05ae8c21" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CollaborationAgreementsDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CollaborationAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/CollaborationAgreementsDetails" xlink:type="extended" id="i3e9f1e9dbdda419a918b15e14f9e6333_CollaborationAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_NumberOfAdditionalTargets_578d3aa8-31cd-4735-9ce3-601258fac406" xlink:href="fhtx-20230331.xsd#fhtx_NumberOfAdditionalTargets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_NumberOfAdditionalTargets_578d3aa8-31cd-4735-9ce3-601258fac406" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_NumberOfPrograms_1aa2ac84-85b7-4686-a877-11faaded227c" xlink:href="fhtx-20230331.xsd#fhtx_NumberOfPrograms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_NumberOfPrograms_1aa2ac84-85b7-4686-a877-11faaded227c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_NumberOfTargets_2b41155b-56fb-47cb-96c4-b3052ec21f4d" xlink:href="fhtx-20230331.xsd#fhtx_NumberOfTargets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_NumberOfTargets_2b41155b-56fb-47cb-96c4-b3052ec21f4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MilestoneReceivableUponAchievement_3a3f1a8d-bb3d-48a9-9a4e-da9756bf4b38" xlink:href="fhtx-20230331.xsd#fhtx_MilestoneReceivableUponAchievement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_MilestoneReceivableUponAchievement_3a3f1a8d-bb3d-48a9-9a4e-da9756bf4b38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_OptOutMilestoneReceivableUponAchievement_073acc37-9483-44d2-905d-12dd7eabc002" xlink:href="fhtx-20230331.xsd#fhtx_OptOutMilestoneReceivableUponAchievement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_OptOutMilestoneReceivableUponAchievement_073acc37-9483-44d2-905d-12dd7eabc002" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_266940ce-4931-489f-875f-d79c57525551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_us-gaap_ContractWithCustomerLiability_266940ce-4931-489f-875f-d79c57525551" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db1c6d4c-a942-4a14-8430-5586dd6a367b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db1c6d4c-a942-4a14-8430-5586dd6a367b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment_2b20393e-9147-41a9-9742-477d9f9207e3" xlink:href="fhtx-20230331.xsd#fhtx_ProceedsFromUpfrontPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_ProceedsFromUpfrontPayment_2b20393e-9147-41a9-9742-477d9f9207e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_PaymentReceivedForAchievementOfMilestones_d54b534f-6dd5-41d9-b067-ed5bed8df4d2" xlink:href="fhtx-20230331.xsd#fhtx_PaymentReceivedForAchievementOfMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_PaymentReceivedForAchievementOfMilestones_d54b534f-6dd5-41d9-b067-ed5bed8df4d2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d7914d40-2a36-46b8-a7d2-d1904667ab22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d7914d40-2a36-46b8-a7d2-d1904667ab22" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8653e662-d6db-454f-9b51-35cbb822965f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:to="loc_srt_CounterpartyNameAxis_8653e662-d6db-454f-9b51-35cbb822965f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8653e662-d6db-454f-9b51-35cbb822965f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_8653e662-d6db-454f-9b51-35cbb822965f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_8653e662-d6db-454f-9b51-35cbb822965f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60c295f3-b283-4233-b2e6-6e846bf4fc65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_8653e662-d6db-454f-9b51-35cbb822965f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60c295f3-b283-4233-b2e6-6e846bf4fc65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_EliLillyMember_b91d87e4-ad7c-4d2b-9720-056b5795f70a" xlink:href="fhtx-20230331.xsd#fhtx_EliLillyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60c295f3-b283-4233-b2e6-6e846bf4fc65" xlink:to="loc_fhtx_EliLillyMember_b91d87e4-ad7c-4d2b-9720-056b5795f70a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MerckMember_30383ad8-ac98-4632-913c-9785e9c228e0" xlink:href="fhtx-20230331.xsd#fhtx_MerckMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60c295f3-b283-4233-b2e6-6e846bf4fc65" xlink:to="loc_fhtx_MerckMember_30383ad8-ac98-4632-913c-9785e9c228e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0ca674f7-a3d6-430e-abc3-838ced512ab5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:to="loc_srt_RangeAxis_0ca674f7-a3d6-430e-abc3-838ced512ab5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0ca674f7-a3d6-430e-abc3-838ced512ab5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0ca674f7-a3d6-430e-abc3-838ced512ab5" xlink:to="loc_srt_RangeMember_0ca674f7-a3d6-430e-abc3-838ced512ab5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4019651f-cb64-48c3-8337-6bec807e3e75" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0ca674f7-a3d6-430e-abc3-838ced512ab5" xlink:to="loc_srt_RangeMember_4019651f-cb64-48c3-8337-6bec807e3e75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_73ddc414-70ad-4c11-909e-1e0247fe199b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4019651f-cb64-48c3-8337-6bec807e3e75" xlink:to="loc_srt_MaximumMember_73ddc414-70ad-4c11-909e-1e0247fe199b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9e44c4f-ca0a-4afa-829c-bd9d78d3be83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9e44c4f-ca0a-4afa-829c-bd9d78d3be83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c9e44c4f-ca0a-4afa-829c-bd9d78d3be83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9e44c4f-ca0a-4afa-829c-bd9d78d3be83" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c9e44c4f-ca0a-4afa-829c-bd9d78d3be83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0788995a-b3c7-4f6d-8ef2-6410d0041db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9e44c4f-ca0a-4afa-829c-bd9d78d3be83" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0788995a-b3c7-4f6d-8ef2-6410d0041db7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ResearchDevelopmentAndRegulatoryMember_98512aa4-6f8d-4dae-9ebd-dd3881788c37" xlink:href="fhtx-20230331.xsd#fhtx_ResearchDevelopmentAndRegulatoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0788995a-b3c7-4f6d-8ef2-6410d0041db7" xlink:to="loc_fhtx_ResearchDevelopmentAndRegulatoryMember_98512aa4-6f8d-4dae-9ebd-dd3881788c37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_SalesBasedMilestoneMember_afae293f-078c-42c4-af56-e76ffa62a73d" xlink:href="fhtx-20230331.xsd#fhtx_SalesBasedMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0788995a-b3c7-4f6d-8ef2-6410d0041db7" xlink:to="loc_fhtx_SalesBasedMilestoneMember_afae293f-078c-42c4-af56-e76ffa62a73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MerckCollaborationAgreementMember_089e0bf6-e221-43b3-b06d-23a2286beb36" xlink:href="fhtx-20230331.xsd#fhtx_MerckCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0788995a-b3c7-4f6d-8ef2-6410d0041db7" xlink:to="loc_fhtx_MerckCollaborationAgreementMember_089e0bf6-e221-43b3-b06d-23a2286beb36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9276cbd6-f920-48b3-80c8-a3f84ec7ab93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9276cbd6-f920-48b3-80c8-a3f84ec7ab93" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9276cbd6-f920-48b3-80c8-a3f84ec7ab93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9276cbd6-f920-48b3-80c8-a3f84ec7ab93" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9276cbd6-f920-48b3-80c8-a3f84ec7ab93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4b9db808-eeec-4cfa-9393-7b94fcd9ea09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9276cbd6-f920-48b3-80c8-a3f84ec7ab93" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4b9db808-eeec-4cfa-9393-7b94fcd9ea09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_ac4b53b6-459d-495d-861b-995d1b6c02bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4b9db808-eeec-4cfa-9393-7b94fcd9ea09" xlink:to="loc_us-gaap_SalesMember_ac4b53b6-459d-495d-861b-995d1b6c02bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/IncomeTaxesDetails" xlink:type="extended" id="i299af1a2c005420f88163419f68089cc_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_40538440-c014-449e-aa1e-e230b1bceead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment_58b88554-ae9e-482f-bf60-a774bc188efe" xlink:href="fhtx-20230331.xsd#fhtx_ProceedsFromUpfrontPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_40538440-c014-449e-aa1e-e230b1bceead" xlink:to="loc_fhtx_ProceedsFromUpfrontPayment_58b88554-ae9e-482f-bf60-a774bc188efe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_77620969-b483-4c86-9aa5-356878f5874c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_40538440-c014-449e-aa1e-e230b1bceead" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_77620969-b483-4c86-9aa5-356878f5874c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6cae297e-d5a2-4d11-9006-951e3012f551" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_77620969-b483-4c86-9aa5-356878f5874c" xlink:to="loc_srt_CounterpartyNameAxis_6cae297e-d5a2-4d11-9006-951e3012f551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6cae297e-d5a2-4d11-9006-951e3012f551_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_6cae297e-d5a2-4d11-9006-951e3012f551" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6cae297e-d5a2-4d11-9006-951e3012f551_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_94e842d6-cc76-41f0-b406-815c3a09c51e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_6cae297e-d5a2-4d11-9006-951e3012f551" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_94e842d6-cc76-41f0-b406-815c3a09c51e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_EliLillyMember_deb3572f-01e4-4dd0-98e9-7c24d220351b" xlink:href="fhtx-20230331.xsd#fhtx_EliLillyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_94e842d6-cc76-41f0-b406-815c3a09c51e" xlink:to="loc_fhtx_EliLillyMember_deb3572f-01e4-4dd0-98e9-7c24d220351b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i69d1e9ec7fbe48c099311044aa819e23_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CommitmentsAndContingenciesLineItems_82706d86-2f73-44ce-b5ca-0c611ee8e36a" xlink:href="fhtx-20230331.xsd#fhtx_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_AnnualLicenseMaintenanceFees_4628ca5a-aa63-466c-b901-46eefe3c5f0c" xlink:href="fhtx-20230331.xsd#fhtx_AnnualLicenseMaintenanceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_CommitmentsAndContingenciesLineItems_82706d86-2f73-44ce-b5ca-0c611ee8e36a" xlink:to="loc_fhtx_AnnualLicenseMaintenanceFees_4628ca5a-aa63-466c-b901-46eefe3c5f0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MilestonesPayableUponEvent_5236f9e7-f4de-4224-90aa-83a3b0c38627" xlink:href="fhtx-20230331.xsd#fhtx_MilestonesPayableUponEvent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fhtx_CommitmentsAndContingenciesLineItems_82706d86-2f73-44ce-b5ca-0c611ee8e36a" xlink:to="loc_fhtx_MilestonesPayableUponEvent_5236f9e7-f4de-4224-90aa-83a3b0c38627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CommitmentsAndContingenciesTable_942856c3-8612-4bc9-8ad5-6f5ee8d378d0" xlink:href="fhtx-20230331.xsd#fhtx_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_fhtx_CommitmentsAndContingenciesLineItems_82706d86-2f73-44ce-b5ca-0c611ee8e36a" xlink:to="loc_fhtx_CommitmentsAndContingenciesTable_942856c3-8612-4bc9-8ad5-6f5ee8d378d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_aa6eb8de-9388-4bff-889d-fa9b10f109be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fhtx_CommitmentsAndContingenciesTable_942856c3-8612-4bc9-8ad5-6f5ee8d378d0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_aa6eb8de-9388-4bff-889d-fa9b10f109be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_aa6eb8de-9388-4bff-889d-fa9b10f109be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_aa6eb8de-9388-4bff-889d-fa9b10f109be" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_aa6eb8de-9388-4bff-889d-fa9b10f109be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bb4f5cbc-1f67-4ac5-b3eb-6e0295ce7f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_aa6eb8de-9388-4bff-889d-fa9b10f109be" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bb4f5cbc-1f67-4ac5-b3eb-6e0295ce7f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_StanfordLicenseAgreementMember_a3eb2793-5cc6-44c0-b377-1f657077f3b7" xlink:href="fhtx-20230331.xsd#fhtx_StanfordLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bb4f5cbc-1f67-4ac5-b3eb-6e0295ce7f71" xlink:to="loc_fhtx_StanfordLicenseAgreementMember_a3eb2793-5cc6-44c0-b377-1f657077f3b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_06babcd6-e4d1-4966-9ccf-38bad44299dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fhtx_CommitmentsAndContingenciesTable_942856c3-8612-4bc9-8ad5-6f5ee8d378d0" xlink:to="loc_srt_RangeAxis_06babcd6-e4d1-4966-9ccf-38bad44299dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_06babcd6-e4d1-4966-9ccf-38bad44299dc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_06babcd6-e4d1-4966-9ccf-38bad44299dc" xlink:to="loc_srt_RangeMember_06babcd6-e4d1-4966-9ccf-38bad44299dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f4f6262d-7ba9-4abd-aad8-fc964439fee8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_06babcd6-e4d1-4966-9ccf-38bad44299dc" xlink:to="loc_srt_RangeMember_f4f6262d-7ba9-4abd-aad8-fc964439fee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d879602-7fd9-4202-b4f6-9a176b09a6d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f4f6262d-7ba9-4abd-aad8-fc964439fee8" xlink:to="loc_srt_MaximumMember_3d879602-7fd9-4202-b4f6-9a176b09a6d1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#RelatedPartiesDetails"/>
  <link:definitionLink xlink:role="http://www.foghorntx.com/role/RelatedPartiesDetails" xlink:type="extended" id="if6ff7ed6260f4c2b9ce06b113151dba2_RelatedPartiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_a2077f38-756b-46fc-8c79-4961967e658f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ServiceAgreementTerm_73b7b3b2-db0d-4ef3-b0f0-86e6e1fb3d41" xlink:href="fhtx-20230331.xsd#fhtx_ServiceAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a2077f38-756b-46fc-8c79-4961967e658f" xlink:to="loc_fhtx_ServiceAgreementTerm_73b7b3b2-db0d-4ef3-b0f0-86e6e1fb3d41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CashPaymentsRelatedParty_9eb87635-d56c-4bda-ac94-463f1bff205b" xlink:href="fhtx-20230331.xsd#fhtx_CashPaymentsRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a2077f38-756b-46fc-8c79-4961967e658f" xlink:to="loc_fhtx_CashPaymentsRelatedParty_9eb87635-d56c-4bda-ac94-463f1bff205b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_5323a1cb-6591-4f51-989b-23faf11576c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a2077f38-756b-46fc-8c79-4961967e658f" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_5323a1cb-6591-4f51-989b-23faf11576c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ab341390-b9a0-452e-a466-b251b69a02b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a2077f38-756b-46fc-8c79-4961967e658f" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ab341390-b9a0-452e-a466-b251b69a02b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8286fa9c-94b5-4b32-8916-25a63e66e73c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ab341390-b9a0-452e-a466-b251b69a02b2" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8286fa9c-94b5-4b32-8916-25a63e66e73c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8286fa9c-94b5-4b32-8916-25a63e66e73c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8286fa9c-94b5-4b32-8916-25a63e66e73c" xlink:to="loc_us-gaap_RelatedPartyDomain_8286fa9c-94b5-4b32-8916-25a63e66e73c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_60eb62ef-d325-44c8-9aea-1537dc391f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8286fa9c-94b5-4b32-8916-25a63e66e73c" xlink:to="loc_us-gaap_RelatedPartyDomain_60eb62ef-d325-44c8-9aea-1537dc391f8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_832ad327-ca24-4244-89d1-4da0e13b6522" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_60eb62ef-d325-44c8-9aea-1537dc391f8f" xlink:to="loc_srt_AffiliatedEntityMember_832ad327-ca24-4244-89d1-4da0e13b6522" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_1bf9c498-5d99-42c6-bd9b-37094ab3a1bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ab341390-b9a0-452e-a466-b251b69a02b2" xlink:to="loc_srt_TitleOfIndividualAxis_1bf9c498-5d99-42c6-bd9b-37094ab3a1bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1bf9c498-5d99-42c6-bd9b-37094ab3a1bc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_1bf9c498-5d99-42c6-bd9b-37094ab3a1bc" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1bf9c498-5d99-42c6-bd9b-37094ab3a1bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b8ac16e-2eee-47e2-9c5d-fa6ec1fed5dd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_1bf9c498-5d99-42c6-bd9b-37094ab3a1bc" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b8ac16e-2eee-47e2-9c5d-fa6ec1fed5dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ScientificFounderMember_5e6833e7-496a-416e-9ebb-9bee76e36354" xlink:href="fhtx-20230331.xsd#fhtx_ScientificFounderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b8ac16e-2eee-47e2-9c5d-fa6ec1fed5dd" xlink:to="loc_fhtx_ScientificFounderMember_5e6833e7-496a-416e-9ebb-9bee76e36354" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>fhtx-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:15bd0678-6723-4159-8d23-9a6c2981f314,g:5f09f729-e9b1-474a-a25d-c866e4e94b81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3b5719ec-0b51-4c83-b550-c130a20cf885_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_198f2efa-28ef-4822-8f80-b5a16ae385dd_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7d368b53-a0f3-42b0-a79f-09727c180b30_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_c79c957b-2ab8-4555-971d-01e369618af9_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leaseholds and Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdsAndLeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_e55a46d9-0e39-41e4-8bfd-f24803c2e462_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6657e597-827b-47ad-8db3-6bf7e95f354b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0a57d1ad-c5a5-42bb-80aa-fe81baa7bca6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4693adf6-79c5-4a38-9451-50dea34ecb3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_0afd6ae3-8231-4daa-b6a4-6bf8b9dc012e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_d2bd242f-4683-42ec-84d1-e73ec97a3d79_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1c939dac-5127-4309-9fb4-c3c913520fbe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_8118c3ab-72b3-482b-9ca3-ce9f77150ba9_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_3b6a3f04-6d52-4701-a563-ee2168d8cffd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_6941a5f5-5b68-442a-93c9-a41e6460a2df_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8c4969c8-7159-4966-aa82-b64afe461aba_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding&#8212;diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_5ce59f59-9d69-4a54-b41e-9a9ece5e26fe_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_AnnualLicenseMaintenanceFees_f4f2416f-7037-43e4-83e5-6a559b25ebb3_terseLabel_en-US" xlink:label="lab_fhtx_AnnualLicenseMaintenanceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual license maintenance fees</link:label>
    <link:label id="lab_fhtx_AnnualLicenseMaintenanceFees_label_en-US" xlink:label="lab_fhtx_AnnualLicenseMaintenanceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual License Maintenance Fees</link:label>
    <link:label id="lab_fhtx_AnnualLicenseMaintenanceFees_documentation_en-US" xlink:label="lab_fhtx_AnnualLicenseMaintenanceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual license maintenance fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_AnnualLicenseMaintenanceFees" xlink:href="fhtx-20230331.xsd#fhtx_AnnualLicenseMaintenanceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_AnnualLicenseMaintenanceFees" xlink:to="lab_fhtx_AnnualLicenseMaintenanceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_ResearchDevelopmentAndRegulatoryMember_3a2d5a6f-4f12-4d0a-84ec-65136c3ffb6d_terseLabel_en-US" xlink:label="lab_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Development And Regulatory</link:label>
    <link:label id="lab_fhtx_ResearchDevelopmentAndRegulatoryMember_label_en-US" xlink:label="lab_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Development And Regulatory [Member]</link:label>
    <link:label id="lab_fhtx_ResearchDevelopmentAndRegulatoryMember_documentation_en-US" xlink:label="lab_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research development and regulatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:href="fhtx-20230331.xsd#fhtx_ResearchDevelopmentAndRegulatoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:to="lab_fhtx_ResearchDevelopmentAndRegulatoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember_fe7cecbd-0d81-4d69-a457-bca736f4289f_terseLabel_en-US" xlink:label="lab_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agencies (due after one year through two years)</link:label>
    <link:label id="lab_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember_label_en-US" xlink:label="lab_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Due After One Year Through Two Years [Member]</link:label>
    <link:label id="lab_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember_documentation_en-US" xlink:label="lab_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Due After One Year Through Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember" xlink:href="fhtx-20230331.xsd#fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember" xlink:to="lab_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember_1b7c6cb8-2848-4abc-b30a-d8de39c224f9_terseLabel_en-US" xlink:label="lab_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate notes and bonds (due after one year through three years)</link:label>
    <link:label id="lab_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember_label_en-US" xlink:label="lab_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities Due After One Year Through Three Years [Member]</link:label>
    <link:label id="lab_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember_documentation_en-US" xlink:label="lab_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities Due After One Year Through Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember" xlink:href="fhtx-20230331.xsd#fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember" xlink:to="lab_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_185e7a4b-e75e-4a0c-8500-f1be636b87df_terseLabel_en-US" xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements</link:label>
    <link:label id="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_label_en-US" xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements [Line Items]</link:label>
    <link:label id="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_documentation_en-US" xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization consolidation and presentation of financial statements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:href="fhtx-20230331.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:to="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_702815bb-987d-490a-a35d-6f9d60319427_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_a19e1602-6f34-4e4a-a6cb-5af5446f31a5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value; 175,000,000 shares authorized at March&#160;31, 2023 and December&#160;31, 2022; 41,824,758 shares issued and outstanding at March&#160;31, 2023 and 41,803,436 shares issued and outstanding at December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_fab936cb-0bf0-4374-9256-521f0f2dc97e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_AccruedResearchAndDevelopmentExpenses_7fc015a4-4192-43da-b8f8-8d03b12c8bfe_terseLabel_en-US" xlink:label="lab_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued external research and development expenses</link:label>
    <link:label id="lab_fhtx_AccruedResearchAndDevelopmentExpenses_label_en-US" xlink:label="lab_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development Expenses</link:label>
    <link:label id="lab_fhtx_AccruedResearchAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred through that date and payable for expenses related to research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:href="fhtx-20230331.xsd#fhtx_AccruedResearchAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:to="lab_fhtx_AccruedResearchAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3f81ad6f-cc5c-4686-90f4-9d9ee816253e_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_CommonStockVotingRightsVotes_4a7e04c7-7227-4af3-931b-778e47cdf986_terseLabel_en-US" xlink:label="lab_fhtx_CommonStockVotingRightsVotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting rights per share (per share)</link:label>
    <link:label id="lab_fhtx_CommonStockVotingRightsVotes_label_en-US" xlink:label="lab_fhtx_CommonStockVotingRightsVotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:label id="lab_fhtx_CommonStockVotingRightsVotes_documentation_en-US" xlink:label="lab_fhtx_CommonStockVotingRightsVotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Votes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CommonStockVotingRightsVotes" xlink:href="fhtx-20230331.xsd#fhtx_CommonStockVotingRightsVotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_CommonStockVotingRightsVotes" xlink:to="lab_fhtx_CommonStockVotingRightsVotes" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_49315f2a-fa35-4e47-a7e9-5842c520d053_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_96924e58-fc2e-4225-bd4c-2caf0fea0dd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Earnings Per Share Diluted Anti Dilutive Impact</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ddc2dc40-87e5-4a95-89a1-eb3d76945f7e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options and employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d50d3493-256f-44f6-a41d-73e081e07f2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_e668462d-1a68-46a7-99e7-f9154e6cf1a4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dee0254b-820d-46ce-aee9-ed587f980b50_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_9e031255-2412-4dad-8f70-ec8141282833_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_OptOutMilestoneReceivableUponAchievement_50b8f439-467b-4be6-9a22-38790f3014ce_terseLabel_en-US" xlink:label="lab_fhtx_OptOutMilestoneReceivableUponAchievement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optout milestone receivable upon achievement</link:label>
    <link:label id="lab_fhtx_OptOutMilestoneReceivableUponAchievement_label_en-US" xlink:label="lab_fhtx_OptOutMilestoneReceivableUponAchievement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opt Out Milestone Receivable Upon Achievement</link:label>
    <link:label id="lab_fhtx_OptOutMilestoneReceivableUponAchievement_documentation_en-US" xlink:label="lab_fhtx_OptOutMilestoneReceivableUponAchievement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opt Out Milestone Receivable Upon Achievement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_OptOutMilestoneReceivableUponAchievement" xlink:href="fhtx-20230331.xsd#fhtx_OptOutMilestoneReceivableUponAchievement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_OptOutMilestoneReceivableUponAchievement" xlink:to="lab_fhtx_OptOutMilestoneReceivableUponAchievement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f48f5bb9-250a-426b-af63-a0321ef5389d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_34553712-a555-4b1f-a871-63419ff7f01f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_154aeec9-0041-4939-b4c3-24cdc243ef11_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash shown in the statement of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_46fb07e7-f532-413a-82fd-a3eb04255256_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_7117c0d0-8993-43c5-a5be-595a6df77bef_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_e1efbca5-e607-41ea-8ad9-3947657397fa_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_ec53c841-8d4d-43e2-85a3-670a8c1907ca_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_8b154579-5bfe-40c9-9e6d-b9f8ffc8b211_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of stock options and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c47d800b-896f-4f9b-ba07-16c403404605_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_036c9e20-396b-4bba-814f-5040be191222_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6eb4659c-eb31-48c3-bbe3-d864e7fafe32_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_8a91ac9a-75c9-44e8-8f7d-335b1e1be635_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0b608baa-a484-4be4-8f85-ffb316b243c9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_cf65071c-bac8-4afc-8914-6e48c78f60d9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8ed99144-7ef1-4894-a892-976f7f1f3b53_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from the calculation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_bb9aa73f-3f56-4fc6-99d2-ea7941b0cec0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment included in accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_56551f06-5de3-45ca-8d70-02a1f909091d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2f92acd4-6426-4d32-8751-997b11d4e686_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b11adfe1-bb7a-458a-aa39-b36ef408758a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_11c1f89f-e917-4695-8dec-aeafb1c6bc56_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_78304f98-4b7e-41b4-b32b-e23b2a9433c3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_35b24261-c825-425c-adcf-80f84bf31aac_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrent_4c974ccb-5851-4a58-8eb7-bc64036c01ec_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, related party (less than)</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_b53c4fd5-f664-419b-b33e-18a2e6d0aa13_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_821a5e73-cf18-4b5d-bae2-906bab1247c8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_c2ae7c70-3b8d-409d-9462-55a1f75c8a29_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b7f69e50-d732-4550-a061-57f98d8d9c4f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_078ce2bd-c2d7-499b-856c-0daaebfc31b3_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_f5b85edf-1c43-4be1-b7fc-247fac24b40d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_36dbbe12-9b21-42d3-901e-0a9c33748e6c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8f30e99f-a256-417b-9ae9-fbbe9f353c34_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a48f050d-9263-436d-b9a2-bd14f2d65bab_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_ba3d548a-60a6-42cb-8baa-aca467c08eb7_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_USGovernmentAgenciesDueWithinOneYearMember_283359bf-4fce-4f39-b8bf-9a6fdfbf7efb_terseLabel_en-US" xlink:label="lab_fhtx_USGovernmentAgenciesDueWithinOneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agencies (due within one year)</link:label>
    <link:label id="lab_fhtx_USGovernmentAgenciesDueWithinOneYearMember_label_en-US" xlink:label="lab_fhtx_USGovernmentAgenciesDueWithinOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Due Within One Year [Member]</link:label>
    <link:label id="lab_fhtx_USGovernmentAgenciesDueWithinOneYearMember_documentation_en-US" xlink:label="lab_fhtx_USGovernmentAgenciesDueWithinOneYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Due Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_USGovernmentAgenciesDueWithinOneYearMember" xlink:href="fhtx-20230331.xsd#fhtx_USGovernmentAgenciesDueWithinOneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_USGovernmentAgenciesDueWithinOneYearMember" xlink:to="lab_fhtx_USGovernmentAgenciesDueWithinOneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c5cea5ea-f121-4292-91cc-3e583eb7fb97_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4937b0cc-b8fa-4d79-9a50-445dcb5c04cb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_6cab7144-51e0-4498-aa62-7fdc041212ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_1ecbce8c-2c1c-4bfa-8b34-1de1d1559c80_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreements [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_8a3c3a06-ce52-4ce7-a1bd-5aebdbcc2bb3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_bab8fb72-0076-4f18-9a1d-764133dd1ec7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fdb33123-eec6-4334-bee3-a35365aae63a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_22438549-4369-4544-97d0-3b1666d75804_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_98a09f84-ee5d-4fbb-bdbe-ab3e5e262f15_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c4731872-8967-40c6-aeaa-75a4b458b7f7_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b8a69a68-8e36-41d9-b68c-6d71440067dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_dcc8f5dd-9632-4020-aeee-91a4c05851ac_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Available for Sale Marketable Securities By Security Type</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember_d66e055f-f3e9-444a-a36f-54a27e0b1557_terseLabel_en-US" xlink:label="lab_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury notes (due within one year)</link:label>
    <link:label id="lab_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember_label_en-US" xlink:label="lab_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Notes Securities Due Within One Year [Member]</link:label>
    <link:label id="lab_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember_documentation_en-US" xlink:label="lab_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Notes Securities Due Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember" xlink:href="fhtx-20230331.xsd#fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember" xlink:to="lab_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_d8b1935d-5b29-413f-8930-e9a104950a04_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ef51be7b-d386-4095-99f7-5af93435f8f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0b36abf3-e91e-46c2-88ae-65dbda095164_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember_10d12545-457a-4ac2-b36c-45ee1e2815cc_verboseLabel_en-US" xlink:label="lab_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate notes and bonds (due within one year)</link:label>
    <link:label id="lab_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember_label_en-US" xlink:label="lab_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities Due Within One Year [Member]</link:label>
    <link:label id="lab_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember_documentation_en-US" xlink:label="lab_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities Due Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember" xlink:href="fhtx-20230331.xsd#fhtx_CorporateDebtSecuritiesDueWithinOneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember" xlink:to="lab_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_A2016StockIncentivePlanMember_bc8d03bf-30ea-4d4e-9bd1-a4a86870e23c_terseLabel_en-US" xlink:label="lab_fhtx_A2016StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Stock Incentive Plan</link:label>
    <link:label id="lab_fhtx_A2016StockIncentivePlanMember_label_en-US" xlink:label="lab_fhtx_A2016StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_fhtx_A2016StockIncentivePlanMember_documentation_en-US" xlink:label="lab_fhtx_A2016StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Stock Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_A2016StockIncentivePlanMember" xlink:href="fhtx-20230331.xsd#fhtx_A2016StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_A2016StockIncentivePlanMember" xlink:to="lab_fhtx_A2016StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_799c6f2c-60ac-4a55-8fba-d733efee51aa_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_MilestoneReceivableUponAchievement_4faca2e8-daa7-4b6b-b1b5-5339b75d7b16_terseLabel_en-US" xlink:label="lab_fhtx_MilestoneReceivableUponAchievement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount receivable for achievement of milestones</link:label>
    <link:label id="lab_fhtx_MilestoneReceivableUponAchievement_label_en-US" xlink:label="lab_fhtx_MilestoneReceivableUponAchievement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Receivable Upon Achievement</link:label>
    <link:label id="lab_fhtx_MilestoneReceivableUponAchievement_documentation_en-US" xlink:label="lab_fhtx_MilestoneReceivableUponAchievement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of consideration to be received upon achievement of specified milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MilestoneReceivableUponAchievement" xlink:href="fhtx-20230331.xsd#fhtx_MilestoneReceivableUponAchievement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_MilestoneReceivableUponAchievement" xlink:to="lab_fhtx_MilestoneReceivableUponAchievement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d9e80d73-e7b3-4385-ae78-b6d45e0948dd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_8b5f8e8d-afd7-4233-8c88-e1725bf6c9f2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8e9e6db3-841f-4626-b321-1594232a6f59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9b550164-5bb7-4971-90f9-f49fc6507b9a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_8d46adea-a973-4fcb-80af-ed64f22bcc07_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_206e6464-8486-469d-a8cf-beeef035f014_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4ff89e34-3be1-4a87-a36f-bc0b2f9ec470_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cbab7ea2-a5c4-483a-bfa3-03e5e63268ad_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_00650cb9-be1d-49bf-9cdf-090119f693a2_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_StanfordLicenseAgreementMember_f2a35444-34bb-4a7a-a510-ab2fdd030631_terseLabel_en-US" xlink:label="lab_fhtx_StanfordLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stanford License Agreement</link:label>
    <link:label id="lab_fhtx_StanfordLicenseAgreementMember_label_en-US" xlink:label="lab_fhtx_StanfordLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stanford License Agreement [Member]</link:label>
    <link:label id="lab_fhtx_StanfordLicenseAgreementMember_documentation_en-US" xlink:label="lab_fhtx_StanfordLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stanford License Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_StanfordLicenseAgreementMember" xlink:href="fhtx-20230331.xsd#fhtx_StanfordLicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_StanfordLicenseAgreementMember" xlink:to="lab_fhtx_StanfordLicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94cf74fc-5ef7-4797-b362-f1ab0175e986_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a2bccbbf-4ad6-4770-a24a-246a70f9dfac_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1296ef0f-f2c8-4819-9a20-60e71c58a709_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_941ef10a-cb0c-4e92-8b68-6c9c8b646d36_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8fa1a030-e276-4814-9819-1b7122888c6b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_45513e18-d3c0-4401-868c-79d6c857fceb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Property and Equipment Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_e2c45377-6ae6-4a0f-b4cb-9ecbcf89caf9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d4d83a13-d7d8-4275-be0b-9759d6c87985_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9f8128f3-962e-4b3e-8528-a33527e0a802_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_eca095ee-a128-47e7-96af-08bfef27e492_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_NumberOfPrograms_09447726-646c-40d2-b901-8f5c3acd1aca_terseLabel_en-US" xlink:label="lab_fhtx_NumberOfPrograms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of programs</link:label>
    <link:label id="lab_fhtx_NumberOfPrograms_label_en-US" xlink:label="lab_fhtx_NumberOfPrograms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Programs</link:label>
    <link:label id="lab_fhtx_NumberOfPrograms_documentation_en-US" xlink:label="lab_fhtx_NumberOfPrograms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_NumberOfPrograms" xlink:href="fhtx-20230331.xsd#fhtx_NumberOfPrograms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_NumberOfPrograms" xlink:to="lab_fhtx_NumberOfPrograms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_501c54de-9605-407c-b844-965cf0c2b473_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5f4a1d98-ef9f-471c-b7f8-d9699dc1d15d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock and Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_InterestIncomeAndOtherIncomeExpense_15f832b8-3ddb-4dc3-9d30-f89a5e4c70c8_terseLabel_en-US" xlink:label="lab_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_fhtx_InterestIncomeAndOtherIncomeExpense_label_en-US" xlink:label="lab_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income And Other Income Expense</link:label>
    <link:label id="lab_fhtx_InterestIncomeAndOtherIncomeExpense_documentation_en-US" xlink:label="lab_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of interest income and income (expense) related to nonoperating activities, classified as other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:href="fhtx-20230331.xsd#fhtx_InterestIncomeAndOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:to="lab_fhtx_InterestIncomeAndOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_TwoThousandTwentyEquityIncentivePlanMember_792c96ce-2892-4cf8-8989-e65722822306_terseLabel_en-US" xlink:label="lab_fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Equity Incentive Plan</link:label>
    <link:label id="lab_fhtx_TwoThousandTwentyEquityIncentivePlanMember_label_en-US" xlink:label="lab_fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:href="fhtx-20230331.xsd#fhtx_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="lab_fhtx_TwoThousandTwentyEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_aca45f62-5cd7-48e2-81b1-2b7bfc039242_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_5b97a8f4-e0b2-45f7-bd4e-7b526ede85ae_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs related to unvested options and unvested restricted stock</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_6be2eeff-3840-463a-9ab4-17e75afdbaa0_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_2daffa3f-d907-4bf9-a37c-2dde2305a00b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_30006278-129f-49a4-a7d9-71b10fc37cfc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_NumberOfTargets_7a4a83ce-e0b1-4da8-85d3-2abe17fb1231_terseLabel_en-US" xlink:label="lab_fhtx_NumberOfTargets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of targets</link:label>
    <link:label id="lab_fhtx_NumberOfTargets_label_en-US" xlink:label="lab_fhtx_NumberOfTargets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Targets</link:label>
    <link:label id="lab_fhtx_NumberOfTargets_documentation_en-US" xlink:label="lab_fhtx_NumberOfTargets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Targets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_NumberOfTargets" xlink:href="fhtx-20230331.xsd#fhtx_NumberOfTargets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_NumberOfTargets" xlink:to="lab_fhtx_NumberOfTargets" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock_ef5db46d-389c-4de9-bb33-036637534a98_terseLabel_en-US" xlink:label="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities and Fair Value Measurements</link:label>
    <link:label id="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock_label_en-US" xlink:label="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities and Fair Value Measurements [Text Block]</link:label>
    <link:label id="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock_documentation_en-US" xlink:label="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for marketable securities and fair value measurements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:href="fhtx-20230331.xsd#fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:to="lab_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_8dbf5f5b-5a79-4c05-8579-fbf200ce2b32_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_b202bc29-45b9-401a-957c-702e34275e00_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_153d6089-d7cd-47cf-8728-e9cd1359d7f6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of each class</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_EliLillyMember_a1b2ba3b-dbe9-488e-8c49-b4c5ddd23678_terseLabel_en-US" xlink:label="lab_fhtx_EliLillyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eli Lilly</link:label>
    <link:label id="lab_fhtx_EliLillyMember_label_en-US" xlink:label="lab_fhtx_EliLillyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eli Lilly [Member]</link:label>
    <link:label id="lab_fhtx_EliLillyMember_documentation_en-US" xlink:label="lab_fhtx_EliLillyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eli Lilly</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_EliLillyMember" xlink:href="fhtx-20230331.xsd#fhtx_EliLillyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_EliLillyMember" xlink:to="lab_fhtx_EliLillyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_a0e32433-35f9-4fde-98f8-f044fb438e80_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_CashPaymentsRelatedParty_bf369f20-fa27-4fbf-89c8-e7234eceea20_terseLabel_en-US" xlink:label="lab_fhtx_CashPaymentsRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments made to related party under service agreement</link:label>
    <link:label id="lab_fhtx_CashPaymentsRelatedParty_label_en-US" xlink:label="lab_fhtx_CashPaymentsRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payments Related Party</link:label>
    <link:label id="lab_fhtx_CashPaymentsRelatedParty_documentation_en-US" xlink:label="lab_fhtx_CashPaymentsRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments made during the period to related parties as part of a service or consulting agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CashPaymentsRelatedParty" xlink:href="fhtx-20230331.xsd#fhtx_CashPaymentsRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_CashPaymentsRelatedParty" xlink:to="lab_fhtx_CashPaymentsRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_MerckMember_56e74267-1e9f-4c2c-b760-b42b92ae77ac_terseLabel_en-US" xlink:label="lab_fhtx_MerckMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck</link:label>
    <link:label id="lab_fhtx_MerckMember_label_en-US" xlink:label="lab_fhtx_MerckMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck [Member]</link:label>
    <link:label id="lab_fhtx_MerckMember_documentation_en-US" xlink:label="lab_fhtx_MerckMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MerckMember" xlink:href="fhtx-20230331.xsd#fhtx_MerckMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_MerckMember" xlink:to="lab_fhtx_MerckMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0c8889f6-dd11-4214-9bd9-411eca123960_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_15f5c6ea-477f-4be6-967d-0d65419f5045_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOther_9ad14473-c6a2-4cf3-b10c-6b02b831bacb_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOther_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther" xlink:to="lab_us-gaap_InterestIncomeOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_c9defa99-3cad-462a-8e75-754a412b219f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashEquivalents_19fbd0f0-1aed-4126-a6b2-f745b8ac3c95_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (current and non-current)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a4162acf-22e0-4acd-8ca7-d0b74631c840_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_adaa65cb-5a93-420d-9ba5-0e424faf02f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization (accretion) of discount on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_715eb935-d539-4845-acdb-81c2ac5eb65c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a5ab8051-a9d9-4873-90b3-0150176a4981_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_83996431-5402-4fb1-beba-fcb580c25c9d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_377e6ef3-90c1-4637-9d75-6ed3beb20942_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c302ef01-d432-4a16-8276-339512f07c60_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasis[Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_06878ef9-4388-41d1-bfc1-c83c355a643c_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_328bdeda-c841-4a40-b8e1-899b1f2eab05_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f0be6749-4e82-4d6b-8b00-ad932b43ae31_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_8c6d3951-2d5b-49a2-95bd-e82d744c74aa_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_55af947c-83de-4c3f-8460-8bd05934b884_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_3c9aa50e-b294-421a-a2ff-13e8bfbb13bd_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aa0db7eb-d154-4930-9234-3c9133c69380_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_51e15189-4343-493a-b460-1b3ae12fe17f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity (deficit):</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c4997260-d46f-4805-b1eb-08d126801480_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_574c0e44-8cc9-4811-96ce-d9c425de989f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_cda95e7f-1918-4e58-a003-f8f4900b1af2_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants to purchase common stock</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1211cc43-5165-475a-9073-def2ae78ff5a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c77ef2fa-ef51-4fc2-8c09-248352bcf8f7_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_05aea96f-0b58-433d-9dbc-2c7ada7e04e7_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_146abace-8e8d-4d89-a841-b40b9a7cc74a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding&#8212;basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_baade1b0-55bf-421a-8250-86d403b396d3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period of unrecognized compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_7b3a4904-085b-45f3-9ff4-9f674b9f19af_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryNotesSecuritiesMember_edf0f1e6-1773-4a57-b98b-3e7bc94dfb98_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryNotesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury notes</link:label>
    <link:label id="lab_us-gaap_USTreasuryNotesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryNotesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Notes Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryNotesSecuritiesMember" xlink:to="lab_us-gaap_USTreasuryNotesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_9c2dfbdb-5298-4bb7-b660-064f3d6fad0c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 10)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2ad9178d-c749-41e8-bc9f-2c00be3ab642_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of each exchange on which registered</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c6f73679-cc71-4757-8779-f0dc91f6391d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1804fd4a-d2e2-4574-b5f2-3556848dd90b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_27eb0f93-a151-48ae-8bf9-249606e1c101_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value; 25,000,000 shares authorized at March&#160;31, 2023 and December&#160;31, 2022; no shares issued and outstanding at March&#160;31, 2023 and December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e1f890bd-99b0-442a-b61c-97d5e0381106_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_c17ae561-c0bc-4a51-98cf-659450396470_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d91ecc3e-736a-4b5e-8c82-51286b661d5d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_572d3e5e-324d-45c1-874c-b9545cb63adf_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_5c0275dc-560f-4f49-8bac-ba96fc4b8967_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_67fbbf8e-8f58-4595-9291-780fbbe8436b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_f93a98ba-5185-40d6-8ac6-2c31495639a9_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_1fd3b348-7487-4e56-948b-14b50608e20a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_913fba57-760d-449e-bff1-fd516d8c01ab_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_c2eb28f6-b516-4790-b2c1-7e3ad989070f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6f04f704-502c-44e4-8a6b-f5730620752b_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_2178fd84-648b-48a8-bfe3-77daabc0b19f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5a6585a5-e0f3-4edf-b480-ed49b9ce2cdb_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_1804b44c-0393-4fef-8589-cd7c7c45c4aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_ef0485b6-5797-4479-8163-064b7baadae4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_73e96642-fd6c-42be-b083-8676880752f9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_MerckCollaborationAgreementMember_a639dee0-8a48-4a52-9db6-5c37c97d4dec_terseLabel_en-US" xlink:label="lab_fhtx_MerckCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck Collaboration Agreement</link:label>
    <link:label id="lab_fhtx_MerckCollaborationAgreementMember_label_en-US" xlink:label="lab_fhtx_MerckCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck Collaboration Agreement [Member]</link:label>
    <link:label id="lab_fhtx_MerckCollaborationAgreementMember_documentation_en-US" xlink:label="lab_fhtx_MerckCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck collaboration agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MerckCollaborationAgreementMember" xlink:href="fhtx-20230331.xsd#fhtx_MerckCollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_MerckCollaborationAgreementMember" xlink:to="lab_fhtx_MerckCollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_c7352db0-64df-4a4d-9ab9-0c093cb20203_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_53f8f1ef-f655-425f-8a6e-65af77b1288e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol(s)</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e56fbfa0-2569-41cc-b382-4341dc2c6e0d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_ScientificFounderMember_f00a39c9-b6dc-429a-81e4-b7b6c3be072c_terseLabel_en-US" xlink:label="lab_fhtx_ScientificFounderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scientific Founder</link:label>
    <link:label id="lab_fhtx_ScientificFounderMember_label_en-US" xlink:label="lab_fhtx_ScientificFounderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scientific Founder [Member]</link:label>
    <link:label id="lab_fhtx_ScientificFounderMember_documentation_en-US" xlink:label="lab_fhtx_ScientificFounderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scientific Founder.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ScientificFounderMember" xlink:href="fhtx-20230331.xsd#fhtx_ScientificFounderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ScientificFounderMember" xlink:to="lab_fhtx_ScientificFounderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_NumberOfAdditionalTargets_4ba677ec-bada-4a0c-9245-bd11a65c3f40_terseLabel_en-US" xlink:label="lab_fhtx_NumberOfAdditionalTargets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional targets</link:label>
    <link:label id="lab_fhtx_NumberOfAdditionalTargets_label_en-US" xlink:label="lab_fhtx_NumberOfAdditionalTargets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Additional Targets</link:label>
    <link:label id="lab_fhtx_NumberOfAdditionalTargets_documentation_en-US" xlink:label="lab_fhtx_NumberOfAdditionalTargets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Additional Targets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_NumberOfAdditionalTargets" xlink:href="fhtx-20230331.xsd#fhtx_NumberOfAdditionalTargets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_NumberOfAdditionalTargets" xlink:to="lab_fhtx_NumberOfAdditionalTargets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_49b4193a-6f1a-43fb-ba9d-dddf89135fdc_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_3d14043b-ec99-49e3-bd83-8b3a8f93bdc0_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_e3778813-1ef8-4e9b-9fc8-c26599782f54_terseLabel_en-US" xlink:label="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash lease expense</link:label>
    <link:label id="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Right Of Use Asset</link:label>
    <link:label id="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in right-of-use assets under an operating lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:href="fhtx-20230331.xsd#fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:to="lab_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_b401046c-698f-4a71-9001-46f96beab1df_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_cfcdbd8e-8150-4120-bd88-d3dd4b6bee72_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales based</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e05db9c8-babc-4359-859c-67bc9d38ca98_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_a9296db5-1748-4a44-8692-eb54b6c6a5fa_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_102840ad-3877-4f05-9017-f6c60b5e2ba4_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_dc43ad2d-6f23-4f76-a613-f9a8748ff297_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ef171592-b660-4518-9f4f-cffd5050c482_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cc8eb6cd-f746-4436-9575-b50f51a7ad26_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_40efbad2-a5a5-417e-965d-b69cad0f2259_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_c4e86be5-c34b-4cf5-a092-c825b856d2fd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c6e11c25-20cb-4133-b550-3fcb24ad9465_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders&#8212;diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5c671db1-59d1-4b6e-850a-4347e57e151c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_529b7b0d-16d9-471b-9100-0aa7dde7e4c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ec180c46-5426-4580-9f75-635d5efb6b5e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period (years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_d56c689b-c8eb-4060-80a7-4308cf9573c9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c945390b-5783-4cf5-9346-e89a27a3a6c8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c12cac34-b5ed-4604-ab74-452a6c63fa38_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ac5a82cb-9b50-4e99-aeeb-995f9f72ad94_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_fde2a1e6-abbc-4744-b5c1-7c6c4df3bd39_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_0b5165cc-13d0-44a6-a1e0-5f4e4daac843_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_0dbde6d3-467c-4ca4-9237-81d6bab5926c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders&#8212;basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_6353f8b8-cf99-45da-b17e-c4cbe94eb749_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsatisfied portion of the performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_372eb059-3620-4fa9-a753-c7c15b00613c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option expiry period (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_92f25a76-c724-470f-9d23-b92610cc8afc_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate notes and bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_f06240e4-ac8e-467e-a6ff-ee71c9a14f1c_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_CollaborationAgreementAbstract_3e0c0d87-3e8b-4920-8942-b2c93e2e26e4_terseLabel_en-US" xlink:label="lab_fhtx_CollaborationAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement [Abstract]</link:label>
    <link:label id="lab_fhtx_CollaborationAgreementAbstract_label_en-US" xlink:label="lab_fhtx_CollaborationAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement [Abstract]</link:label>
    <link:label id="lab_fhtx_CollaborationAgreementAbstract_documentation_en-US" xlink:label="lab_fhtx_CollaborationAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CollaborationAgreementAbstract" xlink:href="fhtx-20230331.xsd#fhtx_CollaborationAgreementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_CollaborationAgreementAbstract" xlink:to="lab_fhtx_CollaborationAgreementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4de4edd2-8c5c-4d8d-aabe-ff4a3e893445_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Street Name</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_CommitmentsAndContingenciesTable_d6adeae1-b1c9-408d-be2d-25dd95a137b3_terseLabel_en-US" xlink:label="lab_fhtx_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_fhtx_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_fhtx_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_fhtx_CommitmentsAndContingenciesTable_documentation_en-US" xlink:label="lab_fhtx_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CommitmentsAndContingenciesTable" xlink:href="fhtx-20230331.xsd#fhtx_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_CommitmentsAndContingenciesTable" xlink:to="lab_fhtx_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_15a9cfe5-0d9c-43a7-aabf-863e2e392b1d_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreements [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_d4d10b8a-5dbc-45a0-8543-bae289eba176_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_968362ac-ec74-4ad3-ad39-0ad49faf9d52_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d96be78c-e838-4948-ae76-5ffe0de9deaf_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_481f0de1-1ed1-4568-8767-b041a98d088b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_ServiceAgreementTerm_6128d7ca-442d-46e6-bf8f-9f2a4d474e58_terseLabel_en-US" xlink:label="lab_fhtx_ServiceAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreement term</link:label>
    <link:label id="lab_fhtx_ServiceAgreementTerm_label_en-US" xlink:label="lab_fhtx_ServiceAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreement Term</link:label>
    <link:label id="lab_fhtx_ServiceAgreementTerm_documentation_en-US" xlink:label="lab_fhtx_ServiceAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The term of a service agreement in 'PnYnMnDTnHnMnS' format.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ServiceAgreementTerm" xlink:href="fhtx-20230331.xsd#fhtx_ServiceAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ServiceAgreementTerm" xlink:to="lab_fhtx_ServiceAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_ProceedsFromUpfrontPayment_c8f07e3b-f6f9-400d-841b-f127ae38feb4_terseLabel_en-US" xlink:label="lab_fhtx_ProceedsFromUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment received</link:label>
    <link:label id="lab_fhtx_ProceedsFromUpfrontPayment_label_en-US" xlink:label="lab_fhtx_ProceedsFromUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Upfront Payment</link:label>
    <link:label id="lab_fhtx_ProceedsFromUpfrontPayment_documentation_en-US" xlink:label="lab_fhtx_ProceedsFromUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from upfront payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment" xlink:href="fhtx-20230331.xsd#fhtx_ProceedsFromUpfrontPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ProceedsFromUpfrontPayment" xlink:to="lab_fhtx_ProceedsFromUpfrontPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember_19f349fc-f2ca-4cf1-a165-afe1972c1f7b_terseLabel_en-US" xlink:label="lab_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:href="fhtx-20230331.xsd#fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:to="lab_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_d18823bd-ba31-49c9-94de-d9e7a6a7d6f1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_331c3200-a654-4833-8493-dc2aad05ed05_terseLabel_en-US" xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum aggregate number of shares added to plan (in shares)</link:label>
    <link:label id="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_label_en-US" xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Maximum Future Increase Shares</link:label>
    <link:label id="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_documentation_en-US" xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum aggregate number of shares that may be added to the plan in future years.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:href="fhtx-20230331.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:to="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_875a89d1-918b-42a4-8f1c-f64fd999ec43_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage_829f203e-809c-47d7-9cc6-e58a9653c9b1_terseLabel_en-US" xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of automatic annual increase in number of shares</link:label>
    <link:label id="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage_label_en-US" xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Automatic Annual Increase, Percentage</link:label>
    <link:label id="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage_documentation_en-US" xlink:label="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of shares authorized to be automatically increased on the first day of the fiscal year, under a share based payment arrangement, as a percentage of common stock outstanding on the last day of the previous fiscal year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage" xlink:href="fhtx-20230331.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage" xlink:to="lab_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_a2369a3f-986c-4a8f-948b-5f77f8f8b1d1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_09678153-b059-4eb6-8a97-8d2071d0ae14_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_047e185c-f2d6-400c-95e3-1d266dee6aa2_terseLabel_en-US" xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements [Table]</link:label>
    <link:label id="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_label_en-US" xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements [Table]</link:label>
    <link:label id="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_documentation_en-US" xlink:label="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization consolidation and presentation of financial statements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:href="fhtx-20230331.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:to="lab_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_SalesBasedMilestoneMember_3ce908d0-e6fc-44fe-9c7e-e858d961b7d3_terseLabel_en-US" xlink:label="lab_fhtx_SalesBasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Based Milestone</link:label>
    <link:label id="lab_fhtx_SalesBasedMilestoneMember_label_en-US" xlink:label="lab_fhtx_SalesBasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Based Milestone [Member]</link:label>
    <link:label id="lab_fhtx_SalesBasedMilestoneMember_documentation_en-US" xlink:label="lab_fhtx_SalesBasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Based Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_SalesBasedMilestoneMember" xlink:href="fhtx-20230331.xsd#fhtx_SalesBasedMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_SalesBasedMilestoneMember" xlink:to="lab_fhtx_SalesBasedMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_002cd149-7e36-449b-9534-78c6a53e1bb7_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_57db181b-c2e9-4767-be9a-fc80c547b76d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_dd8a80cc-aa97-478d-9aeb-4fd2f26db35a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_f57c9aa0-b5e9-4cb5-aefa-3a774040e4f8_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains on marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_92f3b128-00c8-4997-ad77-c0462b40139c_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_fddc06c0-5ccd-418d-9caf-8e94de18df37_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e8e44b52-a6d1-49d8-9573-32f5853f0d02_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_f61a5328-e3d3-43c1-bb1c-0bd27bddff59_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_17d53b49-bca3-4310-a938-b496de8dab43_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_ComputerEquipmentAndSoftwareMember_b333e378-9c50-44d4-bb7b-aa4bcfbcd5ad_terseLabel_en-US" xlink:label="lab_fhtx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_fhtx_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_fhtx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software [Member]</link:label>
    <link:label id="lab_fhtx_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_fhtx_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ComputerEquipmentAndSoftwareMember" xlink:href="fhtx-20230331.xsd#fhtx_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_ComputerEquipmentAndSoftwareMember" xlink:to="lab_fhtx_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_7a033926-5467-4b03-99ba-7cf0d7897ce3_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_cf112a84-ea73-45b0-a775-0f735feb97b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_597c73c9-b60f-4273-93ca-13cd1131ef05_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e0fe916b-b930-4122-b860-6351bb5004ca_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d4b267b2-301c-4955-a951-08bd6a748f68_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of payroll deductions</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e176233b-615b-4d81-80e7-a20c1c9f05f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a061c6d6-5358-451f-8fb4-cf35a1bec076_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_018dfffb-92c8-4b24-8a2d-f1829f38ff6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_fa8423b8-22f8-4c92-8e58-5aded4d786da_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_b2a06d01-dd29-4268-acb9-59e41c45809c_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_6baa2085-44b6-462c-83eb-1c5aee542849_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_436ab5fb-c488-46cf-bd51-94129fa8f329_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f4b21d30-b0fb-43a7-8c8b-62f7ce470a02_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_df7e340b-8a22-4ded-9e19-0b7e176f0239_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property plant and equipment including finance right of use assets, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_bd9e5ebb-47e8-47a9-b4a5-b8f49e649819_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, cost</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_78c5d6a3-c5da-4921-86b1-d259530b8b92_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_62bfd1d7-294b-4444-a7d9-15ccb6fb6eac_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_f390da91-beb4-411a-9d75-4d43e6a77f99_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount of shares rate, percent</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e3a06efb-22ca-4d81-8fca-c908847b800e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_42f0907a-1753-4b2f-8a42-9fe8fba8c0f1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper (due within one year)</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_b3e01ff9-2e7d-4fd0-9a4b-89c404149ca4_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_31982c78-261b-47e0-a0e3-f08ed691db6b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_10875a90-8c7f-4939-bda0-8c6af78d757b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_0003d60f-8b87-44ac-8bd9-1557c6661e3d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_d4e52379-8973-4d1a-af73-795481f47877_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_9b9b5d06-46e1-49de-be1e-ac9dd6f0b494_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_3919b7c4-7fb4-4e94-97ac-4efe95a49d29_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_d366e580-f758-4528-825b-a466eba4a989_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_c4cca410-27e0-4e7f-9f74-fd38b498c6ed_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4f093728-6104-44ce-ac4f-f32191a4eb0d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_a3ce1bed-6770-4dd8-8a15-b1f5c8a3434c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4f04e976-e53b-4131-9b61-df9875b699cb_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8eca6cae-9621-47d2-9881-5c1a2d22ec3e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_4fba4698-6a20-4d20-a29d-b761e5198f87_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_97e0e846-0161-42ae-880f-7a5c4803a970_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_86678d14-e5c9-4405-9157-195a7c4b23e5_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_180f19e0-4597-40ff-aba2-e4a76e47418f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_949bf9fd-0d16-4da1-bcdf-d8c28c5a9a60_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_f92284b8-1ac4-4927-90ce-946b94afb62d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_AssetsNotYetPlacedInServiceMember_ea181efa-a1a4-40ac-aa88-bec0106b58c8_terseLabel_en-US" xlink:label="lab_fhtx_AssetsNotYetPlacedInServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets not yet placed in service</link:label>
    <link:label id="lab_fhtx_AssetsNotYetPlacedInServiceMember_label_en-US" xlink:label="lab_fhtx_AssetsNotYetPlacedInServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Not Yet Placed In service [Member]</link:label>
    <link:label id="lab_fhtx_AssetsNotYetPlacedInServiceMember_documentation_en-US" xlink:label="lab_fhtx_AssetsNotYetPlacedInServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Not Yet Placed In service[Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_AssetsNotYetPlacedInServiceMember" xlink:href="fhtx-20230331.xsd#fhtx_AssetsNotYetPlacedInServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_AssetsNotYetPlacedInServiceMember" xlink:to="lab_fhtx_AssetsNotYetPlacedInServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_dc969098-10ec-492e-a357-26c5de081608_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_e6a6638b-b799-4bca-9de0-a3c82627de73_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_b50583fd-58fc-4aa2-9c76-3c1012976288_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_PaymentReceivedForAchievementOfMilestones_cea94892-afa6-4d46-8dde-d445ac14c74e_terseLabel_en-US" xlink:label="lab_fhtx_PaymentReceivedForAchievementOfMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment received for achievement of milestones</link:label>
    <link:label id="lab_fhtx_PaymentReceivedForAchievementOfMilestones_label_en-US" xlink:label="lab_fhtx_PaymentReceivedForAchievementOfMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Received For Achievement Of Milestones</link:label>
    <link:label id="lab_fhtx_PaymentReceivedForAchievementOfMilestones_documentation_en-US" xlink:label="lab_fhtx_PaymentReceivedForAchievementOfMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Received For Achievement Of Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_PaymentReceivedForAchievementOfMilestones" xlink:href="fhtx-20230331.xsd#fhtx_PaymentReceivedForAchievementOfMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_PaymentReceivedForAchievementOfMilestones" xlink:to="lab_fhtx_PaymentReceivedForAchievementOfMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_CommitmentsAndContingenciesLineItems_612f1364-3848-473d-9f21-6641bc6e5bea_terseLabel_en-US" xlink:label="lab_fhtx_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies</link:label>
    <link:label id="lab_fhtx_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_fhtx_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_fhtx_CommitmentsAndContingenciesLineItems_documentation_en-US" xlink:label="lab_fhtx_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CommitmentsAndContingenciesLineItems" xlink:href="fhtx-20230331.xsd#fhtx_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_CommitmentsAndContingenciesLineItems" xlink:to="lab_fhtx_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cabe5f90-13ea-4d4e-a8e6-1e4a10c555e6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b61c6baa-a5c5-4cc8-bdb8-de4e94bdb322_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_a08cddb2-26ad-4b61-a978-40c5dcab450b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ae2c6453-d97c-40e9-b672-86bf9ec5668a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_ea94887c-e0eb-44d9-8731-3e0a39768b51_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of noncash investing and financing information:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0bb07a63-5c8a-430d-b923-b01c862495d3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_c40c6a2e-d90e-4220-ba91-03d50d6296c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_2b050d76-14c0-46df-af6b-506c0bfb4299_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_5ebb54e0-95cb-4801-9b44-fea2a3cdb8e7_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_454f0eda-45ff-4840-8fe8-b61d8a2345dd_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_5bc849eb-8180-43ee-86e9-b73e18695b9d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_5d026fc4-6964-4ac4-8c17-f479536fbfa7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_07d41ec8-7647-4293-88c8-aa0f7df9efc6_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently issued accounting pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_dfc77e4d-589d-4940-895d-dd90257e9812_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxes" xlink:to="lab_us-gaap_AccruedIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_fhtx_MilestonesPayableUponEvent_1f3c5152-78be-4008-a2bf-0d0c54556a77_terseLabel_en-US" xlink:label="lab_fhtx_MilestonesPayableUponEvent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestones payable upon event</link:label>
    <link:label id="lab_fhtx_MilestonesPayableUponEvent_label_en-US" xlink:label="lab_fhtx_MilestonesPayableUponEvent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestones Payable Upon Event</link:label>
    <link:label id="lab_fhtx_MilestonesPayableUponEvent_documentation_en-US" xlink:label="lab_fhtx_MilestonesPayableUponEvent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount the Company will pay for regulatory milestones on each licensed product upon the occurrence of specific events as outlined in the license agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MilestonesPayableUponEvent" xlink:href="fhtx-20230331.xsd#fhtx_MilestonesPayableUponEvent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fhtx_MilestonesPayableUponEvent" xlink:to="lab_fhtx_MilestonesPayableUponEvent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ac7a31e9-74eb-41e4-b2f9-bb630552ccd5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d61b9b96-f59c-484a-a611-e11144ac9dad_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a5a5be0d-5989-4693-aad6-c7cf8b7a9a38_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f2ac92fe-0b50-4fce-9ed6-9eee9c3fe5ab_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_285a034f-4a1b-4d1b-a97c-72e54cb01027_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Business, Going Concern and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>fhtx-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:15bd0678-6723-4159-8d23-9a6c2981f314,g:5f09f729-e9b1-474a-a25d-c866e4e94b81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.foghorntx.com/role/CoverPage" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2b4a4ddc-4194-459c-99cc-23d44f734b57" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_DocumentType_2b4a4ddc-4194-459c-99cc-23d44f734b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_74fe95db-414d-4342-b3c4-fff8bbe99c9c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_DocumentQuarterlyReport_74fe95db-414d-4342-b3c4-fff8bbe99c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_dda115e7-c706-44ab-9113-e7c0c41f72e9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_DocumentPeriodEndDate_dda115e7-c706-44ab-9113-e7c0c41f72e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_0d2516e3-cb53-41eb-a36c-3e9e70930aa4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_DocumentTransitionReport_0d2516e3-cb53-41eb-a36c-3e9e70930aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_14210e20-0505-4225-b33d-c89387bd4360" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityFileNumber_14210e20-0505-4225-b33d-c89387bd4360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_98e82adc-156c-4bbb-b785-4a375631e626" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityRegistrantName_98e82adc-156c-4bbb-b785-4a375631e626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8023fef9-5208-4b6f-988c-b41a2cfe8352" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8023fef9-5208-4b6f-988c-b41a2cfe8352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8d7875dd-ebfb-4238-84b2-d45641007442" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityTaxIdentificationNumber_8d7875dd-ebfb-4238-84b2-d45641007442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_76cf1500-df6b-4d8c-8a70-0b4edbbab2f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityAddressAddressLine1_76cf1500-df6b-4d8c-8a70-0b4edbbab2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ea9af612-3616-4b9f-bb93-09e485ffeee8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityAddressCityOrTown_ea9af612-3616-4b9f-bb93-09e485ffeee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d2cdc5fa-eb21-4d66-be9b-395f63c5e080" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityAddressStateOrProvince_d2cdc5fa-eb21-4d66-be9b-395f63c5e080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7cc8d2ca-c0a2-46ad-843a-39d8e8cd7096" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityAddressPostalZipCode_7cc8d2ca-c0a2-46ad-843a-39d8e8cd7096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9a42ef2e-d0c9-471a-a099-dc874c4fb970" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_CityAreaCode_9a42ef2e-d0c9-471a-a099-dc874c4fb970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_247b3495-e38c-43fd-9501-8676a70274f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_LocalPhoneNumber_247b3495-e38c-43fd-9501-8676a70274f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_bb79a0e8-bab5-4426-a5a3-23e6f8e34fe6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_Security12bTitle_bb79a0e8-bab5-4426-a5a3-23e6f8e34fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_753e1098-5512-403a-9937-dc90ff862d7f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_TradingSymbol_753e1098-5512-403a-9937-dc90ff862d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d448d857-8cfc-411b-a0c8-0a6fdc551f62" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_SecurityExchangeName_d448d857-8cfc-411b-a0c8-0a6fdc551f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_257f13af-843f-477b-b76b-f0a090456530" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityCurrentReportingStatus_257f13af-843f-477b-b76b-f0a090456530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3338c8ef-33ed-49b9-aeef-6bb672f41730" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityInteractiveDataCurrent_3338c8ef-33ed-49b9-aeef-6bb672f41730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_141c0ba4-d3b9-48d7-ae47-1ad204338b52" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityFilerCategory_141c0ba4-d3b9-48d7-ae47-1ad204338b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d91f76c2-e594-4e6e-b556-14ec0d49439c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntitySmallBusiness_d91f76c2-e594-4e6e-b556-14ec0d49439c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_86f152a8-d744-4a45-bdd7-73ea669f58eb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityEmergingGrowthCompany_86f152a8-d744-4a45-bdd7-73ea669f58eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_0d662e0f-9b36-496f-89e7-e7f1f7805e21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityExTransitionPeriod_0d662e0f-9b36-496f-89e7-e7f1f7805e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e16c7c80-4137-4b21-8dcd-9d56d57f7ba4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityShellCompany_e16c7c80-4137-4b21-8dcd-9d56d57f7ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_35457ecb-a3d3-47bc-aa7b-69ee1c7abfa9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_35457ecb-a3d3-47bc-aa7b-69ee1c7abfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c83bdcff-b86e-4802-8274-b26e17302be8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_AmendmentFlag_c83bdcff-b86e-4802-8274-b26e17302be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_dae351e1-acd7-4fb3-86d4-68a03951216b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_DocumentFiscalYearFocus_dae351e1-acd7-4fb3-86d4-68a03951216b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6638f22c-686e-4040-9bce-2d39ff9e07b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6638f22c-686e-4040-9bce-2d39ff9e07b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f08a0d71-8228-4cf0-bec3-976d3010a7e1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_EntityCentralIndexKey_f08a0d71-8228-4cf0-bec3-976d3010a7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3eda4323-5d68-4fd0-acfe-be4a0507e8ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_38f09450-9a6b-4097-8ddb-6a522229340e" xlink:to="loc_dei_CurrentFiscalYearEndDate_3eda4323-5d68-4fd0-acfe-be4a0507e8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_504c8f72-df48-4184-8e68-a7492da8578e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_31ee6a0b-12dd-4a96-9136-f175d9056e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_504c8f72-df48-4184-8e68-a7492da8578e" xlink:to="loc_us-gaap_AssetsAbstract_31ee6a0b-12dd-4a96-9136-f175d9056e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_6cf7ab61-2c76-40f9-bdef-537e832c996a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31ee6a0b-12dd-4a96-9136-f175d9056e74" xlink:to="loc_us-gaap_AssetsCurrentAbstract_6cf7ab61-2c76-40f9-bdef-537e832c996a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2711db88-aa7c-427d-889a-db334560645f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6cf7ab61-2c76-40f9-bdef-537e832c996a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2711db88-aa7c-427d-889a-db334560645f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_9deab83e-477d-42db-aad1-f2b2a5da4028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6cf7ab61-2c76-40f9-bdef-537e832c996a" xlink:to="loc_us-gaap_MarketableSecurities_9deab83e-477d-42db-aad1-f2b2a5da4028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_88bd18ba-39ce-4e85-ac1b-62ace1ba1892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6cf7ab61-2c76-40f9-bdef-537e832c996a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_88bd18ba-39ce-4e85-ac1b-62ace1ba1892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4b4eb09e-85c1-42b6-beac-638686219262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6cf7ab61-2c76-40f9-bdef-537e832c996a" xlink:to="loc_us-gaap_AssetsCurrent_4b4eb09e-85c1-42b6-beac-638686219262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_cb06fba6-4765-41da-89d7-22e99da2f64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31ee6a0b-12dd-4a96-9136-f175d9056e74" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_cb06fba6-4765-41da-89d7-22e99da2f64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_64818d1f-1d99-4946-87bc-f4585cdae5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31ee6a0b-12dd-4a96-9136-f175d9056e74" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_64818d1f-1d99-4946-87bc-f4585cdae5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c115943b-ce95-4aae-b673-5762c99ab76d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31ee6a0b-12dd-4a96-9136-f175d9056e74" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c115943b-ce95-4aae-b673-5762c99ab76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0b545348-8727-4a70-b214-ef365b47da5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31ee6a0b-12dd-4a96-9136-f175d9056e74" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0b545348-8727-4a70-b214-ef365b47da5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_39407406-395d-4313-a296-f18ab390e707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_31ee6a0b-12dd-4a96-9136-f175d9056e74" xlink:to="loc_us-gaap_Assets_39407406-395d-4313-a296-f18ab390e707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_59f5833f-780d-49d6-b67b-1341952b59fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_504c8f72-df48-4184-8e68-a7492da8578e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_59f5833f-780d-49d6-b67b-1341952b59fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_afd3fbef-a92e-4d1a-82fc-e71e152cb809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_59f5833f-780d-49d6-b67b-1341952b59fa" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_afd3fbef-a92e-4d1a-82fc-e71e152cb809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a0cfd9dc-172f-4fa9-9aa3-d996b7e52937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_afd3fbef-a92e-4d1a-82fc-e71e152cb809" xlink:to="loc_us-gaap_AccountsPayableCurrent_a0cfd9dc-172f-4fa9-9aa3-d996b7e52937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_01465115-7f56-4c6e-86e9-f915b62ca971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_afd3fbef-a92e-4d1a-82fc-e71e152cb809" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_01465115-7f56-4c6e-86e9-f915b62ca971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a55bc41-7ed4-4856-b52a-68fa1aa5148b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_afd3fbef-a92e-4d1a-82fc-e71e152cb809" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a55bc41-7ed4-4856-b52a-68fa1aa5148b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d7b12d1a-9b6a-400d-a67e-2712f405015d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_afd3fbef-a92e-4d1a-82fc-e71e152cb809" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d7b12d1a-9b6a-400d-a67e-2712f405015d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dac1fc13-0d35-44cf-82cc-754af0f5c83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_afd3fbef-a92e-4d1a-82fc-e71e152cb809" xlink:to="loc_us-gaap_LiabilitiesCurrent_dac1fc13-0d35-44cf-82cc-754af0f5c83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_eddba285-1b7a-4084-9d68-4afdf1858750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_59f5833f-780d-49d6-b67b-1341952b59fa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_eddba285-1b7a-4084-9d68-4afdf1858750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_4d3108c7-b292-4a14-9cbd-dcaea27ac7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_59f5833f-780d-49d6-b67b-1341952b59fa" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_4d3108c7-b292-4a14-9cbd-dcaea27ac7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d88a709e-84d8-446b-abf7-d2d16f9ba335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_59f5833f-780d-49d6-b67b-1341952b59fa" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d88a709e-84d8-446b-abf7-d2d16f9ba335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7ef35f78-db05-4826-83d5-887aafc03d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_59f5833f-780d-49d6-b67b-1341952b59fa" xlink:to="loc_us-gaap_Liabilities_7ef35f78-db05-4826-83d5-887aafc03d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_777fe9b4-9110-4c6a-a4d7-7d80442c8632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_59f5833f-780d-49d6-b67b-1341952b59fa" xlink:to="loc_us-gaap_CommitmentsAndContingencies_777fe9b4-9110-4c6a-a4d7-7d80442c8632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_4f0b7c41-6cb9-4aa1-a2db-88e70bfb4dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_59f5833f-780d-49d6-b67b-1341952b59fa" xlink:to="loc_us-gaap_StockholdersEquityAbstract_4f0b7c41-6cb9-4aa1-a2db-88e70bfb4dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_c24f6280-1943-4768-94fe-ab623f52c319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4f0b7c41-6cb9-4aa1-a2db-88e70bfb4dbc" xlink:to="loc_us-gaap_PreferredStockValue_c24f6280-1943-4768-94fe-ab623f52c319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ba025506-12a1-44d0-98dc-3b3a308ff7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4f0b7c41-6cb9-4aa1-a2db-88e70bfb4dbc" xlink:to="loc_us-gaap_CommonStockValue_ba025506-12a1-44d0-98dc-3b3a308ff7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0a20f954-2751-434d-b8c1-b53b7cb4e80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4f0b7c41-6cb9-4aa1-a2db-88e70bfb4dbc" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0a20f954-2751-434d-b8c1-b53b7cb4e80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_69d0f74e-a60f-4111-b924-4ac28ece38a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4f0b7c41-6cb9-4aa1-a2db-88e70bfb4dbc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_69d0f74e-a60f-4111-b924-4ac28ece38a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5f977ee6-d2b5-4cbd-ba6b-ac509b408138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4f0b7c41-6cb9-4aa1-a2db-88e70bfb4dbc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5f977ee6-d2b5-4cbd-ba6b-ac509b408138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_883198ed-9b99-48bb-89e2-4edec582a760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4f0b7c41-6cb9-4aa1-a2db-88e70bfb4dbc" xlink:to="loc_us-gaap_StockholdersEquity_883198ed-9b99-48bb-89e2-4edec582a760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5aa785bf-8106-4d33-93d6-77a2e4acfb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_59f5833f-780d-49d6-b67b-1341952b59fa" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5aa785bf-8106-4d33-93d6-77a2e4acfb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_413bd9c0-299d-4278-bb60-b424b772f065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_dea9f10d-eb52-4c71-96d1-7f2d86eaead4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_413bd9c0-299d-4278-bb60-b424b772f065" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_dea9f10d-eb52-4c71-96d1-7f2d86eaead4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_fc675dbb-153f-41dd-b3d5-63ce5ccc2d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_413bd9c0-299d-4278-bb60-b424b772f065" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_fc675dbb-153f-41dd-b3d5-63ce5ccc2d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_83430d1b-4dc0-4864-b88b-b5c741af4d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_413bd9c0-299d-4278-bb60-b424b772f065" xlink:to="loc_us-gaap_PreferredStockSharesIssued_83430d1b-4dc0-4864-b88b-b5c741af4d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_249f2c13-817e-4c10-9fa6-237fad52dfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_413bd9c0-299d-4278-bb60-b424b772f065" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_249f2c13-817e-4c10-9fa6-237fad52dfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_89778d47-02a7-4f69-8f06-2e62befed2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_413bd9c0-299d-4278-bb60-b424b772f065" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_89778d47-02a7-4f69-8f06-2e62befed2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_29903fa9-fc48-486c-a709-781420cf780b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_413bd9c0-299d-4278-bb60-b424b772f065" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_29903fa9-fc48-486c-a709-781420cf780b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_bdf3aba8-8d1d-40a4-9579-188ff5d9d20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_413bd9c0-299d-4278-bb60-b424b772f065" xlink:to="loc_us-gaap_CommonStockSharesIssued_bdf3aba8-8d1d-40a4-9579-188ff5d9d20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e0954ab5-9427-43f7-93f2-cef0cec939d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_413bd9c0-299d-4278-bb60-b424b772f065" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e0954ab5-9427-43f7-93f2-cef0cec939d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f262370c-31ad-4e8f-9590-e4bd2e3af832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f262370c-31ad-4e8f-9590-e4bd2e3af832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1c9c0615-843a-4c14-8108-bd8dd4d781b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1c9c0615-843a-4c14-8108-bd8dd4d781b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d058b0ac-e71d-494b-b63b-31c58fa8a83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1c9c0615-843a-4c14-8108-bd8dd4d781b6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d058b0ac-e71d-494b-b63b-31c58fa8a83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f8462a3a-f276-4c06-990b-0888157b9ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1c9c0615-843a-4c14-8108-bd8dd4d781b6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f8462a3a-f276-4c06-990b-0888157b9ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6ed125b9-e515-487a-a28d-ecbb7d8ca56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1c9c0615-843a-4c14-8108-bd8dd4d781b6" xlink:to="loc_us-gaap_OperatingExpenses_6ed125b9-e515-487a-a28d-ecbb7d8ca56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2f7a037a-4ed5-4ac5-834e-15def0c31d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_OperatingIncomeLoss_2f7a037a-4ed5-4ac5-834e-15def0c31d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_fff8234f-2f58-4a31-9471-e7db2dd15036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_fff8234f-2f58-4a31-9471-e7db2dd15036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_d21abbee-d0a0-4e2a-b8c2-4746e4d26937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_fff8234f-2f58-4a31-9471-e7db2dd15036" xlink:to="loc_us-gaap_InterestIncomeOther_d21abbee-d0a0-4e2a-b8c2-4746e4d26937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_InterestIncomeAndOtherIncomeExpense_bd738a5f-af7a-4d17-bec4-bf0446da59c6" xlink:href="fhtx-20230331.xsd#fhtx_InterestIncomeAndOtherIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_fff8234f-2f58-4a31-9471-e7db2dd15036" xlink:to="loc_fhtx_InterestIncomeAndOtherIncomeExpense_bd738a5f-af7a-4d17-bec4-bf0446da59c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2e05fab3-a84f-49f3-84f9-9b431882c23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_fff8234f-2f58-4a31-9471-e7db2dd15036" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2e05fab3-a84f-49f3-84f9-9b431882c23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1faaa890-19c2-4022-ba68-ccaf4ab5ad16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1faaa890-19c2-4022-ba68-ccaf4ab5ad16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e4b3bda4-a32a-41d7-a0ed-006f25ff206b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e4b3bda4-a32a-41d7-a0ed-006f25ff206b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a44f2a45-09cf-4b2e-bd82-0fc6333c46c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_NetIncomeLoss_a44f2a45-09cf-4b2e-bd82-0fc6333c46c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b28ea97b-710c-47bb-9735-707df2aba6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_EarningsPerShareBasic_b28ea97b-710c-47bb-9735-707df2aba6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_df6e582e-e7b2-40c2-818d-566177b232e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_df6e582e-e7b2-40c2-818d-566177b232e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d8929302-a5e1-4c58-a023-0a95d9a53de5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d8929302-a5e1-4c58-a023-0a95d9a53de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_657dd330-7c16-4ff0-a793-e87769b78325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_657dd330-7c16-4ff0-a793-e87769b78325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d6318f13-8f75-458b-b6bd-9656faa14228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d6318f13-8f75-458b-b6bd-9656faa14228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b09d996d-cc65-4db8-9059-5661b9cd9a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d6318f13-8f75-458b-b6bd-9656faa14228" xlink:to="loc_us-gaap_NetIncomeLoss_b09d996d-cc65-4db8-9059-5661b9cd9a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_67768406-692e-4e83-9370-c80a11147273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_67768406-692e-4e83-9370-c80a11147273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_78c290c3-181e-4065-969c-7d54809ed1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_67768406-692e-4e83-9370-c80a11147273" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_78c290c3-181e-4065-969c-7d54809ed1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d2529bbb-b73f-4027-b854-50b65de00980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_67768406-692e-4e83-9370-c80a11147273" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d2529bbb-b73f-4027-b854-50b65de00980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6b9ad4bb-389a-4380-8152-e3df6cd30fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6bfebc98-efe5-44c3-84af-78868c8d1dd3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_6b9ad4bb-389a-4380-8152-e3df6cd30fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_bedd3bcd-a88b-490e-9f90-280de2aecb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_56f0154f-7821-4a41-bfec-8d6ad9ea9c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_bedd3bcd-a88b-490e-9f90-280de2aecb5b" xlink:to="loc_us-gaap_StatementTable_56f0154f-7821-4a41-bfec-8d6ad9ea9c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_91afd82c-e920-4228-8322-46ade0e6c05e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_56f0154f-7821-4a41-bfec-8d6ad9ea9c83" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_91afd82c-e920-4228-8322-46ade0e6c05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_91afd82c-e920-4228-8322-46ade0e6c05e" xlink:to="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a9678b35-3496-41a5-ac15-ffa8b1d2add1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:to="loc_us-gaap_CommonStockMember_a9678b35-3496-41a5-ac15-ffa8b1d2add1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8e185a35-86aa-450a-94b6-106177f97b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8e185a35-86aa-450a-94b6-106177f97b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e729e891-39b8-4389-bc36-a453329c0f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e729e891-39b8-4389-bc36-a453329c0f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6a568073-6d3f-4265-a0b2-d35f5f6c10c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_02833336-710d-4574-8d13-716ae4b91397" xlink:to="loc_us-gaap_RetainedEarningsMember_6a568073-6d3f-4265-a0b2-d35f5f6c10c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bb6eb60b-6620-4116-8d0f-9afafb523e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_56f0154f-7821-4a41-bfec-8d6ad9ea9c83" xlink:to="loc_us-gaap_StatementLineItems_bb6eb60b-6620-4116-8d0f-9afafb523e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bb6eb60b-6620-4116-8d0f-9afafb523e81" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f3744c58-153a-4be8-8cb7-fd54f58131ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_StockholdersEquity_f3744c58-153a-4be8-8cb7-fd54f58131ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f7aea109-1bf0-4378-9b8f-89854b5d7a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f7aea109-1bf0-4378-9b8f-89854b5d7a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d06a37f7-7aae-4af7-8c0a-015c6684e060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d06a37f7-7aae-4af7-8c0a-015c6684e060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bd6c72b6-86b3-4388-96ff-80503ae60133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bd6c72b6-86b3-4388-96ff-80503ae60133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e1a14ae6-1826-4384-9776-7563205c9eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e1a14ae6-1826-4384-9776-7563205c9eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_eb411075-fd75-4d17-a2f4-d016f3e62b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_eb411075-fd75-4d17-a2f4-d016f3e62b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_808ebe53-21cc-46ef-9d68-f7d48ddc57f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_NetIncomeLoss_808ebe53-21cc-46ef-9d68-f7d48ddc57f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ebe6952f-68c1-4914-b7af-ae6394991695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_StockholdersEquity_ebe6952f-68c1-4914-b7af-ae6394991695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_35e01770-760f-49a4-bc61-f7e93fe09690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b223d0da-c30e-492f-bed0-f6d01c1ce0f7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_35e01770-760f-49a4-bc61-f7e93fe09690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_266e4f6f-392f-46c0-8f7e-68f055fd3222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_435a3a24-1442-4049-b2f3-8a96d612810d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_266e4f6f-392f-46c0-8f7e-68f055fd3222" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_435a3a24-1442-4049-b2f3-8a96d612810d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6754aad4-f6da-406a-abd9-2c22b533270c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_435a3a24-1442-4049-b2f3-8a96d612810d" xlink:to="loc_us-gaap_NetIncomeLoss_6754aad4-f6da-406a-abd9-2c22b533270c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_988e05f9-679e-4cca-a722-7bf04ce7b9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_435a3a24-1442-4049-b2f3-8a96d612810d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_988e05f9-679e-4cca-a722-7bf04ce7b9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4ff01819-931b-4d25-a3c8-8ff06db90620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_988e05f9-679e-4cca-a722-7bf04ce7b9b8" xlink:to="loc_us-gaap_ShareBasedCompensation_4ff01819-931b-4d25-a3c8-8ff06db90620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f6ca9973-507c-4c59-91ea-be9d18e5574f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_988e05f9-679e-4cca-a722-7bf04ce7b9b8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f6ca9973-507c-4c59-91ea-be9d18e5574f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_5f0e1b54-0d22-49cd-9f03-001fd935820f" xlink:href="fhtx-20230331.xsd#fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_988e05f9-679e-4cca-a722-7bf04ce7b9b8" xlink:to="loc_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_5f0e1b54-0d22-49cd-9f03-001fd935820f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_10ac1827-bdf7-42ec-a11f-0ddcd00a2dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_988e05f9-679e-4cca-a722-7bf04ce7b9b8" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_10ac1827-bdf7-42ec-a11f-0ddcd00a2dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed1e9a21-a826-4e72-988d-a291ecf7db78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_435a3a24-1442-4049-b2f3-8a96d612810d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed1e9a21-a826-4e72-988d-a291ecf7db78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_84690007-d86a-4d59-8781-fd4a2f7c9ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed1e9a21-a826-4e72-988d-a291ecf7db78" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_84690007-d86a-4d59-8781-fd4a2f7c9ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_5ff0fc7a-0659-49c4-9724-d488459d53e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed1e9a21-a826-4e72-988d-a291ecf7db78" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_5ff0fc7a-0659-49c4-9724-d488459d53e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_4754fd8f-03cc-408f-9c95-e86817b1cc77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed1e9a21-a826-4e72-988d-a291ecf7db78" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_4754fd8f-03cc-408f-9c95-e86817b1cc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8ee21528-9d78-4beb-86aa-ad6d0630dba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed1e9a21-a826-4e72-988d-a291ecf7db78" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8ee21528-9d78-4beb-86aa-ad6d0630dba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_19d7c2d9-e55a-4670-a199-50dd92ae404b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed1e9a21-a826-4e72-988d-a291ecf7db78" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_19d7c2d9-e55a-4670-a199-50dd92ae404b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_5953f521-3588-4f5b-8f96-94275ba149e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed1e9a21-a826-4e72-988d-a291ecf7db78" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_5953f521-3588-4f5b-8f96-94275ba149e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce2edc71-df77-4fb4-8758-483d2ba668fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_435a3a24-1442-4049-b2f3-8a96d612810d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ce2edc71-df77-4fb4-8758-483d2ba668fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e0d5f5c6-3c18-46df-9bb5-ea9b18e4b361" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_266e4f6f-392f-46c0-8f7e-68f055fd3222" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e0d5f5c6-3c18-46df-9bb5-ea9b18e4b361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_60f21bb6-2ecb-4a52-9011-27fa30b53ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e0d5f5c6-3c18-46df-9bb5-ea9b18e4b361" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_60f21bb6-2ecb-4a52-9011-27fa30b53ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_aa65404d-aab8-4213-9bd9-60059a74d15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e0d5f5c6-3c18-46df-9bb5-ea9b18e4b361" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_aa65404d-aab8-4213-9bd9-60059a74d15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_bda198b0-fa21-4eb6-a36b-3c22ac92bca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e0d5f5c6-3c18-46df-9bb5-ea9b18e4b361" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_bda198b0-fa21-4eb6-a36b-3c22ac92bca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_92c1f06f-d5fe-4464-bc48-e16e34dfefcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e0d5f5c6-3c18-46df-9bb5-ea9b18e4b361" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_92c1f06f-d5fe-4464-bc48-e16e34dfefcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23a7afe2-4f25-4c7d-8297-c41f4a1196fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_266e4f6f-392f-46c0-8f7e-68f055fd3222" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23a7afe2-4f25-4c7d-8297-c41f4a1196fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_20d50e9c-2f53-4cce-b0a2-933c73eeea48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23a7afe2-4f25-4c7d-8297-c41f4a1196fc" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_20d50e9c-2f53-4cce-b0a2-933c73eeea48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8b1b181-3f23-4527-9c5d-5f46a2fe1b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_23a7afe2-4f25-4c7d-8297-c41f4a1196fc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8b1b181-3f23-4527-9c5d-5f46a2fe1b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64b3fb52-e8b4-44cd-9569-59bfc828ba9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_266e4f6f-392f-46c0-8f7e-68f055fd3222" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64b3fb52-e8b4-44cd-9569-59bfc828ba9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4acab735-ceca-473b-8ad4-72f9494c01d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_266e4f6f-392f-46c0-8f7e-68f055fd3222" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4acab735-ceca-473b-8ad4-72f9494c01d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6f5308c-8379-4682-8c0c-22f25c8cc32d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_266e4f6f-392f-46c0-8f7e-68f055fd3222" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6f5308c-8379-4682-8c0c-22f25c8cc32d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_32e0b79e-ca71-4142-a7d1-08601b3707fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_266e4f6f-392f-46c0-8f7e-68f055fd3222" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_32e0b79e-ca71-4142-a7d1-08601b3707fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d9f19407-fefe-420a-84d7-ce22728f1d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_32e0b79e-ca71-4142-a7d1-08601b3707fe" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d9f19407-fefe-420a-84d7-ce22728f1d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_80810458-3802-42c9-abeb-006cfc9913d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_266e4f6f-392f-46c0-8f7e-68f055fd3222" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_80810458-3802-42c9-abeb-006cfc9913d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8f0571a7-66bd-4587-8c30-4dff66cdc730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_80810458-3802-42c9-abeb-006cfc9913d0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8f0571a7-66bd-4587-8c30-4dff66cdc730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalents_961274c2-beb9-4933-81d1-bf6f3adfe32a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_80810458-3802-42c9-abeb-006cfc9913d0" xlink:to="loc_us-gaap_RestrictedCashEquivalents_961274c2-beb9-4933-81d1-bf6f3adfe32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5edfd157-67f6-43c1-93c2-76734286b691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_80810458-3802-42c9-abeb-006cfc9913d0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5edfd157-67f6-43c1-93c2-76734286b691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentation" xlink:type="simple" xlink:href="fhtx-20230331.xsd#NatureofBusinessGoingConcernandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d29497ba-a0b9-4c3c-953d-b21c08b0717a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_e6e90098-5b9b-46c1-8960-63349f0eb2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d29497ba-a0b9-4c3c-953d-b21c08b0717a" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_e6e90098-5b9b-46c1-8960-63349f0eb2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="fhtx-20230331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bc3e9e36-e036-4a30-add9-69c51ae08255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f0b79ad6-6641-4083-801d-27da481c9b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bc3e9e36-e036-4a30-add9-69c51ae08255" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f0b79ad6-6641-4083-801d-27da481c9b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurements" xlink:type="simple" xlink:href="fhtx-20230331.xsd#MarketableSecuritiesandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_58b9941b-b925-4ae1-b708-08b27b60cf47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock_43148ccf-e216-487a-87e2-75a890765f87" xlink:href="fhtx-20230331.xsd#fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_58b9941b-b925-4ae1-b708-08b27b60cf47" xlink:to="loc_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock_43148ccf-e216-487a-87e2-75a890765f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="fhtx-20230331.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_837e6b3c-01db-4670-b766-e001410272d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_299a4d11-d039-480b-92d8-0c912167cba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_837e6b3c-01db-4670-b766-e001410272d2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_299a4d11-d039-480b-92d8-0c912167cba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="simple" xlink:href="fhtx-20230331.xsd#AccruedExpensesandOtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_1e77ed53-01bb-4194-a549-e8996672078a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_bc6bfdb6-c26b-47c8-b399-7fd9d46f2ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1e77ed53-01bb-4194-a549-e8996672078a" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_bc6bfdb6-c26b-47c8-b399-7fd9d46f2ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CommonStockandNetLossPerShare" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CommonStockandNetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CommonStockandNetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_039605be-9a0d-4c26-b3be-7cfa39b07a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_49adb801-e8b4-4dd1-bee4-92ea4d462703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_039605be-9a0d-4c26-b3be-7cfa39b07a15" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_49adb801-e8b4-4dd1-bee4-92ea4d462703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="fhtx-20230331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a825e1eb-31b3-405c-98ff-3a2b260f4c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_359c185a-c1d9-4a1d-a4a1-7bacf73ea97d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a825e1eb-31b3-405c-98ff-3a2b260f4c87" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_359c185a-c1d9-4a1d-a4a1-7bacf73ea97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CollaborationAgreements" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CollaborationAgreements"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CollaborationAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CollaborationAgreementAbstract_88a80918-a737-456f-93c9-8e595e64a6eb" xlink:href="fhtx-20230331.xsd#fhtx_CollaborationAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_c82d668a-3242-48dc-a22d-6eedfb3bca3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_CollaborationAgreementAbstract_88a80918-a737-456f-93c9-8e595e64a6eb" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_c82d668a-3242-48dc-a22d-6eedfb3bca3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="fhtx-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_42cc9f63-bb6d-4d1e-ba43-bb1602e01680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_305b292e-1410-4f22-ae1d-61c7e773e862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_42cc9f63-bb6d-4d1e-ba43-bb1602e01680" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_305b292e-1410-4f22-ae1d-61c7e773e862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7448f6db-d1aa-4ea9-99ba-49a932898519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_27453035-c672-4ce9-bad5-ac4ef378bd29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7448f6db-d1aa-4ea9-99ba-49a932898519" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_27453035-c672-4ce9-bad5-ac4ef378bd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/DefinedContributionPlan" xlink:type="simple" xlink:href="fhtx-20230331.xsd#DefinedContributionPlan"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/DefinedContributionPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1395e43a-2d97-4101-be40-ac782c597c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_74f0b791-de1b-4564-bc9c-89b3e19d20b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1395e43a-2d97-4101-be40-ac782c597c3f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_74f0b791-de1b-4564-bc9c-89b3e19d20b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/RelatedParties" xlink:type="simple" xlink:href="fhtx-20230331.xsd#RelatedParties"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/RelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_efa0d5c1-48d7-4ed6-b1bf-e4c45b90a3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_03b40cc0-5072-4c6e-babc-97bc13213386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_efa0d5c1-48d7-4ed6-b1bf-e4c45b90a3a2" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_03b40cc0-5072-4c6e-babc-97bc13213386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="fhtx-20230331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cc7c0f66-47fe-464f-8942-0a3b96100604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_92356ee3-bec9-4064-8e42-de73bcdbdd0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cc7c0f66-47fe-464f-8942-0a3b96100604" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_92356ee3-bec9-4064-8e42-de73bcdbdd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8b617415-02b5-4606-abd6-99831dab8c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cc7c0f66-47fe-464f-8942-0a3b96100604" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8b617415-02b5-4606-abd6-99831dab8c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsTables" xlink:type="simple" xlink:href="fhtx-20230331.xsd#MarketableSecuritiesandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2e33f541-ecd2-4a7a-8360-3d343c822501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_8ea1e88c-f33d-4212-9148-899561ceec85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2e33f541-ecd2-4a7a-8360-3d343c822501" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_8ea1e88c-f33d-4212-9148-899561ceec85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4263c834-e434-4fe3-a892-dbc577944859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2e33f541-ecd2-4a7a-8360-3d343c822501" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4263c834-e434-4fe3-a892-dbc577944859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="fhtx-20230331.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_010cc99a-6bfc-497e-b9b8-1ec50f278f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_593272b7-b8d0-4c14-9b3d-b7c67b74ebb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_010cc99a-6bfc-497e-b9b8-1ec50f278f7c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_593272b7-b8d0-4c14-9b3d-b7c67b74ebb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="fhtx-20230331.xsd#AccruedExpensesandOtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_44902f08-5401-4c58-8b8f-ef7025f40af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fec69c3d-9cb5-4efb-85d0-07b241c1c1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_44902f08-5401-4c58-8b8f-ef7025f40af5" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fec69c3d-9cb5-4efb-85d0-07b241c1c1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CommonStockandNetLossPerShareTables" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CommonStockandNetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CommonStockandNetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0f669bfb-5ad4-42ae-9503-66a42901e99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_96f7bc4a-8f56-4008-b24b-54ed390554fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0f669bfb-5ad4-42ae-9503-66a42901e99d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_96f7bc4a-8f56-4008-b24b-54ed390554fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="fhtx-20230331.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c970f57-5664-4b24-bd99-bab335329994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_3aa2142f-c47e-411b-aae9-fbdce60a74fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c970f57-5664-4b24-bd99-bab335329994" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_3aa2142f-c47e-411b-aae9-fbdce60a74fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#NatureofBusinessGoingConcernandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_daf92234-81e6-478e-947d-2c7f62d5741e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_89c1b024-d596-4b14-961f-b54edd668f3a" xlink:href="fhtx-20230331.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_daf92234-81e6-478e-947d-2c7f62d5741e" xlink:to="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_89c1b024-d596-4b14-961f-b54edd668f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_15642b38-ded4-4063-b43d-69978383a652" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_89c1b024-d596-4b14-961f-b54edd668f3a" xlink:to="loc_srt_CounterpartyNameAxis_15642b38-ded4-4063-b43d-69978383a652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_208a9801-f311-468b-8030-959ce2c1b382" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_15642b38-ded4-4063-b43d-69978383a652" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_208a9801-f311-468b-8030-959ce2c1b382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_EliLillyMember_8c6c25b0-5082-48b6-a274-064591e8fe84" xlink:href="fhtx-20230331.xsd#fhtx_EliLillyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_208a9801-f311-468b-8030-959ce2c1b382" xlink:to="loc_fhtx_EliLillyMember_8c6c25b0-5082-48b6-a274-064591e8fe84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MerckMember_2c633346-cc1c-46b2-8d2a-6ae08f12a4ed" xlink:href="fhtx-20230331.xsd#fhtx_MerckMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_208a9801-f311-468b-8030-959ce2c1b382" xlink:to="loc_fhtx_MerckMember_2c633346-cc1c-46b2-8d2a-6ae08f12a4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_42f389bc-4485-4f7d-9dee-1978b5ec4e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_89c1b024-d596-4b14-961f-b54edd668f3a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_42f389bc-4485-4f7d-9dee-1978b5ec4e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_235f68db-3dcd-43cf-8401-4a97069b37b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_42f389bc-4485-4f7d-9dee-1978b5ec4e02" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_235f68db-3dcd-43cf-8401-4a97069b37b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MerckCollaborationAgreementMember_dd83a415-f6a2-4ce2-acdf-fd6df6686c73" xlink:href="fhtx-20230331.xsd#fhtx_MerckCollaborationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_235f68db-3dcd-43cf-8401-4a97069b37b5" xlink:to="loc_fhtx_MerckCollaborationAgreementMember_dd83a415-f6a2-4ce2-acdf-fd6df6686c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:href="fhtx-20230331.xsd#fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable_89c1b024-d596-4b14-961f-b54edd668f3a" xlink:to="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment_0ae524a6-2388-4629-ad2c-7577d3a3d153" xlink:href="fhtx-20230331.xsd#fhtx_ProceedsFromUpfrontPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:to="loc_fhtx_ProceedsFromUpfrontPayment_0ae524a6-2388-4629-ad2c-7577d3a3d153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_PaymentReceivedForAchievementOfMilestones_c921a4da-80b6-4a52-9de2-c0e73a353fdc" xlink:href="fhtx-20230331.xsd#fhtx_PaymentReceivedForAchievementOfMilestones"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:to="loc_fhtx_PaymentReceivedForAchievementOfMilestones_c921a4da-80b6-4a52-9de2-c0e73a353fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ed735c80-c337-4f71-b798-e11727864e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:to="loc_us-gaap_NetIncomeLoss_ed735c80-c337-4f71-b798-e11727864e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_394c174d-8af7-4632-bafb-a363f2385b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems_34df3b4c-39d7-4c8e-831e-f63052afea13" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_394c174d-8af7-4632-bafb-a363f2385b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ee3761d6-d045-41b7-acfe-06d063faca20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_11abcca1-157a-46b8-a060-e3876778ee23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ee3761d6-d045-41b7-acfe-06d063faca20" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_11abcca1-157a-46b8-a060-e3876778ee23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_398295a7-8abc-4139-9518-c29ef4d22b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_11abcca1-157a-46b8-a060-e3876778ee23" xlink:to="loc_us-gaap_FinancialInstrumentAxis_398295a7-8abc-4139-9518-c29ef4d22b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_398295a7-8abc-4139-9518-c29ef4d22b40" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember_c36d9fb7-70d8-4afc-9129-2e79371cc336" xlink:href="fhtx-20230331.xsd#fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember_c36d9fb7-70d8-4afc-9129-2e79371cc336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_USGovernmentAgenciesDueWithinOneYearMember_a45d27c2-7e7d-4180-8039-5d4299ec4d44" xlink:href="fhtx-20230331.xsd#fhtx_USGovernmentAgenciesDueWithinOneYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_fhtx_USGovernmentAgenciesDueWithinOneYearMember_a45d27c2-7e7d-4180-8039-5d4299ec4d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_85bdd7e7-982d-4967-b402-393e23086659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_us-gaap_CommercialPaperMember_85bdd7e7-982d-4967-b402-393e23086659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember_1efcc5a7-3900-4bce-89ea-989a25c365da" xlink:href="fhtx-20230331.xsd#fhtx_CorporateDebtSecuritiesDueWithinOneYearMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_fhtx_CorporateDebtSecuritiesDueWithinOneYearMember_1efcc5a7-3900-4bce-89ea-989a25c365da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember_27a5980c-ab09-47c7-8da4-f4caf5914947" xlink:href="fhtx-20230331.xsd#fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember_27a5980c-ab09-47c7-8da4-f4caf5914947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember_661d7430-8506-4b8a-a7e3-ffc0c369ab47" xlink:href="fhtx-20230331.xsd#fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ef361ac-c340-4af4-aa17-f12097a1887f" xlink:to="loc_fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember_661d7430-8506-4b8a-a7e3-ffc0c369ab47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_11abcca1-157a-46b8-a060-e3876778ee23" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9cc628d4-7f3d-4d7c-8c26-30b7c28ed456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9cc628d4-7f3d-4d7c-8c26-30b7c28ed456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da818efc-288d-4790-b0e4-86170c47c297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_da818efc-288d-4790-b0e4-86170c47c297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bb19e392-7078-47a9-8043-4d39e6866fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_bb19e392-7078-47a9-8043-4d39e6866fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c4630c76-09a1-4c1f-9d61-b28f1c2a0239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_39853f83-f04b-45c8-a037-4ab62b7cb6d9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c4630c76-09a1-4c1f-9d61-b28f1c2a0239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_22946727-b54e-49ce-a328-0babc782ae8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_22946727-b54e-49ce-a328-0babc782ae8a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cc42dbf5-57c9-410e-8b96-da42cd8d52aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cc42dbf5-57c9-410e-8b96-da42cd8d52aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_554549fe-7e9e-4485-bbc5-6463bfe1dd62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_cc42dbf5-57c9-410e-8b96-da42cd8d52aa" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_554549fe-7e9e-4485-bbc5-6463bfe1dd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b48f68b4-a49b-44c0-bb99-f0f665b59e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_554549fe-7e9e-4485-bbc5-6463bfe1dd62" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b48f68b4-a49b-44c0-bb99-f0f665b59e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a923d11a-62e5-457e-8926-b86dcfaa16db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a923d11a-62e5-457e-8926-b86dcfaa16db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc267a16-c7ba-46fe-8e45-9786ffb959ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a923d11a-62e5-457e-8926-b86dcfaa16db" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc267a16-c7ba-46fe-8e45-9786ffb959ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ff914095-1024-456b-aee3-6da18f156913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc267a16-c7ba-46fe-8e45-9786ffb959ed" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ff914095-1024-456b-aee3-6da18f156913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_12ae60b6-f601-439b-b6c9-2c618394d007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc267a16-c7ba-46fe-8e45-9786ffb959ed" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_12ae60b6-f601-439b-b6c9-2c618394d007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_838ba453-29d0-4940-ae48-fc6980980a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bc267a16-c7ba-46fe-8e45-9786ffb959ed" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_838ba453-29d0-4940-ae48-fc6980980a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_2ec255a5-bb68-4836-8a16-9856534ecc02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_2ec255a5-bb68-4836-8a16-9856534ecc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e96c7e9f-8d01-4959-8e9b-ea1c3bf2c0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2ec255a5-bb68-4836-8a16-9856534ecc02" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e96c7e9f-8d01-4959-8e9b-ea1c3bf2c0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_b56362fc-bebf-491b-9294-875fcbf5582c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e96c7e9f-8d01-4959-8e9b-ea1c3bf2c0ee" xlink:to="loc_us-gaap_MoneyMarketFundsMember_b56362fc-bebf-491b-9294-875fcbf5582c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember_001182c9-66fe-4e82-a4eb-2de11ed903c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e96c7e9f-8d01-4959-8e9b-ea1c3bf2c0ee" xlink:to="loc_us-gaap_USTreasuryNotesSecuritiesMember_001182c9-66fe-4e82-a4eb-2de11ed903c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e1565367-e53e-467d-82fe-b11caa2e90a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e96c7e9f-8d01-4959-8e9b-ea1c3bf2c0ee" xlink:to="loc_us-gaap_CommercialPaperMember_e1565367-e53e-467d-82fe-b11caa2e90a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_68eb59f0-3d1c-485e-812c-cfd1caca91fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:to="loc_us-gaap_FinancialInstrumentAxis_68eb59f0-3d1c-485e-812c-cfd1caca91fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_68eb59f0-3d1c-485e-812c-cfd1caca91fc" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryNotesSecuritiesMember_0fbc15a3-672e-497b-8873-de49f9b705a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:to="loc_us-gaap_USTreasuryNotesSecuritiesMember_0fbc15a3-672e-497b-8873-de49f9b705a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_077edb0f-4dc6-427d-b5b9-09a7a8db3502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_077edb0f-4dc6-427d-b5b9-09a7a8db3502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_67edb1bb-55b2-4251-9579-7418743f6212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:to="loc_us-gaap_CommercialPaperMember_67edb1bb-55b2-4251-9579-7418743f6212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_79231edd-676b-442e-97da-149ea0377968" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_99e029f0-990a-4b3b-835d-be95c3ac9069" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_79231edd-676b-442e-97da-149ea0377968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b4359df-b4e3-4d84-b782-92860badd2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1bd5d275-df24-4f34-a4a2-29042bb43328" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b4359df-b4e3-4d84-b782-92860badd2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0055620c-cc34-4b93-9069-e54376aa6efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b4359df-b4e3-4d84-b782-92860badd2fa" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0055620c-cc34-4b93-9069-e54376aa6efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8675c8d2-035b-41f2-a345-8ebb026beb39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b4359df-b4e3-4d84-b782-92860badd2fa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8675c8d2-035b-41f2-a345-8ebb026beb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_28ab4601-e033-4006-bc71-2c1aabfeae18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7b4359df-b4e3-4d84-b782-92860badd2fa" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_28ab4601-e033-4006-bc71-2c1aabfeae18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_59e0f18a-0385-450c-9f78-335f80eab906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ce97c3c6-b4c2-4acf-a439-7316d324483a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_59e0f18a-0385-450c-9f78-335f80eab906" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ce97c3c6-b4c2-4acf-a439-7316d324483a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32abd7aa-4510-4219-ad53-16a7f96dad28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ce97c3c6-b4c2-4acf-a439-7316d324483a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32abd7aa-4510-4219-ad53-16a7f96dad28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_32abd7aa-4510-4219-ad53-16a7f96dad28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_eec6fdfc-caaa-47c7-8133-7bf4c0407f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:to="loc_us-gaap_EquipmentMember_eec6fdfc-caaa-47c7-8133-7bf4c0407f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_09cef66d-3198-471e-9609-7a2f157d03ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_09cef66d-3198-471e-9609-7a2f157d03ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ComputerEquipmentAndSoftwareMember_a781ccad-07b4-4116-8497-b252188a8c61" xlink:href="fhtx-20230331.xsd#fhtx_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:to="loc_fhtx_ComputerEquipmentAndSoftwareMember_a781ccad-07b4-4116-8497-b252188a8c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_f0369cbe-2859-469d-9c92-5248d4fae438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_f0369cbe-2859-469d-9c92-5248d4fae438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_AssetsNotYetPlacedInServiceMember_0ad6d55d-07de-463d-baf0-2fde9ee27fc2" xlink:href="fhtx-20230331.xsd#fhtx_AssetsNotYetPlacedInServiceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6101d38e-64cc-4f3b-b419-ce1cde7b4548" xlink:to="loc_fhtx_AssetsNotYetPlacedInServiceMember_0ad6d55d-07de-463d-baf0-2fde9ee27fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21ab7efb-9526-48fc-8920-88481e43a01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ce97c3c6-b4c2-4acf-a439-7316d324483a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21ab7efb-9526-48fc-8920-88481e43a01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_6277540f-0a21-4a4b-ad88-fe4079fdceb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21ab7efb-9526-48fc-8920-88481e43a01b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_6277540f-0a21-4a4b-ad88-fe4079fdceb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b1d579f0-049e-49eb-80bb-6f0c9a97f65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_6277540f-0a21-4a4b-ad88-fe4079fdceb3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b1d579f0-049e-49eb-80bb-6f0c9a97f65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_4cdb1ea7-8627-4bcc-9f17-dce26bd18f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_6277540f-0a21-4a4b-ad88-fe4079fdceb3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_4cdb1ea7-8627-4bcc-9f17-dce26bd18f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_65c96099-26b9-4fb9-887a-f0d76247e571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract_6277540f-0a21-4a4b-ad88-fe4079fdceb3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_65c96099-26b9-4fb9-887a-f0d76247e571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/PropertyandEquipmentNetAdditionalInformationDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#PropertyandEquipmentNetAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/PropertyandEquipmentNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c76dcecd-4c8d-4306-8966-2fa2ba2af3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fb57671a-f2d1-4623-85af-a5cadd498687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c76dcecd-4c8d-4306-8966-2fa2ba2af3d3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fb57671a-f2d1-4623-85af-a5cadd498687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_8a7808b2-9c4f-49ea-881a-97e284e27d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_AccruedResearchAndDevelopmentExpenses_e7cdf9dd-9a40-4ceb-b21a-348b8bf589bd" xlink:href="fhtx-20230331.xsd#fhtx_AccruedResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_8a7808b2-9c4f-49ea-881a-97e284e27d7b" xlink:to="loc_fhtx_AccruedResearchAndDevelopmentExpenses_e7cdf9dd-9a40-4ceb-b21a-348b8bf589bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_10e1d283-0935-45f1-a027-5446e4e028db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_8a7808b2-9c4f-49ea-881a-97e284e27d7b" xlink:to="loc_us-gaap_AccruedIncomeTaxes_10e1d283-0935-45f1-a027-5446e4e028db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bc1b5f8b-2bd8-4f4f-b666-7b89f454e7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_8a7808b2-9c4f-49ea-881a-97e284e27d7b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_bc1b5f8b-2bd8-4f4f-b666-7b89f454e7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_bcad19e6-aa87-46c5-8b55-23b62585dbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_8a7808b2-9c4f-49ea-881a-97e284e27d7b" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_bcad19e6-aa87-46c5-8b55-23b62585dbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_dd0dd1bf-13f5-46be-86a0-043ff83604cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_8a7808b2-9c4f-49ea-881a-97e284e27d7b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_dd0dd1bf-13f5-46be-86a0-043ff83604cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_024ac071-8d91-47c3-815b-26fb851c5a28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_8a7808b2-9c4f-49ea-881a-97e284e27d7b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_024ac071-8d91-47c3-815b-26fb851c5a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CommonStockandNetLossPerShareNarrativeDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CommonStockandNetLossPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CommonStockandNetLossPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_298a2082-ee60-4607-9bbc-929e6251a84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CommonStockVotingRightsVotes_ba4fb8ae-f692-4244-b286-b9b207169d61" xlink:href="fhtx-20230331.xsd#fhtx_CommonStockVotingRightsVotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_298a2082-ee60-4607-9bbc-929e6251a84b" xlink:to="loc_fhtx_CommonStockVotingRightsVotes_ba4fb8ae-f692-4244-b286-b9b207169d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ea1635a9-d8fb-4ba2-8e32-d885e3fa78e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5bfcab8-2eaa-4cf3-bb4a-34fbd8216733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ea1635a9-d8fb-4ba2-8e32-d885e3fa78e5" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5bfcab8-2eaa-4cf3-bb4a-34fbd8216733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3465cf80-56d5-4d32-be9b-26854b828cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5bfcab8-2eaa-4cf3-bb4a-34fbd8216733" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3465cf80-56d5-4d32-be9b-26854b828cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_76a85f9f-b7e1-49b5-ae79-554aae6d39e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3465cf80-56d5-4d32-be9b-26854b828cc0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_76a85f9f-b7e1-49b5-ae79-554aae6d39e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_20c31564-16fb-4452-a3da-c11a00032288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_76a85f9f-b7e1-49b5-ae79-554aae6d39e7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_20c31564-16fb-4452-a3da-c11a00032288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_730b9943-03a9-4fdb-8721-a85023d73dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_76a85f9f-b7e1-49b5-ae79-554aae6d39e7" xlink:to="loc_us-gaap_WarrantMember_730b9943-03a9-4fdb-8721-a85023d73dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_139d0de7-1824-4c89-a77e-830d8c34e6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5bfcab8-2eaa-4cf3-bb4a-34fbd8216733" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_139d0de7-1824-4c89-a77e-830d8c34e6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b84ebbf4-06fb-4221-b800-9b7f86dacf79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_139d0de7-1824-4c89-a77e-830d8c34e6a1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b84ebbf4-06fb-4221-b800-9b7f86dacf79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22e253aa-0f9c-49cc-b7a4-702a8d5fd3e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_de075fee-a9f0-481d-bb58-62e5a429ef79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22e253aa-0f9c-49cc-b7a4-702a8d5fd3e7" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_de075fee-a9f0-481d-bb58-62e5a429ef79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_dcba3ff2-b4bf-472c-a9f4-62f4af001852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_de075fee-a9f0-481d-bb58-62e5a429ef79" xlink:to="loc_us-gaap_PlanNameAxis_dcba3ff2-b4bf-472c-a9f4-62f4af001852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_69b7cd98-8d83-40cf-929c-72e3a1d12650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_dcba3ff2-b4bf-472c-a9f4-62f4af001852" xlink:to="loc_us-gaap_PlanNameDomain_69b7cd98-8d83-40cf-929c-72e3a1d12650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember_a2efbc54-754c-42c3-98f3-b90fef393793" xlink:href="fhtx-20230331.xsd#fhtx_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_69b7cd98-8d83-40cf-929c-72e3a1d12650" xlink:to="loc_fhtx_TwoThousandTwentyEquityIncentivePlanMember_a2efbc54-754c-42c3-98f3-b90fef393793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_A2016StockIncentivePlanMember_9fb83df4-5424-4f22-b7d5-83a3728563a0" xlink:href="fhtx-20230331.xsd#fhtx_A2016StockIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_69b7cd98-8d83-40cf-929c-72e3a1d12650" xlink:to="loc_fhtx_A2016StockIncentivePlanMember_9fb83df4-5424-4f22-b7d5-83a3728563a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember_9572e926-5e33-4202-8435-ddf9080cae3d" xlink:href="fhtx-20230331.xsd#fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_69b7cd98-8d83-40cf-929c-72e3a1d12650" xlink:to="loc_fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember_9572e926-5e33-4202-8435-ddf9080cae3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_de075fee-a9f0-481d-bb58-62e5a429ef79" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6debdeab-d3f0-410a-9468-ce91a94801cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6debdeab-d3f0-410a-9468-ce91a94801cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4a63e0e7-9fcc-40c6-a024-a7c5b07b5ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4a63e0e7-9fcc-40c6-a024-a7c5b07b5ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage_66db45b7-6def-4065-bcca-0e3327fd0f95" xlink:href="fhtx-20230331.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage_66db45b7-6def-4065-bcca-0e3327fd0f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7428955d-94e4-450c-9906-bcbd30c89a93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7428955d-94e4-450c-9906-bcbd30c89a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1025d3b1-e157-4336-9117-1caa6aa47b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1025d3b1-e157-4336-9117-1caa6aa47b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_00000d90-f85a-42ed-aff9-e6764c485501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_00000d90-f85a-42ed-aff9-e6764c485501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_775c0401-19ff-448b-af08-9edf00dc499e" xlink:href="fhtx-20230331.xsd#fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares_775c0401-19ff-448b-af08-9edf00dc499e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_6a442140-d60a-4d70-ac9f-9f2b5724a211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_6a442140-d60a-4d70-ac9f-9f2b5724a211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_879abfc7-58e2-483d-8e67-df93dc8d7d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_879abfc7-58e2-483d-8e67-df93dc8d7d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b2f4da3-c2a8-4618-b4c7-cc2ea3eeca82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b2f4da3-c2a8-4618-b4c7-cc2ea3eeca82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ca90bb6d-4a12-4e97-a09c-57d437825a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_a8bbcaf9-0fa5-42b6-a77f-f54a456f34cd" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ca90bb6d-4a12-4e97-a09c-57d437825a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_03db2bea-623f-4645-bcb8-afbbdab90e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e69a5c-a3fc-45d8-bb43-55d362335884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_03db2bea-623f-4645-bcb8-afbbdab90e95" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e69a5c-a3fc-45d8-bb43-55d362335884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e3e30918-d089-404f-a6bb-5f310b302a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e69a5c-a3fc-45d8-bb43-55d362335884" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e3e30918-d089-404f-a6bb-5f310b302a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_22a799a8-7706-4f5b-bde0-5ef357d9e237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e3e30918-d089-404f-a6bb-5f310b302a26" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_22a799a8-7706-4f5b-bde0-5ef357d9e237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_664d0b2a-e7ae-4d11-94d6-a36689a3cae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_22a799a8-7706-4f5b-bde0-5ef357d9e237" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_664d0b2a-e7ae-4d11-94d6-a36689a3cae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_59111e8f-04f1-424c-a5b8-911c05ae8c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_22a799a8-7706-4f5b-bde0-5ef357d9e237" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_59111e8f-04f1-424c-a5b8-911c05ae8c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_e2fdfe2e-8df6-4556-9eb2-e561add072bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e69a5c-a3fc-45d8-bb43-55d362335884" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_e2fdfe2e-8df6-4556-9eb2-e561add072bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5c89aa42-d9e8-464f-95f8-914e29cdb804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_e2fdfe2e-8df6-4556-9eb2-e561add072bd" xlink:to="loc_us-gaap_ShareBasedCompensation_5c89aa42-d9e8-464f-95f8-914e29cdb804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CollaborationAgreementsDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CollaborationAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CollaborationAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CollaborationAgreementAbstract_06435a8a-62ad-4bc1-a02f-8b19d8d40ddf" xlink:href="fhtx-20230331.xsd#fhtx_CollaborationAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_CollaborationAgreementAbstract_06435a8a-62ad-4bc1-a02f-8b19d8d40ddf" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_8653e662-d6db-454f-9b51-35cbb822965f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:to="loc_srt_CounterpartyNameAxis_8653e662-d6db-454f-9b51-35cbb822965f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60c295f3-b283-4233-b2e6-6e846bf4fc65" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_8653e662-d6db-454f-9b51-35cbb822965f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60c295f3-b283-4233-b2e6-6e846bf4fc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_EliLillyMember_b91d87e4-ad7c-4d2b-9720-056b5795f70a" xlink:href="fhtx-20230331.xsd#fhtx_EliLillyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60c295f3-b283-4233-b2e6-6e846bf4fc65" xlink:to="loc_fhtx_EliLillyMember_b91d87e4-ad7c-4d2b-9720-056b5795f70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MerckMember_30383ad8-ac98-4632-913c-9785e9c228e0" xlink:href="fhtx-20230331.xsd#fhtx_MerckMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_60c295f3-b283-4233-b2e6-6e846bf4fc65" xlink:to="loc_fhtx_MerckMember_30383ad8-ac98-4632-913c-9785e9c228e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0ca674f7-a3d6-430e-abc3-838ced512ab5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:to="loc_srt_RangeAxis_0ca674f7-a3d6-430e-abc3-838ced512ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4019651f-cb64-48c3-8337-6bec807e3e75" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0ca674f7-a3d6-430e-abc3-838ced512ab5" xlink:to="loc_srt_RangeMember_4019651f-cb64-48c3-8337-6bec807e3e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_73ddc414-70ad-4c11-909e-1e0247fe199b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4019651f-cb64-48c3-8337-6bec807e3e75" xlink:to="loc_srt_MaximumMember_73ddc414-70ad-4c11-909e-1e0247fe199b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9e44c4f-ca0a-4afa-829c-bd9d78d3be83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9e44c4f-ca0a-4afa-829c-bd9d78d3be83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0788995a-b3c7-4f6d-8ef2-6410d0041db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9e44c4f-ca0a-4afa-829c-bd9d78d3be83" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0788995a-b3c7-4f6d-8ef2-6410d0041db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ResearchDevelopmentAndRegulatoryMember_98512aa4-6f8d-4dae-9ebd-dd3881788c37" xlink:href="fhtx-20230331.xsd#fhtx_ResearchDevelopmentAndRegulatoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0788995a-b3c7-4f6d-8ef2-6410d0041db7" xlink:to="loc_fhtx_ResearchDevelopmentAndRegulatoryMember_98512aa4-6f8d-4dae-9ebd-dd3881788c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_SalesBasedMilestoneMember_afae293f-078c-42c4-af56-e76ffa62a73d" xlink:href="fhtx-20230331.xsd#fhtx_SalesBasedMilestoneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0788995a-b3c7-4f6d-8ef2-6410d0041db7" xlink:to="loc_fhtx_SalesBasedMilestoneMember_afae293f-078c-42c4-af56-e76ffa62a73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MerckCollaborationAgreementMember_089e0bf6-e221-43b3-b06d-23a2286beb36" xlink:href="fhtx-20230331.xsd#fhtx_MerckCollaborationAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0788995a-b3c7-4f6d-8ef2-6410d0041db7" xlink:to="loc_fhtx_MerckCollaborationAgreementMember_089e0bf6-e221-43b3-b06d-23a2286beb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9276cbd6-f920-48b3-80c8-a3f84ec7ab93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9276cbd6-f920-48b3-80c8-a3f84ec7ab93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4b9db808-eeec-4cfa-9393-7b94fcd9ea09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9276cbd6-f920-48b3-80c8-a3f84ec7ab93" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4b9db808-eeec-4cfa-9393-7b94fcd9ea09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_ac4b53b6-459d-495d-861b-995d1b6c02bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4b9db808-eeec-4cfa-9393-7b94fcd9ea09" xlink:to="loc_us-gaap_SalesMember_ac4b53b6-459d-495d-861b-995d1b6c02bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_cf121a7c-60c4-486e-8f80-62538f5eed88" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_NumberOfAdditionalTargets_578d3aa8-31cd-4735-9ce3-601258fac406" xlink:href="fhtx-20230331.xsd#fhtx_NumberOfAdditionalTargets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_NumberOfAdditionalTargets_578d3aa8-31cd-4735-9ce3-601258fac406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_NumberOfPrograms_1aa2ac84-85b7-4686-a877-11faaded227c" xlink:href="fhtx-20230331.xsd#fhtx_NumberOfPrograms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_NumberOfPrograms_1aa2ac84-85b7-4686-a877-11faaded227c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_NumberOfTargets_2b41155b-56fb-47cb-96c4-b3052ec21f4d" xlink:href="fhtx-20230331.xsd#fhtx_NumberOfTargets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_NumberOfTargets_2b41155b-56fb-47cb-96c4-b3052ec21f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MilestoneReceivableUponAchievement_3a3f1a8d-bb3d-48a9-9a4e-da9756bf4b38" xlink:href="fhtx-20230331.xsd#fhtx_MilestoneReceivableUponAchievement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_MilestoneReceivableUponAchievement_3a3f1a8d-bb3d-48a9-9a4e-da9756bf4b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_OptOutMilestoneReceivableUponAchievement_073acc37-9483-44d2-905d-12dd7eabc002" xlink:href="fhtx-20230331.xsd#fhtx_OptOutMilestoneReceivableUponAchievement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_OptOutMilestoneReceivableUponAchievement_073acc37-9483-44d2-905d-12dd7eabc002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_266940ce-4931-489f-875f-d79c57525551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_us-gaap_ContractWithCustomerLiability_266940ce-4931-489f-875f-d79c57525551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db1c6d4c-a942-4a14-8430-5586dd6a367b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db1c6d4c-a942-4a14-8430-5586dd6a367b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment_2b20393e-9147-41a9-9742-477d9f9207e3" xlink:href="fhtx-20230331.xsd#fhtx_ProceedsFromUpfrontPayment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_ProceedsFromUpfrontPayment_2b20393e-9147-41a9-9742-477d9f9207e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_PaymentReceivedForAchievementOfMilestones_d54b534f-6dd5-41d9-b067-ed5bed8df4d2" xlink:href="fhtx-20230331.xsd#fhtx_PaymentReceivedForAchievementOfMilestones"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_fhtx_PaymentReceivedForAchievementOfMilestones_d54b534f-6dd5-41d9-b067-ed5bed8df4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d7914d40-2a36-46b8-a7d2-d1904667ab22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_4517bbdf-6404-4c54-9acc-fd71930a8851" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d7914d40-2a36-46b8-a7d2-d1904667ab22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0a854928-7aa0-48aa-aed4-05dc7b3eec7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_014de585-4ff7-4347-b5a0-ae3989faa458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a854928-7aa0-48aa-aed4-05dc7b3eec7f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_014de585-4ff7-4347-b5a0-ae3989faa458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c6951f0-e02a-4ab1-af5d-81983bd09409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a854928-7aa0-48aa-aed4-05dc7b3eec7f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5c6951f0-e02a-4ab1-af5d-81983bd09409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_77620969-b483-4c86-9aa5-356878f5874c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a854928-7aa0-48aa-aed4-05dc7b3eec7f" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_77620969-b483-4c86-9aa5-356878f5874c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6cae297e-d5a2-4d11-9006-951e3012f551" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_77620969-b483-4c86-9aa5-356878f5874c" xlink:to="loc_srt_CounterpartyNameAxis_6cae297e-d5a2-4d11-9006-951e3012f551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_94e842d6-cc76-41f0-b406-815c3a09c51e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_6cae297e-d5a2-4d11-9006-951e3012f551" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_94e842d6-cc76-41f0-b406-815c3a09c51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_EliLillyMember_deb3572f-01e4-4dd0-98e9-7c24d220351b" xlink:href="fhtx-20230331.xsd#fhtx_EliLillyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_94e842d6-cc76-41f0-b406-815c3a09c51e" xlink:to="loc_fhtx_EliLillyMember_deb3572f-01e4-4dd0-98e9-7c24d220351b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_40538440-c014-449e-aa1e-e230b1bceead" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_77620969-b483-4c86-9aa5-356878f5874c" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_40538440-c014-449e-aa1e-e230b1bceead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ProceedsFromUpfrontPayment_58b88554-ae9e-482f-bf60-a774bc188efe" xlink:href="fhtx-20230331.xsd#fhtx_ProceedsFromUpfrontPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_40538440-c014-449e-aa1e-e230b1bceead" xlink:to="loc_fhtx_ProceedsFromUpfrontPayment_58b88554-ae9e-482f-bf60-a774bc188efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8aebbadc-aa7a-4f81-bb99-e519f2dc1406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CommitmentsAndContingenciesTable_942856c3-8612-4bc9-8ad5-6f5ee8d378d0" xlink:href="fhtx-20230331.xsd#fhtx_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8aebbadc-aa7a-4f81-bb99-e519f2dc1406" xlink:to="loc_fhtx_CommitmentsAndContingenciesTable_942856c3-8612-4bc9-8ad5-6f5ee8d378d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_aa6eb8de-9388-4bff-889d-fa9b10f109be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_CommitmentsAndContingenciesTable_942856c3-8612-4bc9-8ad5-6f5ee8d378d0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_aa6eb8de-9388-4bff-889d-fa9b10f109be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bb4f5cbc-1f67-4ac5-b3eb-6e0295ce7f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_aa6eb8de-9388-4bff-889d-fa9b10f109be" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bb4f5cbc-1f67-4ac5-b3eb-6e0295ce7f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_StanfordLicenseAgreementMember_a3eb2793-5cc6-44c0-b377-1f657077f3b7" xlink:href="fhtx-20230331.xsd#fhtx_StanfordLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bb4f5cbc-1f67-4ac5-b3eb-6e0295ce7f71" xlink:to="loc_fhtx_StanfordLicenseAgreementMember_a3eb2793-5cc6-44c0-b377-1f657077f3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_06babcd6-e4d1-4966-9ccf-38bad44299dc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_CommitmentsAndContingenciesTable_942856c3-8612-4bc9-8ad5-6f5ee8d378d0" xlink:to="loc_srt_RangeAxis_06babcd6-e4d1-4966-9ccf-38bad44299dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f4f6262d-7ba9-4abd-aad8-fc964439fee8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_06babcd6-e4d1-4966-9ccf-38bad44299dc" xlink:to="loc_srt_RangeMember_f4f6262d-7ba9-4abd-aad8-fc964439fee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3d879602-7fd9-4202-b4f6-9a176b09a6d1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f4f6262d-7ba9-4abd-aad8-fc964439fee8" xlink:to="loc_srt_MaximumMember_3d879602-7fd9-4202-b4f6-9a176b09a6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CommitmentsAndContingenciesLineItems_82706d86-2f73-44ce-b5ca-0c611ee8e36a" xlink:href="fhtx-20230331.xsd#fhtx_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_CommitmentsAndContingenciesTable_942856c3-8612-4bc9-8ad5-6f5ee8d378d0" xlink:to="loc_fhtx_CommitmentsAndContingenciesLineItems_82706d86-2f73-44ce-b5ca-0c611ee8e36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_AnnualLicenseMaintenanceFees_4628ca5a-aa63-466c-b901-46eefe3c5f0c" xlink:href="fhtx-20230331.xsd#fhtx_AnnualLicenseMaintenanceFees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_CommitmentsAndContingenciesLineItems_82706d86-2f73-44ce-b5ca-0c611ee8e36a" xlink:to="loc_fhtx_AnnualLicenseMaintenanceFees_4628ca5a-aa63-466c-b901-46eefe3c5f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_MilestonesPayableUponEvent_5236f9e7-f4de-4224-90aa-83a3b0c38627" xlink:href="fhtx-20230331.xsd#fhtx_MilestonesPayableUponEvent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fhtx_CommitmentsAndContingenciesLineItems_82706d86-2f73-44ce-b5ca-0c611ee8e36a" xlink:to="loc_fhtx_MilestonesPayableUponEvent_5236f9e7-f4de-4224-90aa-83a3b0c38627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/DefinedContributionPlanDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#DefinedContributionPlanDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/DefinedContributionPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_adbc218d-7572-42d3-96c5-73ddec0e836a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_e1cb0e8e-e3e1-4cd6-a337-8b773bd614aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_adbc218d-7572-42d3-96c5-73ddec0e836a" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_e1cb0e8e-e3e1-4cd6-a337-8b773bd614aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.foghorntx.com/role/RelatedPartiesDetails" xlink:type="simple" xlink:href="fhtx-20230331.xsd#RelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://www.foghorntx.com/role/RelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_d6f1f88f-9d07-4691-b636-abad04f56af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ab341390-b9a0-452e-a466-b251b69a02b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_d6f1f88f-9d07-4691-b636-abad04f56af3" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ab341390-b9a0-452e-a466-b251b69a02b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8286fa9c-94b5-4b32-8916-25a63e66e73c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ab341390-b9a0-452e-a466-b251b69a02b2" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8286fa9c-94b5-4b32-8916-25a63e66e73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_60eb62ef-d325-44c8-9aea-1537dc391f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8286fa9c-94b5-4b32-8916-25a63e66e73c" xlink:to="loc_us-gaap_RelatedPartyDomain_60eb62ef-d325-44c8-9aea-1537dc391f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_832ad327-ca24-4244-89d1-4da0e13b6522" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_60eb62ef-d325-44c8-9aea-1537dc391f8f" xlink:to="loc_srt_AffiliatedEntityMember_832ad327-ca24-4244-89d1-4da0e13b6522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_1bf9c498-5d99-42c6-bd9b-37094ab3a1bc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ab341390-b9a0-452e-a466-b251b69a02b2" xlink:to="loc_srt_TitleOfIndividualAxis_1bf9c498-5d99-42c6-bd9b-37094ab3a1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b8ac16e-2eee-47e2-9c5d-fa6ec1fed5dd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_1bf9c498-5d99-42c6-bd9b-37094ab3a1bc" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b8ac16e-2eee-47e2-9c5d-fa6ec1fed5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ScientificFounderMember_5e6833e7-496a-416e-9ebb-9bee76e36354" xlink:href="fhtx-20230331.xsd#fhtx_ScientificFounderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8b8ac16e-2eee-47e2-9c5d-fa6ec1fed5dd" xlink:to="loc_fhtx_ScientificFounderMember_5e6833e7-496a-416e-9ebb-9bee76e36354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_a2077f38-756b-46fc-8c79-4961967e658f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ab341390-b9a0-452e-a466-b251b69a02b2" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_a2077f38-756b-46fc-8c79-4961967e658f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_ServiceAgreementTerm_73b7b3b2-db0d-4ef3-b0f0-86e6e1fb3d41" xlink:href="fhtx-20230331.xsd#fhtx_ServiceAgreementTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a2077f38-756b-46fc-8c79-4961967e658f" xlink:to="loc_fhtx_ServiceAgreementTerm_73b7b3b2-db0d-4ef3-b0f0-86e6e1fb3d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fhtx_CashPaymentsRelatedParty_9eb87635-d56c-4bda-ac94-463f1bff205b" xlink:href="fhtx-20230331.xsd#fhtx_CashPaymentsRelatedParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a2077f38-756b-46fc-8c79-4961967e658f" xlink:to="loc_fhtx_CashPaymentsRelatedParty_9eb87635-d56c-4bda-ac94-463f1bff205b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_5323a1cb-6591-4f51-989b-23faf11576c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_a2077f38-756b-46fc-8c79-4961967e658f" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_5323a1cb-6591-4f51-989b-23faf11576c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770914140032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Foghorn Therapeutics Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-5271393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Street Name</a></td>
<td class="text">500 Technology Square, Ste 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City</a></td>
<td class="text">Cambridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">586-3100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of each class</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol(s)</a></td>
<td class="text">FHTX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of each exchange on which registered</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,824,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001822462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770915785840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,641<span></span>
</td>
<td class="nump">$ 52,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">265,329<span></span>
</td>
<td class="nump">293,584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,729<span></span>
</td>
<td class="nump">5,601<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">320,699<span></span>
</td>
<td class="nump">351,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">15,225<span></span>
</td>
<td class="nump">15,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,708<span></span>
</td>
<td class="nump">1,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">2,364<span></span>
</td>
<td class="nump">2,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">32,887<span></span>
</td>
<td class="nump">34,086<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">372,883<span></span>
</td>
<td class="nump">404,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,288<span></span>
</td>
<td class="nump">5,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">8,831<span></span>
</td>
<td class="nump">11,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">6,346<span></span>
</td>
<td class="nump">5,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">33,331<span></span>
</td>
<td class="nump">32,820<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">55,796<span></span>
</td>
<td class="nump">55,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">43,493<span></span>
</td>
<td class="nump">45,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">298,180<span></span>
</td>
<td class="nump">304,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">397,469<span></span>
</td>
<td class="nump">404,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 25,000,000 shares authorized at March&#160;31, 2023 and December&#160;31, 2022; no shares issued and outstanding at March&#160;31, 2023 and December&#160;31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 175,000,000 shares authorized at March&#160;31, 2023 and December&#160;31, 2022; 41,824,758 shares issued and outstanding at March&#160;31, 2023 and 41,803,436 shares issued and outstanding at December&#160;31, 2022</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">381,906<span></span>
</td>
<td class="nump">377,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(2,870)<span></span>
</td>
<td class="num">(3,986)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(403,626)<span></span>
</td>
<td class="num">(373,138)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="num">(24,586)<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 372,883<span></span>
</td>
<td class="nump">$ 404,883<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770915736624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">175,000,000<span></span>
</td>
<td class="nump">175,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">41,824,758<span></span>
</td>
<td class="nump">41,803,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">41,824,758<span></span>
</td>
<td class="nump">41,803,436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770914191568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Collaboration revenue</a></td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 3,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">29,985<span></span>
</td>
<td class="nump">24,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">8,641<span></span>
</td>
<td class="nump">7,216<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">38,626<span></span>
</td>
<td class="nump">31,724<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(33,317)<span></span>
</td>
<td class="num">(27,804)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">2,669<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_InterestIncomeAndOtherIncomeExpense', window );">Other income, net</a></td>
<td class="nump">720<span></span>
</td>
<td class="nump">655<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income, net</a></td>
<td class="nump">3,389<span></span>
</td>
<td class="nump">890<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(29,928)<span></span>
</td>
<td class="num">(26,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(560)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (30,488)<span></span>
</td>
<td class="num">$ (26,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders&#8212;basic (in dollars per share)</a></td>
<td class="num">$ (0.73)<span></span>
</td>
<td class="num">$ (0.65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders&#8212;diluted (in dollars per share)</a></td>
<td class="num">$ (0.73)<span></span>
</td>
<td class="num">$ (0.65)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding&#8212;basic (in shares)</a></td>
<td class="nump">41,811,087<span></span>
</td>
<td class="nump">41,370,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding&#8212;diluted (in shares)</a></td>
<td class="nump">41,811,087<span></span>
</td>
<td class="nump">41,370,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (30,488)<span></span>
</td>
<td class="num">$ (26,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gains (losses) on marketable securities</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="num">(1,184)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss)</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="num">(1,184)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (29,372)<span></span>
</td>
<td class="num">$ (28,098)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_InterestIncomeAndOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income and income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_InterestIncomeAndOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770915660704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 96,871<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 361,133<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="num">$ (264,256)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,299,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options and employee stock purchase plan</a></td>
<td class="nump">384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options and employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">3,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Gains on marketable securities</a></td>
<td class="num">(1,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(26,914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,914)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">72,401<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">364,761<span></span>
</td>
<td class="num">(1,194)<span></span>
</td>
<td class="num">(291,170)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,429,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">377,232<span></span>
</td>
<td class="num">(3,986)<span></span>
</td>
<td class="num">(373,138)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">41,803,436<span></span>
</td>
<td class="nump">41,803,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options and employee stock purchase plan</a></td>
<td class="nump">$ 102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options and employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized Gains on marketable securities</a></td>
<td class="nump">1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(30,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,488)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="num">$ (24,586)<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 381,906<span></span>
</td>
<td class="num">$ (2,870)<span></span>
</td>
<td class="num">$ (403,626)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="nump">41,824,758<span></span>
</td>
<td class="nump">41,824,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770916493440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (30,488)<span></span>
</td>
<td class="num">$ (26,914)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">4,572<span></span>
</td>
<td class="nump">3,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">859<span></span>
</td>
<td class="nump">811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset', window );">Noncash lease expense</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">1,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization (accretion) of discount on marketable securities</a></td>
<td class="num">(770)<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">887<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Collaboration receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,691<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(2,154)<span></span>
</td>
<td class="num">(2,542)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(1,668)<span></span>
</td>
<td class="num">(1,752)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(5,309)<span></span>
</td>
<td class="num">(3,920)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(31,180)<span></span>
</td>
<td class="nump">271,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(636)<span></span>
</td>
<td class="num">(247)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(26,232)<span></span>
</td>
<td class="num">(212,294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from maturities of marketable securities</a></td>
<td class="nump">56,373<span></span>
</td>
<td class="nump">53,132<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">29,505<span></span>
</td>
<td class="num">(159,409)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock upon exercise of stock options and employee stock purchase plan</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">384<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">384<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents and restricted cash</a></td>
<td class="num">(1,573)<span></span>
</td>
<td class="nump">112,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">53,922<span></span>
</td>
<td class="nump">102,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">52,349<span></span>
</td>
<td class="nump">215,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment included in accounts payable and accrued expenses</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">50,641<span></span>
</td>
<td class="nump">213,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalents', window );">Restricted cash (current and non-current)</a></td>
<td class="nump">1,708<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash shown in the statement of cash flows</a></td>
<td class="nump">$ 52,349<span></span>
</td>
<td class="nump">$ 215,378<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right-of-use assets under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770920295296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business, Going Concern and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Nature of Business, Going Concern and Basis of Presentation</a></td>
<td class="text">Nature of Business, Going Concern and Basis of Presentation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foghorn Therapeutics&#160;Inc. (the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company discovering and developing a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. The Company uses its proprietary Gene Traffic Control platform to identify, validate and potentially drug targets within the system. The Company was founded in October 2015 as a Delaware corporation. The Company is headquartered in Cambridge, Massachusetts.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks similar to those of other early-stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, and the need to obtain adequate additional financing to fund the development of its products. There can be no assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going concern</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. Since inception, the Company has funded its operations primarily with proceeds from sales of preferred stock, debt financing, an upfront payment from a collaboration agreement, a public offering and a stock purchase agreement all prior to 2022. In January 2022, the Company received an upfront payment of $300.0 million pursuant to a collaboration agreement completed with Lilly (the &#8220;Lilly Collaboration Agreement&#8221;) (see Note 8). In the third quarter of 2022, the Company achieved a research milestone related to the Merck Collaboration Agreement and received a $5.0 million milestone payment from Merck. The Company has incurred recurring losses, including net losses of $30.5&#160;million and $26.9&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively. As of March&#160;31, 2023, the Company had an accumulated deficit of $403.6 million. The Company expects to continue to generate operating losses in the foreseeable future. As of the issuance date of these interim condensed consolidated financial statements the Company expects that its cash, cash equivalents and marketable securities will be sufficient to fund its operating expenses and capital expenditure requirements for at least 12 months.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will need to obtain additional funding through public or private equity offerings, debt financings, collaborations, strategic alliances and/or licensing arrangements to continue to fund its operations. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborative or strategic alliances or licensing arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company&#8217;s stockholders. Arrangements with collaborators or others may require the Company to relinquish rights to certain of its technologies or programs. If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate some or all of its research and development programs, pipeline expansion or commercialization efforts, which could adversely affect its business prospects. Although management will continue to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding in the future on terms acceptable to the Company to fund continuing operations when needed or at all.</span></div><div style="margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770920458448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the Company are set forth in Note 2 to the consolidated financial statements contained in the Company&#8217;s 2022 Annual Report on Form 10-K. The Company includes herein certain updates to those policies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities are classified as&#160;available-for-sale&#160;and are carried at fair value with the unrealized gains and losses reported as a component of accumulated other comprehensive loss in stockholders&#8217; equity. The Company classifies its marketable securities with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities are available for current operations. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews marketable securities whenever the fair value of an investment is less than the amortized cost and evidence indicates that an investment&#8217;s carrying value is not recoverable. For available-for-sale debt securities, the credit allowance is limited to the amount that fair value is less than amortized cost. Unrealized losses are evaluated for impairment under ASC 326, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine if the impairment is credit-related or noncredit-related. Credit-related impairment is recognized as an allowance on the condensed consolidated balance sheets with a corresponding adjustment to earnings, and noncredit-related impairment is recognized in other comprehensive loss. Evidence considered in this assessment includes reasons for the impairment, compliance with our investment policy, the severity of the impairment, collectability of the security, and any adverse conditions specifically related to the security, an industry, or geographic area.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses are included as a component of accumulated other comprehensive loss in the consolidated balance sheets and condensed consolidated statements of stockholders&#8217; equity and a component of total comprehensive loss. Realized gains and losses are included as a component of other income (expense), net based on the specific identification method.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently issued accounting pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to &#8220;opt out&#8221; of the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i)&#160;irrevocably elects to opt out of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No.&#160;2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The new standard adjusts the accounting for assets held at amortized costs basis by eliminating the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses as an allowance for credit losses. For nonpublic entities and emerging growth companies that choose to take advantage of the extended transition period, the guidance was initially effective for annual reporting periods beginning after December&#160;15, 2020. However, in November 2019, the FASB issued ASU No.&#160;2019-10, which deferred the effective date for nonpublic entities to annual reporting periods beginning after December&#160;15, 2022, including interim periods within those fiscal years. The Company adopted this s as of January 1, 2023 and the adoption had no material impact to the Company&#8217;s consolidated financial position, results of operation, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770920318592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock', window );">Marketable Securities and Fair Value Measurements</a></td>
<td class="text">Marketable Securities and Fair Value Measurements<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, available for sale marketable securities by security type consisted of (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes (due within one year)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies (due within one year)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper (due within one year)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due within one year)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies (due after one year through two years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due after one year through three<br/>&#160;&#160;&#160;years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,199&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,883)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,329&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, available for sale marketable securities by security type consisted of (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes (due within one year)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper (due within one year)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due within one year)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due after one year through three<br/>&#160;&#160;&#160;years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,992)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s fair value hierarchy for its assets and liabilities, which are measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at March 31, 2023 Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,327&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,546&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at December 31, 2022 Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,721&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022, there were no transfers between Level&#160;1, Level&#160;2 and Level&#160;3.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for marketable securities and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770920318592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:70.138%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,884&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets not yet placed in service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,695&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,922&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,611)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,225&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,311&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Depreciation and amortization expense was $0.9&#160;million and $0.8&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139771001682032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">Accrued Expenses and Other Current Liabilities<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:70.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.932%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued external research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,831&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139771002172992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock and Net Loss Per Share</a></td>
<td class="text">Common Stock and Net Loss Per Share<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#8217;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents presented based on amounts outstanding at each period end have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,666,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,772,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,684,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,790,503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139771001660368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Equity Incentive Plan</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2020 Equity Incentive Plan ( the &#8220;2020 Plan&#8221;) provides for the grant of incentive stock options, non-qualified options, stock appreciation rights, restricted stock awards, restricted stock units and other stock-based awards. The number of shares initially reserved for issuance under the 2020 Plan was (i) 2,200,000 shares (the &#8220;share pool&#8221;), plus (ii) the number of shares of common stock available for issuance under the Company&#8217;s 2016 Stock Incentive Plan (the &#8220;2016 Plan&#8221;) as of the effective date of the 2020 Plan, plus the number of shares of common stock underlying awards under the 2016 Plan that on or </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">after the date of adoption expire or become unexercisable without delivery of shares, are forfeited to, or repurchased for cash, are settled in cash, or otherwise become available again for grant under the 2016 Plan, in each case, in accordance with its terms (up to an aggregate of 5,078,295 shares). As of March&#160;31, 2023, 1,359,407 shares remained available for future grant under the 2020 Plan.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The share pool will automatically increase on January 1 of each year from 2021 to 2030 by the lesser of (i) four percent of the number of shares of our common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares determined by the board of directors on or prior to such date for such year. The number of shares reserved for issuance under the 2020 Plan was increased by 1,672,137 shares effective January 1, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Plan is administered by the board of directors or, at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or its committee if so delegated. Stock options granted with service-based vesting conditions generally vest over four years and expire after ten years. The exercise price for stock options granted is not less than the fair value of common stock on the date of grant. The Company bases fair value of common stock on the quoted market price. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Employee Stock Purchase Plan</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 21, 2020, the Company&#8217;s board of directors adopted and its stockholders approved the 2020 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;), which became effective on October 21, 2020. The aggregate number of shares of common stock available for purchase pursuant to the exercise of options under the ESPP is 360,000 shares, plus an automatic annual increase, as of January 1 of each year from 2021 to 2030, equal to the lesser of one percent of the number of shares of common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares determined by the board of directors on or prior to such date for such year (up to a maximum of 3,220,520 shares). The number of shares reserved for issuance under the ESPP was increased by 418,034 shares to 1,184,497 shares effective January 1, 2023.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eligible employees may authorize payroll deductions of up to 15% of their eligible compensation during an offering period. The purchase of shares is done at a 15% discount on the lesser of (i) the Fair Market Value of a share of Stock on the first day of the offering period and (ii) the Fair Market Value of a share of Stock on the last day of the offering period. The Company currently holds two offering periods, September 1 and March 1, respectively.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first offering period commenced under the ESPP on September 1, 2021. The Company recognized a de minimis amount of expense related to the ESPP for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:72.490%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,244&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, total unrecognized compensation cost related to unvested options was $40.6 million, which is expected to be recognized over a weighted average period of 2.7 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770919103056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_CollaborationAgreementAbstract', window );"><strong>Collaboration Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration Agreements</a></td>
<td class="text">Collaboration Agreements<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lilly Collaboration Agreement and Stock Purchase Agreement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into the Lilly Collaboration Agreement with Lilly to create novel oncology medicines by applying Foghorn&#8217;s proprietary Gene Traffic Control platform. The collaboration includes a co-development and co-commercialization agreement for the Company&#8217;s selective BRM oncology target, consisting of two programs, and one additional undisclosed oncology target (collectively, the &#8220;Joint Programs&#8221;). The collaboration also includes three additional discovery targets or programs (collectively, the &#8220;Discovery Programs&#8221;) for a total of six programs directed at five targets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the Joint Programs, the Company will lead discovery and early research activities through the successful completion of dose finding toxicity studies for the identified compound, while Lilly will lead development and commercialization activities of the identified compound with participation from the Company in development activities and 50% cost sharing until registrational clinical trials. The Company and Lilly may jointly develop and commercialize the Joint Program compound though the Company may, in its sole discretion, opt-out on a program-by-program basis of further </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">participation in the development and commercialization efforts prior to the first registrational clinical trial. If the Company does not opt-out, Lilly and the Company will continue to share in the costs to further develop and commercialize the Joint Program compound on a worldwide basis, equally share in the U.S. profits on product sales, subject to certain adjustments and receive royalties on sales outside of the United States (&#8220;Ex-U.S.&#8221;) at royalty rates ranging from low double digits to high twenties. If the Company opts-out of further development and commercialization efforts, it will have no further obligations to share in the development and commercialization costs, will receive royalties rather than profit share on U.S. sales and will receive royalties at a lower rate on Ex-U.S. sales.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the Discovery Programs, the Company will lead discovery and early research activities through the successful completion of dose finding toxicity studies for the identified compounds. The Company may, in its sole discretion, opt-in on a program-by-program basis after the successful completion of dose finding toxicity to participate in the further development and commercialization efforts of the Discovery Program compounds. If the Company opts-in to the development and commercialization of the Discovery Program compounds, it will be eligible to receive milestone payments of up to $10.0 million per program upon specified research and development milestones and up to $180.0 million per program upon achievement of specified regulatory and commercial milestones and will also be eligible to share in the U.S. profits at pre-determined percentages on product sales. The Company would also be eligible to receive tiered Ex-U.S. royalty rates, calculated on a product-by-product and country-by-country basis, on net sales outside of the United States, if any, ranging from low single digits to low double digits, but less then teens. If the Company does not opt-in to further development and commercialization efforts for the Discovery Programs, it will be eligible to receive milestone payments of up to $70.0 million per program upon specified research and development milestones and up to $360.0 million per program upon achievement of specified regulatory and commercial milestones per approved product, if any. The Company would also be eligible to receive tiered royalties on net sales of products worldwide at royalty rates ranging from low single digits to low double digits, but less then teens.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lilly has the right to make substitutions for each of the five targets during the research term of each program, subject to certain limitations. Pursuant to the Lilly Collaboration Agreement, the Company will also participate in joint decision-making through the joint steering committee and subcommittees. Unless terminated earlier, the Lilly Collaboration Agreement will continue on a product-by-product basis until the expiration of all royalty obligations under the Lilly Collaboration Agreement and when neither the Company nor Lilly is developing, commercializing or manufacturing any product under the Lilly Collaboration Agreement. The Company or Lilly may terminate the Lilly Collaboration Agreement upon an uncured material breach by the other party. Lilly may also terminate the Lilly Collaboration Agreement in its entirety or on a target-by-target, program-by-program or product-by-product basis for any reason upon certain notice to the Company.</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that (1) the research activities performed by the Company for both the Joint Programs and the Discovery Programs (2) the development activities and cost sharing for the Joint Program development efforts after dose finding toxicity until registrational clinical trials (3) the research, development, manufacture and commercialization licenses and (4) service on the joint steering committee and subcommittees represent a single performance obligation under the Lilly Collaboration Agreement. The Company determined that Lilly cannot benefit from the licenses separately from the research activities, the development activities until registrational clinical trials and participation on the joint steering committee and subcommittees because these services are specialized and rely on the Company&#8217;s expertise such that these activities are highly interrelated and therefore not distinct. Accordingly, the promised goods and services represent one combined performance obligation, and the entire transaction price was allocated to that single combined performance obligation. The performance obligation will be satisfied over time as the Company performs the research activities, participates and shares in the cost of the development activities for the Joint Programs and participates in a joint steering committee and subcommittees to oversee these activities. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s options to share in further development and commercialization efforts via its opt-in/opt-out rights will be assessed and accounted for as separate units of accounting under the relevant guidance if, and when, such options are exercised by the Company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation was $315.1&#160;million, which is expected to be recognized as revenue through 2029 or beyond depending on the timing of certain clinical development activities. As of December 31, 2022, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation was $319.8&#160;million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022, the Company had recorded $4.7 million and $3.8 million, respectively, of revenue under the Lilly Collaboration Agreement, which was included in deferred revenue at the beginning of the respective periods.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merck Collaboration Agreement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company entered into a collaboration agreement (the &#8220;Merck Collaboration Agreement&#8221;) with Merck Sharp &amp; Dohme Corp. (or &#8220;Merck&#8221;). The Company and Merck will apply Foghorn&#8217;s proprietary Gene Traffic Control platform to discover and develop novel therapeutics. Under the Merck Collaboration Agreement, the Company granted Merck exclusive global rights to develop, manufacture and commercialize drugs that target dysregulation of a single transcription factor. Under the terms of the Merck Collaboration Agreement, the Company and Merck are each responsible to perform certain research activities in accordance with a mutually-agreed upon research plan. Merck may substitute the selected transcription factor during certain stages of the research program, subject to certain limitations. Following completion of the research program, Merck is responsible for the development and commercialization of the compounds developed pursuant to the research program and any product containing such compounds. Pursuant to the Merck Collaboration Agreement, the Company will also participate on a joint steering committee.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, Foghorn received a nonrefundable upfront payment of $15.0 million from Merck, and is eligible to receive up to $245.0 million upon achievement of specified research, development and regulatory milestones by any product candidate generated by the collaboration, and up to $165.0 million upon achievement of specified sales-based milestones per approved product from the collaboration, if any. The Company will be eligible to receive tiered royalties, calculated on a product-by-product and country-by-country basis, on net sales of approved products from the collaboration, if any, at royalty rates ranging from the mid-single digits to low tens, depending on whether the products are covered by patent rights it licenses to Merck.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless terminated earlier, the Merck Collaboration Agreement will continue in full force and effect until one or more products has received marketing authorization and, thereafter, until expiration of all royalty obligations under the Merck Collaboration Agreement. The Company or Merck may terminate the Merck Collaboration Agreement upon an uncured material breach by the other party or insolvency of the other party. Merck may also terminate the Merck Collaboration Agreement for any reason upon certain notice to the Company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the (1)&#160;research, development, manufacture and commercialization licenses, (2) the research activities performed by the Company and (3)&#160;service on the joint committees represent a single performance obligation under the Merck Collaboration Agreement. The Company determined that Merck cannot benefit from the licenses separately from the research activities and participation on the joint steering committee because these services are specialized and rely on the Company&#8217;s expertise such that these activities are highly interrelated and therefore not distinct. Accordingly, the promised goods and services represent one combined performance obligation and the entire transaction price was allocated to that single combined performance obligation. The performance obligation will be satisfied over the research term as the Company performs the research activities and participates in a joint steering committee to oversee research activities.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the $240.0 million of potential research, development and regulatory milestone payments that the Company is eligible to receive and have not already been achieved were excluded from the transaction price as they were fully constrained by uncertain events. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, the Company achieved a research milestone related to the Merck Collaboration Agreement and received a $5.0 million milestone payment from Merck.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation is $16.4 million, which is expected to be recognized as revenue through approximately 2028. As of December&#160;31, 2022, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation is $17.0 million.</span></div>For the three months ended March&#160;31, 2023 and 2022, the Company had recorded $0.6 million and $0.1 million, respectively, of the revenue under the Merck Collaboration Agreement, which was included in deferred revenue at the beginning of the respective periods and the classification of deferred revenue between short term and long term.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_CollaborationAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_CollaborationAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI https://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770919946944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesFor the three months ended March&#160;31, 2023, the Company recorded a provision for income taxes of $0.6&#160;million representing an effective tax rate of 1.86%. The income tax provision and the effective tax rate is primarily driven by the current federal and state taxes related to the $300.0 million upfront payment for Lilly Collaboration Agreement, which will be recognized as taxable income in the current year, and the required capitalization of research and development costs pursuant to Internal Revenue Code Section 174. As a result, the Company expects to have taxable income in the current year, which will be reduced by utilizing available net operating loss carryforwards and research and development tax credit carryforwards.The Company accrued the provision for income taxes in accrued expenses and other current liabilities on the condensed consolidated balance sheets.The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. Management has considered the Company&#8217;s history of cumulative net losses incurred since inception and its lack of commercialization of any products that would generate revenue from product sales and has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770920563120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases office space under a non-cancelable operating lease. There have been no material changes to the Company's lease during the three months ended March&#160;31, 2023. For additional information, see Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the consolidated financial statements in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License agreements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into various exclusive and non-exclusive license agreements for certain technologies. Under the terms of these license agreements, the Company could be required to reimburse the licensors for patent expenses and remit amounts in the low single-digit as sales-based royalties upon the occurrence of specific events as outlined in the corresponding license agreements. The Company is also required to make annual license maintenance fees of less than $0.3&#160;million and pay up to $1.1&#160;million in regulatory milestones on each licensed product upon the occurrence of specific events as outlined in one of the license agreements. None of our product candidates utilize technologies covered by these licenses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification agreements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, contract research organizations, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and its executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. The Company has not incurred any material costs as a result of such indemnifications and is not currently aware of any indemnification claims.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in litigation or other legal proceedings. The Company is not currently a party to any material litigation or legal proceedings.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139771001696176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Defined Contribution Plan</a></td>
<td class="text">Defined Contribution PlanThe Company has a 401(k) defined contribution plan (the &#8220;401(k) Plan&#8221;) for its employees. Eligible employees may make pretax contributions to the 401(k) Plan up to statutory limits. During the three months ended March&#160;31, 2023, the Company recognized $0.2&#160;million of expense related to 401(k) discretionary match. For the three months ended March&#160;31, 2022, there was no discretionary match made under the 401(k)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770919947872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text">Related PartiesIn October 2015, the Company entered into a five-year consulting agreement with a scientific founder of the Company who is also a shareholder. This agreement was amended and extended to January 1, 2024 and is subject to automatic one-year renewal terms until terminated.  During the three months ended March&#160;31, 2023 and 2022, the Company paid the scientific founder a de minimis amount. As of March&#160;31, 2023 and December&#160;31, 2022, the Company had less than $0.1&#160;million accounts payable to the scientific founder.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770919084576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text"><div style="margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) of the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently issued accounting pronouncements</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently issued accounting pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to &#8220;opt out&#8221; of the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i)&#160;irrevocably elects to opt out of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No.&#160;2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;The new standard adjusts the accounting for assets held at amortized costs basis by eliminating the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses as an allowance for credit losses. For nonpublic entities and emerging growth companies that choose to take advantage of the extended transition period, the guidance was initially effective for annual reporting periods beginning after December&#160;15, 2020. However, in November 2019, the FASB issued ASU No.&#160;2019-10, which deferred the effective date for nonpublic entities to annual reporting periods beginning after December&#160;15, 2022, including interim periods within those fiscal years. The Company adopted this s as of January 1, 2023 and the adoption had no material impact to the Company&#8217;s consolidated financial position, results of operation, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770920297024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Available for Sale Marketable Securities By Security Type</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, available for sale marketable securities by security type consisted of (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes (due within one year)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies (due within one year)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper (due within one year)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due within one year)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies (due after one year through two years)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due after one year through three<br/>&#160;&#160;&#160;years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,199&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,883)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,329&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, available for sale marketable securities by security type consisted of (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes (due within one year)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper (due within one year)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(301)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due within one year)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds (due after one year through three<br/>&#160;&#160;&#160;years)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,570&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,992)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s fair value hierarchy for its assets and liabilities, which are measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at March 31, 2023 Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,327&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,546&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at December 31, 2022 Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,077&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,721&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345,798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770920577344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment Net</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:70.138%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,884&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets not yet placed in service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,695&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,922&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,611)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,225&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,311&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770920331808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:70.244%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.932%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued external research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,831&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,001&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770919199680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Earnings Per Share Diluted Anti Dilutive Impact</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents presented based on amounts outstanding at each period end have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,666,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,772,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,684,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,790,503&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770919134176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:72.490%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,735&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,572&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,244&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770911842368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business, Going Concern and Basis of Presentation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_ProceedsFromUpfrontPayment', window );">Upfront payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (30,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (26,914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (403,626)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (373,138)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=fhtx_EliLillyMember', window );">Eli Lilly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_ProceedsFromUpfrontPayment', window );">Upfront payment received</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=fhtx_MerckMember', window );">Merck | Merck Collaboration Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_PaymentReceivedForAchievementOfMilestones', window );">Payment received for achievement of milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization consolidation and presentation of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_PaymentReceivedForAchievementOfMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Received For Achievement Of Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_PaymentReceivedForAchievementOfMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ProceedsFromUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from upfront payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ProceedsFromUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=fhtx_EliLillyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=fhtx_EliLillyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=fhtx_MerckMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=fhtx_MerckMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_MerckCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_MerckCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770915307296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements - Summary of Available for Sale Marketable Securities By Security Type (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 268,199<span></span>
</td>
<td class="nump">$ 297,570<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2,883)<span></span>
</td>
<td class="num">(3,992)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">265,329<span></span>
</td>
<td class="nump">293,584<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember', window );">U.S. treasury notes (due within one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">2,992<span></span>
</td>
<td class="nump">7,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">2,912<span></span>
</td>
<td class="nump">7,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=fhtx_USGovernmentAgenciesDueWithinOneYearMember', window );">U.S. government agencies (due within one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">7,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">7,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper (due within one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">38,436<span></span>
</td>
<td class="nump">56,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(102)<span></span>
</td>
<td class="num">(301)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">38,334<span></span>
</td>
<td class="nump">56,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=fhtx_CorporateDebtSecuritiesDueWithinOneYearMember', window );">Corporate notes and bonds (due within one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">165,157<span></span>
</td>
<td class="nump">139,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,565)<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">163,599<span></span>
</td>
<td class="nump">138,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember', window );">U.S. government agencies (due after one year through two years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">2,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">2,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember', window );">Corporate notes and bonds (due after one year through three years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">50,754<span></span>
</td>
<td class="nump">93,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,132)<span></span>
</td>
<td class="num">(2,234)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 49,624<span></span>
</td>
<td class="nump">$ 90,892<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=fhtx_USGovernmentAgenciesDueWithinOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=fhtx_USGovernmentAgenciesDueWithinOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=fhtx_CorporateDebtSecuritiesDueWithinOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=fhtx_CorporateDebtSecuritiesDueWithinOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770911045248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities and Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 265,329<span></span>
</td>
<td class="nump">$ 293,584<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">38,334<span></span>
</td>
<td class="nump">56,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">315,546<span></span>
</td>
<td class="nump">345,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">2,912<span></span>
</td>
<td class="nump">7,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">10,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">38,334<span></span>
</td>
<td class="nump">56,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Corporate notes and bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">213,223<span></span>
</td>
<td class="nump">229,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">33,219<span></span>
</td>
<td class="nump">28,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">16,998<span></span>
</td>
<td class="nump">1,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">33,219<span></span>
</td>
<td class="nump">28,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | U.S. treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Corporate notes and bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">33,219<span></span>
</td>
<td class="nump">28,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | U.S. treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">282,327<span></span>
</td>
<td class="nump">317,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | U.S. treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">2,912<span></span>
</td>
<td class="nump">7,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">10,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">38,334<span></span>
</td>
<td class="nump">56,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Corporate notes and bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">213,223<span></span>
</td>
<td class="nump">229,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | U.S. treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">16,998<span></span>
</td>
<td class="nump">1,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | U.S. treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Corporate notes and bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | U.S. treasury notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryNotesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryNotesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasuryNotesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasuryNotesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770915832128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Summary of Property and Equipment Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract', window );"><strong>Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property plant and equipment including finance right of use assets, gross</a></td>
<td class="nump">$ 24,695<span></span>
</td>
<td class="nump">$ 23,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(9,470)<span></span>
</td>
<td class="num">(8,611)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">15,225<span></span>
</td>
<td class="nump">15,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract', window );"><strong>Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property plant and equipment including finance right of use assets, gross</a></td>
<td class="nump">6,337<span></span>
</td>
<td class="nump">5,884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract', window );"><strong>Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property plant and equipment including finance right of use assets, gross</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_ComputerEquipmentAndSoftwareMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract', window );"><strong>Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property plant and equipment including finance right of use assets, gross</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract', window );"><strong>Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property plant and equipment including finance right of use assets, gross</a></td>
<td class="nump">17,235<span></span>
</td>
<td class="nump">17,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_AssetsNotYetPlacedInServiceMember', window );">Assets not yet placed in service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract', window );"><strong>Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property plant and equipment including finance right of use assets, gross</a></td>
<td class="nump">$ 193<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_AssetsNotYetPlacedInServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=fhtx_AssetsNotYetPlacedInServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770919103584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 859<span></span>
</td>
<td class="nump">$ 811<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139771073205264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_AccruedResearchAndDevelopmentExpenses', window );">Accrued external research and development expenses</a></td>
<td class="nump">$ 5,891<span></span>
</td>
<td class="nump">$ 5,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxes', window );">Accrued income taxes</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee compensation and benefits</a></td>
<td class="nump">1,671<span></span>
</td>
<td class="nump">4,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 8,831<span></span>
</td>
<td class="nump">$ 11,001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_AccruedResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for expenses related to research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_AccruedResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770919066912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock and Net Loss Per Share - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>vote</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_CommonStockVotingRightsVotes', window );">Voting rights per share (per share)</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_CommonStockVotingRightsVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Votes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_CommonStockVotingRightsVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770915755760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Net Loss Per Share - Summary of Earnings Per Share Diluted Anti Dilutive Impact (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from the calculation of earnings per share (in shares)</a></td>
<td class="nump">9,684,756<span></span>
</td>
<td class="nump">7,790,503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from the calculation of earnings per share (in shares)</a></td>
<td class="nump">9,666,311<span></span>
</td>
<td class="nump">7,772,058<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from the calculation of earnings per share (in shares)</a></td>
<td class="nump">18,445<span></span>
</td>
<td class="nump">18,445<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770911950656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
<th class="th"><div>Oct. 21, 2020</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="nump">1,184,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation costs related to unvested options and unvested restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period of unrecognized compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,359,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage', window );">Percentage of automatic annual increase in number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,672,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option expiry period (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_A2016StockIncentivePlanMember', window );">2016 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,078,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember', window );">2020 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage', window );">Percentage of automatic annual increase in number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="nump">418,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares', window );">Maximum aggregate number of shares added to plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,220,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Percentage of payroll deductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate', window );">Discount of shares rate, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of shares authorized to be automatically increased on the first day of the fiscal year, under a share based payment arrangement, as a percentage of common stock outstanding on the last day of the previous fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum aggregate number of shares that may be added to the plan in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on offering date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fhtx_A2016StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fhtx_A2016StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770914154160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 4,572<span></span>
</td>
<td class="nump">$ 3,244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2,039<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,533<span></span>
</td>
<td class="nump">$ 1,735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770916390368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>target </div>
<div>program</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_ProceedsFromUpfrontPayment', window );">Upfront payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Sales based</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_MilestoneReceivableUponAchievement', window );">Amount receivable for achievement of milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Research Development And Regulatory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_MilestoneReceivableUponAchievement', window );">Amount receivable for achievement of milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=fhtx_EliLillyMember', window );">Eli Lilly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_NumberOfAdditionalTargets', window );">Number of additional targets | target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_NumberOfPrograms', window );">Number of programs | program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_NumberOfTargets', window );">Number of targets | target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 319,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_ProceedsFromUpfrontPayment', window );">Upfront payment received</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=fhtx_EliLillyMember', window );">Eli Lilly | Sales Based Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_MilestoneReceivableUponAchievement', window );">Amount receivable for achievement of milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_OptOutMilestoneReceivableUponAchievement', window );">Optout milestone receivable upon achievement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=fhtx_EliLillyMember', window );">Eli Lilly | Maximum | Research Development And Regulatory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_MilestoneReceivableUponAchievement', window );">Amount receivable for achievement of milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_OptOutMilestoneReceivableUponAchievement', window );">Optout milestone receivable upon achievement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=fhtx_MerckMember', window );">Merck</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Unsatisfied portion of the performance obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=fhtx_MerckMember', window );">Merck | Research Development And Regulatory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_MilestoneReceivableUponAchievement', window );">Amount receivable for achievement of milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=fhtx_MerckMember', window );">Merck | Merck Collaboration Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_PaymentReceivedForAchievementOfMilestones', window );">Payment received for achievement of milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_MilestoneReceivableUponAchievement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration to be received upon achievement of specified milestones.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_MilestoneReceivableUponAchievement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_NumberOfAdditionalTargets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Additional Targets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_NumberOfAdditionalTargets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_NumberOfPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Programs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_NumberOfPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_NumberOfTargets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Targets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_NumberOfTargets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_OptOutMilestoneReceivableUponAchievement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Opt Out Milestone Receivable Upon Achievement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_OptOutMilestoneReceivableUponAchievement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_PaymentReceivedForAchievementOfMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Received For Achievement Of Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_PaymentReceivedForAchievementOfMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ProceedsFromUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from upfront payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ProceedsFromUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_ResearchDevelopmentAndRegulatoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_ResearchDevelopmentAndRegulatoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=fhtx_EliLillyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=fhtx_EliLillyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_SalesBasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_SalesBasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=fhtx_MerckMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=fhtx_MerckMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_MerckCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_MerckCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770915699872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 560<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_ProceedsFromUpfrontPayment', window );">Upfront payment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=fhtx_EliLillyMember', window );">Eli Lilly</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_ProceedsFromUpfrontPayment', window );">Upfront payment received</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ProceedsFromUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from upfront payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ProceedsFromUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=fhtx_EliLillyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=fhtx_EliLillyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770915626304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - Stanford License Agreement - Maximum<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_AnnualLicenseMaintenanceFees', window );">Annual license maintenance fees</a></td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_MilestonesPayableUponEvent', window );">Milestones payable upon event</a></td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_AnnualLicenseMaintenanceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual license maintenance fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_AnnualLicenseMaintenanceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments And Contingencies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_MilestonesPayableUponEvent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount the Company will pay for regulatory milestones on each licensed product upon the occurrence of specific events as outlined in the license agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_MilestonesPayableUponEvent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_StanfordLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=fhtx_StanfordLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770919153776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan, cost</a></td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139770910992096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details) - Affiliated Entity - Scientific Founder - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2015</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_ServiceAgreementTerm', window );">Service agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_fhtx_CashPaymentsRelatedParty', window );">Payments made to related party under service agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accounts payable, related party (less than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_CashPaymentsRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments made during the period to related parties as part of a service or consulting agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_CashPaymentsRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fhtx_ServiceAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The term of a service agreement in 'PnYnMnDTnHnMnS' format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fhtx_ServiceAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fhtx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=fhtx_ScientificFounderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=fhtx_ScientificFounderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>fhtx-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:fhtx="http://www.foghorntx.com/20230331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fhtx-20230331.xsd" xlink:type="simple"/>
    <context id="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia84f4b765c1c48fdba1e4fd385e7f0b1_I20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="ifc737888b72c4abab3c2751c5194dcad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9b067aab926342a7b5676d4d0a0c6d41_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ef9ae80fb5b4395b13666e9e9eec82c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7bae992474dd40a79505422be056e6f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9fdced88f45c4e409092a68fcf300833_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf21555867444ead906d71488062bf8e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i19705a121aa44c47a0ae367e9f64af9d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i23676a510c4248498851adfc7c094aaf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i63934d7043544300b103bf3da31fea12_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3eccb4d2959a4de3bd53fc39077255b5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i11b5f1d57baf4341bcf36040f1462577_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idbd53253722c4ae18279a572bbe8e780_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iff92410149e84214befd6916fd3f5b77_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i624ef726f33c46a5a6ec3afd0efedb0a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7d893999d4a40eaa90ed425123e9436_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if526a94d14254a2cb8672d7917c4be62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i349820509fee4399845fd358bd72501a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06768c28c0ca47a8bc549474a90e8b80_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibbe741aac4fe4bb0a0aac627966aa459_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4436ac0de3fc454787e9c9e801be2074_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7dd7d3cc806949ecb93485d8665161b4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie34084e716da4a5392ab043797b8f9eb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0f0c2d1581754c7d9a66865d89a11383_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icac4105ae32e47b4aab639de679600d4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9c0a4519d9204d06bd778e69b95b2266_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i23366ef09153432283da882a9c6f62f8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4605cd6df8cb432e8da81b434c0b12ff_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i8f17ba797a20458c8d273718a2faf5b2_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:MerckCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic5ff53cf442042cdb4b36d6e72142a1b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:USTreasuryNotesSecuritiesDueWithinOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1a624a02dc70405cb5fbe4a2e977a9f9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:USGovernmentAgenciesDueWithinOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i87b3ffa3baf7435c93a45a49e8b25af7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i74970c52e4004e8b8552988d5f7c2170_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:CorporateDebtSecuritiesDueWithinOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idda5759b36f940b19380a66d34dae73c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieb5c24a093394ecba28d4a9c5bcdbb9d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib2a16fe60e7940d0acb3671bc0544537_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:USTreasuryNotesSecuritiesDueWithinOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if2f9150da3aa40d8b086ad8ea1702556_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icccd4d043a644533bb05611e707ac152_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:CorporateDebtSecuritiesDueWithinOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8a297b2b298d4b4d8e5832e54f043948_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">fhtx:CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e7d370e72b448e2a20136c9d41a611a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i686a387809184aaa8b50bc8cc6187e9a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i86ecb94b9d984d25b19dab4395167083_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i24b9d85917e44b37a2c2ee5fba4bb13d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id28c0fdc526e4f449092eb7231d7981a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i78bf0b3f545e49799c0cf64e8fcc4d0d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic48f4328d06740f69e82bae9d7f08326_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i226002d2e8c3483999dbe6e1536bc05d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6e4e5e96f3f249ad8b7059648464f925_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i02cfa68b2fd349328e287ea50a6ac000_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibc1aa441de3a4917a6058ce4f3a680f5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iec137b73eb794feb8171dd03dd591a9e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic7a6e0cb2e5a44cbb8cc75a960fa04b7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib00daf24652143c5a0de12e6924f3607_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6d88f74ab4b24a56895f526a176976f8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i60b16e50543348558175caaea85b3122_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id59576d83db143329d18b549ecb1cac8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7519c80b092a4ac7a57f59e62e77991e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1225ef2f386f4a42975c134708350d10_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i685de5a7038c45189760b9c211f5be9d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i469fee02bf054803a29064895742bcca_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4b3eb52799bb4915b8ccdde486715eba_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i644cf406771343be85fb0303035cc30a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i20240e23302249feb5d81f005bfe4920_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2ab63392b2c74b5ab99240d3a67ddf2e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idf60218770ed4221baf7f3056c9eb494_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id35b96fd44f74edfa4730b85402d177b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia9d68f7e99d1431eb12bc2400a498113_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaae8d45dbde14f8d8de46117ec781d4d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i57c7ac8901bd4d7daac300b48c7919ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id695c0b8a3e24d06a747342d16c3d091_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f4e06b5736f4b7f90965814e6fb2834_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3816c705b119429ea8c4ca667dd7af1a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib3e370a92af44ccbaa5d713dfe2a8fb1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if5aa2802907e4a0e80ba161a3b27fac2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9f3c7b44e12a4950b574e402e90a4e96_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id11f9d139c334e3e877bbc1b71a3bcb0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2b0898b80bf94bd3a1898a19e50c68e4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i91c08e1329914a148a2969a210c89c47_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i71476e1da87a4e8f9ea82e1558b4b1a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icec32c8d710e4052a2ea76320025a801_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i73e10639ef0246c198a7a50e793bbcbd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i314ef289b4614198b2006dc7331ea1c7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie4950fd3c93f40b8917a76b077c0c64b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id2b1e949f6974b58964fd91bd5f979d7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifa55d59c40f34aaba7d356a0fbff653f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i817ec589b1634a54955b21c64565e8ea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9df0cfa07c49422683e3147992721a62_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibf0f225480c34371bc29f61873b9ae64_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icee323c63b8a4f55a03f6972bf66bacb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1ce20a435b94f1782ba0f50fd86a8b8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie8a50f4fbb394949aeccc379c70c428a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4a9f200afdd4b0499bec1ec0815830a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8af856e6f8244114882cf272fe719890_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f76a5224ab9460ab1687a0e61c62469_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i313c23ac84db459aa067b05c470e8c41_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0e381c984bf544cfb0a2749f7b7bde14_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia478d511da57498795c16881932b6687_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8db8c7bc36df4ad98557037afc88e098_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4069cd6268314c4eb4dc21bd8aa31034_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15776fdc2f634cd2b8afecdccc812ee3_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8c2ae1d1ba35403ba1cfeec4178824b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iff620723fc0c49618aaa87a660c11285_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i51a85b1b3aa94e2a88d7205cbf50b9a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic713b3b8646d4e9c952914b317f34c25_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:AssetsNotYetPlacedInServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2f03ccf48fbd464fbb077f9ae05ad5f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fhtx:AssetsNotYetPlacedInServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4cc0d48a32c3455495ce27d4f7ddeea1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icdd9cd9080824f859292dd01a8c3382f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9d6f5962b24a487098593ec15299f24a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i253b75ffb52440b49b4e9bbe4fb210dd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ff3d19669cd4af68367e024a5550402_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id06ab9cb3fff4cedb3c46e4ccf43eb35_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:A2016StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1d79c74373c442b499c7ddd85c70b8dd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c27d19751c94d7eb6c46feae55f646f_D20220101-20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="i69fa4e2b8bc24bf388f1f890c4ecf2e2_I20201021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-21</instant>
        </period>
    </context>
    <context id="ib8a38bc229cb4e8bb77f5c2c4c4b0cd0_D20201021-20201021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-21</startDate>
            <endDate>2020-10-21</endDate>
        </period>
    </context>
    <context id="i891fd370eb434c04aa39afcf2287fbff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i09392e1f7a274b01845cedcdc8ed5acd_D20230101-20230101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-01</endDate>
        </period>
    </context>
    <context id="i6182cbed24bc4b8ab1aa853c3f9e2cb3_I20230101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="id6ce4bd203a74a629ec0457813c1657f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fhtx:TwoThousandTwentyEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i95f74147740a473d8c886cfbe8d8cf9f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2e516a981dbe4601a952b105e005f398_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6112131b7aec49b494f0b988b8f51e90_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5ac8dbde3e704d4ea43e4284fbd658c5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id704eaec79f3499d8b4e968f504e58eb_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3e63d9fb12c49febbf0ab26cfed6a9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2d1ee7b60654dcdbf509fe84739b901_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:ResearchDevelopmentAndRegulatoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2c5f857c11b4186bd0df9d1860dcca9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:SalesBasedMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic8e4b7ca8d86457dbee60cfa6bc83796_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:ResearchDevelopmentAndRegulatoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i932a791f229b4a74be687fda2016ec96_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:SalesBasedMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0a2f456ce08c4f34b028f7e715d90a75_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iee2a6d2ade0542e99376dda986298f86_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib745f408204748faa6b611ba2acc4301_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i09acd48542c84107bda3a6fcc7e01a93_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibd64aeec1acc4410ab6e14c3aec0a76f_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i0f0b1f2ac17b45e3b3937dfb1cd9b00a_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:ResearchDevelopmentAndRegulatoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i6c03ef7903fc425585c24387daf3a22a_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i12af85d4d118413c83b0955c275f72f5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:ResearchDevelopmentAndRegulatoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4780b20d5ac143ea81ecc13b5a9624b9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if77adc7cf7cb4adc886eb30f55a05415_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i23ab0c9afb5749d5ab747dfcc565c03a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:MerckCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1ac24b7249a14fd6a8da298f2934b7dd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:MerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:MerckCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i207a64c5b4d845b1a5061cf046b448ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fhtx:EliLillyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i863abf2c04774158b2e8e819d2eb86f1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">fhtx:StanfordLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iddc9c1a9a4bd41f8b1fbb60001dd16b4_D20151001-20151031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-10-01</startDate>
            <endDate>2015-10-31</endDate>
        </period>
    </context>
    <context id="id0a4bd34abd04cd7a7c910806002b5ce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibbf92bd0426f4ca5a06dce27507acf0c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibd8b8e5dc009459889ce53123905d4df_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6b1fc9ad680a4413a21c30cd0cfce61f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822462</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fhtx:ScientificFounderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="vote">
        <measure>fhtx:vote</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="target">
        <measure>fhtx:target</measure>
    </unit>
    <unit id="program">
        <measure>fhtx:program</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180L2ZyYWc6YzYxNjUyOTBmN2EwNDc5MmE4YmFiNjY1MmQzMGRjMDgvdGFibGU6NzM5YjRiMTJiYTFmNDFmZmI4ZWQ1MTRhODA5YWZkMzAvdGFibGVyYW5nZTo3MzliNGIxMmJhMWY0MWZmYjhlZDUxNGE4MDlhZmQzMF8zLTEtMS0xLTU0NDgz_b2ae829e-c78f-4fab-9bed-03ecff0d9bb4">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180L2ZyYWc6YzYxNjUyOTBmN2EwNDc5MmE4YmFiNjY1MmQzMGRjMDgvdGFibGU6NzM5YjRiMTJiYTFmNDFmZmI4ZWQ1MTRhODA5YWZkMzAvdGFibGVyYW5nZTo3MzliNGIxMmJhMWY0MWZmYjhlZDUxNGE4MDlhZmQzMF81LTEtMS0xLTU0NDgz_b9031f36-59b6-47c4-81a5-5a26e412e374">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180L2ZyYWc6YzYxNjUyOTBmN2EwNDc5MmE4YmFiNjY1MmQzMGRjMDgvdGFibGU6NzM5YjRiMTJiYTFmNDFmZmI4ZWQ1MTRhODA5YWZkMzAvdGFibGVyYW5nZTo3MzliNGIxMmJhMWY0MWZmYjhlZDUxNGE4MDlhZmQzMF82LTEtMS0xLTU0NDgz_c5bec5f3-53d8-47eb-baa0-02436b3367fc">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180L2ZyYWc6YzYxNjUyOTBmN2EwNDc5MmE4YmFiNjY1MmQzMGRjMDgvdGFibGU6NzM5YjRiMTJiYTFmNDFmZmI4ZWQ1MTRhODA5YWZkMzAvdGFibGVyYW5nZTo3MzliNGIxMmJhMWY0MWZmYjhlZDUxNGE4MDlhZmQzMF84LTEtMS0xLTU0NDgz_c2145b4d-3b17-4cdb-bc23-fb9e085b62e6">0001822462</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180L2ZyYWc6YzYxNjUyOTBmN2EwNDc5MmE4YmFiNjY1MmQzMGRjMDgvdGFibGU6NzM5YjRiMTJiYTFmNDFmZmI4ZWQ1MTRhODA5YWZkMzAvdGFibGVyYW5nZTo3MzliNGIxMmJhMWY0MWZmYjhlZDUxNGE4MDlhZmQzMF85LTEtMS0xLTU0NDgz_5e9d13ee-df5c-43ad-8e7b-85ce4822a8b9">--12-31</dei:CurrentFiscalYearEndDate>
    <fhtx:CashPaymentsRelatedParty
      contextRef="ibd8b8e5dc009459889ce53123905d4df_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN183MC9mcmFnOjEyMGEwMWQyN2FhOTQyNDFiZTBmNDFkOTJkYjRkM2RiL3RleHRyZWdpb246MTIwYTAxZDI3YWE5NDI0MWJlMGY0MWQ5MmRiNGQzZGJfMTY0OTI2NzQ0MTY3MQ_ef5a2369-ab26-40e6-a272-9eef7626d373"
      unitRef="usd">0</fhtx:CashPaymentsRelatedParty>
    <fhtx:CashPaymentsRelatedParty
      contextRef="i6b1fc9ad680a4413a21c30cd0cfce61f_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN183MC9mcmFnOjEyMGEwMWQyN2FhOTQyNDFiZTBmNDFkOTJkYjRkM2RiL3RleHRyZWdpb246MTIwYTAxZDI3YWE5NDI0MWJlMGY0MWQ5MmRiNGQzZGJfMTY0OTI2NzQ0MTY3MQ_f74b5a4f-e17b-46e8-a070-dec805e4ad45"
      unitRef="usd">0</fhtx:CashPaymentsRelatedParty>
    <dei:DocumentType
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDg5_78714738-2e1d-4ee4-8734-60663754aa8d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6MmUxMDA3YTc1NGMwNDQ0MTk3M2Q2ODA1YmQwNDQwYzgvdGFibGVyYW5nZToyZTEwMDdhNzU0YzA0NDQxOTczZDY4MDViZDA0NDBjOF8wLTAtMS0xLTU0NDgz_341a4547-cb10-484e-a266-537968aba7c2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8xNzY_f191b156-a4d6-418e-81cc-bcb0abed7684">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6MDAwNzdkYjA3MjRlNGVjNGI0NTY1YjMxOTJkMjBhZTEvdGFibGVyYW5nZTowMDA3N2RiMDcyNGU0ZWM0YjQ1NjViMzE5MmQyMGFlMV8wLTAtMS0xLTU0NDgz_45e2b859-97f1-441b-bccd-c50706b3f3c8">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDg0_65ddc675-2d9e-42d8-9b75-437cdee5a08f">001-39634</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDkx_04f0b981-69f2-49b0-8c33-e419f64d1187">Foghorn Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8wLTAtMS0xLTU0NDgzL3RleHRyZWdpb246ZWJhOTNhOTM5NGQzNDAzMGFhOTk0MDY3YzI1MzFiZDRfNQ_32f23715-b329-4c1d-b8cf-17de0d69dd84">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8wLTEtMS0xLTU0NDgzL3RleHRyZWdpb246M2VhYzczZjk0YmZiNDcyZmIyYzAzM2MwZGYzNjE5NDlfNQ_0be7ae35-adce-458a-83c9-8551c48e1877">47-5271393</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8yLTAtMS0xLTU0NDgzL3RleHRyZWdpb246MWFjZWM2ODZiNDIwNDhiNTg5ODkyYTM1OGU4MzBmZmJfNQ_052bced7-9e23-45eb-9d16-c2a288cc0c70">500 Technology Square, Ste 700</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8yLTAtMS0xLTU0NDgzL3RleHRyZWdpb246MWFjZWM2ODZiNDIwNDhiNTg5ODkyYTM1OGU4MzBmZmJfOA_63169b38-1fef-418d-a61e-d882a5a04c41">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8yLTAtMS0xLTU0NDgzL3RleHRyZWdpb246MWFjZWM2ODZiNDIwNDhiNTg5ODkyYTM1OGU4MzBmZmJfMTE_c0871467-b65b-4dc8-9a10-857c0043309d">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6ZDFiNzk5ZWQxZDQyNGE5Njg4MWNhYTZiZWI2ODJlM2QvdGFibGVyYW5nZTpkMWI3OTllZDFkNDI0YTk2ODgxY2FhNmJlYjY4MmUzZF8yLTEtMS0xLTU0NDgzL3RleHRyZWdpb246YmQ2NTZmNjc2ZmU5NDlhNDhjM2Y2ZmZiZTFlNDk0NzdfNA_9561c621-bad0-4122-9389-f4454add5a3d">02139</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl80NzI_b758dc50-6f05-4ac1-b1d6-727658a5b52c">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDg2_e5b3cbf5-3779-4063-97ae-95ee107218b7">586-3100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6YTY1ZTY2ODMzY2QzNDk0NjgyZGZjZDhjYjRiYzU1ZWIvdGFibGVyYW5nZTphNjVlNjY4MzNjZDM0OTQ2ODJkZmNkOGNiNGJjNTVlYl8xLTAtMS0xLTU0NDgz_1eb581ee-db3f-487a-9790-b19834f26e98">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6YTY1ZTY2ODMzY2QzNDk0NjgyZGZjZDhjYjRiYzU1ZWIvdGFibGVyYW5nZTphNjVlNjY4MzNjZDM0OTQ2ODJkZmNkOGNiNGJjNTVlYl8xLTItMS0xLTU0NDgz_01541d82-d8d4-4e28-b0fd-627543fb811c">FHTX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6YTY1ZTY2ODMzY2QzNDk0NjgyZGZjZDhjYjRiYzU1ZWIvdGFibGVyYW5nZTphNjVlNjY4MzNjZDM0OTQ2ODJkZmNkOGNiNGJjNTVlYl8xLTQtMS0xLTU0NDgz_14349fd7-5a07-423c-b515-b4115ad9193e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDg3_c443274a-35c9-425e-b09d-8ae3579f16d6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDky_6f51ada0-2b90-48f2-921a-8e0379517d09">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6NjYxZDBiZTQ0NTE3NGQ0OWJlYjQzZGYxZDBmOTYyMWQvdGFibGVyYW5nZTo2NjFkMGJlNDQ1MTc0ZDQ5YmViNDNkZjFkMGY5NjIxZF8yLTAtMS0xLTU0NDgz_d7c25dfc-c6f8-4e42-b033-1b57df324833">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6NjYxZDBiZTQ0NTE3NGQ0OWJlYjQzZGYxZDBmOTYyMWQvdGFibGVyYW5nZTo2NjFkMGJlNDQ1MTc0ZDQ5YmViNDNkZjFkMGY5NjIxZF8yLTMtMS0xLTU0NDgz_8e1589fd-4c3d-4453-9ab5-f5c659174679">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGFibGU6NjYxZDBiZTQ0NTE3NGQ0OWJlYjQzZGYxZDBmOTYyMWQvdGFibGVyYW5nZTo2NjFkMGJlNDQ1MTc0ZDQ5YmViNDNkZjFkMGY5NjIxZF80LTMtMS0xLTU0NDgz_30d28db3-8a60-4840-8369-a613f1b5e07f">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDkz_cf22cc16-f46a-4bf8-910d-965ecb726e2e">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDg4_82febb18-238a-40e3-8bbc-0ea2e9d6ca6f">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia84f4b765c1c48fdba1e4fd385e7f0b1_I20230428"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18xL2ZyYWc6N2FiOWU4OTFlZjE1NDUzM2EyYzRmNDFlMTIzMmRhMWYvdGV4dHJlZ2lvbjo3YWI5ZTg5MWVmMTU0NTMzYTJjNGY0MWUxMjMyZGExZl8yMDIw_af77dd0c-492e-411b-a773-e683d0185726"
      unitRef="shares">41824758</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMy0xLTEtMS01NDQ4Mw_6af70139-a9d1-4e3b-8fca-d4822f1e3d36"
      unitRef="usd">50641000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMy0zLTEtMS01NDQ4Mw_ceb90a20-e45f-49ab-8e56-ea2f4b35b8d6"
      unitRef="usd">52214000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfNC0xLTEtMS01NDQ4Mw_66c83866-d3dd-48c7-abb1-dd8a90d35eeb"
      unitRef="usd">265329000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfNC0zLTEtMS01NDQ4Mw_35772d55-71c6-424e-9e5a-302ea1e9d7d1"
      unitRef="usd">293584000</us-gaap:MarketableSecurities>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfNy0xLTEtMS01NDQ4Mw_145ec95d-2e3c-4722-bdc8-0cc21291c0c3"
      unitRef="usd">4729000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfNy0zLTEtMS01NDQ4Mw_5d5ca720-2cc5-40fc-8b56-e4014188176b"
      unitRef="usd">5601000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfOC0xLTEtMS01NDQ4Mw_f4ba0233-12d2-4c14-b752-dd246848d05e"
      unitRef="usd">320699000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfOC0zLTEtMS01NDQ4Mw_ca8a5993-d5ba-4112-8979-93833e1abbcb"
      unitRef="usd">351399000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfOS0xLTEtMS01NDQ4Mw_bf6e5a30-1325-4a91-b34d-618aebd2774b"
      unitRef="usd">15225000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfOS0zLTEtMS01NDQ4Mw_80fabe03-097b-4fc2-89d4-259ca32e62c4"
      unitRef="usd">15311000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTAtMS0xLTEtNTQ0ODM_8d00c16b-7aa2-4c9e-b930-de51aaf3b911"
      unitRef="usd">1708000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTAtMy0xLTEtNTQ0ODM_89abbbd4-ac4d-400a-8443-8cc7760ecfdc"
      unitRef="usd">1708000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTEtMS0xLTEtNTQ0ODM_7b5c52f8-a4aa-454c-b0db-b155064c51d7"
      unitRef="usd">2364000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTEtMy0xLTEtNTQ0ODM_03e7812f-b72e-4030-9e1d-5602fcf4c790"
      unitRef="usd">2379000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTItMS0xLTEtNTQ0ODM_ab94d871-b502-44f5-94d4-7ba4606989e6"
      unitRef="usd">32887000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTItMy0xLTEtNTQ0ODM_f001a22b-4dd4-47fe-ae1b-d460e93ed4ac"
      unitRef="usd">34086000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Assets
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTMtMS0xLTEtNTQ0ODM_b26e4a56-7980-408c-bffa-bf2c5d9a9c35"
      unitRef="usd">372883000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTMtMy0xLTEtNTQ0ODM_c11a304d-20c5-4ba5-b2f0-b5a619c03370"
      unitRef="usd">404883000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTYtMS0xLTEtNTQ0ODM_79340950-f710-494d-a608-3a5f7face453"
      unitRef="usd">7288000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTYtMy0xLTEtNTQ0ODM_b0c5ea6a-7e88-4cf6-9876-9c1c1840abcf"
      unitRef="usd">5414000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTctMS0xLTEtNTQ0ODM_531c8419-cc7f-44f1-8499-0a73efddd1d6"
      unitRef="usd">8831000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTctMy0xLTEtNTQ0ODM_7d2d9b6d-95e3-4bab-a168-b44be6283e71"
      unitRef="usd">11001000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTgtMS0xLTEtNTQ0ODM_36efa1b4-3394-4ba5-a730-33abbac798b7"
      unitRef="usd">6346000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTgtMy0xLTEtNTQ0ODM_aa87c241-10cb-4085-84e3-033e2c1e1bc7"
      unitRef="usd">5970000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTktMS0xLTEtNTQ0ODM_e3a5361c-3a09-449a-bbae-648d3b331bdf"
      unitRef="usd">33331000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMTktMy0xLTEtNTQ0ODM_2c1c57bf-2eae-48c9-bd7c-a165139006cb"
      unitRef="usd">32820000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjAtMS0xLTEtNTQ0ODM_a9f2685a-74e8-47b2-a9a5-3b95c3da5301"
      unitRef="usd">55796000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjAtMy0xLTEtNTQ0ODM_382ef9bd-65b2-4802-ad19-f7ddaebd0dc7"
      unitRef="usd">55205000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjEtMS0xLTEtNTQ0ODM_ca57bdd4-9589-44cc-ae30-7dc1d32687d0"
      unitRef="usd">43493000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjEtMy0xLTEtNTQ0ODM_5d132f17-827e-4095-b64a-a7e13cda3e5b"
      unitRef="usd">45537000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjItMS0xLTEtNTQ0ODM_8e811bf6-d41f-460d-9de9-3eee87a4a557"
      unitRef="usd">298180000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjItMy0xLTEtNTQ0ODM_22c8f02f-cc40-4bac-b656-5ecad81ce0e5"
      unitRef="usd">304000000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjMtMS0xLTEtNTQ0ODM_7690230a-66ad-4013-84c8-78eb036ad559"
      unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjMtMy0xLTEtNTQ0ODM_290b4c11-ab1f-473e-a18f-e930a19769c8"
      unitRef="usd">29000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjQtMS0xLTEtNTQ0ODM_bbc28d7e-b4c5-4096-ac2e-eef7d8cefd5b"
      unitRef="usd">397469000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjQtMy0xLTEtNTQ0ODM_4b86c82a-beff-48a7-9ebb-6a0b292a726f"
      unitRef="usd">404771000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjUtMS0xLTEtNTQ0ODM_05a3ed3f-c1e6-4f88-98a1-7b7a2f88fd0b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjUtMy0xLTEtNTQ0ODM_09e0f124-3f0d-4775-a022-b3208352be01"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl8yMQ_70e2d580-4d2a-4911-94a5-57b6f4505ede"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl8yMQ_c90bad1d-4833-4520-b9be-80a2ee8a9608"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl8zNQ_31c4ae08-ac2b-40d6-8a0c-bf4baab37b4c"
      unitRef="shares">25000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl8zNQ_80f4c759-cdad-4d25-b8d1-c604c56c0128"
      unitRef="shares">25000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl83Mw_62ab0460-e9b6-4df7-8f9b-f247ed9cd793"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl83Mw_699ab8c2-1299-4feb-bc40-396dd0b58011"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl83Mw_8090a041-87aa-4f95-8a61-984504f42d0b"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjo5MmRjMTliMWRlNTk0MjliYjNmZGNhNmQ0MzYyYzhmZl83Mw_c618dba6-ad11-441d-bd0b-90ee5fafa992"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMS0xLTEtNTQ0ODM_eb8c356f-6927-47f9-a91d-3de05feecbfc"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjctMy0xLTEtNTQ0ODM_c53cc8af-c6f4-4614-93a8-833bcc029866"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8xOA_485be21a-0ab8-43dd-9358-cded15236928"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8xOA_d35d0612-704a-4ff7-b2fc-3f021e2218dc"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8zMg_3b9c9955-71a8-4c3b-abb9-93b9a696acd4"
      unitRef="shares">175000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8zMg_e2d22eb0-2cd3-4d3c-953d-2056a8f21491"
      unitRef="shares">175000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF82Nw_4489adc4-f061-420c-a196-2e0d7fc1e95d"
      unitRef="shares">41824758</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF82Nw_c044553c-31a8-4377-9612-1193efc1bdc9"
      unitRef="shares">41824758</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8xMTA_4691e49e-3bc8-4fb5-b5a9-341180a47452"
      unitRef="shares">41803436</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMC0xLTEtNTQ0ODMvdGV4dHJlZ2lvbjpmYzY2YzlmOTFjN2I0N2NkOGM3OTFlMmE2ZWZjZTJmOF8xMTA_b1147e5b-b3a4-495c-bec6-ca6240f3e97e"
      unitRef="shares">41803436</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMS0xLTEtNTQ0ODM_8fd3e9bd-3ad2-4a8e-9c9c-f739ce53bdcc"
      unitRef="usd">4000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjgtMy0xLTEtNTQ0ODM_8727dc79-1eb1-4d4b-8079-54d536a0e542"
      unitRef="usd">4000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjktMS0xLTEtNTQ0ODM_2c44f8c1-00d9-462f-90ad-8137451236ae"
      unitRef="usd">381906000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMjktMy0xLTEtNTQ0ODM_6d314ccf-26d7-49d4-9199-7c473d09ef7d"
      unitRef="usd">377232000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzAtMS0xLTEtNTQ0ODM_6116a8bb-53d0-4dde-a3ed-8704a3a84dbf"
      unitRef="usd">-2870000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzAtMy0xLTEtNTQ0ODM_c00a61f2-b1c3-497b-99da-e0b4b67bbdef"
      unitRef="usd">-3986000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzEtMS0xLTEtNTQ0ODM_79a59d4f-1f45-4635-afc9-20a0e2d6407c"
      unitRef="usd">-403626000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzEtMy0xLTEtNTQ0ODM_049793b0-e666-4814-befb-d3e25314e46b"
      unitRef="usd">-373138000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzItMS0xLTEtNTQ0ODM_df101cee-c77b-4438-b735-606a181a81c3"
      unitRef="usd">-24586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzItMy0xLTEtNTQ0ODM_f37de219-06f9-47fd-96d2-fce0de577556"
      unitRef="usd">112000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzMtMS0xLTEtNTQ0ODM_55744605-51cd-4912-909d-17cdf8f177fa"
      unitRef="usd">372883000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yMi9mcmFnOmQyY2U0MTI3NDUwMTQ3ODY4YTFiN2I3NjAxN2QwZjY0L3RhYmxlOmJkNzM3Y2NiOGQwNzQxODc5MDE1YTc3OGZjZDljMDY1L3RhYmxlcmFuZ2U6YmQ3MzdjY2I4ZDA3NDE4NzkwMTVhNzc4ZmNkOWMwNjVfMzMtMy0xLTEtNTQ0ODM_869497ad-7cc6-4474-b20a-4e2a9c2a8048"
      unitRef="usd">404883000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMi01LTEtMS01NDQ4Mw_32fb303b-0c6a-4c93-aa69-984f5c665507"
      unitRef="usd">5309000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMi03LTEtMS01NDQ4Mw_3686c246-7995-4996-a550-a8cb77480331"
      unitRef="usd">3920000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNC01LTEtMS01NDQ4Mw_91be1fc9-c90c-415a-8f21-26593e53c960"
      unitRef="usd">29985000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNC03LTEtMS01NDQ4Mw_485d96b8-96a5-4a44-ae38-9bb6addaab1a"
      unitRef="usd">24508000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNS01LTEtMS01NDQ4Mw_5a5d6135-b609-4f01-bf27-2828b303df14"
      unitRef="usd">8641000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNS03LTEtMS01NDQ4Mw_13cccbe3-eaa5-44a0-baa8-d19de97f26b3"
      unitRef="usd">7216000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNi01LTEtMS01NDQ4Mw_27774282-b201-4ff9-85cd-83a80a56a340"
      unitRef="usd">38626000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNi03LTEtMS01NDQ4Mw_9e05dd97-a921-4537-9cef-8a07138d8348"
      unitRef="usd">31724000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNy01LTEtMS01NDQ4Mw_e771c7db-0e55-4e91-a6a0-d314d299cfd6"
      unitRef="usd">-33317000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfNy03LTEtMS01NDQ4Mw_92755bf0-1088-41e5-bbaa-7664c1262c11"
      unitRef="usd">-27804000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOther
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfOS01LTEtMS01NDQ4Mw_82f44ae2-05e0-4580-b0e5-ff5f5ee7c179"
      unitRef="usd">2669000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfOS03LTEtMS01NDQ4Mw_2bb2cec1-2bd2-4e99-bb0f-cd9c9b99d133"
      unitRef="usd">235000</us-gaap:InterestIncomeOther>
    <fhtx:InterestIncomeAndOtherIncomeExpense
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTAtNS0xLTEtNTQ0ODM_d2ec6e37-e7ca-4da3-b2fc-3336d2c47b9d"
      unitRef="usd">720000</fhtx:InterestIncomeAndOtherIncomeExpense>
    <fhtx:InterestIncomeAndOtherIncomeExpense
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTAtNy0xLTEtNTQ0ODM_aff1fe59-6b76-42e5-9378-a0f6023814a5"
      unitRef="usd">655000</fhtx:InterestIncomeAndOtherIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTEtNS0xLTEtNTQ0ODM_a602f0a3-b090-4057-acd2-6c0e78a75481"
      unitRef="usd">3389000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTEtNy0xLTEtNTQ0ODM_ad6b90c2-f927-47ce-beaa-04c906136ecc"
      unitRef="usd">890000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTItNS0xLTEtNzIzMTM_1ee14342-ff87-432c-8923-6624df0cc528"
      unitRef="usd">-29928000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTItNy0xLTEtNzIzMjE_c92275db-110f-4750-a195-bb92d6f42de5"
      unitRef="usd">-26914000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNS0xLTEtNzIzMTM_97d2a64c-6e9a-4751-bff2-5f2e22f3443b"
      unitRef="usd">560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNy0xLTEtNzIzMjE_1f3f859f-fed7-453f-a32b-e76273c0b814"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTItNS0xLTEtNTQ0ODM_7c510c1c-9452-408f-abde-5769f5b318c9"
      unitRef="usd">-30488000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTItNy0xLTEtNTQ0ODM_2dad6f1d-a00f-4454-8be2-87454564cadc"
      unitRef="usd">-26914000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNS0xLTEtNTQ0ODM_b6cd1595-c49e-4573-852c-0d09b9f83de0"
      unitRef="usdPerShare">-0.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNS0xLTEtNTQ0ODM_f7d4cd43-d987-4eae-ade8-2b2b7e2dcb9e"
      unitRef="usdPerShare">-0.73</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNy0xLTEtNTQ0ODM_11455191-f170-4303-aed1-e017ff4ee198"
      unitRef="usdPerShare">-0.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTMtNy0xLTEtNTQ0ODM_e309a4f3-4e31-4557-9b99-e360145236d5"
      unitRef="usdPerShare">-0.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTQtNS0xLTEtNTQ0ODM_483478b4-6c92-46a6-aad1-ad854506f28c"
      unitRef="shares">41811087</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTQtNS0xLTEtNTQ0ODM_5327cca9-3144-4497-a382-882efb7ca4a2"
      unitRef="shares">41811087</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTQtNy0xLTEtNTQ0ODM_369add31-726a-44a4-a306-6feb15e71c14"
      unitRef="shares">41370186</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTQtNy0xLTEtNTQ0ODM_90ca0f06-8e3f-4557-a515-9b3d7e8e67a4"
      unitRef="shares">41370186</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTYtNS0xLTEtNTQ0ODM_c01d24e9-f57d-418e-a0b4-c57b244a6db0"
      unitRef="usd">-30488000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTYtNy0xLTEtNTQ0ODM_f201a4d5-f658-4cac-82b1-c05568286891"
      unitRef="usd">-26914000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTgtNS0xLTEtNTQ0ODM_adc3ed4d-ac30-4157-8bf8-4f4e3f58c7f8"
      unitRef="usd">1116000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTgtNy0xLTEtNTQ0ODM_971d2086-30b4-43bc-84ec-7cee9474d59b"
      unitRef="usd">-1184000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTktNS0xLTEtNTQ0ODM_21a17253-568e-49d9-a35c-ec56c314a1bc"
      unitRef="usd">1116000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMTktNy0xLTEtNTQ0ODM_6117c351-e81e-407d-8953-a5fdc04b6cfa"
      unitRef="usd">-1184000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMjAtNS0xLTEtNTQ0ODM_5bb24026-106b-4acb-90b0-5d2a9a8a587c"
      unitRef="usd">-29372000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yNS9mcmFnOjVhYWVhNDk1NzcxMTQ5YWU5Njc1YWZiM2U2NWZlYTJkL3RhYmxlOjAzNzdjM2QwNjE2MTRiMWViNTJmMmM5ZDA2MTIxMGU1L3RhYmxlcmFuZ2U6MDM3N2MzZDA2MTYxNGIxZWI1MmYyYzlkMDYxMjEwZTVfMjAtNy0xLTEtNTQ0ODM_003d2e06-6b29-4ff1-87b4-ae628d9112cd"
      unitRef="usd">-28098000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9b067aab926342a7b5676d4d0a0c6d41_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi0xLTEtMS01NDQ4Mw_2a2cc546-1757-426a-905d-84dae9f92d1c"
      unitRef="shares">41803436</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9b067aab926342a7b5676d4d0a0c6d41_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi0zLTEtMS01NDQ4Mw_666a3c61-62a9-4be4-ba79-a726fb7347fa"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6ef9ae80fb5b4395b13666e9e9eec82c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi01LTEtMS01NDQ4Mw_671edee3-46f0-41d3-8aea-f713345958a4"
      unitRef="usd">377232000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7bae992474dd40a79505422be056e6f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi03LTEtMS01NDQ4Mw_54e182d1-43a6-45ca-b8d4-b6b187f039f1"
      unitRef="usd">-3986000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9fdced88f45c4e409092a68fcf300833_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi05LTEtMS01NDQ4Mw_53c2d8dd-3fd5-4399-a0d3-00f2d5beb0d1"
      unitRef="usd">-373138000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMi0xMS0xLTEtNTQ0ODM_d10ab4ad-3e81-465e-a939-13eabc31276d"
      unitRef="usd">112000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="icf21555867444ead906d71488062bf8e_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMy0xLTEtMS01NDQ4Mw_45479f61-7ff1-4d7f-9212-81ed4c8ddafd"
      unitRef="shares">21322</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i19705a121aa44c47a0ae367e9f64af9d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMy01LTEtMS01NDQ4Mw_d20ed687-a5e7-41bf-8ce9-b50a647686f1"
      unitRef="usd">102000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMy0xMS0xLTEtNTQ0ODM_4de49a6f-8b39-4d6d-9262-3b8c419d14a1"
      unitRef="usd">102000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i19705a121aa44c47a0ae367e9f64af9d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNC01LTEtMS01NDQ4Mw_3532b390-d40e-4f47-a318-ebbc18e03f16"
      unitRef="usd">4572000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNC0xMS0xLTEtNTQ0ODM_02435cca-d37a-466e-9542-5c6ae1b53284"
      unitRef="usd">4572000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i23676a510c4248498851adfc7c094aaf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNS03LTEtMS01NDQ4Mw_dac6d1b8-b9e6-4bc1-b6b7-e0ff91893066"
      unitRef="usd">1116000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNS0xMS0xLTEtNTQ0ODM_21ad53d4-89c3-4deb-833e-13d80aee09ac"
      unitRef="usd">1116000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i63934d7043544300b103bf3da31fea12_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNi05LTEtMS01NDQ4Mw_54937ab6-534e-46da-ba31-00a4860841e5"
      unitRef="usd">-30488000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfNi0xMS0xLTEtNTQ0ODM_adcfdae8-fa4b-4b34-be6a-e61ef2647c94"
      unitRef="usd">-30488000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3eccb4d2959a4de3bd53fc39077255b5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctMS0xLTEtNTQ0ODM_339f71c3-1edd-4eb8-a5fa-3ad46d3c3e53"
      unitRef="shares">41824758</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3eccb4d2959a4de3bd53fc39077255b5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctMy0xLTEtNTQ0ODM_28b0260a-c443-45cf-b8e6-ef2b4162403d"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i11b5f1d57baf4341bcf36040f1462577_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctNS0xLTEtNTQ0ODM_9a056183-a630-46f6-95cc-009421d4bf0a"
      unitRef="usd">381906000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idbd53253722c4ae18279a572bbe8e780_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctNy0xLTEtNTQ0ODM_753b8a6a-2969-4369-a2af-063f1c6a4335"
      unitRef="usd">-2870000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iff92410149e84214befd6916fd3f5b77_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctOS0xLTEtNTQ0ODM_bcb9b26e-fe5d-4d66-a859-a17fefb9c9f9"
      unitRef="usd">-403626000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOmUxZDQzMWFhYTljOTQyMWNhMGRiZDM4NDFlYmIzN2U0L3RhYmxlcmFuZ2U6ZTFkNDMxYWFhOWM5NDIxY2EwZGJkMzg0MWViYjM3ZTRfMTctMTEtMS0xLTU0NDgz_913c62a6-8bb2-4567-8db5-3a71564ec68b"
      unitRef="usd">-24586000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i624ef726f33c46a5a6ec3afd0efedb0a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi0xLTEtMS01NDQ4Mw_0950599a-3e67-447a-90df-8853f5fcb2e4"
      unitRef="shares">41299720</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i624ef726f33c46a5a6ec3afd0efedb0a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi0zLTEtMS01NDQ4Mw_13692a24-8855-4628-b314-3bd8c8f8ddea"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if7d893999d4a40eaa90ed425123e9436_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi01LTEtMS01NDQ4Mw_7e9fee3e-d926-4a4e-9ab2-908f841a5fc9"
      unitRef="usd">361133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if526a94d14254a2cb8672d7917c4be62_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi03LTEtMS01NDQ4Mw_0258d749-1250-4c48-871e-27b3c0b75e8e"
      unitRef="usd">-10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i349820509fee4399845fd358bd72501a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi05LTEtMS01NDQ4Mw_17c4232f-d2e3-47c0-a407-dd6f80342875"
      unitRef="usd">-264256000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i06768c28c0ca47a8bc549474a90e8b80_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMi0xMS0xLTEtNTQ0ODM_33a09f80-b5ea-41e7-abeb-5dcf2b87b9e3"
      unitRef="usd">96871000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibbe741aac4fe4bb0a0aac627966aa459_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMy0xLTEtMS01NDQ4Mw_90bc5ca9-4ea7-4910-82cb-d36243475a30"
      unitRef="shares">129895</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4436ac0de3fc454787e9c9e801be2074_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMy01LTEtMS01NDQ4Mw_dcccbdf0-52cd-40d0-8199-f5e4df2f8641"
      unitRef="usd">384000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMy0xMS0xLTEtNTQ0ODM_22356679-1816-42cf-a801-7195602d662d"
      unitRef="usd">384000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4436ac0de3fc454787e9c9e801be2074_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNC01LTEtMS01NDQ4Mw_408eb2b2-5b86-4eb5-a854-2407d233783d"
      unitRef="usd">3244000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNC0xMS0xLTEtNTQ0ODM_3bfacaa6-89b9-4bb7-a47e-3c4febe5876e"
      unitRef="usd">3244000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i7dd7d3cc806949ecb93485d8665161b4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNS03LTEtMS01NDQ4Mw_7e6dafb0-80e8-4e92-9676-c7e8fdbf3f9a"
      unitRef="usd">-1184000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNS0xMS0xLTEtNTQ0ODM_612db69d-f213-4919-a2ce-3e0d67620450"
      unitRef="usd">-1184000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie34084e716da4a5392ab043797b8f9eb_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNi05LTEtMS01NDQ4Mw_341d0f3c-eaec-40df-b6af-57040dc9c447"
      unitRef="usd">-26914000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfNi0xMS0xLTEtNTQ0ODM_427ab4f1-b8bc-451e-b29d-16986f02dcdb"
      unitRef="usd">-26914000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0f0c2d1581754c7d9a66865d89a11383_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctMS0xLTEtNTQ0ODM_c3227894-1a1f-4323-886e-1807a920d7a4"
      unitRef="shares">41429615</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i0f0c2d1581754c7d9a66865d89a11383_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctMy0xLTEtNTQ0ODM_6e5eda4b-8eda-4b76-98ef-e4029e3c90d8"
      unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icac4105ae32e47b4aab639de679600d4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctNS0xLTEtNTQ0ODM_03b97bd2-41ab-42df-9c60-f72797e3ba04"
      unitRef="usd">364761000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9c0a4519d9204d06bd778e69b95b2266_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctNy0xLTEtNTQ0ODM_93fb0eeb-1ee5-43ec-9956-93a9abe54ae7"
      unitRef="usd">-1194000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i23366ef09153432283da882a9c6f62f8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctOS0xLTEtNTQ0ODM_f9931280-9b06-437e-b805-f2776bc9c28d"
      unitRef="usd">-291170000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18yOC9mcmFnOjIxYjg4NjYyYzgzNzQ0Nzk4YTBjNjQ5N2RhNmI4MTdlL3RhYmxlOjBiNWRjMTZiODk5ODQyNjM5MjBlNGM2YmZjNTg3MzkwL3RhYmxlcmFuZ2U6MGI1ZGMxNmI4OTk4NDI2MzkyMGU0YzZiZmM1ODczOTBfMTctMTEtMS0xLTU0NDgz_3074faca-cf7c-4f45-a440-9406b491b93d"
      unitRef="usd">72401000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMy0xLTEtMS01NDQ4Mw_83eeff9e-ee12-412e-89af-f0e3ab05a9b7"
      unitRef="usd">-30488000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMy0zLTEtMS01NDQ4Mw_0c2e45a6-a882-4d34-8e25-879d1265b34a"
      unitRef="usd">-26914000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfNS0xLTEtMS01NDQ4Mw_5f671949-d917-4a8e-aafb-da339ea3dc2f"
      unitRef="usd">4572000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfNS0zLTEtMS01NDQ4Mw_d22c7e1b-15d3-4855-b1ef-a2fd31ca61fb"
      unitRef="usd">3244000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfNi0xLTEtMS01NDQ4Mw_cfa26681-4f80-4e0c-b88e-cfcd231af7d6"
      unitRef="usd">859000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfNi0zLTEtMS01NDQ4Mw_dafb12e3-1b98-49ce-94bb-8480111650d8"
      unitRef="usd">811000</us-gaap:DepreciationDepletionAndAmortization>
    <fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfOC0xLTEtMS01NDQ4Mw_11cf8150-e2ca-4c0d-b5f0-8f78e8d90c6c"
      unitRef="usd">1200000</fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfOC0zLTEtMS01NDQ4Mw_ac6b78ac-30de-470d-a70a-96b698e98f58"
      unitRef="usd">1114000</fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTAtMS0xLTEtNTQ0ODM_cc2c7671-8f3f-4c96-a978-d567659dc394"
      unitRef="usd">770000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTAtMy0xLTEtNTQ0ODM_b470377c-6d62-4b4d-9816-5cebb3f0a61d"
      unitRef="usd">-38000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTItMS0xLTEtNTQ0ODM_ff0fdb69-ede2-4721-bfcd-9137730ebf29"
      unitRef="usd">-887000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTItMy0xLTEtNTQ0ODM_0bc5bb29-2364-456e-8e19-a8f061b4fdf6"
      unitRef="usd">-184000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTMtMS0xLTEtNTQ0ODM_dda42500-f1a9-4d2d-84cb-d20302740e7b"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTMtMy0xLTEtNTQ0ODM_5a202d3d-2627-495d-99fa-7a3dd30d3935"
      unitRef="usd">-300000000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTQtMS0xLTEtNTQ0ODM_bd36364e-256c-4978-90ed-a7e6aacb6ca5"
      unitRef="usd">1691000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTQtMy0xLTEtNTQ0ODM_2182f493-45df-46f2-b1b0-359c32e30aa2"
      unitRef="usd">1271000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTUtMS0xLTEtNTQ0ODM_0c9027b2-8f33-4b5c-bd87-f335275a2054"
      unitRef="usd">-2154000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTUtMy0xLTEtNTQ0ODM_b56b13ae-dbbb-432c-b80e-ac46c716d0bb"
      unitRef="usd">-2542000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTYtMS0xLTEtNTQ0ODM_62497fb6-ccb9-48c9-8b49-408dd32871e5"
      unitRef="usd">-1668000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTYtMy0xLTEtNTQ0ODM_989f7a54-5565-4c47-8f79-19b0564c5a15"
      unitRef="usd">-1752000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTctMS0xLTEtNTQ0ODM_b81eabe6-26ce-403c-b1e5-c3874123aa97"
      unitRef="usd">-5309000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTctMy0xLTEtNTQ0ODM_fb2d0e9f-9cec-4ef1-a52c-4d716c7684bd"
      unitRef="usd">-3920000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTgtMS0xLTEtNTQ0ODM_ce44d3ac-25ee-4bd9-83f3-7333e16298a0"
      unitRef="usd">-31180000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMTgtMy0xLTEtNTQ0ODM_2416e50e-dfc9-4a2a-977c-73d1952b1592"
      unitRef="usd">271534000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjAtMS0xLTEtNTQ0ODM_4be9910a-0aa8-4c94-a1db-6654e541a1b3"
      unitRef="usd">636000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjAtMy0xLTEtNTQ0ODM_46573b5f-b9a9-4399-abcd-0cc62c5aecec"
      unitRef="usd">247000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjItMS0xLTEtNTQ0ODM_403dabed-4db6-4a11-9ebf-8a1124b4f227"
      unitRef="usd">26232000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjItMy0xLTEtNTQ0ODM_1e705d99-edfa-403c-b1da-11b4ebb7a20f"
      unitRef="usd">212294000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjMtMS0xLTEtNTQ0ODM_f24bc524-bdb8-42b5-842b-bdab9090a1fc"
      unitRef="usd">56373000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjMtMy0xLTEtNTQ0ODM_6a3fa2cc-e913-4d2c-ba4b-525f0c030e60"
      unitRef="usd">53132000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjQtMS0xLTEtNTQ0ODM_c390abef-1064-440d-ac5c-308f17d7d674"
      unitRef="usd">29505000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjQtMy0xLTEtNTQ0ODM_cce7e235-d65d-4187-a7d9-a918c2de6e5b"
      unitRef="usd">-159409000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjYtMS0xLTEtNTQ0ODM_49a56c0b-317a-4894-b2bd-a504c3308ab7"
      unitRef="usd">102000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjYtMy0xLTEtNTQ0ODM_ea3ef048-3241-4a2a-8ba5-315f5696b152"
      unitRef="usd">384000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjgtMS0xLTEtNTQ0ODM_f42a9132-9b03-446e-8359-5c2904c1110a"
      unitRef="usd">102000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjgtMy0xLTEtNTQ0ODM_7d4f033c-34b0-4ee2-81cc-622d27b4c677"
      unitRef="usd">384000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjktMS0xLTEtNTQ0ODM_b317da86-7a33-43c8-a0ff-604ca3ab700e"
      unitRef="usd">-1573000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMjktMy0xLTEtNTQ0ODM_b89880f1-8535-44fc-bf84-9826b8d879d8"
      unitRef="usd">112509000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzAtMS0xLTEtNTQ0ODM_ea8e1063-8ac3-45be-b89c-1bbbed7d8d81"
      unitRef="usd">53922000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i06768c28c0ca47a8bc549474a90e8b80_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzAtMy0xLTEtNTQ0ODM_79cc7892-df02-4095-9560-6b6ab64ae801"
      unitRef="usd">102869000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzEtMS0xLTEtNTQ0ODM_c0210794-a079-4915-abc4-fe5a851963e2"
      unitRef="usd">52349000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzEtMy0xLTEtNTQ0ODM_209d7dde-b638-4f90-8712-97ee9fe48209"
      unitRef="usd">215378000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzUtMS0xLTEtNTQ0ODM_2d6bd656-14e5-4f96-beeb-a220c16ccee2"
      unitRef="usd">298000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzUtMy0xLTEtNTQ0ODM_a45a49c9-0328-465c-931b-d0c21774adb6"
      unitRef="usd">239000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzctMS0xLTEtNTQ0ODM_0dd0b711-675b-40bb-99b8-dd8cb1999436"
      unitRef="usd">50641000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzctMy0xLTEtNTQ0ODM_301af3a0-f612-4653-91e7-9750858494cc"
      unitRef="usd">213645000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalents
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzgtMS0xLTEtNTQ0ODM_2238154b-f32c-4501-9467-2ca45db9a797"
      unitRef="usd">1708000</us-gaap:RestrictedCashEquivalents>
    <us-gaap:RestrictedCashEquivalents
      contextRef="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzgtMy0xLTEtNTQ0ODM_2af005e4-1862-478e-8ac3-e17dd134dc5a"
      unitRef="usd">1733000</us-gaap:RestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzktMS0xLTEtNTQ0ODM_ae43c108-a07a-4e7e-9cf7-8d8d39b85929"
      unitRef="usd">52349000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1b8dec84d151411a9ef8e6a3a39b602e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zMS9mcmFnOjliZDY3YTYwMTlhOTRmMDlhMjkwM2EwYjg5YmU2NGJiL3RhYmxlOmMzODgyYTUzYjFkYzRlZmFhYzJiM2I0ZGU5ZmJlYTU0L3RhYmxlcmFuZ2U6YzM4ODJhNTNiMWRjNGVmYWFjMmIzYjRkZTlmYmVhNTRfMzktMy0xLTEtNTQ0ODM_8defc577-cb72-45dc-b3ba-a9dc818c3056"
      unitRef="usd">215378000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfNTIwMA_be4fdd83-b136-42a1-bf86-bd16dde69ce0">Nature of Business, Going Concern and Basis of Presentation&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foghorn Therapeutics&#160;Inc. (the &#x201c;Company&#x201d;) is a clinical-stage biopharmaceutical company discovering and developing a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. The Company uses its proprietary Gene Traffic Control platform to identify, validate and potentially drug targets within the system. The Company was founded in October 2015 as a Delaware corporation. The Company is headquartered in Cambridge, Massachusetts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to risks similar to those of other early-stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, and the need to obtain adequate additional financing to fund the development of its products. There can be no assurance that the Company&#x2019;s research and development will be successfully completed, that adequate protection for the Company&#x2019;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#x2019;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Going concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. Since inception, the Company has funded its operations primarily with proceeds from sales of preferred stock, debt financing, an upfront payment from a collaboration agreement, a public offering and a stock purchase agreement all prior to 2022. In January 2022, the Company received an upfront payment of $300.0 million pursuant to a collaboration agreement completed with Lilly (the &#x201c;Lilly Collaboration Agreement&#x201d;) (see Note 8). In the third quarter of 2022, the Company achieved a research milestone related to the Merck Collaboration Agreement and received a $5.0 million milestone payment from Merck. The Company has incurred recurring losses, including net losses of $30.5&#160;million and $26.9&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively. As of March&#160;31, 2023, the Company had an accumulated deficit of $403.6 million. The Company expects to continue to generate operating losses in the foreseeable future. As of the issuance date of these interim condensed consolidated financial statements the Company expects that its cash, cash equivalents and marketable securities will be sufficient to fund its operating expenses and capital expenditure requirements for at least 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will need to obtain additional funding through public or private equity offerings, debt financings, collaborations, strategic alliances and/or licensing arrangements to continue to fund its operations. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborative or strategic alliances or licensing arrangements. The terms of any financing may adversely affect the holdings or the rights of the Company&#x2019;s stockholders. Arrangements with collaborators or others may require the Company to relinquish rights to certain of its technologies or programs. If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate some or all of its research and development programs, pipeline expansion or commercialization efforts, which could adversely affect its business prospects. Although management will continue to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding in the future on terms acceptable to the Company to fund continuing operations when needed or at all.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:16pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <fhtx:ProceedsFromUpfrontPayment
      contextRef="i4605cd6df8cb432e8da81b434c0b12ff_D20220101-20220131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfMjQ1OA_41fd2593-a07c-4dc5-8cf7-be8d53f11440"
      unitRef="usd">300000000</fhtx:ProceedsFromUpfrontPayment>
    <fhtx:PaymentReceivedForAchievementOfMilestones
      contextRef="i8f17ba797a20458c8d273718a2faf5b2_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfNTQ5NzU1ODE0NTE3NA_155bfef4-8f34-4f68-9d04-0819116db676"
      unitRef="usd">5000000</fhtx:PaymentReceivedForAchievementOfMilestones>
    <us-gaap:NetIncomeLoss
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfMjU5Mw_737a6c1a-bcdb-4791-8e87-6a8278802f1d"
      unitRef="usd">-30500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfMjYwMA_0bab6652-4fc7-48e6-b4a4-bb028be4310e"
      unitRef="usd">-26900000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfMjcwNA_9edb47fb-a459-41a6-924b-c97463539918"
      unitRef="usd">-403600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN18zNy9mcmFnOmFiMGMyNjg4YWNmZDQ1ODZhOWJkODRmZTQwZGJmYTNjL3RleHRyZWdpb246YWIwYzI2ODhhY2ZkNDU4NmE5YmQ4NGZlNDBkYmZhM2NfNTE5OQ_5aeff100-3a9f-4e68-947d-8d539f6be33e">&lt;div style="margin-top:16pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation. Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) of the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180MC9mcmFnOmVjNDIzZGFjNDE5MDRkNGZiZWZmMjIxZDBhM2RmZDdiL3RleHRyZWdpb246ZWM0MjNkYWM0MTkwNGQ0ZmJlZmYyMjFkMGEzZGZkN2JfMjU3MA_8c10fa83-80d6-458e-9c6b-bf1da4e42768">Summary of Significant Accounting Policies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting policies of the Company are set forth in Note 2 to the consolidated financial statements contained in the Company&#x2019;s 2022 Annual Report on Form 10-K. The Company includes herein certain updates to those policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities are classified as&#160;available-for-sale&#160;and are carried at fair value with the unrealized gains and losses reported as a component of accumulated other comprehensive loss in stockholders&#x2019; equity. The Company classifies its marketable securities with maturities beyond one year as short-term, based on their highly liquid nature and because such marketable securities are available for current operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews marketable securities whenever the fair value of an investment is less than the amortized cost and evidence indicates that an investment&#x2019;s carrying value is not recoverable. For available-for-sale debt securities, the credit allowance is limited to the amount that fair value is less than amortized cost. Unrealized losses are evaluated for impairment under ASC 326, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to determine if the impairment is credit-related or noncredit-related. Credit-related impairment is recognized as an allowance on the condensed consolidated balance sheets with a corresponding adjustment to earnings, and noncredit-related impairment is recognized in other comprehensive loss. Evidence considered in this assessment includes reasons for the impairment, compliance with our investment policy, the severity of the impairment, collectability of the security, and any adverse conditions specifically related to the security, an industry, or geographic area.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized gains and losses are included as a component of accumulated other comprehensive loss in the consolidated balance sheets and condensed consolidated statements of stockholders&#x2019; equity and a component of total comprehensive loss. Realized gains and losses are included as a component of other income (expense), net based on the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently issued accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to &#x201c;opt out&#x201d; of the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i)&#160;irrevocably elects to opt out of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No.&#160;2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;The new standard adjusts the accounting for assets held at amortized costs basis by eliminating the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses as an allowance for credit losses. For nonpublic entities and emerging growth companies that choose to take advantage of the extended transition period, the guidance was initially effective for annual reporting periods beginning after December&#160;15, 2020. However, in November 2019, the FASB issued ASU No.&#160;2019-10, which deferred the effective date for nonpublic entities to annual reporting periods beginning after December&#160;15, 2022, including interim periods within those fiscal years. The Company adopted this s as of January 1, 2023 and the adoption had no material impact to the Company&#x2019;s consolidated financial position, results of operation, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180MC9mcmFnOmVjNDIzZGFjNDE5MDRkNGZiZWZmMjIxZDBhM2RmZDdiL3RleHRyZWdpb246ZWM0MjNkYWM0MTkwNGQ0ZmJlZmYyMjFkMGEzZGZkN2JfMjU3MQ_5d788564-075a-415c-b989-3d40f3959166">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently issued accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to &#x201c;opt out&#x201d; of the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i)&#160;irrevocably elects to opt out of such extended transition period or (ii)&#160;no longer qualifies as an emerging growth company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No.&#160;2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#160;The new standard adjusts the accounting for assets held at amortized costs basis by eliminating the probable initial recognition threshold and requires an entity to reflect its current estimate of all expected credit losses as an allowance for credit losses. For nonpublic entities and emerging growth companies that choose to take advantage of the extended transition period, the guidance was initially effective for annual reporting periods beginning after December&#160;15, 2020. However, in November 2019, the FASB issued ASU No.&#160;2019-10, which deferred the effective date for nonpublic entities to annual reporting periods beginning after December&#160;15, 2022, including interim periods within those fiscal years. The Company adopted this s as of January 1, 2023 and the adoption had no material impact to the Company&#x2019;s consolidated financial position, results of operation, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <fhtx:MarketableSecuritiesAndFairValueMeasurementsTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RleHRyZWdpb246Njc5Y2YwNGUwMTg5NGQxMmI3ZmFiYTIwZGVhNGY1NmNfNTIw_504a7d97-791b-436b-97a3-3a8fc9338bfe">Marketable Securities and Fair Value Measurements&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, available for sale marketable securities by security type consisted of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies (due after one year through two years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds (due after one year through three&lt;br/&gt;&#160;&#160;&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, available for sale marketable securities by security type consisted of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds (due after one year through three&lt;br/&gt;&#160;&#160;&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s fair value hierarchy for its assets and liabilities, which are measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at March 31, 2023 Using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at December 31, 2022 Using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023 and 2022, there were no transfers between Level&#160;1, Level&#160;2 and Level&#160;3.&lt;/span&gt;&lt;/div&gt;</fhtx:MarketableSecuritiesAndFairValueMeasurementsTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RleHRyZWdpb246Njc5Y2YwNGUwMTg5NGQxMmI3ZmFiYTIwZGVhNGY1NmNfNTIx_aee71e01-912f-4a96-b637-9c6ed5f8d0a9">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, available for sale marketable securities by security type consisted of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies (due after one year through two years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds (due after one year through three&lt;br/&gt;&#160;&#160;&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, available for sale marketable securities by security type consisted of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds (due within one year)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds (due after one year through three&lt;br/&gt;&#160;&#160;&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic5ff53cf442042cdb4b36d6e72142a1b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMS0xLTEtMS01NDQ4Mw_c292daec-a8ad-4f0e-a998-2a8652e59381"
      unitRef="usd">2992000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic5ff53cf442042cdb4b36d6e72142a1b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMS0zLTEtMS01NDQ4Mw_42b98b59-5a53-422b-95c4-9d62554abc5a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic5ff53cf442042cdb4b36d6e72142a1b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMS01LTEtMS01NDQ4Mw_85dac92a-3f76-428b-8d76-a7b37f71bf4e"
      unitRef="usd">80000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic5ff53cf442042cdb4b36d6e72142a1b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMS03LTEtMS01NDQ4Mw_3aada0d2-9506-4571-996f-bbd4426a7c90"
      unitRef="usd">2912000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1a624a02dc70405cb5fbe4a2e977a9f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi0xLTEtMS03MTk5Ng_c51b5b0e-138b-46d5-bb62-e2bd0699ee01"
      unitRef="usd">7998000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1a624a02dc70405cb5fbe4a2e977a9f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi0zLTEtMS03MTk5Ng_40780b2c-3e3d-401d-be6a-021228d14cee"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1a624a02dc70405cb5fbe4a2e977a9f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi01LTEtMS03MTk5Ng_9fd7c483-fbd7-42e3-97ae-1ec59a5e3b40"
      unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1a624a02dc70405cb5fbe4a2e977a9f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi03LTEtMS03MTk5Ng_54998c3b-510c-478a-bda9-77f7fc4318e3"
      unitRef="usd">7995000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i87b3ffa3baf7435c93a45a49e8b25af7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi0xLTEtMS01NDQ4Mw_2ce7e4fd-121d-4df6-8923-e862b6885fa1"
      unitRef="usd">38436000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i87b3ffa3baf7435c93a45a49e8b25af7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi0zLTEtMS01NDQ4Mw_68c82073-cc51-4560-b634-68e09c0daaf5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i87b3ffa3baf7435c93a45a49e8b25af7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi01LTEtMS01NDQ4Mw_519bcd80-234d-4e64-93c0-966429af7458"
      unitRef="usd">102000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i87b3ffa3baf7435c93a45a49e8b25af7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMi03LTEtMS01NDQ4Mw_b8fa8e1f-b2f5-4f42-b71c-33f1dea4f515"
      unitRef="usd">38334000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i74970c52e4004e8b8552988d5f7c2170_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMy0xLTEtMS01NDQ4Mw_4776964a-9aa9-450f-86aa-f1fdf2d1deea"
      unitRef="usd">165157000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i74970c52e4004e8b8552988d5f7c2170_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMy0zLTEtMS01NDQ4Mw_198769b2-b147-41f1-b408-64c2ac45ab10"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i74970c52e4004e8b8552988d5f7c2170_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMy01LTEtMS01NDQ4Mw_e32180e8-5aa1-4c1e-a942-156279041c1e"
      unitRef="usd">1565000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i74970c52e4004e8b8552988d5f7c2170_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfMy03LTEtMS01NDQ4Mw_d65d914c-1ff7-4cc8-91ad-6623401e4030"
      unitRef="usd">163599000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idda5759b36f940b19380a66d34dae73c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi0xLTEtMS03MjAwNA_ec22d341-30b2-47ed-9432-15cd380e9329"
      unitRef="usd">2862000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idda5759b36f940b19380a66d34dae73c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi0zLTEtMS03MjAwNA_22bc8b0b-af2c-41c6-8691-12d970f00b1c"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idda5759b36f940b19380a66d34dae73c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi01LTEtMS03MjAwNA_18cc3279-35b2-467d-82f1-f4b91faae346"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idda5759b36f940b19380a66d34dae73c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi03LTEtMS03MjAwNA_bef55b29-9e11-476b-b567-46dd1c16737f"
      unitRef="usd">2865000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ieb5c24a093394ecba28d4a9c5bcdbb9d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNS0xLTEtMS01NDQ4Mw_d7b43d7c-641e-4734-8ce6-b59d01690e45"
      unitRef="usd">50754000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ieb5c24a093394ecba28d4a9c5bcdbb9d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNS0zLTEtMS01NDQ4Mw_a85cc2a1-cd97-47ac-90b3-11d79c8ab105"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ieb5c24a093394ecba28d4a9c5bcdbb9d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNS01LTEtMS01NDQ4Mw_db08430f-60a9-45a2-9091-ad315e644e8c"
      unitRef="usd">1132000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb5c24a093394ecba28d4a9c5bcdbb9d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNS03LTEtMS01NDQ4Mw_72186336-3f90-477c-a2ad-25ddd1ecbf7a"
      unitRef="usd">49624000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi0xLTEtMS01NDQ4Mw_f827bdd6-4d0b-439b-8ab5-7242fb7fd468"
      unitRef="usd">268199000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi0zLTEtMS01NDQ4Mw_a0c66a6f-aaa6-4ffb-acb3-1e91f814b704"
      unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi01LTEtMS01NDQ4Mw_d159ffc0-b77a-42a1-891d-86d4d19f84a7"
      unitRef="usd">2883000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFlNGEyY2VjYzI3NzRkOGVhODkxOGRiOTQ1MDA3MDUyL3RhYmxlcmFuZ2U6MWU0YTJjZWNjMjc3NGQ4ZWE4OTE4ZGI5NDUwMDcwNTJfNi03LTEtMS01NDQ4Mw_27e5dd4b-3351-4401-b5fa-cd6bd6436206"
      unitRef="usd">265329000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib2a16fe60e7940d0acb3671bc0544537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS0xLTEtMS03MDY4MA_703d533a-17e1-4992-b436-969628529b3d"
      unitRef="usd">7987000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib2a16fe60e7940d0acb3671bc0544537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS0zLTEtMS03MDY4Mg_cbceee27-c21b-46dd-8625-fa6c2599861d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib2a16fe60e7940d0acb3671bc0544537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS01LTEtMS03MDY4NA_c7746442-c0f6-4ef7-a1bb-82db0b29b6c6"
      unitRef="usd">115000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib2a16fe60e7940d0acb3671bc0544537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS03LTEtMS03MDY4Ng_29b14461-ac0b-4429-a109-3d2b61bbe680"
      unitRef="usd">7872000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if2f9150da3aa40d8b086ad8ea1702556_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS0xLTEtMS01NDQ4Mw_0da3ef82-3a3e-4c32-88cb-31f3a0ba13c4"
      unitRef="usd">56697000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if2f9150da3aa40d8b086ad8ea1702556_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS0zLTEtMS01NDQ4Mw_ea7560a1-480b-48c1-ab93-ff90e7dfc623"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if2f9150da3aa40d8b086ad8ea1702556_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS01LTEtMS01NDQ4Mw_3abcf502-0055-4c42-9a62-586cafc44b4d"
      unitRef="usd">301000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if2f9150da3aa40d8b086ad8ea1702556_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMS03LTEtMS01NDQ4Mw_8d2c3f67-29fd-4ebd-82aa-e16cfdf20f40"
      unitRef="usd">56398000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icccd4d043a644533bb05611e707ac152_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMi0xLTEtMS01NDQ4Mw_08405a94-e085-46a0-85e9-7786416b5036"
      unitRef="usd">139764000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icccd4d043a644533bb05611e707ac152_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMi0zLTEtMS01NDQ4Mw_40fbb4d3-4b01-48ee-888b-1ebe1dcdbce7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icccd4d043a644533bb05611e707ac152_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMi01LTEtMS01NDQ4Mw_06da0a0c-4415-4372-b2ce-efb6704b53f2"
      unitRef="usd">1342000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icccd4d043a644533bb05611e707ac152_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMi03LTEtMS01NDQ4Mw_d34a5af0-16de-40f9-aa4d-6693d3ef12db"
      unitRef="usd">138422000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8a297b2b298d4b4d8e5832e54f043948_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfNC0xLTEtMS03MDY3Mg_e4ad1207-2925-4b6d-a2e6-f23716e2a037"
      unitRef="usd">93122000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8a297b2b298d4b4d8e5832e54f043948_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfNC0zLTEtMS03MDY3NA_a9a930b6-479e-4ccf-9cd6-71d7ed3e2bc4"
      unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8a297b2b298d4b4d8e5832e54f043948_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfNC01LTEtMS03MDY3Ng_73ae31fb-fef6-46a2-a9f8-06f53a9f9ede"
      unitRef="usd">2234000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8a297b2b298d4b4d8e5832e54f043948_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfNC03LTEtMS03MDY3OA_80ea432c-8b87-468b-b74d-f24f8488b656"
      unitRef="usd">90892000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMy0xLTEtMS01NDQ4Mw_9be58dfa-46bb-44ca-bf6c-162c6efb8afa"
      unitRef="usd">297570000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMy0zLTEtMS01NDQ4Mw_42d19926-75d5-4312-b829-476983e170e6"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMy01LTEtMS01NDQ4Mw_a2582c63-54c3-40b5-a7d6-3eccd25fe51d"
      unitRef="usd">3992000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOjFkNDQ5ODkwYjY5NzRiYTM5MTQ2YjdjYTFlOTUzNjVjL3RhYmxlcmFuZ2U6MWQ0NDk4OTBiNjk3NGJhMzkxNDZiN2NhMWU5NTM2NWNfMy03LTEtMS01NDQ4Mw_0c4844f7-aa6b-4054-a126-01454424eccc"
      unitRef="usd">293584000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RleHRyZWdpb246Njc5Y2YwNGUwMTg5NGQxMmI3ZmFiYTIwZGVhNGY1NmNfNTIy_9710f799-a39f-492c-a7d6-cb7b9137ff33">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s fair value hierarchy for its assets and liabilities, which are measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at March 31, 2023 Using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at December 31, 2022 Using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9e7d370e72b448e2a20136c9d41a611a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNC0xLTEtMS01NDQ4Mw_861a9582-ba00-42bc-922a-ec9fb1114aef"
      unitRef="usd">33219000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i686a387809184aaa8b50bc8cc6187e9a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNC0zLTEtMS01NDQ4Mw_3e7483cb-9a2f-4f2d-9624-bddc56b7363f"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i86ecb94b9d984d25b19dab4395167083_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNC01LTEtMS01NDQ4Mw_69d954d0-9ca3-42e5-87c7-bb89a01524e0"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i24b9d85917e44b37a2c2ee5fba4bb13d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNC03LTEtMS01NDQ4Mw_b1a187a8-0638-49ec-8ca3-3381b74b25c7"
      unitRef="usd">33219000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id28c0fdc526e4f449092eb7231d7981a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNi0xLTEtMS03MjA3Nw_51c4cc66-2a2a-45dc-bce3-de3de5c45f7d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i78bf0b3f545e49799c0cf64e8fcc4d0d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNi0zLTEtMS03MjA3Nw_921be66d-4958-4b7f-8c5a-a31d711be43f"
      unitRef="usd">16998000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic48f4328d06740f69e82bae9d7f08326_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNi01LTEtMS03MjA3Nw_6e732331-d7ef-46a4-933a-2d2122fb6b88"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i226002d2e8c3483999dbe6e1536bc05d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfNi03LTEtMS03MjA3Nw_7307d213-6738-438c-a168-27e56ead9287"
      unitRef="usd">16998000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6e4e5e96f3f249ad8b7059648464f925_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOC0xLTEtMS01NDQ4Mw_655aff9b-083e-4f11-bcd7-ddd1ec015361"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i02cfa68b2fd349328e287ea50a6ac000_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOC0zLTEtMS01NDQ4Mw_4139c6bd-d47d-4c2c-acdb-a5fbd4363110"
      unitRef="usd">2912000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc1aa441de3a4917a6058ce4f3a680f5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOC01LTEtMS01NDQ4Mw_e3466847-ba16-41f4-adee-9737e356c35b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iec137b73eb794feb8171dd03dd591a9e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOC03LTEtMS01NDQ4Mw_4fd31c70-d8ed-4cc5-a0be-c0ff471f0d1a"
      unitRef="usd">2912000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic7a6e0cb2e5a44cbb8cc75a960fa04b7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtMS0xLTEtNzIwODM_b085a524-9b61-4b47-a305-469de16ab173"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib00daf24652143c5a0de12e6924f3607_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtMy0xLTEtNzIwODM_35a4d73d-0ceb-4578-8272-c60e1bbf1bba"
      unitRef="usd">10860000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6d88f74ab4b24a56895f526a176976f8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtNS0xLTEtNzIwODM_f2da6e97-164f-41a0-bcc4-6685d05fdbd6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i60b16e50543348558175caaea85b3122_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtNy0xLTEtNzIwODM_cda436c0-8dc8-4130-852f-20ed00f54159"
      unitRef="usd">10860000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id59576d83db143329d18b549ecb1cac8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOS0xLTEtMS01NDQ4Mw_de998947-e3d3-4afd-90e2-b8f471aa2bfa"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7519c80b092a4ac7a57f59e62e77991e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOS0zLTEtMS01NDQ4Mw_b4f719e6-e183-40d4-aa72-3c05420e4dd0"
      unitRef="usd">38334000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1225ef2f386f4a42975c134708350d10_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOS01LTEtMS01NDQ4Mw_c6601e81-94aa-4af4-9b88-bb87f37ec2f7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i685de5a7038c45189760b9c211f5be9d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfOS03LTEtMS01NDQ4Mw_fc35c30d-f90b-4e7e-a950-270f945b9609"
      unitRef="usd">38334000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i469fee02bf054803a29064895742bcca_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtMS0xLTEtNTQ0ODM_729ccc66-c1a5-4dcc-9b8f-f6477f1d0ffa"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4b3eb52799bb4915b8ccdde486715eba_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtMy0xLTEtNTQ0ODM_4da33bf6-3b5c-4aab-bb84-bcfe9c8b9077"
      unitRef="usd">213223000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i644cf406771343be85fb0303035cc30a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtNS0xLTEtNTQ0ODM_9dcca048-4d52-44bd-90c0-d583395212dd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i20240e23302249feb5d81f005bfe4920_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTAtNy0xLTEtNTQ0ODM_1d5b0057-1323-416d-8bba-28cbd43fb83c"
      unitRef="usd">213223000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2ab63392b2c74b5ab99240d3a67ddf2e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTEtMS0xLTEtNTQ0ODM_71502a63-93c1-4e94-886c-f90e867b1e49"
      unitRef="usd">33219000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idf60218770ed4221baf7f3056c9eb494_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTEtMy0xLTEtNTQ0ODM_1a8ce7ee-df02-45fe-8834-27481c2cdd56"
      unitRef="usd">282327000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id35b96fd44f74edfa4730b85402d177b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTEtNS0xLTEtNTQ0ODM_040d87ce-635f-4c4b-84a3-16ab08797dbe"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia9d68f7e99d1431eb12bc2400a498113_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTEtNy0xLTEtNTQ0ODM_1f259b01-fe2d-42e7-a2a8-887366be1de5"
      unitRef="usd">315546000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iaae8d45dbde14f8d8de46117ec781d4d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTYtMS0xLTEtNTQ0ODM_3a9bc025-353f-4fa2-b246-167869aeeb28"
      unitRef="usd">28077000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i57c7ac8901bd4d7daac300b48c7919ec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTYtMy0xLTEtNTQ0ODM_7a37740e-ebe1-4aa3-ac77-9b3fb7a8c611"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id695c0b8a3e24d06a747342d16c3d091_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTYtNS0xLTEtNTQ0ODM_b9c66a53-e2dd-491b-b453-551663d810ed"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5f4e06b5736f4b7f90965814e6fb2834_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTYtNy0xLTEtNTQ0ODM_1599477f-adf5-45a1-a2f2-e5325f92e3d6"
      unitRef="usd">28077000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3816c705b119429ea8c4ca667dd7af1a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctMS0xLTEtNzA2OTA_e4b224a7-0969-43b8-8533-eede28957902"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib3e370a92af44ccbaa5d713dfe2a8fb1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctMy0xLTEtNzA2OTA_56e3216f-b52c-4d8c-8209-bbcd1b2cb5ef"
      unitRef="usd">1998000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if5aa2802907e4a0e80ba161a3b27fac2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctNS0xLTEtNzA2OTA_e8fb3a1f-e4a9-47ae-b953-5a1e59888cec"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9f3c7b44e12a4950b574e402e90a4e96_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctNy0xLTEtNzA2OTA_60eece9d-4eb2-4e26-be36-d80441b23679"
      unitRef="usd">1998000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id11f9d139c334e3e877bbc1b71a3bcb0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctMS0xLTEtNTQ0ODM_add91716-4835-45a7-be90-9e98f3a57a53"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2b0898b80bf94bd3a1898a19e50c68e4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctMy0xLTEtNTQ0ODM_afc8ec87-cdd8-49e4-93a0-ccef4529a084"
      unitRef="usd">22139000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i91c08e1329914a148a2969a210c89c47_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctNS0xLTEtNTQ0ODM_e831cb7a-c561-4df1-b4d5-54b82f66591c"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i71476e1da87a4e8f9ea82e1558b4b1a0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTctNy0xLTEtNTQ0ODM_7c0d6727-7a50-4ede-8343-f37b89dfab6d"
      unitRef="usd">22139000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icec32c8d710e4052a2ea76320025a801_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtMS0xLTEtNzA2OTI_b0c42bd4-47a7-4b55-b15c-dfa82a776894"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i73e10639ef0246c198a7a50e793bbcbd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtMy0xLTEtNzA2OTI_ec911bef-50a7-4997-90f1-489ba4c43bdd"
      unitRef="usd">7872000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i314ef289b4614198b2006dc7331ea1c7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtNS0xLTEtNzA2OTI_a4abcf34-5a03-4bd2-b681-3e1451d6b8d7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie4950fd3c93f40b8917a76b077c0c64b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtNy0xLTEtNzA2OTI_03b6a9a1-853b-4649-b3d6-b759e000205f"
      unitRef="usd">7872000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id2b1e949f6974b58964fd91bd5f979d7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTktMS0xLTEtNTQ0ODM_e8aec726-00e5-4059-8095-ca11eab0b683"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa55d59c40f34aaba7d356a0fbff653f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTktMy0xLTEtNTQ0ODM_ca51fde4-51b1-4e8d-a193-6a7e4e7eea85"
      unitRef="usd">56398000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i817ec589b1634a54955b21c64565e8ea_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTktNS0xLTEtNTQ0ODM_5836d21b-4fab-4199-a6e5-f050d60b4b92"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9df0cfa07c49422683e3147992721a62_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMTktNy0xLTEtNTQ0ODM_5ab67153-d2b7-4b1d-a816-9646e43968fe"
      unitRef="usd">56398000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf0f225480c34371bc29f61873b9ae64_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtMS0xLTEtNTQ0ODM_f7755e71-d8bd-4716-97c3-32a1cdb8adb5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icee323c63b8a4f55a03f6972bf66bacb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtMy0xLTEtNTQ0ODM_68ca4775-d393-4f7f-a814-ba5133bdb716"
      unitRef="usd">229314000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib1ce20a435b94f1782ba0f50fd86a8b8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtNS0xLTEtNTQ0ODM_0897cf91-8b1c-4291-a491-1df78be014d8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie8a50f4fbb394949aeccc379c70c428a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjAtNy0xLTEtNTQ0ODM_710de2b5-5693-42dd-b2cb-bf981d6d991a"
      unitRef="usd">229314000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia4a9f200afdd4b0499bec1ec0815830a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjEtMS0xLTEtNTQ0ODM_5599deb0-acc5-4127-a641-764a0201a184"
      unitRef="usd">28077000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8af856e6f8244114882cf272fe719890_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjEtMy0xLTEtNTQ0ODM_45bb9ae1-8caa-4904-a417-099fe4c8a666"
      unitRef="usd">317721000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0f76a5224ab9460ab1687a0e61c62469_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjEtNS0xLTEtNTQ0ODM_459e03d2-a9b0-4ba9-b202-26199f8df3bc"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i313c23ac84db459aa067b05c470e8c41_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180My9mcmFnOjY3OWNmMDRlMDE4OTRkMTJiN2ZhYmEyMGRlYTRmNTZjL3RhYmxlOmExNjY3ZjlhYWJjNDQ0YzdiMjIxZjdhZDRlZGI1ZWE3L3RhYmxlcmFuZ2U6YTE2NjdmOWFhYmM0NDRjN2IyMjFmN2FkNGVkYjVlYTdfMjEtNy0xLTEtNTQ0ODM_433b22ff-9a4c-4886-b7f8-89a2c0a5bff1"
      unitRef="usd">345798000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RleHRyZWdpb246NTM5ZTZjYzRmZDhkNGM5NGJhODZhZTczMTE1MDNkYjFfMjcy_c65e8433-a9a7-48cf-a59e-3ac9cee9fde4">Property and Equipment, Net&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets not yet placed in service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Depreciation and amortization expense was $0.9&#160;million and $0.8&#160;million for the three months ended March&#160;31, 2023 and 2022, respectively</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RleHRyZWdpb246NTM5ZTZjYzRmZDhkNGM5NGJhODZhZTczMTE1MDNkYjFfMjcz_246b1089-9389-434f-a814-cda794533784">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets not yet placed in service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i0e381c984bf544cfb0a2749f7b7bde14_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMS0xLTEtMS01NDQ4Mw_8fad5d10-7352-4422-8669-000608f1d3fb"
      unitRef="usd">6337000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ia478d511da57498795c16881932b6687_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMS0zLTEtMS01NDQ4Mw_8ebd4119-54e9-425f-ba91-95648e7c75a0"
      unitRef="usd">5884000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i8db8c7bc36df4ad98557037afc88e098_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMi0xLTEtMS01NDQ4Mw_4b20be78-6cb5-4960-929f-192ddfd17af4"
      unitRef="usd">815000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i4069cd6268314c4eb4dc21bd8aa31034_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMi0zLTEtMS01NDQ4Mw_732de853-5d4a-4590-998a-d8dcf6f51c1c"
      unitRef="usd">815000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i15776fdc2f634cd2b8afecdccc812ee3_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMy0xLTEtMS01NDQ4Mw_3a4d921e-159d-4011-910b-e0966c5e55cb"
      unitRef="usd">115000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i8c2ae1d1ba35403ba1cfeec4178824b6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfMy0zLTEtMS01NDQ4Mw_8db3beb1-dabc-4363-a998-8ec9a8ff14b9"
      unitRef="usd">100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="iff620723fc0c49618aaa87a660c11285_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNC0xLTEtMS01NDQ4Mw_0e2065e8-be72-486e-964e-d0f869aa39da"
      unitRef="usd">17235000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i51a85b1b3aa94e2a88d7205cbf50b9a0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNC0zLTEtMS01NDQ4Mw_1c900e34-75b5-4b0d-9855-aa4be2447ecb"
      unitRef="usd">17123000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ic713b3b8646d4e9c952914b317f34c25_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNS0xLTEtMS01NDQ4Mw_13848450-edf7-478c-8df5-5b493fee69bc"
      unitRef="usd">193000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i2f03ccf48fbd464fbb077f9ae05ad5f5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNS0zLTEtMS01NDQ4Mw_10dd9c4d-e68c-47e4-a3d4-4673c7b290d1"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNi0xLTEtMS01NDQ4Mw_1edad350-c288-445c-84ec-4a16a0fb9936"
      unitRef="usd">24695000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNi0zLTEtMS01NDQ4Mw_0fd2678c-ca77-4467-b871-fba054a230e8"
      unitRef="usd">23922000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNy0xLTEtMS01NDQ4Mw_5d90d259-b0f9-429a-ae37-9ccb01751ec6"
      unitRef="usd">9470000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfNy0zLTEtMS01NDQ4Mw_2314d414-4893-4d51-95b0-4e52304b92e5"
      unitRef="usd">8611000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfOC0xLTEtMS01NDQ4Mw_98b2d215-bc95-4b02-bd70-43a1c85a1547"
      unitRef="usd">15225000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RhYmxlOjYxZjJhZjVlZDg5YjQ1ZDY5MDAxMTc4NWE0OWE5OGRiL3RhYmxlcmFuZ2U6NjFmMmFmNWVkODliNDVkNjkwMDExNzg1YTQ5YTk4ZGJfOC0zLTEtMS01NDQ4Mw_2d1df288-fd8e-4fec-85a6-c28ed9c10e0c"
      unitRef="usd">15311000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RleHRyZWdpb246NTM5ZTZjYzRmZDhkNGM5NGJhODZhZTczMTE1MDNkYjFfMTQ5_8df2eb02-71aa-4579-bb36-f02bf2b54523"
      unitRef="usd">900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180Ni9mcmFnOjUzOWU2Y2M0ZmQ4ZDRjOTRiYTg2YWU3MzExNTAzZGIxL3RleHRyZWdpb246NTM5ZTZjYzRmZDhkNGM5NGJhODZhZTczMTE1MDNkYjFfNTQ5NzU1ODEzOTI4OA_476dc952-842e-4770-99f5-715cba724b09"
      unitRef="usd">800000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RleHRyZWdpb246OThlNDNkYTc5OTE1NDA1OTlhNmQwN2E1NDU3Yjk2MDRfMTE0_6456c431-b597-4bc5-b7f7-85e817a98a7e">Accrued Expenses and Other Current Liabilities&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued external research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RleHRyZWdpb246OThlNDNkYTc5OTE1NDA1OTlhNmQwN2E1NDU3Yjk2MDRfMTEz_ae8b28bf-569d-4e6b-9b32-2a006f5598e4">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued external research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <fhtx:AccruedResearchAndDevelopmentExpenses
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMS0xLTEtMS03Mzg2Nw_0b8f159f-56fc-4c23-88be-d28b234e3e87"
      unitRef="usd">5891000</fhtx:AccruedResearchAndDevelopmentExpenses>
    <fhtx:AccruedResearchAndDevelopmentExpenses
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMS0zLTEtMS03Mzg2Nw_75af4f39-13b7-4e86-9d0d-72e78e464422"
      unitRef="usd">5262000</fhtx:AccruedResearchAndDevelopmentExpenses>
    <us-gaap:AccruedIncomeTaxes
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMi0xLTEtMS03Mzg4Ng_d5214ac0-cdc6-4190-99b5-499e0e78866c"
      unitRef="usd">560000</us-gaap:AccruedIncomeTaxes>
    <us-gaap:AccruedIncomeTaxes
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMi0zLTEtMS03Mzg4Ng_9aeadf4d-92e6-4684-bc4e-5adfdb3b6979"
      unitRef="usd">0</us-gaap:AccruedIncomeTaxes>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMS0xLTEtMS01NDQ4Mw_c393d574-0893-4848-aeb4-389397538fb9"
      unitRef="usd">1671000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMS0zLTEtMS01NDQ4Mw_41847210-4e81-436a-9821-5a36c9edcf67"
      unitRef="usd">4743000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMy0xLTEtMS01NDQ4Mw_d5273256-a591-4233-9873-291f5e9cfd7d"
      unitRef="usd">574000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfMy0zLTEtMS01NDQ4Mw_a8cd3dff-eb9c-4622-a10e-8f79d6ed2667"
      unitRef="usd">678000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfNS0xLTEtMS01NDQ4Mw_5b14e13e-160e-473d-9e27-9e9a1d0b7bc7"
      unitRef="usd">135000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfNS0zLTEtMS01NDQ4Mw_8be12e06-8161-4c57-85e4-1059dca141d8"
      unitRef="usd">318000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfNi0xLTEtMS01NDQ4Mw_2f1b4252-ec75-4e31-908c-b602dde59320"
      unitRef="usd">8831000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7e122d6defbe4f6dbe52b8c770283e5f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN180OS9mcmFnOjk4ZTQzZGE3OTkxNTQwNTk5YTZkMDdhNTQ1N2I5NjA0L3RhYmxlOjJlMmFhZWFlZTNmYTQzNmU5YmQ4MmU0Mjc4OTMwNWJiL3RhYmxlcmFuZ2U6MmUyYWFlYWVlM2ZhNDM2ZTliZDgyZTQyNzg5MzA1YmJfNi0zLTEtMS01NDQ4Mw_a6c61d1e-23b3-4d5c-92da-23cc7798bc0f"
      unitRef="usd">11001000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RleHRyZWdpb246YTE2NDI4ZjYxN2RhNDY0N2FlNWYyZGI4MGY1YmU0MWZfNTMw_784529fb-7a08-4d46-b5de-560be1b6c6d0">Common Stock and Net Loss Per Share&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#x2019;s stockholders. Common stockholders are not entitled to receive dividends, unless declared by the board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents presented based on amounts outstanding at each period end have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,666,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,772,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,684,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,790,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <fhtx:CommonStockVotingRightsVotes
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RleHRyZWdpb246YTE2NDI4ZjYxN2RhNDY0N2FlNWYyZGI4MGY1YmU0MWZfMTA1_6a8dc13a-4bb7-4707-b73a-51f3187e970e"
      unitRef="vote">1</fhtx:CommonStockVotingRightsVotes>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RleHRyZWdpb246YTE2NDI4ZjYxN2RhNDY0N2FlNWYyZGI4MGY1YmU0MWZfNTMy_67688bb0-3b0e-48c2-8e56-8400bfdd5cf4">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents presented based on amounts outstanding at each period end have been excluded from the calculation of diluted net loss per share because including them would have had an anti-dilutive impact:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,666,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,772,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,684,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,790,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4cc0d48a32c3455495ce27d4f7ddeea1_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfMi0xLTEtMS01NDQ4Mw_d4089eb5-e6b9-4014-a478-3da78a998af2"
      unitRef="shares">9666311</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icdd9cd9080824f859292dd01a8c3382f_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfMi0zLTEtMS01NDQ4Mw_011d4d88-ea92-4245-a5e4-aae1aac46f4e"
      unitRef="shares">7772058</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9d6f5962b24a487098593ec15299f24a_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfMy0xLTEtMS01NDQ4Mw_fdd983d8-56f2-4916-9cb6-6a41258e0c8d"
      unitRef="shares">18445</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i253b75ffb52440b49b4e9bbe4fb210dd_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfMy0zLTEtMS01NDQ4Mw_bc5f1f56-a2a0-466b-a7e7-d6d8aa02cd76"
      unitRef="shares">18445</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfNC0xLTEtMS01NDQ4Mw_b47464b5-f4d8-4ae5-a7d9-6ff4fccef3dd"
      unitRef="shares">9684756</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181Mi9mcmFnOmExNjQyOGY2MTdkYTQ2NDdhZTVmMmRiODBmNWJlNDFmL3RhYmxlOjJkN2UzZmVhOGI4MzQ1ZTA5NTI3NmU2YzY3NjQ2M2YzL3RhYmxlcmFuZ2U6MmQ3ZTNmZWE4YjgzNDVlMDk1Mjc2ZTZjNjc2NDYzZjNfNC0zLTEtMS01NDQ4Mw_e444dd47-b44b-4ed2-bbc4-4beaa39812d4"
      unitRef="shares">7790503</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNDEzNQ_637b94e0-e18c-4811-97cc-a26f2a0bb2f9">Stock-Based Compensation&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2020 Equity Incentive Plan ( the &#x201c;2020 Plan&#x201d;) provides for the grant of incentive stock options, non-qualified options, stock appreciation rights, restricted stock awards, restricted stock units and other stock-based awards. The number of shares initially reserved for issuance under the 2020 Plan was (i) 2,200,000 shares (the &#x201c;share pool&#x201d;), plus (ii) the number of shares of common stock available for issuance under the Company&#x2019;s 2016 Stock Incentive Plan (the &#x201c;2016 Plan&#x201d;) as of the effective date of the 2020 Plan, plus the number of shares of common stock underlying awards under the 2016 Plan that on or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;after the date of adoption expire or become unexercisable without delivery of shares, are forfeited to, or repurchased for cash, are settled in cash, or otherwise become available again for grant under the 2016 Plan, in each case, in accordance with its terms (up to an aggregate of 5,078,295 shares). As of March&#160;31, 2023, 1,359,407 shares remained available for future grant under the 2020 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The share pool will automatically increase on January 1 of each year from 2021 to 2030 by the lesser of (i) four percent of the number of shares of our common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares determined by the board of directors on or prior to such date for such year. The number of shares reserved for issuance under the 2020 Plan was increased by 1,672,137 shares effective January 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Plan is administered by the board of directors or, at the discretion of the board of directors, by a committee of the board of directors. The exercise prices, vesting and other restrictions are determined at the discretion of the board of directors, or its committee if so delegated. Stock options granted with service-based vesting conditions generally vest over four years and expire after ten years. The exercise price for stock options granted is not less than the fair value of common stock on the date of grant. The Company bases fair value of common stock on the quoted market price. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 21, 2020, the Company&#x2019;s board of directors adopted and its stockholders approved the 2020 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;), which became effective on October 21, 2020. The aggregate number of shares of common stock available for purchase pursuant to the exercise of options under the ESPP is 360,000 shares, plus an automatic annual increase, as of January 1 of each year from 2021 to 2030, equal to the lesser of one percent of the number of shares of common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares determined by the board of directors on or prior to such date for such year (up to a maximum of 3,220,520 shares). The number of shares reserved for issuance under the ESPP was increased by 418,034 shares to 1,184,497 shares effective January 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Eligible employees may authorize payroll deductions of up to 15% of their eligible compensation during an offering period. The purchase of shares is done at a 15% discount on the lesser of (i) the Fair Market Value of a share of Stock on the first day of the offering period and (ii) the Fair Market Value of a share of Stock on the last day of the offering period. The Company currently holds two offering periods, September 1 and March 1, respectively.&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The first offering period commenced under the ESPP on September 1, 2021. The Company recognized a de minimis amount of expense related to the ESPP for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, total unrecognized compensation cost related to unvested options was $40.6 million, which is expected to be recognized over a weighted average period of 2.7 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i3ff3d19669cd4af68367e024a5550402_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNzQz_421ebac8-ee46-4bd2-945d-b70e0b5e7d05"
      unitRef="shares">2200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="id06ab9cb3fff4cedb3c46e4ccf43eb35_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMTI4MA_4d2ccb6e-1ce2-491b-8841-eafcf15d5417"
      unitRef="shares">5078295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i3ff3d19669cd4af68367e024a5550402_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMTMwMg_1a9ca0d4-cbc1-420b-b4fe-5a235e63b459"
      unitRef="shares">1359407</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage
      contextRef="i1d79c74373c442b499c7ddd85c70b8dd_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMTQ3Nw_651d5f68-a920-4329-9d53-2aa02b5f4b0f"
      unitRef="number">0.04</fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i2c27d19751c94d7eb6c46feae55f646f_D20220101-20220101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMTgwMA_03c51650-3c02-4ae4-8651-cc0b635af110"
      unitRef="shares">1672137</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1d79c74373c442b499c7ddd85c70b8dd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMjIxMA_4ed4e167-3b3e-44d2-98a1-b992cba43cde">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i1d79c74373c442b499c7ddd85c70b8dd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMjIzMA_7f80503a-cf57-4633-8c62-4ff42c91863a">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i69fa4e2b8bc24bf388f1f890c4ecf2e2_I20201021"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMzExNA_24770ea8-9e02-40b7-a19c-f82656279f04"
      unitRef="shares">360000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage
      contextRef="ib8a38bc229cb4e8bb77f5c2c4c4b0cd0_D20201021-20201021"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMzIzMQ_1518ffb6-20c7-4b03-adfe-64cda1d5b0cb"
      unitRef="number">0.01</fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage>
    <fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares
      contextRef="i891fd370eb434c04aa39afcf2287fbff_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMzQ4OQ_3a4ddcec-ceec-4a1f-9927-67182b81f84b"
      unitRef="shares">3220520</fhtx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i09392e1f7a274b01845cedcdc8ed5acd_D20230101-20230101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMzU3Ng_bdf238a6-65b0-4e77-81d9-a1443069ac07"
      unitRef="shares">418034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i6182cbed24bc4b8ab1aa853c3f9e2cb3_I20230101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfMzU4OQ_ebe4fb74-4f34-44b7-a317-d147d4eefe35"
      unitRef="shares">1184497</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i891fd370eb434c04aa39afcf2287fbff_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNjU5NzA2OTc3NTMyNA_c4b159b9-7192-4a93-8eec-ab5dd1df81fd"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
      contextRef="id6ce4bd203a74a629ec0457813c1657f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNjU5NzA2OTc3NTMxOA_1c425423-e397-46b5-88f5-9cd37a15d908"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNDEzNw_64eddafa-515b-46a5-a2d5-d41d675f7bbb">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i95f74147740a473d8c886cfbe8d8cf9f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfMi01LTEtMS01NDQ4Mw_003d88e6-e4aa-4c91-9e96-e30799d50b0d"
      unitRef="usd">2039000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2e516a981dbe4601a952b105e005f398_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfMi03LTEtMS01NDQ4Mw_3ccb7a70-ffe8-46a2-bbb9-824b5f7a70b0"
      unitRef="usd">1509000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6112131b7aec49b494f0b988b8f51e90_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfMy01LTEtMS01NDQ4Mw_96b32c0d-ac2a-4fab-ad0e-6cbe13267a8d"
      unitRef="usd">2533000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5ac8dbde3e704d4ea43e4284fbd658c5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfMy03LTEtMS01NDQ4Mw_de8891f9-9d57-4ea9-9025-f0f36f20ac4b"
      unitRef="usd">1735000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfNC01LTEtMS01NDQ4Mw_5c445cca-c032-490e-8a3b-b2138e1d385a"
      unitRef="usd">4572000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iff99a815e1ab4e7ea2ad525b0b669866_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RhYmxlOjZkZGRlYWMyYTU1NzQ5MzliYmU2OGE4NGNiOWIwZjgyL3RhYmxlcmFuZ2U6NmRkZGVhYzJhNTU3NDkzOWJiZTY4YTg0Y2I5YjBmODJfNC03LTEtMS01NDQ4Mw_8e2184fd-e51d-48ce-9cea-7454de94fde8"
      unitRef="usd">3244000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ifc737888b72c4abab3c2751c5194dcad_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNDA2MA_3d8fe3d2-9b16-496a-8b32-fb810d6079ff"
      unitRef="usd">40600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181NS9mcmFnOjQ1N2I3ZGI4MjJjNzQzNDU4NzVkYjUyMzk3MTgzNjE2L3RleHRyZWdpb246NDU3YjdkYjgyMmM3NDM0NTg3NWRiNTIzOTcxODM2MTZfNDEzMw_702d1bc8-47c0-4082-9014-5d5640972391">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTg1MzM_95c0e76d-537a-43ef-97e7-3a32cf9695ce">Collaboration Agreements&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lilly Collaboration Agreement and Stock Purchase Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company entered into the Lilly Collaboration Agreement with Lilly to create novel oncology medicines by applying Foghorn&#x2019;s proprietary Gene Traffic Control platform. The collaboration includes a co-development and co-commercialization agreement for the Company&#x2019;s selective BRM oncology target, consisting of two programs, and one additional undisclosed oncology target (collectively, the &#x201c;Joint Programs&#x201d;). The collaboration also includes three additional discovery targets or programs (collectively, the &#x201c;Discovery Programs&#x201d;) for a total of six programs directed at five targets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to the Joint Programs, the Company will lead discovery and early research activities through the successful completion of dose finding toxicity studies for the identified compound, while Lilly will lead development and commercialization activities of the identified compound with participation from the Company in development activities and 50% cost sharing until registrational clinical trials. The Company and Lilly may jointly develop and commercialize the Joint Program compound though the Company may, in its sole discretion, opt-out on a program-by-program basis of further &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;participation in the development and commercialization efforts prior to the first registrational clinical trial. If the Company does not opt-out, Lilly and the Company will continue to share in the costs to further develop and commercialize the Joint Program compound on a worldwide basis, equally share in the U.S. profits on product sales, subject to certain adjustments and receive royalties on sales outside of the United States (&#x201c;Ex-U.S.&#x201d;) at royalty rates ranging from low double digits to high twenties. If the Company opts-out of further development and commercialization efforts, it will have no further obligations to share in the development and commercialization costs, will receive royalties rather than profit share on U.S. sales and will receive royalties at a lower rate on Ex-U.S. sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to the Discovery Programs, the Company will lead discovery and early research activities through the successful completion of dose finding toxicity studies for the identified compounds. The Company may, in its sole discretion, opt-in on a program-by-program basis after the successful completion of dose finding toxicity to participate in the further development and commercialization efforts of the Discovery Program compounds. If the Company opts-in to the development and commercialization of the Discovery Program compounds, it will be eligible to receive milestone payments of up to $10.0 million per program upon specified research and development milestones and up to $180.0 million per program upon achievement of specified regulatory and commercial milestones and will also be eligible to share in the U.S. profits at pre-determined percentages on product sales. The Company would also be eligible to receive tiered Ex-U.S. royalty rates, calculated on a product-by-product and country-by-country basis, on net sales outside of the United States, if any, ranging from low single digits to low double digits, but less then teens. If the Company does not opt-in to further development and commercialization efforts for the Discovery Programs, it will be eligible to receive milestone payments of up to $70.0 million per program upon specified research and development milestones and up to $360.0 million per program upon achievement of specified regulatory and commercial milestones per approved product, if any. The Company would also be eligible to receive tiered royalties on net sales of products worldwide at royalty rates ranging from low single digits to low double digits, but less then teens.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lilly has the right to make substitutions for each of the five targets during the research term of each program, subject to certain limitations. Pursuant to the Lilly Collaboration Agreement, the Company will also participate in joint decision-making through the joint steering committee and subcommittees. Unless terminated earlier, the Lilly Collaboration Agreement will continue on a product-by-product basis until the expiration of all royalty obligations under the Lilly Collaboration Agreement and when neither the Company nor Lilly is developing, commercializing or manufacturing any product under the Lilly Collaboration Agreement. The Company or Lilly may terminate the Lilly Collaboration Agreement upon an uncured material breach by the other party. Lilly may also terminate the Lilly Collaboration Agreement in its entirety or on a target-by-target, program-by-program or product-by-product basis for any reason upon certain notice to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that (1) the research activities performed by the Company for both the Joint Programs and the Discovery Programs (2) the development activities and cost sharing for the Joint Program development efforts after dose finding toxicity until registrational clinical trials (3) the research, development, manufacture and commercialization licenses and (4) service on the joint steering committee and subcommittees represent a single performance obligation under the Lilly Collaboration Agreement. The Company determined that Lilly cannot benefit from the licenses separately from the research activities, the development activities until registrational clinical trials and participation on the joint steering committee and subcommittees because these services are specialized and rely on the Company&#x2019;s expertise such that these activities are highly interrelated and therefore not distinct. Accordingly, the promised goods and services represent one combined performance obligation, and the entire transaction price was allocated to that single combined performance obligation. The performance obligation will be satisfied over time as the Company performs the research activities, participates and shares in the cost of the development activities for the Joint Programs and participates in a joint steering committee and subcommittees to oversee these activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s options to share in further development and commercialization efforts via its opt-in/opt-out rights will be assessed and accounted for as separate units of accounting under the relevant guidance if, and when, such options are exercised by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation was $315.1&#160;million, which is expected to be recognized as revenue through 2029 or beyond depending on the timing of certain clinical development activities. As of December 31, 2022, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation was $319.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023 and 2022, the Company had recorded $4.7 million and $3.8 million, respectively, of revenue under the Lilly Collaboration Agreement, which was included in deferred revenue at the beginning of the respective periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Merck Collaboration Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company entered into a collaboration agreement (the &#x201c;Merck Collaboration Agreement&#x201d;) with Merck Sharp &amp;amp; Dohme Corp. (or &#x201c;Merck&#x201d;). The Company and Merck will apply Foghorn&#x2019;s proprietary Gene Traffic Control platform to discover and develop novel therapeutics. Under the Merck Collaboration Agreement, the Company granted Merck exclusive global rights to develop, manufacture and commercialize drugs that target dysregulation of a single transcription factor. Under the terms of the Merck Collaboration Agreement, the Company and Merck are each responsible to perform certain research activities in accordance with a mutually-agreed upon research plan. Merck may substitute the selected transcription factor during certain stages of the research program, subject to certain limitations. Following completion of the research program, Merck is responsible for the development and commercialization of the compounds developed pursuant to the research program and any product containing such compounds. Pursuant to the Merck Collaboration Agreement, the Company will also participate on a joint steering committee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the agreement, Foghorn received a nonrefundable upfront payment of $15.0 million from Merck, and is eligible to receive up to $245.0 million upon achievement of specified research, development and regulatory milestones by any product candidate generated by the collaboration, and up to $165.0 million upon achievement of specified sales-based milestones per approved product from the collaboration, if any. The Company will be eligible to receive tiered royalties, calculated on a product-by-product and country-by-country basis, on net sales of approved products from the collaboration, if any, at royalty rates ranging from the mid-single digits to low tens, depending on whether the products are covered by patent rights it licenses to Merck.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless terminated earlier, the Merck Collaboration Agreement will continue in full force and effect until one or more products has received marketing authorization and, thereafter, until expiration of all royalty obligations under the Merck Collaboration Agreement. The Company or Merck may terminate the Merck Collaboration Agreement upon an uncured material breach by the other party or insolvency of the other party. Merck may also terminate the Merck Collaboration Agreement for any reason upon certain notice to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that the (1)&#160;research, development, manufacture and commercialization licenses, (2) the research activities performed by the Company and (3)&#160;service on the joint committees represent a single performance obligation under the Merck Collaboration Agreement. The Company determined that Merck cannot benefit from the licenses separately from the research activities and participation on the joint steering committee because these services are specialized and rely on the Company&#x2019;s expertise such that these activities are highly interrelated and therefore not distinct. Accordingly, the promised goods and services represent one combined performance obligation and the entire transaction price was allocated to that single combined performance obligation. The performance obligation will be satisfied over the research term as the Company performs the research activities and participates in a joint steering committee to oversee research activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the $240.0 million of potential research, development and regulatory milestone payments that the Company is eligible to receive and have not already been achieved were excluded from the transaction price as they were fully constrained by uncertain events. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the third quarter of 2022, the Company achieved a research milestone related to the Merck Collaboration Agreement and received a $5.0 million milestone payment from Merck.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation is $16.4 million, which is expected to be recognized as revenue through approximately 2028. As of December&#160;31, 2022, the aggregate amount of the transaction price related to the unsatisfied portion of the performance obligation is $17.0 million.&lt;/span&gt;&lt;/div&gt;For the three months ended March&#160;31, 2023 and 2022, the Company had recorded $0.6 million and $0.1 million, respectively, of the revenue under the Merck Collaboration Agreement, which was included in deferred revenue at the beginning of the respective periods and the classification of deferred revenue between short term and long term.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <fhtx:NumberOfAdditionalTargets
      contextRef="id704eaec79f3499d8b4e968f504e58eb_D20211201-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNTgx_113d35b8-30b6-4cfb-ad07-ac91c2452358"
      unitRef="target">3</fhtx:NumberOfAdditionalTargets>
    <fhtx:NumberOfPrograms
      contextRef="id3e63d9fb12c49febbf0ab26cfed6a9a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNjgx_b864110e-55d1-4d45-8892-0b2d71077412"
      unitRef="program">6</fhtx:NumberOfPrograms>
    <fhtx:NumberOfTargets
      contextRef="id3e63d9fb12c49febbf0ab26cfed6a9a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNzA1_ca76e40c-59b9-46be-88f2-47a020ecb7b0"
      unitRef="target">5</fhtx:NumberOfTargets>
    <fhtx:MilestoneReceivableUponAchievement
      contextRef="ie2d1ee7b60654dcdbf509fe84739b901_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMjcxNg_808c18f3-c87a-4a61-a298-1f11b49f2732"
      unitRef="usd">10000000</fhtx:MilestoneReceivableUponAchievement>
    <fhtx:MilestoneReceivableUponAchievement
      contextRef="ia2c5f857c11b4186bd0df9d1860dcca9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMjc5Mg_79998fee-f1cc-4b91-9837-df9884d50009"
      unitRef="usd">180000000</fhtx:MilestoneReceivableUponAchievement>
    <fhtx:OptOutMilestoneReceivableUponAchievement
      contextRef="ic8e4b7ca8d86457dbee60cfa6bc83796_D20211201-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMzQxNA_17db4506-0579-4c95-98d8-7585700b4c45"
      unitRef="usd">70000000</fhtx:OptOutMilestoneReceivableUponAchievement>
    <fhtx:OptOutMilestoneReceivableUponAchievement
      contextRef="i932a791f229b4a74be687fda2016ec96_D20211201-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMzQ5MA_904e8027-c339-4194-becd-95c73bee85a4"
      unitRef="usd">360000000</fhtx:OptOutMilestoneReceivableUponAchievement>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i0a2f456ce08c4f34b028f7e715d90a75_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfOTMyNA_24a5d6bc-423e-40bf-8ebc-a89ee127c392"
      unitRef="usd">315100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iee2a6d2ade0542e99376dda986298f86_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNTQ5NzU1ODE4MzMxNg_77a4ef9a-93bc-48c0-bb43-273d2a8616a9"
      unitRef="usd">319800000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib745f408204748faa6b611ba2acc4301_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTA4NjU_c40b238e-8008-4bb5-a33d-c060472931ae"
      unitRef="usd">4700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09acd48542c84107bda3a6fcc7e01a93_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNzY5NjU4MTQyNzIwMg_ccbafb2e-719e-404d-98e2-6ed79afbdddb"
      unitRef="usd">3800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <fhtx:ProceedsFromUpfrontPayment
      contextRef="ibd64aeec1acc4410ab6e14c3aec0a76f_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTIzODc_e70b149d-c755-4592-bec7-eb962e3232e8"
      unitRef="usd">15000000</fhtx:ProceedsFromUpfrontPayment>
    <fhtx:MilestoneReceivableUponAchievement
      contextRef="i0f0b1f2ac17b45e3b3937dfb1cd9b00a_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTI0MzU_32ba094d-4ea6-4eac-8873-3403fa059d2b"
      unitRef="usd">245000000</fhtx:MilestoneReceivableUponAchievement>
    <fhtx:MilestoneReceivableUponAchievement
      contextRef="i6c03ef7903fc425585c24387daf3a22a_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTI1ODM_a91aef3a-ea02-4b94-be3b-296181569f51"
      unitRef="usd">165000000</fhtx:MilestoneReceivableUponAchievement>
    <fhtx:MilestoneReceivableUponAchievement
      contextRef="i12af85d4d118413c83b0955c275f72f5_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNTQ5NzU1ODE3MjExMw_4f5c83eb-ea54-4cbd-80da-ef4996ffa058"
      unitRef="usd">240000000</fhtx:MilestoneReceivableUponAchievement>
    <fhtx:PaymentReceivedForAchievementOfMilestones
      contextRef="i8f17ba797a20458c8d273718a2faf5b2_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNTQ5NzU1ODE4NDIzOA_155bfef4-8f34-4f68-9d04-0819116db676"
      unitRef="usd">5000000</fhtx:PaymentReceivedForAchievementOfMilestones>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i4780b20d5ac143ea81ecc13b5a9624b9_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTY2ODQ_9e3e91e4-c293-459c-bc4c-a81ee37c29cd"
      unitRef="usd">16400000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="if77adc7cf7cb4adc886eb30f55a05415_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfNTQ5NzU1ODE4NDA1NA_fbecd130-87f1-492f-808d-e3a6990ddfc4"
      unitRef="usd">17000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23ab0c9afb5749d5ab747dfcc565c03a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTgzMjQ_2885ec68-521a-4a08-b109-d28f63882d4a"
      unitRef="usd">600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ac24b7249a14fd6a8da298f2934b7dd_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN181OC9mcmFnOmRlNDUzYThkZGJkNDRiMzk4N2M3ZDUxZmE3NDM4YjY5L3RleHRyZWdpb246ZGU0NTNhOGRkYmQ0NGIzOTg3YzdkNTFmYTc0MzhiNjlfMTgzMzE_3384fed8-6279-4a6d-b1ea-155e56fc92b3"
      unitRef="usd">100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN185NTAvZnJhZzowNWEzNDAwZDM0YzM0ZjRlODRlNjJjNzkzMTFkYzQ2Mi90ZXh0cmVnaW9uOjA1YTM0MDBkMzRjMzRmNGU4NGU2MmM3OTMxMWRjNDYyXzE2NDkyNjc0NDE4NTY_e4f6a0de-7262-4571-b193-7516924b3625">Income TaxesFor the three months ended March&#160;31, 2023, the Company recorded a provision for income taxes of $0.6&#160;million representing an effective tax rate of 1.86%. The income tax provision and the effective tax rate is primarily driven by the current federal and state taxes related to the $300.0 million upfront payment for Lilly Collaboration Agreement, which will be recognized as taxable income in the current year, and the required capitalization of research and development costs pursuant to Internal Revenue Code Section 174. As a result, the Company expects to have taxable income in the current year, which will be reduced by utilizing available net operating loss carryforwards and research and development tax credit carryforwards.The Company accrued the provision for income taxes in accrued expenses and other current liabilities on the condensed consolidated balance sheets.The Company has evaluated the positive and negative evidence bearing upon its ability to realize the deferred tax assets. Management has considered the Company&#x2019;s history of cumulative net losses incurred since inception and its lack of commercialization of any products that would generate revenue from product sales and has concluded that it is more likely than not that the Company will not realize the benefits of the deferred tax assets. Accordingly, a full valuation allowance has been established against the net deferred tax assets.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN185NTAvZnJhZzowNWEzNDAwZDM0YzM0ZjRlODRlNjJjNzkzMTFkYzQ2Mi90ZXh0cmVnaW9uOjA1YTM0MDBkMzRjMzRmNGU4NGU2MmM3OTMxMWRjNDYyXzE4MTQxOTQxODYyNDg4_232999a1-cce5-4a3b-9dfc-31cfe7c2421e"
      unitRef="usd">600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN185NTAvZnJhZzowNWEzNDAwZDM0YzM0ZjRlODRlNjJjNzkzMTFkYzQ2Mi90ZXh0cmVnaW9uOjA1YTM0MDBkMzRjMzRmNGU4NGU2MmM3OTMxMWRjNDYyXzY1OTcwNjk3NzA4MzI_74d5c123-9f0d-4135-ae7b-96f27fa27814"
      unitRef="number">0.0186</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <fhtx:ProceedsFromUpfrontPayment
      contextRef="i207a64c5b4d845b1a5061cf046b448ba_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN185NTAvZnJhZzowNWEzNDAwZDM0YzM0ZjRlODRlNjJjNzkzMTFkYzQ2Mi90ZXh0cmVnaW9uOjA1YTM0MDBkMzRjMzRmNGU4NGU2MmM3OTMxMWRjNDYyXzU0OTc1NTgxNDIzNDg_7cc305a0-3105-4f41-bbf2-b7ae9a3d215f"
      unitRef="usd">300000000</fhtx:ProceedsFromUpfrontPayment>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182MS9mcmFnOjgyNWViZDE4NzdiNzQ4ZTk4M2UyMmJmYzU4ZGRlNjA5L3RleHRyZWdpb246ODI1ZWJkMTg3N2I3NDhlOTgzZTIyYmZjNThkZGU2MDlfMjI5OQ_0a4b4058-c1a8-4127-924e-adc33b4a5962">Commitments and Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases office space under a non-cancelable operating lease. There have been no material changes to the Company's lease during the three months ended March&#160;31, 2023. For additional information, see Note 10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to the consolidated financial statements in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;License agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into various exclusive and non-exclusive license agreements for certain technologies. Under the terms of these license agreements, the Company could be required to reimburse the licensors for patent expenses and remit amounts in the low single-digit as sales-based royalties upon the occurrence of specific events as outlined in the corresponding license agreements. The Company is also required to make annual license maintenance fees of less than $0.3&#160;million and pay up to $1.1&#160;million in regulatory milestones on each licensed product upon the occurrence of specific events as outlined in one of the license agreements. None of our product candidates utilize technologies covered by these licenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, contract research organizations, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and its executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. The Company has not incurred any material costs as a result of such indemnifications and is not currently aware of any indemnification claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may become involved in litigation or other legal proceedings. The Company is not currently a party to any material litigation or legal proceedings.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <fhtx:AnnualLicenseMaintenanceFees
      contextRef="i863abf2c04774158b2e8e819d2eb86f1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182MS9mcmFnOjgyNWViZDE4NzdiNzQ4ZTk4M2UyMmJmYzU4ZGRlNjA5L3RleHRyZWdpb246ODI1ZWJkMTg3N2I3NDhlOTgzZTIyYmZjNThkZGU2MDlfODU3_c39cac8f-f679-4278-92a4-722756ee6a68"
      unitRef="usd">300000</fhtx:AnnualLicenseMaintenanceFees>
    <fhtx:MilestonesPayableUponEvent
      contextRef="i863abf2c04774158b2e8e819d2eb86f1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182MS9mcmFnOjgyNWViZDE4NzdiNzQ4ZTk4M2UyMmJmYzU4ZGRlNjA5L3RleHRyZWdpb246ODI1ZWJkMTg3N2I3NDhlOTgzZTIyYmZjNThkZGU2MDlfODc0_14a24a73-54d3-4ef9-8c0c-3bb6d79e86f1"
      unitRef="usd">1100000</fhtx:MilestonesPayableUponEvent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182NC9mcmFnOjAwYzMzOGQ1ODlhNzQzOTg5YzU4YThiNTE2ZGYyZjA3L3RleHRyZWdpb246MDBjMzM4ZDU4OWE3NDM5ODljNThhOGI1MTZkZjJmMDdfMjkx_4012d7e7-42e9-4272-8912-265c82a97117">Defined Contribution PlanThe Company has a 401(k) defined contribution plan (the &#x201c;401(k) Plan&#x201d;) for its employees. Eligible employees may make pretax contributions to the 401(k) Plan up to statutory limits. During the three months ended March&#160;31, 2023, the Company recognized $0.2&#160;million of expense related to 401(k) discretionary match. For the three months ended March&#160;31, 2022, there was no discretionary match made under the 401(k)</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182NC9mcmFnOjAwYzMzOGQ1ODlhNzQzOTg5YzU4YThiNTE2ZGYyZjA3L3RleHRyZWdpb246MDBjMzM4ZDU4OWE3NDM5ODljNThhOGI1MTZkZjJmMDdfNTQ5NzU1ODEzOTQyNQ_c4af7988-a115-4db1-988e-3af7a23f06af"
      unitRef="usd">200000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182Ny9mcmFnOjk4NGVlNTlkY2JkODRkNzliMmMyMzg1NDAzMGMxMDBlL3RleHRyZWdpb246OTg0ZWU1OWRjYmQ4NGQ3OWIyYzIzODU0MDMwYzEwMGVfNTgz_0814dedd-e6ec-4fe7-91a4-918b1b0d0420">Related PartiesIn October 2015, the Company entered into a five-year consulting agreement with a scientific founder of the Company who is also a shareholder. This agreement was amended and extended to January 1, 2024 and is subject to automatic one-year renewal terms until terminated.  During the three months ended March&#160;31, 2023 and 2022, the Company paid the scientific founder a de minimis amount. As of March&#160;31, 2023 and December&#160;31, 2022, the Company had less than $0.1&#160;million accounts payable to the scientific founder.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <fhtx:ServiceAgreementTerm
      contextRef="iddc9c1a9a4bd41f8b1fbb60001dd16b4_D20151001-20151031"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182Ny9mcmFnOjk4NGVlNTlkY2JkODRkNzliMmMyMzg1NDAzMGMxMDBlL3RleHRyZWdpb246OTg0ZWU1OWRjYmQ4NGQ3OWIyYzIzODU0MDMwYzEwMGVfNTg1_dbccaa3e-d8e8-4283-b697-f3d5b9e01b17">P5Y</fhtx:ServiceAgreementTerm>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="id0a4bd34abd04cd7a7c910806002b5ce_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182Ny9mcmFnOjk4NGVlNTlkY2JkODRkNzliMmMyMzg1NDAzMGMxMDBlL3RleHRyZWdpb246OTg0ZWU1OWRjYmQ4NGQ3OWIyYzIzODU0MDMwYzEwMGVfMzI5ODUzNDg4NDA3NA_3e8fbd12-93b6-480a-936c-95326986098f"
      unitRef="usd">100000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="ibbf92bd0426f4ca5a06dce27507acf0c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQxOTE0MmE4MWI1ZjQ3OTM4MGE1YTViNDYwNjE4MWQ3L3NlYzpkMTkxNDJhODFiNWY0NzkzODBhNWE1YjQ2MDYxODFkN182Ny9mcmFnOjk4NGVlNTlkY2JkODRkNzliMmMyMzg1NDAzMGMxMDBlL3RleHRyZWdpb246OTg0ZWU1OWRjYmQ4NGQ3OWIyYzIzODU0MDMwYzEwMGVfMzI5ODUzNDg4NDA3NA_a60eefa5-7d87-49f9-bb6d-ad7f31f0719c"
      unitRef="usd">100000</us-gaap:AccountsPayableRelatedPartiesCurrent>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>51
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MD)* <O4!O%\S)O<WZ@>JX_G9_U!+ P04    " "@.*A6UQBP<  &  #!&0
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M5&+NO*0[ &",VYL*@]0YQD%?])HI@=BGA,/)ZSB&FE+)R%P,NJ. ";9AK+#
M;H8&8A\:2MC=16=$:AH.0G=,VEA-<H$3MO?!PX-3NXR)57&8*0',)E?E\5;]
MMCXPO2J."5OOK_'E37GLV9@I3V'OJ%CI!96R)9B$K@@.%.7!9OF@^+HX&YQS
MI7A6W,:,0C_6 O#_DG.U?] ?J(^79_\!4$L#!!0    ( * XJ%8K-/]FS@4
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M H58+I41_[V*>.: F<>+'F"/#,9^O/,MWGDX5R ";;!E'/P;PC=WOHVA9?<
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M\<$VH?+B39.K_'C_$H8/UJ][ZZ_7CPK\(-U"G)_-Q7JU/G]$WOF QCG+.W]
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MV_'-S='V3;]]Z.9/O5+B9_"#>/D=>T$2T+9<+E)7(0N_=@EM12MV:60I.*"
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M2^J6BC:8U+O_V)+Z03(^2#("A=4Q DUXH;&RT\:RV E0.8D:\MJ565"'(%)
M3)N@=MJVA%H [-CWUJ'B6O,[)+8P.\H^ZV/$.4%\[TX ;'7C'1#D@"!.;=U:
M =E#3Y#7@2JNJCL2#0PORDQQ5WE;4HB=5XH^MR;M#U$<W,&N=,QO,1KULG]>
MT][#6ABE]J0#FQDK6'R2*-13J:G\EOV$XQ7*J-TK:W!\J1RKR2BMJ= M A3;
MHGH&\0%C9AXJ: B"14-!<QN(APX%VG&=/^8)<*(=4.,0C,+"R#K@MJ.8F*S*
M1&4)4*9*9Z[J&@Y*N H?D]B/DTIR!6%?B>P2TE4Z'6H:*,5\V'-^Y1-Q@/,)
MYA8>]K"=,V;Z4XPJ:9U&3DQSN@4J#<ZR:,):C(#%IC9,C"XC83)2.MLT\O7
MM4.W9NK3 RT[,G((B'?FQ(:)!DB;(#"UZ -!7=W>J-/5ZZEZ/Z3]SPXUM\UY
M?Z)NLK%_S1JG;&!)3!94 V5RF1EIA879O9- '=4#T'*'B[-.[2!TJ(&11=W[
MO4LC-X(J4Y/K$>(7Q?=1[5IK*U+2@COR<Q:"=Q&)6'(,=?F?MF,*?$$..*PB
M,DR+KPP];A@2]5@2S]2//;W8.OP,?>&$#LU QJRQKX,(7(2DA.@0T*GHMT;<
M$G]\&\9LEQ*YS\2*G!^H$WWY/U1C>?C2:V-'$ATU]]E]:14E=,2,L)$D5;&A
M0IJ0M9RD&9B.J&,%G$R -N !?FS);X-N*E,P#_4!/[\JF\S4#HT_4SJ_:F:/
M",$G'J'.J-GAP.,U. -U:%[R"7GS%!$^_E&/LY<0\#6I%_2E89-?3I5#%Q\7
MZ2$XBAF7)$PR8=>$%EJR!076$3@38\M'C::%X!U^%YW;[X.O5<*0+['%?S[M
M_ID-XD+6NMZ+,>^O;J\Y]MEZ0.I*'4H>/63_VI>FK[0'XTGI&]8WS"V=4U!,
MFPW)74%QF [[Q6<,&[G_Y2K!@5HMWL&ZL.7CMICID##%PX"P6KYC65P4QK/,
M+VW=P%:,+']';EVW$2_!IUM>:IN(P4M"LEHL5Q+!"BKD)D.E- + U1T--Y"?
MJ3^J\X:^).*A6V&4!3E2OD(-:20)+NU%\ILQ!X3<#.-AO'H\4:SND59HO 1]
M&4[NCN#0 #D*31>:L2X8CUK.]I<&P$HWU@W*2T>:/'YQ%6K:M>7,S46Q>\I(
M#GUL&$2X0G,(9?61_8-%7<R%8$^H_%\T</;BK-*KZ!6#8O, DDG[F%5DA(4O
MS$MET !VOD!OWN?(R8S914ORG=4\%2>,*L8+B"\,%#F/_'5;J'U,OB.LFZ&=
M@F#HE:#/Z^E#EG31N;K]A&%\)F]/EJ?'^K#4(##JL!N_^,TWP!#]^Z7*J<'0
M/> EG2[F@>*!1AQ>;D*)YV\K@3D<)2)7&!!HS6!A+L'<Q_M8#2K 6@8SXX /
MC.PZHF"5*K19+IH2J<#U,E &!R>C= )S7/,9?YE8^WD0K<Q@1,VCG+6*JYTD
M5S<H]17ST2@@(^58(D]A#]R24R5"//$]&9^A'!65YPL'5SY]1]P%<>726WHN
MAS,W<DRW&)!SC]:Q!X?)-I0O03W?C_(=00JJ:."I'*8YF4XVF*W4#RC:]1H_
MEJ_D?KV8J9_\/7?W:;Z][?)KL.;[9SGU_<ERT5<+5#T*/(F(/P=U5:Q[ CC
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MM^MDF0#'AO72?S'[7W&,9Q;X:B-=_(?]8%O.$ZA[YXT:P:1 "3U\V?.8AQ/
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M=+&'5L931X[#EIY M,& ]AM#EW><! ?'1W7S#U!+ P04    " "@.*A6#:.
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M\#R7Q(T7K*ER:;)"&9%OTF(GI(WG5:R]/TB*Z?GS7Q0<P3X$PN[+B^</ATS
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M M"G'EB55X;[2YU:$R)7*.0H#RIS8KID ;T"T@Z0]U#: <?8[QG\:5SG1 D
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MU%"E5>(1.K4^<$F4QA "(=UPAHU B-6438;:=*I?KI]P$>T PEG96'?[<.K
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M0/CQ@1TC'2QE?CJX9[28(L?]?@F]9-HL)1$H$;HJXIU(X*]2DXO!-,VCH.O
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MYQ\SX=+5)"V";>-U(+<!EXOX6.,V1XX-\+VR-AP6'&"X'Z[^!5!+ P04
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M\9PE>@Q5JO])M7KE7:4BY@8)$W['RF(VN%T N=1I75TG$(&+9 P6GEDMZ*E
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M!2] FM-;+XL"AHV-^L;&HSW(?DP4)\.,<<<8'V6T!]803]QW+1SO\?1C0O\
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MZ"N>#45NA:!L!7K<5+ "L-<,J$_\C5S3",86'FD)8@M6^/F3VW>^-JGM".Q
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M&X+&G0\#SFPS)8V!I@Z=N39(?1Z6)3TL8'T [6^,P9/A$[1/5?874$L#!!0
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MQ&/[/V$TZ[6H86[J3H'V0QPMR "HW5:T+F.:*YAE9^8.+%OP#81!X;^<-\,
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M>OG7'ZS;-:E5V1S\6?=78/8%4$L! A0#%     @ H#BH5@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "@.*A6XN.^*^\    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "@.*A6F5R<(Q &  "<)P  $P
M    @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( * XJ%;C
M7Z#4WP4  *H?   8              " @0X(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "@.*A6UQBP<  &  #!&0  &
M    @($C#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
MH#BH5AY>%9?^ @  90H  !@              ("!610  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    ( * XJ%:=JVSN5@4  &H6   8
M          " @8T7  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    " "@.*A6*S3_9LX%  "7)0  &               @($9'0  >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ H#BH5DFS1 'E!@  +QX
M !@              ("!'2,  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+
M 0(4 Q0    ( * XJ%8]%I;-T@D  /T8   8              " @3@J  !X
M;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "@.*A6 E:;"P$(
M  !S%   &               @(% -   >&PO=V]R:W-H965T<R]S:&5E=#@N
M>&UL4$L! A0#%     @ H#BH5K1E]#4.!0  K0X  !@              ("!
M=SP  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( * XJ%8O
MC^:5[0(  &,&   9              " @;M!  !X;"]W;W)K<VAE971S+W-H
M965T,3 N>&UL4$L! A0#%     @ H#BH5JC81$R_ @  1P8  !D
M     ("!WT0  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( * XJ%;49'_ZT04  . -   9              "
M@9)E  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ H#BH
M5G]&KEG, @  ;08  !D              ("!FFL  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    " "@.*A6\Y6O&O("  "V!@  &0
M        @(&=;@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   ( * XJ%8ME@$4NP8  ,80   9              " @<9Q  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ H#BH5CT(4Z4>!0  ' \
M !D              ("!N'@  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    " "@.*A6 K*F?_P"  !:!@  &0              @($-?@
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( * XJ%:*6U 3
MS@(   \&   9              " @4"!  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ H#BH5FE'8DSS @  4P8  !D
M ("!180  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "@
M.*A66H'\,[P"   +!@  &0              @(%OAP  >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( * XJ%:_E2@46@0  (H;   9
M          " @6**  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#
M%     @ H#BH5I:)8ND(!@  /24  !D              ("!\XX  'AL+W=O
M<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "@.*A6(1TUL( )  #B
M9   &0              @($RE0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM
M;%!+ 0(4 Q0    ( * XJ%::9&1^* 0  -X6   9              " @>F>
M  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ H#BH5HO1
M'HAT @  W04  !D              ("!2*,  'AL+W=O<FMS:&5E=',O<VAE
M970R.2YX;6Q02P$"% ,4    " "@.*A6GV@73N<"  !5"   &0
M    @('SI0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M * XJ%:!@+4R"@(  "0$   9              " @1&I  !X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ H#BH5F9 ,\TU P  9PP  !D
M             ("!4JL  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    " "@.*A6HN)D0=\%  !V*   &0              @(&^K@  >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( * XJ%;XF.)@ @,
M #@+   9              " @=2T  !X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ H#BH5FI1J\ G"   TUP  !D              ("!
M#;@  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "@.*A6
M-*4Z3)@#  #.$P  &0              @(%KP   >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    ( * XJ%8QYC119@(  &0%   9
M      " @3K$  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ H#BH5KN[%Z\Q @  M@0  !D              ("!U\8  'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " "@.*A6SGB@6P(#  #["@
M&0              @($_R0  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    ( * XJ%;@$'#=-0,  $H3   -              "  7C,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ H#BH5I>*NQS     $P(   L
M         ( !V,\  %]R96QS+RYR96QS4$L! A0#%     @ H#BH5EA#VP*>
M P  E1H   \              ( !P=   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( * XJ%9 N\,MAP$  +P7   :              "  8S4  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( * XJ%;_>6J2GP$
M !T8   3              "  4O6  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     O "\ P P  !O8      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>152</ContextCount>
  <ElementCount>170</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>42</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Nature of Business, Going Concern and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentation</Role>
      <ShortName>Nature of Business, Going Concern and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Marketable Securities and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurements</Role>
      <ShortName>Marketable Securities and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Common Stock and Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CommonStockandNetLossPerShare</Role>
      <ShortName>Common Stock and Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Collaboration Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CollaborationAgreements</Role>
      <ShortName>Collaboration Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Defined Contribution Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/DefinedContributionPlan</Role>
      <ShortName>Defined Contribution Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsTables</Role>
      <ShortName>Marketable Securities and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurements</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilities</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Common Stock and Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CommonStockandNetLossPerShareTables</Role>
      <ShortName>Common Stock and Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/CommonStockandNetLossPerShare</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/StockBasedCompensation</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Nature of Business, Going Concern and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails</Role>
      <ShortName>Nature of Business, Going Concern and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Available for Sale Marketable Securities By Security Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails</Role>
      <ShortName>Marketable Securities and Fair Value Measurements - Summary of Available for Sale Marketable Securities By Security Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Marketable Securities and Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net - Summary of Property and Equipment Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Property and Equipment, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/PropertyandEquipmentNetAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Common Stock and Net Loss Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CommonStockandNetLossPerShareNarrativeDetails</Role>
      <ShortName>Common Stock and Net Loss Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Common Stock and Net Loss Per Share - Summary of Earnings Per Share Diluted Anti Dilutive Impact (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails</Role>
      <ShortName>Common Stock and Net Loss Per Share - Summary of Earnings Per Share Diluted Anti Dilutive Impact (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Collaboration Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CollaborationAgreementsDetails</Role>
      <ShortName>Collaboration Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/CollaborationAgreements</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/CommitmentsandContingencies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Defined Contribution Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/DefinedContributionPlanDetails</Role>
      <ShortName>Defined Contribution Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/DefinedContributionPlan</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="fhtx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.foghorntx.com/role/RelatedPartiesDetails</Role>
      <ShortName>Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.foghorntx.com/role/RelatedParties</ParentRole>
      <Position>39</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept AccountsPayableRelatedPartiesCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. fhtx-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: fhtx:CashPaymentsRelatedParty -  fhtx-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="fhtx-20230331.htm">fhtx-20230331.htm</File>
    <File>fhtx-20230331.xsd</File>
    <File>fhtx-20230331_cal.xml</File>
    <File>fhtx-20230331_def.xml</File>
    <File>fhtx-20230331_lab.xml</File>
    <File>fhtx-20230331_pre.xml</File>
    <File>fhtx-20230331xex311.htm</File>
    <File>fhtx-20230331xex312.htm</File>
    <File>fhtx-20230331xex321.htm</File>
    <File>fhtx-20230331xex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="386">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>57
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fhtx-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 14,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 386,
    "http://xbrl.sec.gov/dei/2022": 30
   },
   "contextCount": 152,
   "dts": {
    "calculationLink": {
     "local": [
      "fhtx-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fhtx-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "fhtx-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fhtx-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fhtx-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fhtx-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 295,
   "entityCount": 1,
   "hidden": {
    "http://www.foghorntx.com/20230331": 2,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 7
   },
   "keyCustom": 18,
   "keyStandard": 152,
   "memberCustom": 17,
   "memberStandard": 23,
   "nsprefix": "fhtx",
   "nsuri": "http://www.foghorntx.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.foghorntx.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Property and Equipment, Net",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.foghorntx.com/role/PropertyandEquipmentNet",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Common Stock and Net Loss Per Share",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.foghorntx.com/role/CommonStockandNetLossPerShare",
     "shortName": "Common Stock and Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.foghorntx.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Collaboration Agreements",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.foghorntx.com/role/CollaborationAgreements",
     "shortName": "Collaboration Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.foghorntx.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.foghorntx.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Defined Contribution Plan",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.foghorntx.com/role/DefinedContributionPlan",
     "shortName": "Defined Contribution Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Related Parties",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.foghorntx.com/role/RelatedParties",
     "shortName": "Related Parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "19",
     "role": "http://www.foghorntx.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Marketable Securities and Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsTables",
     "shortName": "Marketable Securities and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Property and Equipment, Net (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.foghorntx.com/role/PropertyandEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Common Stock and Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.foghorntx.com/role/CommonStockandNetLossPerShareTables",
     "shortName": "Common Stock and Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Stock-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.foghorntx.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ibd64aeec1acc4410ab6e14c3aec0a76f_D20200701-20200731",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "fhtx:ProceedsFromUpfrontPayment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Nature of Business, Going Concern and Basis of Presentation (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails",
     "shortName": "Nature of Business, Going Concern and Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Available for Sale Marketable Securities By Security Type (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails",
     "shortName": "Marketable Securities and Fair Value Measurements - Summary of Available for Sale Marketable Securities By Security Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Marketable Securities and Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Marketable Securities and Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ia9d68f7e99d1431eb12bc2400a498113_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment Net (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails",
     "shortName": "Property and Equipment, Net - Summary of Property and Equipment Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Property and Equipment, Net - Additional Information (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.foghorntx.com/role/PropertyandEquipmentNetAdditionalInformationDetails",
     "shortName": "Property and Equipment, Net - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "fhtx:AccruedResearchAndDevelopmentExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
     "shortName": "Accrued Expenses and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "fhtx:AccruedResearchAndDevelopmentExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "fhtx:CommonStockVotingRightsVotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Common Stock and Net Loss Per Share - Narrative (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.foghorntx.com/role/CommonStockandNetLossPerShareNarrativeDetails",
     "shortName": "Common Stock and Net Loss Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "ifc737888b72c4abab3c2751c5194dcad_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "fhtx:CommonStockVotingRightsVotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Common Stock and Net Loss Per Share - Summary of Earnings Per Share Diluted Anti Dilutive Impact (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails",
     "shortName": "Common Stock and Net Loss Per Share - Summary of Earnings Per Share Diluted Anti Dilutive Impact (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i6182cbed24bc4b8ab1aa853c3f9e2cb3_I20230101",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i6182cbed24bc4b8ab1aa853c3f9e2cb3_I20230101",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i95f74147740a473d8c886cfbe8d8cf9f_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Collaboration Agreements (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
     "shortName": "Collaboration Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i6c03ef7903fc425585c24387daf3a22a_I20200731",
      "decimals": "-5",
      "lang": "en-US",
      "name": "fhtx:MilestoneReceivableUponAchievement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.foghorntx.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i863abf2c04774158b2e8e819d2eb86f1_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "fhtx:AnnualLicenseMaintenanceFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i863abf2c04774158b2e8e819d2eb86f1_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "fhtx:AnnualLicenseMaintenanceFees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Defined Contribution Plan (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.foghorntx.com/role/DefinedContributionPlanDetails",
     "shortName": "Defined Contribution Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "iddc9c1a9a4bd41f8b1fbb60001dd16b4_D20151001-20151031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fhtx:ServiceAgreementTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Related Parties (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.foghorntx.com/role/RelatedPartiesDetails",
     "shortName": "Related Parties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "iddc9c1a9a4bd41f8b1fbb60001dd16b4_D20151001-20151031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fhtx:ServiceAgreementTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i06768c28c0ca47a8bc549474a90e8b80_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i06768c28c0ca47a8bc549474a90e8b80_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "fhtx:IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Nature of Business, Going Concern and Basis of Presentation",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentation",
     "shortName": "Nature of Business, Going Concern and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.foghorntx.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fhtx:MarketableSecuritiesAndFairValueMeasurementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Marketable Securities and Fair Value Measurements",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurements",
     "shortName": "Marketable Securities and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fhtx-20230331.htm",
      "contextRef": "i141c6ed4b87e400ea9a275fed46b4056_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fhtx:MarketableSecuritiesAndFairValueMeasurementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 42,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Street Name"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of each class"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Name of each exchange on which registered"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol(s)"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "fhtx_A2016StockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Stock Incentive Plan",
        "label": "2016 Stock Incentive Plan [Member]",
        "terseLabel": "2016 Stock Incentive Plan"
       }
      }
     },
     "localname": "A2016StockIncentivePlanMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_AccruedResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for expenses related to research and development. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Research And Development Expenses",
        "terseLabel": "Accrued external research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpenses",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fhtx_AnnualLicenseMaintenanceFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual license maintenance fees.",
        "label": "Annual License Maintenance Fees",
        "terseLabel": "Annual license maintenance fees"
       }
      }
     },
     "localname": "AnnualLicenseMaintenanceFees",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fhtx_AssetsNotYetPlacedInServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets Not Yet Placed In service[Member].",
        "label": "Assets Not Yet Placed In service [Member]",
        "terseLabel": "Assets not yet placed in service"
       }
      }
     },
     "localname": "AssetsNotYetPlacedInServiceMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_CashPaymentsRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments made during the period to related parties as part of a service or consulting agreement.",
        "label": "Cash Payments Related Party",
        "terseLabel": "Payments made to related party under service agreement"
       }
      }
     },
     "localname": "CashPaymentsRelatedParty",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fhtx_CollaborationAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Agreement",
        "label": "Collaboration Agreement [Abstract]",
        "terseLabel": "Collaboration Agreement [Abstract]"
       }
      }
     },
     "localname": "CollaborationAgreementAbstract",
     "nsuri": "http://www.foghorntx.com/20230331",
     "xbrltype": "stringItemType"
    },
    "fhtx_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fhtx_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fhtx_CommonStockVotingRightsVotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Votes",
        "label": "Common Stock, Voting Rights, Votes",
        "terseLabel": "Voting rights per share (per share)"
       }
      }
     },
     "localname": "CommonStockVotingRightsVotes",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CommonStockandNetLossPerShareNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "fhtx_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer equipment and software",
        "label": "Computer equipment and software [Member]",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Debt Securities Due After One Year Through Three Years",
        "label": "Corporate Debt Securities Due After One Year Through Three Years [Member]",
        "terseLabel": "Corporate notes and bonds (due after one year through three years)"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesDueAfterOneYearThroughThreeYearsMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_CorporateDebtSecuritiesDueWithinOneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Debt Securities Due Within One Year",
        "label": "Corporate Debt Securities Due Within One Year [Member]",
        "verboseLabel": "Corporate notes and bonds (due within one year)"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesDueWithinOneYearMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_EliLillyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eli Lilly",
        "label": "Eli Lilly [Member]",
        "terseLabel": "Eli Lilly"
       }
      }
     },
     "localname": "EliLillyMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/IncomeTaxesDetails",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_IncreaseDecreaseInOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in right-of-use assets under an operating lease.",
        "label": "Increase (Decrease) In Operating Lease Right Of Use Asset",
        "terseLabel": "Noncash lease expense"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fhtx_InterestIncomeAndOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income and income (expense) related to nonoperating activities, classified as other.",
        "label": "Interest Income And Other Income Expense",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "InterestIncomeAndOtherIncomeExpense",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fhtx_MarketableSecuritiesAndFairValueMeasurementsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for marketable securities and fair value measurements.",
        "label": "Marketable Securities and Fair Value Measurements [Text Block]",
        "terseLabel": "Marketable Securities and Fair Value Measurements"
       }
      }
     },
     "localname": "MarketableSecuritiesAndFairValueMeasurementsTextBlock",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "fhtx_MerckCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merck collaboration agreement.",
        "label": "Merck Collaboration Agreement [Member]",
        "terseLabel": "Merck Collaboration Agreement"
       }
      }
     },
     "localname": "MerckCollaborationAgreementMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_MerckMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merck",
        "label": "Merck [Member]",
        "terseLabel": "Merck"
       }
      }
     },
     "localname": "MerckMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_MilestoneReceivableUponAchievement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of consideration to be received upon achievement of specified milestones.",
        "label": "Milestone Receivable Upon Achievement",
        "terseLabel": "Amount receivable for achievement of milestones"
       }
      }
     },
     "localname": "MilestoneReceivableUponAchievement",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fhtx_MilestonesPayableUponEvent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount the Company will pay for regulatory milestones on each licensed product upon the occurrence of specific events as outlined in the license agreement.",
        "label": "Milestones Payable Upon Event",
        "terseLabel": "Milestones payable upon event"
       }
      }
     },
     "localname": "MilestonesPayableUponEvent",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fhtx_NumberOfAdditionalTargets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Additional Targets",
        "label": "Number Of Additional Targets",
        "terseLabel": "Number of additional targets"
       }
      }
     },
     "localname": "NumberOfAdditionalTargets",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "fhtx_NumberOfPrograms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Programs",
        "label": "Number Of Programs",
        "terseLabel": "Number of programs"
       }
      }
     },
     "localname": "NumberOfPrograms",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "fhtx_NumberOfTargets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Targets",
        "label": "Number Of Targets",
        "terseLabel": "Number of targets"
       }
      }
     },
     "localname": "NumberOfTargets",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "fhtx_OptOutMilestoneReceivableUponAchievement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opt Out Milestone Receivable Upon Achievement",
        "label": "Opt Out Milestone Receivable Upon Achievement",
        "terseLabel": "Optout milestone receivable upon achievement"
       }
      }
     },
     "localname": "OptOutMilestoneReceivableUponAchievement",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization consolidation and presentation of financial statements.",
        "label": "Organization Consolidation And Presentation Of Financial Statements [Line Items]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fhtx_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization consolidation and presentation of financial statements.",
        "label": "Organization Consolidation And Presentation Of Financial Statements [Table]",
        "terseLabel": "Organization Consolidation And Presentation Of Financial Statements [Table]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fhtx_PaymentReceivedForAchievementOfMilestones": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Received For Achievement Of Milestones",
        "label": "Payment Received For Achievement Of Milestones",
        "terseLabel": "Payment received for achievement of milestones"
       }
      }
     },
     "localname": "PaymentReceivedForAchievementOfMilestones",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fhtx_ProceedsFromUpfrontPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from upfront payment",
        "label": "Proceeds From Upfront Payment",
        "terseLabel": "Upfront payment received"
       }
      }
     },
     "localname": "ProceedsFromUpfrontPayment",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/IncomeTaxesDetails",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fhtx_ResearchDevelopmentAndRegulatoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research development and regulatory.",
        "label": "Research Development And Regulatory [Member]",
        "terseLabel": "Research Development And Regulatory"
       }
      }
     },
     "localname": "ResearchDevelopmentAndRegulatoryMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_SalesBasedMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Based Milestone",
        "label": "Sales Based Milestone [Member]",
        "terseLabel": "Sales Based Milestone"
       }
      }
     },
     "localname": "SalesBasedMilestoneMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_ScientificFounderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scientific Founder.",
        "label": "Scientific Founder [Member]",
        "terseLabel": "Scientific Founder"
       }
      }
     },
     "localname": "ScientificFounderMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_ServiceAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of a service agreement in 'PnYnMnDTnHnMnS' format.",
        "label": "Service Agreement Term",
        "terseLabel": "Service agreement term"
       }
      }
     },
     "localname": "ServiceAgreementTerm",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of shares authorized to be automatically increased on the first day of the fiscal year, under a share based payment arrangement, as a percentage of common stock outstanding on the last day of the previous fiscal year.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Automatic Annual Increase, Percentage",
        "terseLabel": "Percentage of automatic annual increase in number of shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAutomaticAnnualIncreasePercentage",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fhtx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum aggregate number of shares that may be added to the plan in future years.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Future Increase Shares",
        "terseLabel": "Maximum aggregate number of shares added to plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumFutureIncreaseShares",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fhtx_StanfordLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stanford License Agreement",
        "label": "Stanford License Agreement [Member]",
        "terseLabel": "Stanford License Agreement"
       }
      }
     },
     "localname": "StanfordLicenseAgreementMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_TwoThousandTwentyEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty Employee Stock Purchase Plan [Member]",
        "terseLabel": "2020 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyEmployeeStockPurchasePlanMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_TwoThousandTwentyEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty Equity Incentive Plan [Member]",
        "terseLabel": "2020 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyEquityIncentivePlanMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Government Agencies Due After One Year Through Two Years",
        "label": "US Government Agencies Due After One Year Through Two Years [Member]",
        "terseLabel": "U.S. government agencies (due after one year through two years)"
       }
      }
     },
     "localname": "USGovernmentAgenciesDueAfterOneYearThroughTwoYearsMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_USGovernmentAgenciesDueWithinOneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Government Agencies Due Within One Year",
        "label": "US Government Agencies Due Within One Year [Member]",
        "terseLabel": "U.S. government agencies (due within one year)"
       }
      }
     },
     "localname": "USGovernmentAgenciesDueWithinOneYearMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fhtx_USTreasuryNotesSecuritiesDueWithinOneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Treasury Notes Securities Due Within One Year",
        "label": "US Treasury Notes Securities Due Within One Year [Member]",
        "terseLabel": "U.S. treasury notes (due within one year)"
       }
      }
     },
     "localname": "USTreasuryNotesSecuritiesDueWithinOneYearMember",
     "nsuri": "http://www.foghorntx.com/20230331",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r373",
      "r431",
      "r465",
      "r466",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Affiliated Entity"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r125",
      "r126",
      "r198",
      "r203",
      "r377",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Agreements [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/IncomeTaxesDetails",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r241",
      "r336",
      "r359",
      "r374",
      "r375",
      "r386",
      "r390",
      "r395",
      "r429",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r223",
      "r241",
      "r246",
      "r247",
      "r248",
      "r312",
      "r336",
      "r359",
      "r374",
      "r375",
      "r386",
      "r390",
      "r395",
      "r425",
      "r429",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r223",
      "r241",
      "r246",
      "r247",
      "r248",
      "r312",
      "r336",
      "r359",
      "r374",
      "r375",
      "r386",
      "r390",
      "r395",
      "r425",
      "r429",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r125",
      "r126",
      "r198",
      "r203",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Agreements [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/IncomeTaxesDetails",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r416",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r10",
      "r394"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrent": {
     "auth_ref": [
      "r10",
      "r79",
      "r80",
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Related Parties, Current",
        "verboseLabel": "Accounts payable, related party (less than)"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedTerseLabel": "Amortization (accretion) of discount on marketable securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxes": {
     "auth_ref": [
      "r1",
      "r2",
      "r66",
      "r83",
      "r90"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes.",
        "label": "Accrued Income Taxes",
        "terseLabel": "Accrued income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r104",
      "r355",
      "r364",
      "r365"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r18",
      "r21",
      "r73",
      "r299",
      "r360",
      "r361",
      "r406",
      "r407",
      "r408",
      "r413",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r5",
      "r394"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r413",
      "r414",
      "r415",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r61",
      "r62",
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive shares excluded from the calculation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r82",
      "r89",
      "r103",
      "r122",
      "r154",
      "r157",
      "r161",
      "r170",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r274",
      "r276",
      "r290",
      "r394",
      "r427",
      "r428",
      "r469"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r99",
      "r105",
      "r122",
      "r170",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r274",
      "r276",
      "r290",
      "r394",
      "r427",
      "r428",
      "r469"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r167",
      "r177"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r46",
      "r166",
      "r177",
      "r351"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Estimated Fair Value",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails",
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r0",
      "r41",
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Nature of Business, Going Concern and Basis of Presentation"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r37",
      "r38",
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property and equipment included in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r36",
      "r101",
      "r376"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r31",
      "r36",
      "r40"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash shown in the statement of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r31",
      "r78"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of noncash investing and financing information:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaboration Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper",
        "verboseLabel": "Commercial paper (due within one year)"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails",
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r16",
      "r85",
      "r93"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 10)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r52",
      "r183",
      "r184",
      "r369",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r413",
      "r414",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r4",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r4",
      "r394"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 175,000,000 shares authorized at March\u00a031, 2023 and December\u00a031, 2022; 41,824,758 shares issued and outstanding at March\u00a031, 2023 and 41,803,436 shares issued and outstanding at December\u00a031, 2022"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r22",
      "r111",
      "r113",
      "r117",
      "r352",
      "r356"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive loss:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r217",
      "r218",
      "r222"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r217",
      "r218",
      "r222"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r217",
      "r218",
      "r222"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r387",
      "r389",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate notes and bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Summary of Available for Sale Marketable Securities By Security Type"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r240"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Defined contribution plan, cost"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/DefinedContributionPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r34",
      "r152"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.foghorntx.com/role/PropertyandEquipmentNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r244",
      "r249",
      "r250",
      "r252",
      "r256",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r118",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r140",
      "r142",
      "r144",
      "r145",
      "r146",
      "r148",
      "r281",
      "r282",
      "r353",
      "r357",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share attributable to common stockholders\u2014basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r118",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r142",
      "r144",
      "r145",
      "r146",
      "r148",
      "r281",
      "r282",
      "r353",
      "r357",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share attributable to common stockholders\u2014diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate, percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs related to unvested options and unvested restricted stock"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period of unrecognized compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options to purchase common stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r54",
      "r97",
      "r114",
      "r115",
      "r116",
      "r127",
      "r128",
      "r129",
      "r131",
      "r137",
      "r139",
      "r149",
      "r171",
      "r216",
      "r253",
      "r254",
      "r255",
      "r262",
      "r263",
      "r280",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r299",
      "r360",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r283",
      "r284",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "verboseLabel": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasis[Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r75",
      "r76",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r199",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r284",
      "r309",
      "r310",
      "r311",
      "r384",
      "r385",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r199",
      "r225",
      "r230",
      "r284",
      "r309",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r199",
      "r225",
      "r230",
      "r284",
      "r310",
      "r384",
      "r385",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r199",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r284",
      "r311",
      "r384",
      "r385",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r199",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r309",
      "r310",
      "r311",
      "r384",
      "r385",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r287",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r168",
      "r169",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r179",
      "r180",
      "r200",
      "r214",
      "r278",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r383",
      "r418",
      "r419",
      "r420",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails",
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r23",
      "r81",
      "r87",
      "r95",
      "r154",
      "r156",
      "r160",
      "r162",
      "r354",
      "r382"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r123",
      "r259",
      "r260",
      "r261",
      "r264",
      "r266",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r124",
      "r138",
      "r139",
      "r153",
      "r257",
      "r265",
      "r267",
      "r358"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Provision for income taxes",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.foghorntx.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "auth_ref": [
      "r409"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "negatedTerseLabel": "Collaboration receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r337",
      "r409"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r409",
      "r464"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestIncomeOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income earned from interest bearing assets classified as other.",
        "label": "Interest Income, Other",
        "verboseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdsAndLeaseholdImprovementsMember": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset held by lessee under finance lease and addition or improvement to asset held under lease arrangement.",
        "label": "Leaseholds and Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdsAndLeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r12",
      "r122",
      "r170",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r275",
      "r276",
      "r277",
      "r290",
      "r381",
      "r427",
      "r469",
      "r470"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r9",
      "r84",
      "r92",
      "r394",
      "r411",
      "r421",
      "r460"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r100",
      "r122",
      "r170",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r275",
      "r276",
      "r277",
      "r290",
      "r394",
      "r427",
      "r469",
      "r470"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r26"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Marketable Securities, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized Gains on marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r31",
      "r32",
      "r35"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r24",
      "r35",
      "r88",
      "r94",
      "r98",
      "r109",
      "r112",
      "r116",
      "r122",
      "r130",
      "r132",
      "r133",
      "r134",
      "r135",
      "r138",
      "r139",
      "r143",
      "r154",
      "r156",
      "r160",
      "r162",
      "r170",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r282",
      "r290",
      "r382",
      "r427"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently issued accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r154",
      "r156",
      "r160",
      "r162",
      "r382"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r298"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r298"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r106",
      "r107",
      "r108"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized gains (losses) on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r70",
      "r71",
      "r72",
      "r110",
      "r113"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r223",
      "r224",
      "r230",
      "r231",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r242",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Defined Contribution Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/DefinedContributionPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r3",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r3",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r3",
      "r394"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, $0.0001 par value; 25,000,000 shares authorized at March\u00a031, 2023 and December\u00a031, 2022; no shares issued and outstanding at March\u00a031, 2023 and December\u00a031, 2022"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r30",
      "r59"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of stock options and employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r423",
      "r462",
      "r463"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedTerseLabel": "Less: Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r424",
      "r463"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization [Abstract]",
        "terseLabel": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r404",
      "r422",
      "r461"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Property plant and equipment including finance right of use assets, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r51",
      "r370",
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property and Equipment Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r232",
      "r302",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r232",
      "r302",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r300",
      "r301",
      "r303",
      "r304",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r64",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r64",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/CommitmentsandContingenciesDetails",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r63",
      "r96",
      "r477"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashEquivalents": {
     "auth_ref": [
      "r366",
      "r368",
      "r410",
      "r478",
      "r480"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash Equivalents",
        "terseLabel": "Restricted cash (current and non-current)"
       }
      }
     },
     "localname": "RestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r367",
      "r403",
      "r410"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r6",
      "r55",
      "r91",
      "r363",
      "r365",
      "r394"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.foghorntx.com/role/NatureofBusinessGoingConcernandBasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r97",
      "r127",
      "r128",
      "r129",
      "r131",
      "r137",
      "r139",
      "r171",
      "r253",
      "r254",
      "r255",
      "r262",
      "r263",
      "r280",
      "r360",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "verboseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r150",
      "r151",
      "r155",
      "r158",
      "r159",
      "r163",
      "r164",
      "r165",
      "r220",
      "r221",
      "r338"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Collaboration revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails",
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r219"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Unsatisfied portion of the performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales based"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Summary of Earnings Per Share Diluted Anti Dilutive Impact"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CommonStockandNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CollaborationAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r57",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r283",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r79",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.foghorntx.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period (years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on offering date that participants pay for shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date",
        "terseLabel": "Discount of shares rate, percent"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Percentage of payroll deductions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Common stock shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Stock option expiry period (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r41",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r17",
      "r54",
      "r97",
      "r114",
      "r115",
      "r116",
      "r127",
      "r128",
      "r129",
      "r131",
      "r137",
      "r139",
      "r149",
      "r171",
      "r216",
      "r253",
      "r254",
      "r255",
      "r262",
      "r263",
      "r280",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r299",
      "r360",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r149",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r3",
      "r4",
      "r54",
      "r55",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Issuance of common stock upon exercise of stock options and employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r54",
      "r55"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options and employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r4",
      "r7",
      "r8",
      "r44",
      "r394",
      "r411",
      "r421",
      "r460"
     ],
     "calculation": {
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity (deficit):"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r56",
      "r121",
      "r202",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Common Stock and Net Loss Per Share"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CommonStockandNetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r168",
      "r169",
      "r200",
      "r214",
      "r278",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r418",
      "r419",
      "r420",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofAvailableforSaleMarketableSecuritiesBySecurityTypeDetails",
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "U.S. government agencies"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryNotesSecuritiesMember": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one to ten years, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "US Treasury Notes Securities [Member]",
        "terseLabel": "U.S. treasury notes"
       }
      }
     },
     "localname": "USTreasuryNotesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/MarketableSecuritiesandFairValueMeasurementsSummaryofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants to purchase common stock"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CommonStockandNetLossPerShareSummaryofEarningsPerShareDilutedAntiDilutiveImpactDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r141",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common shares outstanding\u2014diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r140",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding\u2014basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.foghorntx.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org/topic&trid=5833765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r396": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r397": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r398": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r399": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r401": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r402": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r482": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r483": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r484": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r485": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r486": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r487": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r488": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>58
<FILENAME>0001628280-23-016255-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-016255-xbrl.zip
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M7-D[_V*)"8KHD#NI8LZBL;FV,*&(!A<C\MI:MK!43N\?KZ\0^"'I/34O:\7
MF?9.,/TU^&50$_A[!,8W":P1!0,J<JZM */I6*ZPX3DW!(PF)H%*(' BPI/1
M]P.TW_,UA>]%87*#PH[;X'BD.:=> 86#S:TQR9HQ*BRE0D:WL+2)'Y&^JUVP
M)V=O@<)]TU[O^G#Z/^&LINWW:,MNTI9@!M#5Y]1BF3/G@;8.D'&T.B#%K2!!
M+"PA@'^*$";((]+X[:C?OZ*B5[M^!7R!FLS?(S._068>M,<TA-Q'[G)&C<]5
MD#97W 4&E#7*ZH6E'-!I3N^2X[6^<0G*9J-N,:;P:. 7KI+<>F55X-XAI!G7
M2FD7.,6$:L0]\[$D.9F2G(Q)[H,K.@  _ES(^90!$GI\\]8,]C^8LZ3(!UNA
MG?S #Z8_!$%/+ %WH:?E!=IXJSNNL];=.%@]@S9/H)VS)EG;WVC!O_#\;N(-
MN'>C]?<AT/VP0;:*]W2K'?Z]=;;[V1]9$*E&:_UDI[5\NKNR3G<^K_+FRCK0
M]N]VXUVB\2;PU!;0??-\]]W?L=':01NM==(\WT3PF38VOX0(AI8*G1M+P/RB
M(,!GE237(40IB/!44A#@*4VG1/P1H@J+H]/&"W!T&</4$.PH<AZYZ(+ \58Y
MKHGZ"T2-DEEN6,P#!B%E(JC<((ERF%2%>&#&,WXK45]?]9;Z(0;0H2X,;G'R
MDK_X9E Z]$#GK(PMO!F":_?GPJ#H'+63(UG^MM]/;'#%GWMU"EP"K[O:QOC]
M7U\ZZ<.@-^J7W\I@Q)L);XV)_#,V8MI0*$' ]%OAT_=8A'Y6=BC<ZN6_7?^?
MJ^;L^L-+TY^NMGY40LCIM\$0.#;9HA+7YM YA*?/?;UVT4U_Z59:*MBK5Z;?
MIR]Y?66B;ITWHUAD5@KNL&,J>FMP8-%3Q8.,R.(OZ^5T,:(J,%WC<-%P,@,L
M)^JBH<F5^\U TE'E\ ?[!MCJ8F2=8 :C?EB:$*"\.&UB>FWZ/;5QZXQ&)ZE4
M2EE)'#/66.J $['C6#/OC)_,:#48\.J,7N:IGYS142G/5Z=L$GYZ\W%[Y8=G
M4P9,B!<^1 M\*;P-G%CEI$1$T<!C.9L$@$'%9I-,(="OSB;XG-N)$2^&YXMC
MZ-;E6TM\98:]_D]._(WGTX\KH=OK%-W;FKVO>%QIXO75WG]7BJ+61F$>L+$L
MR&"(\9QPBZP06@EQ&P!\>@:XHL_)_?4YF9D^UQ8):8S51%!&C+1<2 &(&1GD
MX%_\>/(R&7782PAM_-7#RTZ/VH4KAHW0L? *7\#5\<K-9!7CS?80AIZ>6?UG
ME'SS7N>HUTT@;_FT %4]O0U^[_2ZV\.>.QRW]<?K6U]Q,6L7/7E$0;Y"&A&B
M-D&A:,%1III;3(400<,?@&/$/1O2+'M?)!AIVA],X=>[;\U1,33M.2&3M"9H
M39ADWC-DI.:(,T)L !091.3/ATS.C3JCTG':&.Z'?KJO'_93:\=AO>MZG3 G
M)-/1N^"5BHP[!O!?(TV,4-%%BI"B]-F0;"L,3=$-?M7TNT5W;S G]'&18,ZY
M$I(Q%HS72'B)F5)($!M5> +G;)ZMT]-[C5A+Q TFV!C&'),&F4"%##H*9J+V
MSX^@CV;3GIZX!"@I#,?(,<(4TTIQ;#RXM0YI9LRM8;HY)^Y36,*G)[2@FC(O
M$:.<,;"4%B-J(_6&XAA NI\?H1_>?CX]56EPSC)/-->&^4"MYS0ZJI&4A'/+
M'R_^-,\V=E:!L:MF,V7Z8<_!Q8B,,FP!H K$4,0P@US*9T.:I_  9T<FGT2&
M<"I)BN &F$:I#9?$VJ""5.CYD.F)/<#9D2Q&\-C!4#$=%".8V1"]T%A$3R.W
MSTBR'M4#G!U]!&$A2B(BI8X!N#0B.&JB1R$&;Y$IZ8.?@8?^6$8)S\PYC](K
M3;76GAF&@C$:!<\(!V($S:AX-J1Y"J,T0S)Q(HQF'@-IF"'.*B&)EQI+!]I.
MD.=#IB<V2K,C&07?F2".= R!@80IQL$><64]('&$GX_2>U2C-#OZ("&%<D0Y
MY R31EG'F4Z[=4 #*CO!>8]"GZ>: 4"TDF%C'(N!6;##"#X+@+M"&,.X?H)5
MUGFVST^__,O 8!N'P.V/CG$FE0S: 29&V :")'M^!'V:P.R3$%=Z+SUU3B&A
MP=%Q5E.FN%="<"RP?8[$??+ [),0.E"&% L2"V^8X5038Q&C4DNKH@[V^1'Z
MD0.S3T)5%)$C'G.%)6=.>FV$4 +D5QN,J9JL4C\#8CY>:LZLPA,.$!!&W 1*
M I.6&6,%U3X(0$((>?9L2/,TJ3FS(I-V"% IUEX3Q#P2X$A)%82VFEM"A'@^
M9'KRU)Q9D8Q0*D2(2&-.&25$46^4(D8[$06)ZMF0[)%3<V:V)&55V@S"P"YA
MAK'1(8)$&6JHM@*1\'CT>:H98 )QYX6/REG@T*!\JLC!*'/(8A)O;#7#U6/5
M07\(1G<$@^H?I2U03=,)8^XL=TJMMHOW1;M]5BE0A6<#JE3$TAI Q@9, E=.
M>2*IQ,J0:")8A0GUY)1ZFJ(YHUXC]+^+H^ZMS+;"()B^VU^&&0_'H=T[2IU<
M[O=-=Z]4<JDT1]H%UNI]"/U4OF*MUR]-T."OLU2NXWK'WO;:;6-[_;(XR?)>
M/Y2M/#RGR?MSFLXIF@&G.1XCIRXR!IQ&G+?,4N%%D"05\<&V^DN,:T77=%V1
M-KH/AOVRKL$E<G[<;O7+31QGS=XP#+:#&_4!*X;!RBA\+H;[17>C&]+VZ3E9
M<L1&$&80\4XB!BK>\K2%R)"@I30ZZOFGU[O><>AWRY_W MPXMZ12TM(8#;4F
M2D:YTQ1@ODEK^99P^&V.2779)P9]623'"V9F3@@CF9;(<9*VU+*T)L(YT4IY
M'J4C6,Y!)LRW9>AMKW^4;%=8"78X]QK/>\,EUV"6HF8 7LN*<D)XRKP)DKIY
MI]8=&F\Y G*:4*JUW^^-]O9;)[WT;5ZR8X+E+MDJ3:EFP5E#E&?@(G,+,,/J
M1]PR_-AB=AOM]@%$SA/U+* _$8- 08+8>60<2*#$UB'.&*>R^KN/Y@$8SFXW
M4B118XZ\H<8 O91%2ABO@@&#1C@7<TROIT ;,]PFYES:J<RH$4EPJ+6("XR#
M1-(XS,D<$Z8R:&-VU%*&:&F)!4#HF64@0%Q1$CB+0$'-U/.EUM,9K1ENF0W2
M4PDFBUC&5" F!3:%TYZ!WXPGN6G5AARFZ'\R[5'XZZPQ+CZ1&ECKAW]&  W/
MKBK$BYLOW3K82D3M%]V]64774DFJY:Y/_Z3%@F/3OKE.T.AUPUG#] _#<&W4
M]=_CEY^9CHN/_X8)3M&^L_<IUG?'C*QWCT;#07D'GA/$)<!@4R45TE@Q8XRR
M'%FGG!,X)3S5S/L2F9?,"?,JD3*W&+AU6C%/./CIWI0%0;"0:)(&4C/OXS,0
MK; D585Y2>);Q366@3%+I2&.A,"C-<Q:3.<A4E$]YGW&_.)3=GWTCJ<:WI&Q
M5)DE6 E.@9=:S0/,O ]Q[HR0/(!ZJPK3OB2\*96-R-+(&0],2ZT=<E&PH*)S
MS*,YT'HU%]? ,]5W992H=((10U'HH$BJ=>9E!-A)1,W%+YF+OX=^J\+%A B$
MB"=!.<I4N6_9!A$PIR*MN-2ZN&I<7!7&22>O\:!%I)$P;;RR$G$MF&*"14WF
MH"[.,]4\WT.!]^_,]Y;%?E:JJL+"B+AHA+(D>LHTF/) E R&(Y,V?:)Y2,=Y
MGBS\/0A8L_!%LH0K:T9B'ZAA&DLC$%<NL$B!L5&LM7!5\5_-PA?96@Y3:24-
M5FH6@U588N\1]9[KM(&F9N&::V[QOD'5!>0L"3S5S+56.2>YT0)%@YB=AQSG
MN>2:KRFCTX0.:&$ _M<T@_1!?:MG'QJU"'D##I7@!#/JN$$^8!*$)BS5MJS9
MNF;K>8R5BG2:@&3&,DN8X4)I7A9@PU)H*2;;EFNVKMEZOH*G EDL0CK0A*;2
M064I$F=,,(I;B@FIV;KJ;%T53@)?ATO0DM1;L/N4:(^5Y655*NR,JQ7D@W#2
MC^7UUX#U%L:5'&NGD$U'!#$#7AF7D>L@2)!2:UQ[[R^-<><%DH)YYB&22)6(
MS#"BP71CRE+**$<>U\'_E\:X<P,Z%?>!&XFH<HQC!0X4LMH1C".W82YVMSY[
MQJT*KS"1BF4C8B/X* I10S02#+QOR8AU;@[R1:O(*W.U2'_'OKMY86!+@^4$
MH*2U3&.>POS>!Z:$Q#S8FH&K"O-J!IY8:\9<9$A(">"2VJ!XM(BF/]PYBFH&
MKBK<JQEXDB"*"$.!4(J LP!-6.X5C@AQ&P/3I/:3:IZYR3.IWC/5Q!(GF>7&
MI@/ D:=&2.\CJ8-"586=56$@'P4B6$E9GIU%<*ID%RGBPND .)#5#%11V%<9
M!J+<:A$]8U&RX*-ADB*K.$/$8RGGH;KH\V2@>8FR&>V%BC)H[3&C.%A,K ,C
MA@S3"N.ZK$ 5:6:"\HQ[ZP-F47GE Q,8R^"DPI[Y.2BA5#VAG_<Z)@\+>697
M08I+)XU3&F$+K"J],2Z=(<^4DQKKX&KF?8',^[!P:W;,ZX7F#O"5H8&DDV2,
M!+S% &H)1SW2N&;>BL*MIY2DJC OCRP@8;FD(C(KHT9:<(59$-$215G-O#6_
M7#F'6(%:DXA;C#4C.ACEF#,BQ;:DB9,B/)7FEQ>V9;[&F[=PL:6!2F0T,9$Q
MYZPQW$M,?0S$J&CGP&377%P#S\B-(0H1C61@!@6%K,$"&VJ)C,;-08WKFHOG
M-=@XP^K1D3II&0N8&*8Y BS* D,D:&18T'-00O^%<7%5&,=C'+7'5#M*6:!!
M26FMPU8F#>@LJC[C/%/-,[/\OOL(UGP>3T$L4EI9L-A1,^NIP?#58!TX<D*%
MVNVN*O:K>;?0V"$5,"5:8V8P2X=W"&T(1DYIQ^;AC*+GR;N/&N^<3]Z5F$D1
ML#=*FE1S-P6P2,"<*\LL-C5FJ-GE2J&=X"AQRDN,P"7AQ)!@I* $(<*-0G,0
M)ZH@NU0*8E:T5M0,-1X-& FJ0T3 6PX#S)2&I_,%*7A+MLX+F7ND^>Q9F&(6
M(E':,H$9,+ %_2N\DY3B8+"K >?< \YGS\(A13:CIT[3R)!5J5JI%!9)Z<#A
M9[9FX9IK;G*-)Q8'S704.FTE45JPZ#6VGD<MM:\57P5VNU<*]E:%<:/AW'/M
M&(J4&6.-])0+@Z*-47 ::\9]88P[+TOJ*B7,@Z*U6 #C<K#:W!(,%IH+'E28
M@_2FFG%?YBJZC\A%@Z1CFA$B% W@-DFMB238B#G(!7G^C%L57K$114)231Q'
M&978.@(0$RM)K39!U(N/585WLV3<Q]]B/\NP?*"$.D&M,BQR;A!-+A*Q40AK
M7.U-5Q7FU0P\T<#8!8(,2QNU6<0R'9Z(8HH0*6&4534#5Q3NU0P\B6<J ]S*
MHK54 ^ $V."<HU([B1PCJO:3:IZYP3.&&1T)0B9ZSRQB6MO@<'!(8:ZFU<!J
MGJD>[*P* RD3%1=!1$48PY@I15P$_S8&B;72=?).56%?51@(12D,!ZH:@%T"
M&8N%D@8%@9T 4NN:@2H*NZK"0!131ZAQBGG+N#8&"6D1=TRBH!RK\\$J2#,4
MJ,).*V8C3_5(+3)$,AVEE66MG.H7,_K0[\%XAV<?VC %RUV?DBR/4AM_G;7.
MCL)5FEU<?%#RS+!N$9/*<XR]X4 5)35WH)45UI18 >JY^B)50?+,$'-YJYRT
MC@H?F?%:<2X1E28ZI0+2<W VSP^19VW4[Q9#4'5PXUIQFC[-2]U1AH1V7J2E
M'\P<"Y9Y1[#URAB*T3Q4\J@VI68G4YA+*2)0)PK*G"<6')O@O'-.81+"')37
MNQ>EXO[P-*V0 <H+_8L[X.[M7AR>F'Z8$\%2CIB /;:&<H:H-=C%$ #M27!
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MG?YRZW]W=OLRLY,*,?O:QE8C^P-L7+?7;8XZT(C+)J9P*RG: C/L1/#,*AE
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M_<(6=5[,/-&,U*N[5:4.7UC:AKDSPY^.C3]LFF$M?K].8/+-1-)[UH)=N+O
MT2-76KJ%)6XMI/,(%"KKY12S*/>$45WOZ676>WJ$%9^23;<_K):5/)H;K=5L
M:_7=\M;*>O-=MK:Q]1D^YN\W-OXG?=]N+;=6&ZO-UO:]RCZAV1=MO*?8M=+1
MF9LCDT[!;)]EX^-WLUXW6^OU.QE&^699B=$4W?+$X!/3]WF[USN<%&:>;HXH
M#\XT_9!9D_*QX?G.S8Q$&]I%B..E9#,8C#I'7S<MPA-%=UQ],64CNO%!EM C
M<VR*=LDPP]ZE1E]ER^WVY1[T)A5NRRF\O&D#!@A>?3*,600'?S =S[C"[?#[
MXT_#NGOHK[)U>&.O$S('0Q\L9F>]$7R$X:1ZG$4\^]:TV;,,WML9C$\3-8/I
M67@=<W;]++V3HMV^<;[>?F_4]M=_#:='P0VO_WK4-MT;!_A!!UUQ!-VY?L7=
MUG"1I/7&K\-T5MG-U_5[![?THJSJV8&^W'QER1W'-WX.@V'1N>7VHW[PQ2W#
M["6-4ICV]/=>__*[B^XH7+J2"I-VP]XXU6M<X3B5,B]) I?'/#4H0.Y,/X-Y
M!727$FJ!RJ8]A,G?VR]+H*>SQ;]!Y0G#35H_Z?4]<,W:W?<77=<>^;"8V=%8
MJ-([VM"+87D"[>*UMEWH=Q,NO&^YV F.S!-H?,/9%$E."LCFA+SB3Z:.2MJ(
MARG=?#\;=V5VL$XSD;BD/"6SU$V+&3 DW+&8RM'O)8XH%5C_:^YT;Y0JV@^"
MZ2>AAFL>^+K=.TH4&S]D.H/%\G!B>'VIF=)=%U\&PY$ODBH9,\+%8<93UDZ-
M)U"7%.6D+'<<I2+>TP;2GM*QEKT0<#_I=7H 8&0 75668IT^XLW0W/O@U9J#
M?I"#$D<86[2+X5DR8\8?EU4U4L5UX <_<L-D,GRY@6EB3$\"6+NS*>N4U"P/
MGW8.."Z1^VQ\GD(8AN]R4DW81R)L.YU[#@BE5 %CE=&^D/ATPP4Y_7C;Q?CR
M=09()UCME6V\"]V0M?HFQL)EDUR\;\Z @C\_,P/RU?7*C[=/P0U7-+%.SEZ1
MHYL!"- Q8T?EO_\32_:$E%M8RA+D2/"R%H6'$H5+1FZ0E>Q1HI62C9.F"L,B
MK:Z-T7XI'GXT&/;/:HH\DG("_%I:$8 +8\P.B.)HU#87IW^G^R^4U?36B?\U
M;@5N C!1E"0N3_29&IIA@NG=O9J6CT3+GBT]BG[82P3L]<%//DJG(YG2$<G6
M_KV2$R4F&!!<T%&*3-]F:F*_URGI_/'5=G)*>F/@N-(?[67+'A!C>6A#"35_
M2[=-?*FUE>6)&_6OL4"7GM+E[HS /^J#K;@5?=PSFD<7:DYZ:$ZZ"%,D,I:1
M-=#,\/N$9=J%2UOL,P.>SL3E+!%F*D)N)W' &E\^%K&F(8ST&4SL60I4C>TK
M($,#DGW9TTQT@BZ-4M1KU"\197_/=(OSB<;_;2++;U<:&X,+:>Y=:NW"B;WC
MP:U+SR6UD[IR]8T3SWC<2C<$7_/*@_'*)>U[!8N-(T_9QVYQ4=%F+,1 ,FBQ
MFY4G[?5K/_$!:;,'?EP?C', V>IUQJ=OC3W *V$>\./'$4;3/[MV"RAFP%A9
M.N ;OG=ZW3!,-\4V&/31I>I_@]'148H-["=\ $TD\PU/U[1]M.#.<*P\QZJO
MA&F'X2P;N*(TM$#[B6*>K&2DXXX&O6XWM&L2/60$=^!Z1V7,$U#P<'QF: JR
MI?CZ='D)! P^%H-]$+ D-(EV8U@$JM*5JT"E)+;3\:>C<>P&J =T+[,I4C3^
M.)1V;P+ %TN3>!5]?_6 ;PON? U49#4W/" W'/5 SW[U:DVB3KO7W0,+N9>(
MV"U%<[ _&OK>2??"&QZ,["#\,TK7BLY1$O/>V+I>\I#35_"/OBX@W>X6)88;
MPD!!6:?C;V&PZ25':>/%8#!90[AX#M[;*<9K3[^7]]7,\9"+/1/2CFGY=N/3
M^DJ.=9;")R$9[PGJGLKQ5V>H][60ITU!W)*2%Y5T+EOZ>ZT133CB>\M$9@"*
MK-U._R8  0WLA=Y1#_BQO*_H)K4V9L^OOOH5B%BN.*3EANEB*##E9!(N,W<Z
MZGD('\]A4I+3L#BN-[R5/EUD +1[K@S]I:/[P+F<SN(5^'FOL_PP><*LB&\M
M^?] WD"OVTY+/.52]05$^YHGT4YQN$MNW#CK(1NOX%\"=9/5]/'WL@K)Q*8
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MM\C;W&+.D6! 0B\7EL@B%57:?%#',RJ*'VH)?G@)O@8>$ U281)ST+X!P .
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M@8Q82;G%-'B%.1;>B>0BMS0:I:Q)IG';+3R@M<_==@SF)G8//GE!G' X(L)
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M))'#2RRV*C"9J,8F$6/6KOF>DA@ A;H8B>2:"1V)4!9KZ;EPB:;+%'YL^P=
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M'06KS?03ZW-KQDQ;;IU/C"-A,0,S'2AR4A,$H,T%"=*!*U:;Z5>@T3&GQ*3
MO&&)8Z<- ;]-.JR4QUYR5YOIM5;K&3.-F9/66))STAWBDAOD6)#(*6$BR!S%
M(JV?F7Y5=3,/DASS*A+W G4D&FZ2-+FSCC:2IV"("R(994+M;*PE*NU\F\N-
MB=I&KZA$&$>!.!8&:6P$\I: V^@P>!X/EQM3I^*NKT8G*T00QG,,KJ>USJK
MA+0XN92D8*EV-M9:K6<.W+P5)(4(>PCB<NLL'9 EAB%I5>2Y9XS5XLT[(9ML
MK5)Q:ZU^8*W6F5$-S+,C$K1:P(9".$I@\R"DB#HN7=Q:V^DG5NC9S!BAF0R4
MN,RM!O\08Y"58+$3%CA([+@S=6WK:]!H$Q+VR6+EN>&4@GL6&>'*&*HHL7+I
M*KC:3O\4M9ZQT\(ZJ8A@"#94^4B.@)W61"+83\G(F9$ZQ36TTZ\J6>#W;N^T
MV[.#6"4*-.Q):+CN K+:.G(Y+L!/.%$JN,:><::(\]0D2;1BSM@HETZTK]V.
MGY4R,,2GI)0041$4M N(YR(:HSQ#C%KB@],V.%&?1;P"C89W9)1YR6#->1+Y
M:"K'_JA+4L*4U&<1ZZW6,VZ'U-YR4&T4F&&PI<AT7IIPY*P@C+G@0-%S/JYI
M@F]9J_7+56M'?*38\MS)E">B-'46IWSJJ*753M>&>DTU>JZCJ0:[G Q!&I84
M<0H_60[_D)"4=A$3'G1MJ%^!1D=M07UY<HX9#O]GH_>>*>-5SO[4CQSQJPWU
M R4-C IG" Z1.H&$S(8Z,P-GPBODDM$DR& ,L>MHJ!\R;8"M.]'O?-.WNE?R
MG7B0'W)J7@R@6VY-HAC;% )WF!OCHB?18TV$9GAY0*][)3\^@K^?BZ (84R(
M#B/KO4"<4(6LY 0IR2VFF%A22 H>A"_Y ?7G)Y_WU.A9H^?#'(#;I(6,,FG*
M.2%<:^H3531%18PV2Q>2U^CY-.@YX_]RX?*) 6QKO;6(&\QA6TLRP[-)D7MM
MI92YT[QJ*DIJ^*SALX;/!X5/G)2T(K.J.\,EMHY(K2R.DGA)N30/#)]U0/#.
MR#D;$.2YJH %BJP!YY,[:Y"#M4)4$L!.'1)S#\ZQ6R-GC9PU<H[*,9FGS'K-
M@P-=M!9+Y;#P7.&H/5^>-:%V/)\$/F<=3\8<I2DA8[E'L&W(A5I)(VTL]=@*
MEQ(!QY.+IGJPS*R?"9\E8/O?A?X'_AO:W]^-7JIU=@S*XM_]'_CCZ!6.;>^@
M?5+&(@M\/K$RTJR,'[J]QN PPO]Z,3:.X?N'_48\"3$TMFS/'U:+P$BS 9K&
M2MI65KEFOJ@7&^?YGY-N8]"#,:38ZS=<')S'>-+X3_P>.]75</'$;[3<9.(/
M[.UXC<=3EE&@?7)FBR!,3MIP\)R^50)>\+3;;^?O_-:+'?CR]_BO\W88'(Z0
M9N+"H4#@JTNL@^4_&UQ_R<3B^PBHU/M):Z1FYF?BWSS:"IJ((9Q:39Q(7!FF
M0;U P<#=E$23H/:Y?#.ZZ+ W>H-3>Q"1ZT7[#=D$+_B;[9S;B_Z;_YX65)#2
MF7F?G;)K)R:E1YN82CD!JW->85Y0 (/8R]^",=FU&4L#- MLV?^Z?8G4FW<[
MA3JLFQJ_9S-X,NC_G_^V[Q8M_V(<(33K1(5D*#M#OXT)T]HPH)/!;\@\ =3,
M<:,5,>9O&_]G"@VG;3WAL!V*@3NM(DQQM& DE$CP%^DX%G)_,R,0)IB@\@/+
M1G_:S/_5ZYX"/E_\U;$G@XV3D-D*3X_AM:\,_@X\[]^=KO_VDTUZJSTRZ5\N
MM[]^H;MT"^\=?^)@CH_ K+=W=P[H[M<O;.L2S/?.QB68Z!]@GCOQ_WZ^V/L:
M3G-C^-;.EM@#4[][^?EX;_,0S/&6:/V1G[]WN+?C+[=VWI.MS1:8Z ]@GOW%
MOL_U*F"483N324ZT3\C"#@>!AV5\C"87.U4>&&!O#!O9+>+")V6UA(\\=R%H
M*C2LBV/**8HUR'<$+^DTPV7O##1OM 8%Y<<+T 0A&LP9PRFYGD']:GEN?_KT
M: FW'FNMF8<)PM:8: F1,A*!/8B4&'N?3RZ"KUCP+O?A&D>P-@A0+S>5X\-4
M.1^L,EPPIC2?%:2U<Y6F)#M>2?9)'&0QZK?[ _": +NS/Y6ZG4[W'&"X\4O[
M!/[2/8-'A_ZOOTT+_4WO.*21'+DOQ7&%=^W8TW[\;?3#OT*[?]JQ%[^U3\J(
MRT7_&MYKZ/-D@SWCMQ:34'T\M.7&O"649G,^S#@8/GAHZ=\62S_CA%>?*?R6
M,'WMQ_#IM9_==%M"WQIR_:4WW?;FSP13CS-8OM1M;\GJ6(&;<F;+\J\Y?_5I
MMOUZ6694?]@8;2268$1]J1.Q&7T\=K$WF@LZ-1</5!2TUD&Q_UB7W>1N[^(*
M1E?-KWJ=0<+57O[%A %Q9)IXH[E+@G.?' :_C)L$3J +D5254$-W[*8PX+7.
M&?S\H7UB3WS\3[3]^#D/<SM]Z<<2./QW3-U>W/#^[/BL8\'(;\;3'CRF^*EP
MZ<9Q%Z;ULOSZ/ **=W0"JX#BT>Z/O:,_#_>._NGL;1X(N#?9V]P56YL;/[9V
M/(?GX>VO[\7V'Y_;LP'%UM&'XZWC#\>MK_]\V][LP'O\\ZUU].U\:Q.><WD
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MEWT/1H$R'9'&6"/NG$"6L8 \EK!FU#!BXYMW_.V"OI^CH'26F97< F-]X!I
MT&M.L'+!,BN3]RIFME]V&V%(+12/5Z"P*T H^-;.IXO6Y<?SK8-][YU-CL;<
M!#-[$#P@HR-%,@9EX),00FYLO0 EKW@")GNT-;-5'7D)2P8N1L['L,%UKI8+
M589\ROOL,+Y?M2\'9P-P]V14Y%?M+(<#&/4(7*JT_!7GE!-<)Y6OQUB>,*G\
MUB3QV9IQIYUPQ.7,<RX!*)2BE@MB H6_B&=2,[X5>_[;=="SWL[=QY/&GV>
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M7$>AN 'CX!17L#Q>2.$QLW4.\T]LS7*Y=?1IGVHMH@<G2U"2*<6P1HY@@T"
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MPKH8F6EQ@!?RQ>QFPPMGY:;9I73D>.)2.KRV;(0H-NF78-8]RUY/M=V:@&\
M2LH-!:(:R-]::;@ ,.@1AL-N;>-+)4LD63^Y7\INW7%2U1H(:LRK&@E?ZUMJ
M;D%XU'D$9SB/<3R7S<P9I;K9= HSK9N-5KVU-M=:MD'D,@SWS@W&"F0!]%@B
M9DJ1S]PO] 6S&-<TJLENG*(RWEYV%F8C7P_L&7"_#IAP3TX=,\R*'C:'I@97
M(\1!1<]TF%(%+W7@](+82R=\VY*H]8W!Z5+,SZOKR_;$W)^]:)%;4D$N 4P,
MU<B6G:JA ,X+9=45K*ZKLNO6, )9+L7<L#+H %/'<E8T5)?98U#O%C!'9X%E
MMF<-":*1L0;L; :-**,4VVV'3,+$]>=!U,_8.".+,4C(B<5X(6.FH_UI +4S
M7'S6='89O@5,L3B2*$K1"F3S0D[/ZM@Q032F7G[<'Y%;W*GBC'OV@&[@A0F;
MLS@_G1")>P16G>!,6H&-/G.IBY;VZ;.R=T;OR<U&6=<**1JQVA6A5%2%B4.Y
MT>"FC667+$V^C9R<NT#:ELTJT)1<5DZWRLHIQUR>"_Y)'# .U4D6N7@GX[0E
M-XLN5R=W%_;Y<JG! UXA<#@*O?78)TE*OK*,6&"(W4-]D'/H,6P&(T['63C\
MMY!,@NL9Z2>5P/#SR<G'K&'OIUOUSJS?Q*[3)JDJVWUPD7L:$P CP>HFLFW]
M!#MLJP@[_^JOU+\Q,#S<T4A(W##=LX1AP[BNA)2,;2ID6Z7CVT8D(I>'+3M-
MRTGQO1SM%]<D)@KOW-3RP=J\_*(]X!Z9*@R4+1(VE#4\<3!.+ X$Q57P>@&H
M!*I.ZB7J <)_578%1QA',G-%!7E4*T[D%@SK1(P=EA5LY.Q#6VZGA@QBC<H%
M9K>";R^Y+3,W9LQHX@ZC=";AH4$?XI=H& B#&$M;QW24MV$P.Q_#N.X465H5
M8O"J9%"2[0+94G=A\R@PER3I9"I!$D.J")=M/.2U*_5R83QFM4B*]%/?9EUU
ME)B<QSNE.SOGW\%D#[9W&?<8UR3LAV@!_]24","S7B#4'2<6X0U9LA"^H2]F
MB&X'_Z1NA<W,<=[<D) >/&'78KGSX/]H()=1@' +18V*+.47F$'G'1L<D@5;
ME#F!T(\W9!77)#5&]+^WWXLVZI#2><A*AJ@.*TNA\;PX'Q->65%"G7JQ#?($
M4_ \I1-E\9%Q9@GA0G-Z(O0UZ+<)>5(4L707J!EU&.GL!7D-F&@&4M,KY,7<
M#)D'LUF>[HN:.P;>"HR2C^8*KXT3^2^@#N]B*5D5VWXHKCB0W3\'KK1Z=>M"
M]X)(K#.0-"G=GO$M:>B.YZC:,(-,,_2IDNWTS%H@O7+1Z%$E;H%>VQ+KLO.B
MM'["L: B3D!*!TD&!_.)"GXO(BKX?;>QX+?<)@N%5B.,*1'Z!AFN8'SA=?]7
M M*)35/5@+]E[MZI]'FK\CG*=?R[G(@*SL1@']:H3GV:B#?J+V_!C9B.W?F;
M(*2%T8\4R(Z,Z& (XT[$I!MDM(8<>/XZBV[4&QSAF,7P?U^]67Y=IZ]^F/G+
MWW6;]6Z[N?+K1MTQOX.9XP[\XT7KA7I.K2&,*)IQO$]NO:5.H]X9=+;=TAV^
M:_7;#_KE,4VVVUC]M3GL#W00XE4TEAG*;QJ60^>U'"SV@"<'2TMJ3K_@HMXN
MQ7<7Y0B+D,>6V_U-NK7!8KM8!Z%%H:7LZEW9@7R%CSX7[GC:)Z5>(Y-G.K/(
MW[.0==X>%"^BCM^"Y^1JI5[.+QCGMWDWMF"G;W_)H6QY\Q&V_!$W]J"V[Y2B
M([D-+*-$<SJ;1<7![?TKBBM%*0SA)Z]WH<&RSX]IZ.#SKUD_5E!]G]5O]K<:
MRR#[\0+(?EDUU?=W$U82>^N3T+ .@1]>+M+^\=9OKIL@!$NU\([=:@PX4/!D
M6X#?[K@5ZU3@)OFSJ!PJ5GX>K-RR!\W&\V;E9\"M!\20CMWJ/U"V/@;/[6S'
MR;N;0[+C+I=P"=]45MR.,D>2?2L9N(V+NHFOOF6,(YWD([E<+/$')3^SJ] F
MJX-;\&1S-R8H5/KETXS-@3WH=_:G&A_)'#MV*K7M3J-?4:G<5.K8[5[OX*W,
MPU!=JZ$+*N6UXX$K8(,#.7!]N]MV=CQP:YC^J:3BM@;M<1*I9S>=;D6D<A/)
ML=O-7:W 1R328WI=K5[)5=<G;E*X%"^I%-?#+,5ONS4HWUEL@5IK[BHQ#RQ\
M_JSIZ]B]9KNB[['2MVL/&LV2DO<YW$3\@J@*7,>Y7&51+NU67MVZ2P#]@,[F
MJU;+;CF]U[L:N:61NX_HIAP=;9L]N]]H5[0]1MIV[([3*A]IGT.&9C$07G6[
M_T"3^>DNSK>UR9_O))_5%<D"Z&AU7I]--+=I=[N[IKM5(??O3:36'@/N%8FV
M.T?MUJZ!NI+>BI1>6YE6IHTXF96^>C:),[V'5@L<:,3[ $G4[51)@J4GT7'D
MGAW*!7ZEL*H[AN+JM]V+C:I0],&0MS_8U5BIB'LPQ 6/;U#6L_L<[AKH[GXH
M1E&LFR[,<LUERJ7=RJM;-X7(#_%POL)BI69_^UO G3;A@)R3(Z-JUQXX.US;
M5U0]!*JV[$;IB/H<LM\^QM%=0!C3"$A;Z=!G>0'XJM-M[)PL<Z NR &2!WO;
M.,VWU?5?N<FTMU/T'#R]#[*!8*65=K:.).9H"[C+C[#[+%M(WV _EHX['@J=
M]FU;4W)QU&K8[?Z#W=]OVIH]NU'5P:@.QI-%$*J#41V,(ST8+;O3.ZQS0:;O
M#]2XYL<R]D0J;AITF@.QOEH L2YEGZ/3(MQMZ]Y-J$^\I7J5JYY=VW4VPAZG
M$VX..XNLEZWZX&$#-;GK:Q!ZV#Z46BUZA?,-L*/W+ Z&J>PL/S/;-VW57ZF+
M?;&9<VLHU=ZTNDK487_[</:FYO3W1B9J@]O508+O/X7\WCCM.O6C@EF8Q/DE
MP):_Q20R6TI&(^MEPV"*:1Q@8RWXK<\-Y^^C^+,U%3$V?P6"1MQR\:>K"^M:
MC+D]/?PHNHG=B35-XR3%[H62[#R)/%^?W "W(:3A6T2*JMCA^[##A8B]SUNS
M0T>S@V0";G^,;4==_PY;!%.G4=EL+H&78R>TJ?""48"'/H;%>'% [7%E*V)K
M!@05,Z/C<-&47,4<=6LE9RPT?Y]&"4W]#763!FY<:@>OM2MKST;V$W<(NA+D
MU,J?++6IV!.3.;VBMNO\YVVL9C-U;T1M"#3_7'-',-DW[OC>G2<O?LB?+#A6
M"WNXN/R5B]Q/T_H?_^Z69BX6*,O1/U[\U^:^E[T7/WZB%H%P3$[AA=S+U?VQ
MB)('8%#ED&G/C'[#[Q;!DDII7&W71')#1^7=3*^JJ61)@KBE""$?7Y_&@YIL
MU50R_V355+)J*EDUE:R:2A[<EE=-):NFDH>X]\^\J>2JQB8Z=ECU*/I&%*.R
M8 "5>HQ'A1MJE/S,O?_G6:W9[U8':LGO.Y[+] .Z^V[;C=;ZWA!/E\:Q(5NC
MXH>]\$.[MQX@H>*'Y\0/K]KME9DQ)<KA/AS=WVT,*MV_8VW$X8+--.UN_X$]
M*DJ4/GGT1&HY>VQ[7!%I*[B8[N'W#"RU<OHX=F>83V8OW+D'B1?!/.<V_3,-
MW?$X\ES,(ZRB0]L]^:T77'M_]%D9:>H<$+LS>AF<AO$<YN'>B.QPP!)$#*<!
M=B295?5YST<3]6RG\<"^5)6Y\+V(U+&=;D6DDA/)L0?M/4+:/JM[AX\B3J(P
M%&.+<K+!?'L5A-XXQ97 7"+O<VWH)L*GTA0PZRC'=BGR4Q+%4A:U=HAGKF&W
M>JV217B/8VM[]L IVUW*<>QLTVYWU_>*K&+1N\:B72\8![.Y5@?:W:ED_K,Q
MP#IV;[!>8E56\MZ)U+:[K2H\77(B.;;3>6 WX]*Y,F7O@<.-!396AE5Z;)D'
MUT%6--:EI"^F]AYV L8C[D.YQ1)"0?<W-#QYM+WXKME %2L_-U9NVYU&OV+E
MBI4/GI4[=KNW(9MA[YR\-<+4_N #5I:O:&R >Q$+ZV6K46\\#E)3LVW L'P;
M5%.%R/3$4]@*@F>J;D5J*@Q&M_D$N=/,:&U;V5V)FP?C,4=;=8VB&-(FZ)X,
MS0G(KG[N6[?"]3UPT; 1]7KHBU$:>CCLV]5X/!6;/"Z;;)D3$H1W(IDAD9B%
MG S$ZVU%J^]#JY$,;->6 MN97F#:-+/C+2&ULM-H4A*^2-+I-(IG)*5O8L:K
M67D^H_C&#8.O$CT+OLQRAD; 1;.DXH7OQ LH1F72O:YIS01\H][68MQ-DL@+
MB%_N@]DM$?KC+0[C6!Z\&^TD"_0U_ GC7L_#Z [_?@UDA940E:\O3JY.?W)J
M"-=NS=))%"?UBM!/1.A/MV!!(0QG,L8G011'HU$B9M9P#AK:%\L\T.QW-_"
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M6;6><I\>=+MA$/=& GUE!R))@:4E3!:9%NP?"!G4"J9Z#U P?P1!BY^-X?3
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M+78Y7PBZ#NV290=.2?+_!4MOW6>#2_6LYX[K_GU$],Y?153OB+.N(:%*M<1
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M-O^7'P:;V[3E88O=VJU>\*GORLOI<ET)(8P$_F!Z=+!<MURL>K F-ANNC=?
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MZ_5F?5VL.V\^,H_/\^)!3\M-I6#^S+6(4P5F^?Q.%C][BU]P^3J<#F2P:FG
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M&$LKRM1K+986\+9FHR\X>[<1#U=BV0C;;R&6?5!ZK,/2ZNS%R[#L*VY3A>7
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MX5N%EO[JI=+2J;&Q6[K[Q;MG[CA3>6FM1*OR4B_EX[N#V&\QIE,"C*$HDP5
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M?*Y7C$.5A5,2<9)P":.,1!!Q;7MF)"-0)CB-HBS2^-M7&[3O=VRLKK]HP<I
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MSXOF(_-<.&&4"AFR &+,5!T_D$4X@%DB4!"SF"0B[A*O.(SXHZ??Q[K&MZ:
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MEB9Z5-B[/AS$];SOPZ5H]7V:U(@'5O(!(Z ?[X=3JG=R?SC8X&#^#Z?4:3M
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MT!] RZIGC):9N]MX]H-@:;[U FW?AT9K5&NI@18;&+F!62CG?#J;-D?DG\^
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M728H9"8/GR/.)$&2%<AI5V$E=6K$\D?EWUFK4HJVXYQQ*&X>I"&)5G^PW W
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M4VG3WVP#VE'1^?QY]Q$+H%\,LS%0Y6J] 4)O&9I:I*I<ZTNK'<(-V"XTAYN
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MMH,I*:#FRS_7=7KE<E=*E>ZT=ZQ6/6!N[$R.L'@'YAE3Z:,"NU7?9+W^8D8
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M 1(+ I0)F4Y%&8B+3+YXRA1]MXA==JV]'SPZ3G@V$NO(X*A6[\42PX9N'Y3
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MBR$XEW[C6^)FTWXPB=%@-"R",=59Y-R06%@!'THH40N)KK5G=)>*3N:--XS
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M;*5.CD&2=?AHL?6),.\ .;?".J/0M>XPOT' ]WI.'H>PXW5Q,)"^XC(NFD7
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M?[1R;3#J]D*\_3,CO@_%]W($'"&#2V6>QE5:3C=-+!_"FF*KH)3@BD$VC"Q
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MV3#0M^?1*DE0)40'0:WDF)P,VD@,FXY&G5=P+BTJ D]-&QL!&W7)2;IFII;
M;F*:J:&NI06PP6=DG):89FAH:FZ63-2U[2343,2X:Z"OTJ-!VJ)9M)"=U,I2
MBY+RB9MP@TJ B*3$XE0[+@!02P,$%     @ H#BH5DGZ!/]V"   ]2<  !<
M  !F:'1X+3(P,C,P,S,Q>&5X,S$Q+FAT;>U::V\;MQ+]?G\%J^"F-K!Z2W[(
MC@%%4AH!J>W*,M)^NJ"67"UA[G)+<B6KO[XSY.IARTX4N&E5X^:#HUV2PQG.
MX9E#2N<_]*]ZX]^N!R2VB237M^\_#7ND5*Y6/S=[U6I_W"<?QS]_(JU*K4[&
MFJ9&6*%2*JO5P66)E&)KLTZU.I_/*_-F1>EI=3RJHJE652IE>(595KHXQS?P
MEU-V\9_S'\IETE=AGO#4DE!S:CDCN1'IE'QFW-R1<KGHU5/90HMI;$FCUFB2
MSTK?B1GU[598R2^6=LZK_OF\ZB8YGRBVN#AG8D8$>U<248U%[>,CQH[82:O9
M.J6L=L*/:M%Q6)M$DQ/ZOSHX687N?HRQ"\G?E1*1EF..\W=:C<IQ.[-G<\%L
MW*G7:O\MN:X7YY%*+<RG8;S_Z,UL&;/\WI:I%-.TXT(J^:'+YE!)I3MO:N[?
M&;:4(YH(N>C\.!8)-^22S\E()33],3"0AK+A6D2^HQ%_</ )W'./<^_R,=B1
M(N7+$.H-='IP'XN)L*19K]0?>KP9.-53B-VJK--H@=D-WT-8;*[_(>=[@]%X
M^&'8ZXZ'5Y< UM'-;?=R3,97ST:R+YZ/;C\-;DB]2<OUU@$])-W+/JFW6?%T
M>]D?C,CXXX#<#'JWH^%X")T'O_8^=B]_&I!N;TRN/I#Z:;,5['V@W1O2[5]=
MCP?]S?Q@7"YGS5H#8W&A=D?ONY>#F_+5KY\&ORVC;-1JC5UPB>Y\]Q!;3X8X
M#$B7:4%3\I.RUH0QE7<!";FV(EH0&U/[]DW[Y&RG*!HP8T89 _(K2Q[93N-X
MN=]$RB"1G3*^^8<BK5>60?S]LS]<EOIII8W+,"0QG7&B^4SP.90-&PM#?LFI
M!L3+!1GQ3&E+5$H^*)V0>JW\"U$1/$QCI5,RCKFF&<^M" T9IF$%$G7Z&A+5
MV+M$O:<&T@.)2!;D+E5SR=F4!SY?VF>)*7 A5: !8 8J4D+3!<E3JW,.$8 J
M< (!TD=) D^PXR2): BO-%$)U#"K?+^M#BD/N3%4+[!+0N\XS+MAT\ [!L[
ME-*I"Y@#.X1"@YJ ;BD,!T\8UV0>BS F)L<_Z_%SKGEA! -(A)$@.U#!S(6-
M(4"3\= YB'8S<$TQ"',&PQB9+#:7X;5 L/GO@2 GD4@AR8B7=5(#P!]TAV:]
MT2[2")B$HNB%SZ',&=@$X&QD, #0"62?#/*.D$4H2[G&9 $'\VAJ@#US:CK
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MZU2>P":Z*],( NQ0.:<+4_I^OQO8W L>Y]8=)U>A:CB#E@%PDF:&=Y8?SJ"
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M7M\+EVC.#W>Q]:2+PS+I2DE3,N)05R8AUU9$"V)C:E^_:I^>[V5_ ^;*@).
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M@M*0@&VHX1EN&FP" MSC%S:7R("_7PR"PT-"L*?BP8S*W/$5AI='$<A$,8/
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M";#/#7($> 82-DCR\!]%]7(3\M]S >:[#9>GH;MP./[_J>O'I?JN!)D&LE$
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M$[+"8F_5?9.O7)CK9W5]-W\DG/P#4$L! A0#%     @ H#BH5OL79&+++0$
M3LL, !$              ( !     &9H='@M,C R,S S,S$N:'1M4$L! A0#
M%     @ H#BH5MOVSS0K#   5G8  !$              ( !^BT! &9H='@M
M,C R,S S,S$N>'-D4$L! A0#%     @ H#BH5I<,*J"$%   8<   !4
M         ( !5#H! &9H='@M,C R,S S,S%?8V%L+GAM;%!+ 0(4 Q0    (
M * XJ%;$/3YTARD  $N] 0 5              "  0M/ 0!F:'1X+3(P,C,P
M,S,Q7V1E9BYX;6Q02P$"% ,4    " "@.*A6>0(NSVJ*  #&G 4 %0
M        @ '%> $ 9FAT>"TR,#(S,#,S,5]L86(N>&UL4$L! A0#%     @
MH#BH5EX()!0G3P  ;74# !4              ( !8@," &9H='@M,C R,S S
M,S%?<')E+GAM;%!+ 0(4 Q0    ( * XJ%9)^@3_=@@  /4G   7
M      "  ;Q2 @!F:'1X+3(P,C,P,S,Q>&5X,S$Q+FAT;5!+ 0(4 Q0    (
M * XJ%:O VV=:P@  . G   7              "  6=; @!F:'1X+3(P,C,P
M,S,Q>&5X,S$R+FAT;5!+ 0(4 Q0    ( * XJ%9BD^;[S 0  +(0   7
M          "  0=D @!F:'1X+3(P,C,P,S,Q>&5X,S(Q+FAT;5!+ 0(4 Q0
M   ( * XJ%;,U4S7P@0  *,0   7              "  0AI @!F:'1X+3(P
F,C,P,S,Q>&5X,S(R+FAT;5!+!08     "@ * )X"  #_;0(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
